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Chapter 1. Literature Review
1.1 Introduction
T h e  p r e v a l e n c e  o f  o b e s i t y  a n d  c o n s e q u e n t  c o - m o r b i d i t i e s  s u c h  a s  t y p e  2  d i a b e t e s  
m e l l i t u s  ( T 2 D M ) ,  c o r o n a r y  h e a r t  d i s e a s e  a n d  s t r o k e  a r e  r i s i n g  r a p i d l y  a n d  p r o j e c t e d  t o  
c o n t i n u e  r i s i n g  ( F o r e s i g h t ,  2 0 0 7 ) .
O b e s i t y  a e t i o l o g y  i s  g o v e r n e d  b y  a  c o m p l e x  a n d  m u l t i f a c e t e d  c o m b i n a t i o n  o f  
b i o l o g i c a l  a n d  b e h a v i o u r a l  p r o c e s s e s  i n f l u e n c e d  b y  a  m u l t i t u d e  o f  c u l t u r a l ,  
e n v i r o n m e n t a l  a n d  s o c i a l  d e t e r m i n a n t s .  C e n t r a l  t o  t h i s  i s  t h e  b i o l o g i c a l  s y s t e m  
r e g u l a t i n g  e n e r g y  h o m e o s t a s i s ,  w h i c h  e v o l v e d  t o  e n s u r e  e n e r g y  r e q u i r e m e n t s  a r e  m e t ,  
t h u s  p r o m o t i n g  a  p o s i t i v e  e n e r g y  b a l a n c e  t h e r e b y  p r e d i s p o s i n g  h u m a n s  t o  g a i n  w e i g h t .  
H u m a n s  a r e  l i v i n g  i n  a n  i n c r e a s i n g l y  ‘o b e s o g e n i c ’ e n v i r o n m e n t  w i t h  e a s i l y  a c c e s s e d ,  
e n e r g y  d e n s e  f o o d s  a n d  s e d e n t a r y  l i f e s t y l e s .  T h e s e  ‘o b e s o g e n i c ’ f a c t o r s  c a n  o v e r r i d e  
h o m e o s t a t i c  s y s t e m s  r e s u l t i n g  i n  a  g r a d u a l  i n c r e a s e  i n  t h e  p o p u l a t i o n  b o d y  w e i g h t  
( B W ) ,  a  p h e n o m e n o n  t h a t  h a s  b e e n  c o i n e d  ‘p a s s i v e  o b e s i t y ’ ( F o r e s i g h t ,  2 0 0 7 ) .
T h e  n e e d  f o r  s t r a t e g i e s  t o  p r e v e n t  t h e  r i s e  i n  o b e s i t y  a r e  t h e r e f o r e  b e c o m i n g  
i n c r e a s i n g l y  u r g e n t .  O n e  a p p r o a c h  t h a t  m a y  b e  a d o p t e d  i s  t o  i d e n t i f y  a n d  d e v e l o p  f o o d s  
t h a t  e n h a n c e  s a t i e t y .  T h e  p r o v i s i o n  o f  s a t i e t y - e n h a n c i n g  f o o d s  m a y  r e s u l t  i n  e a r l i e r  
t e r m i n a t i o n  o f  e a t i n g  e p i s o d e s ,  t h e r e b y  c o n t r o l l i n g  m e a l  s i z e ,  t h u s  r e d u c i n g  e n e r g y  
i n t a k e  ( E l )  ( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ,  C u m m i n g s  a n d  O v e r d u i n ,  2 0 0 7 ) .
T h e  f o l l o w i n g  l i t e r a t u r e  r e v i e w  e x p l o r e s  h u m a n  e a t i n g  b e h a v i o u r  a n d  a p p e t i t e  
r e g u l a t i o n .  T h e  e f f e c t s  o f  s h o r t - c h a i n  f a t t y  a c i d s  ( S C F A )  d e l i v e r e d  b o t h  o r a l l y  ( f o r  
e x a m p l e  v i n e g a r )  a n d  c o l o n i c a l l y  ( v i a  f e r m e n t a b l e  n o n  d i g e s t i b l e  c a r b o h y d r a t e s  ( N D C ) )  
o n  a p p e t i t e  a n d  m e t a b o l i c  r e s p o n s e  a r e  r e v i e w e d ,  f o l l o w e d  b y  a  r e v i e w  o f  t h e  i n f l u e n c e  
c e p h a l i c  p h a s e  r e s p o n s e s  a n d  f o o d  p a l a t a b i l i t y  m a y  h a v e  o n  a p p e t i t e  a n d  t h e  m e t a b o l i c  
r e s p o n s e .
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1.2 Human eating behaviour
1.2.1 General overview
E a t i n g  b e h a v i o u r  i s  a  c o m p l e x  p h e n o m e n o n  c h a r a c t e r i s e d  b y  d i s c r e t e  e a t i n g  e p i s o d e s  o f  
m e a l s  a n d  s n a c k s  s e p a r a t e d  b y  i n t e r v a l s  o f  t i m e  ( d e  G r a a f  e t  a l . ,  2 0 0 4 ) .  M e c h a n i s m s  t o  
r e g u l a t e  e a t i n g  p a t t e r n s  a n d  f o o d  c h o i c e s  ( a n d  t h e r e f o r e  n u t r i e n t  i n t a k e )  a r e  o u t c o m e s  
t h a t  a r e  i n f l u e n c e d  b y  a  d i v e r s e  a r r a y  o f  i n t e r a c t i n g  b i o l o g i c a l  a n d  e n v i r o n m e n t a l  i n p u t s  
( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ,  B l u n d e l l  e t  a l . ,  1 9 9 4 ) .  F o o d  i n t a k e  i s  r e g a r d e d  n o t  o n l y  a  
b i o l o g i c a l  p h e n o m e n o n  t o  m e e t  p h y s i o l o g i c a l  n e e d s ,  b u t  a l s o  a  s o c i a l  p h e n o m e n o n  
i n f l u e n c e d  b y  p s y c h o l o g i c a l  a n d  e n v i r o n m e n t a l  s t i m u l i  w i t h  b i o l o g i c a l  c o n s e q u e n c e s  
( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ) .  T h e s e  s t i m u l i  i n c l u d e  c o g n i t i v e  f a c t o r s  s u c h  a s  l e a r n e d  
h a b i t s  ( e . g .  h a b i t u a l  m e a l t i m e s ,  f a m i l i a l '  f o o d s ) ,  h e a l t h  b e l i e f s  a n d  d i e t a r y  r e s t r a i n t  a n d  
a l s o  e n v i r o n m e n t a l  f a c t o r s  s u c h  a s  f o o d  a v a i l a b i l i t y ,  t i m e  o f  d a y ,  t i m e  a v a i l a b i l i t y ,  
s e n s o r y  a n d  n u t r i t i o n a l  p r o p e r t i e s  o f  f o o d ,  s o c i a l  c i r c u m s t a n c e s ,  c u l t u r a l  i n f l u e n c e s ,  
s t r e s s  a n d  b o r e d o m  ( B l u n d e l l  e t  a l . ,  1 9 9 4 ,  G e r s t e i n  e t  a l . ,  2 0 0 4 ,  M a t t e s  e t  a l . ,  2 0 0 5 ,  
B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ) .  I n d e e d ,  p h y s i o l o g i c a l  m e c h a n i s m s  r e g u l a t i n g  h o m e o s t a s i s  
m a y  o f t e n  b e  o v e r r i d d e n  b y  e n v i r o n m e n t a l  a n d  p s y c h o l o g i c a l  f a c t o r s  ( F i g u r e  1 . 1 ) .
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F i g u r e  1 . 1 .  S c h e m e  t o  i l l u s t r a t e  t h e  i n t e r a c t i n g  b i o l o g i c a l  a n d  e n v i r o n m e n t a l  i n f l u e n c e s  
o n  e a t i n g  b e h a v i o u r  p a t t e r n s .  A d a p t e d  f r o m  ( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ) ___________________
2
1.2.2 Appetite regulation and the ‘Satiety Cascade’ concept
A p p e t i t e  h a s  b e e n  d e f i n e d  a s  “ t h e  i n t e r n a l  d r i v i n g  f o r c e  f o r  t h e  s e a r c h ,  c h o i c e  a n d  
i n g e s t i o n  o f  f o o d ”  ( d e  G r a a f  e t  a l . ,  2 0 0 4 ) ,  w h i l e  h u n g e r  d e s c r i b e s  t h e  s e n s a t i o n s  
a s s o c i a t e d  w i t h  t h e  n e e d  f o r  f o o d ,  t h u s  a c t i n g  a s  a  b i o l o g i c a l  d r i v e  t o  s e e k  f o o d  ( M a t t e s  
a n d  F r i e d m a n ,  1 9 9 3 ,  M a t t e s  e t  a l . ,  2 0 0 5 ,  G r e e n  e t  a l . ,  1 9 9 7 ) .
T h e  i n f l u e n c e  o f  f o o d  o r  b e v e r a g e  c o n s u m p t i o n  o n  a p p e t i t e  i s  g e n e r a l l y  c o n s i d e r e d  t o  
o c c u r  i n  t w o  d i s t i n c t  p h a s e s ,  s a t i a t i o n  a n d  s a t i e t y ,  a l s o  r e f e r r e d  t o  a s  i n t r a -  a n d  i n t e r ­
m e a l  s a t i e t y  r e s p e c t i v e l y  ( G r e e n  e t  a l . ,  1 9 9 7 ) .
S a t i a t i o n  ( i n t r a - m e a l  s a t i e t y )  i s  c o n c e r n e d  w i t h  t h e  p r o c e s s e s  t h a t  t a k e  p l a c e  
d u r i n g  i n g e s t i o n  t o  p r o m o t e  t h e  t e r m i n a t i o n  o f  a n  e a t i n g  e p i s o d e  ( C u m m i n g s  a n d  
O v e r d u i n ,  2 0 0 7 ,  B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ,  G r e e n  e t  a l . ,  1 9 9 7 ) .  O n c e  a  m e a l  i s  
i n i t i a t e d ,  h u n g e r  s e n s a t i o n s  d i m i n i s h  a s  t h e  m e a l  i s  c o n s u m e d ,  w h i l e  s e n s a t i o n s  l i n k e d  
w i t h  s a t i a t i o n  t e n d  t o  d e v e l o p  ( M a t t e s  e t  a l . ,  2 0 0 5 ,  G e r s t e i n  e t  a l . ,  2 0 0 4 ) .  S a t i a t i o n  t h u s  
c o n t r o l s  b o t h  m e a l  s i z e  a n d  d u r a t i o n .
S a t i e t y  ( i n t e r - m e a l  s a t i e t y )  r e f e r s  t o  p o s t p r a n d i a l  e v e n t s  f o l l o w i n g  a n  e a t i n g  
e p i s o d e  t h a t  i n h i b i t  h u n g e r  a n d  f u r t h e r  e a t i n g  ( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ,  C u m m i n g s  
a n d  O v e r d u i n ,  2 0 0 7 ) .  S a t i e t y  t h e r e f o r e  r e g u l a t e s  t h e  i n t e r v a l  o f  t i m e  b e t w e e n  m e a l s  a n d  
m e a l  f r e q u e n c y  ( C u m m i n g s  a n d  O v e r d u i n ,  2 0 0 7 ) ,  a n d  m a y  a l s o  r e d u c e  f o o d  q u a n t i t y  
c o n s u m e d  a t  t h e  n e x t  e a t i n g  e p i s o d e  ( G e r s t e i n  e t  a l . ,  2 0 0 4 ) .
T h e  S a t i e t y  C a s c a d e  ( F i g u r e  1 . 2 )  i s  a  m o d e l  p r o p o s e d  b y  B l u n d e l l  a n d  H a l f o r d  t o  
c o n c e p t u a l i s e  t h e  p r o c e s s e s  i n i t i a t e d  p r i o r  t o ,  d u r i n g  a n d  f o l l o w i n g  a n  e a t i n g  e p i s o d e  
r e s u l t i n g  f r o m  i n t e r a c t i o n s  b e t w e e n  f o o d  c h a r a c t e r i s t i c s  ( e . g .  e n e r g y  d e n s i t y  a n d  n u t r i e n t  
c o m p o s i t i o n ,  s e n s o r y  p r o p e r t i e s ,  q u a n t i t y )  a n d  p s y c h o b i o l o g i c a l  r e s p o n s e s  t o  e a t i n g  
( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ) .
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F i g u r e  1 . 2 .  T h e  S a t i e t y  C a s c a d e  C o n c e p t .  T a k e n  f r o m  ( G r e e n  e t  a l . ,  1 9 9 7 )
F o u r  o v e r l a p p i n g  ( o r  c a s c a d i n g )  m e d i a t i n g  p r o c e s s e s  h a v e  b e e n  i d e n t i f i e d  t h a t  o c c u r  
d u r i n g  a n d  f o l l o w i n g  t h e  o n s e t  o f  a  m e a l ,  d i v i d e d  i n t o :  s e n s o r y ,  c o g n i t i v e ,  p o s t -  
i n g e s t i v e / p r e - a b s o r p t i v e  a n d  p o s t - a b s o r p t i v e  m e c h a n i s m s .  T o g e t h e r  t h e s e  c a s c a d i n g  
s t i m u l i  i n f l u e n c e  e v e n t s  w i t h i n  a n d  b e t w e e n  m e a l s ,  u l t i m a t e l y  t o  d e t e r m i n e  s a t i e t y  a n d  
s a t i a t i o n  e f f e c t s ,  t h u s  i n f l u e n c i n g  e a t i n g  b e h a v i o u r .  T h e  i n t e n s i t y  a n d  t i m e - c o u r s e  o f  
c a s c a d e  m e c h a n i s m s ,  p a r t i c u l a r l y  a t  t h e  p o s t - i n g e s t i v e  a n d  p o s t - a b s o r p t i v e  s t a g e  w i l l  b e  
i n f l u e n c e d  b y  f o o d  c h a r a c t e r i s t i c s  ( B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ,  G r e e n  e t  a l . ,  1 9 9 7 ) .  T h i s  
s u p p o r t s  t h e  c o n c e p t  t h a t  f o o d  c h a r a c t e r i s t i c s  i n f l u e n c e  t h e  ‘s a t i e t y  p o w e r ’ , o r  c a p a c i t y  
o f  a  s p e c i f i c  f o o d  t o  s u p p r e s s  h u n g e r  a n d  e n h a n c e  s a t i e t y  t h e r e b y  i n f l u e n c i n g  t h e  
i n t e r m e a l  i n t e r v a l  ( K i s s i l e f f  e t  a l . ,  1 9 8 4 ,  B l u n d e l l  a n d  H a l f o r d ,  1 9 9 4 ) .
1.3 Central and peripheral regulation of appetite
T h e  p h y s i o l o g i c a l  s y s t e m  r e g u l a t i n g  e a t i n g  b e h a v i o u r  a n d  e n e r g y  e x p e n d i t u r e  ( E E ) ,  
t h e r e b y  i n f l u e n c i n g  e n e r g y  h o m e o s t a s i s ,  c o m p r i s e s  a  s y n e r g y  o f  m u l t i p l e  a f f e r e n t  
p e r i p h e r a l  s i g n a l s .  T h e s e  s i g n a l s  i n c l u d e  a  v a r i e t y  o f  g u t - ,  p a n c r e a s -  a n d  a d i p o s e -  
d e r i v e d  h o r m o n e s ,  w h i c h  a r e  c e n t r a l l y  i n t e g r a t e d  i n  t h e  h y p o t h a l a m u s ,  p r i m a r i l y  w i t h i n
4
the arcuate nucleus (ARC) (Arora, 2006, Cummings and Overduin, 2007, Druce and 
Bloom, 2006, Druce et al., 2004, Stanley et al., 2006) (Figure 1.3).
Physiological regulation of appetite therefore needs to be considered at two 
levels: peripheral afferent signals such as gut-derived hormones (section 1.3.1) and 
central processes within the ARC in the hypothalamus and via the brain stem (section 
1.3.2).
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Figure 1.3. Peripheral and central regulation of energy homeostasis. Continuous 
lines represent stimulatory effects and dashed lines represent inhibitory effects. Taken 
from (Murphy and Blooom, 2004).1
'A gR P  (agouti-related peptide), GLP-1 (glucagon-like peptide-1), a-M SH (alpha-melanocyte-stimulating 
hormone), N P Y  (neuropeptide Y ), Oxm (oxyntomodulin), POM C (proopiomelanocortin), PP (pancreatic 
polypeptide), P Y Y  (peptide Y Y ).
1.3.1 Peripheral hormonal signals to regulate appetite
Peripheral signals involved in regulation of food intake and EE include both short term 
gut-derived hormones produced acutely in response to ingested nutrients (section
1.3.1 . 1 ), and markers of long term energy status released in levels proportional to body 
adipose stores from the pancreas (insulin) and adipose tissue (leptin and adiponectin)
5
( s e c t i o n  1 . 3 . 1 . 2 ) .  W h i l e  t h e  f o r m e r  a r e  r e l e a s e d  p h a s i c a l l y  d u r i n g  e a t i n g  e p i s o d e s ,  t h e  
l a t t e r  a r e  t o n i c a l l y  a c t i v e .  T h e  p r o d u c t i o n ,  m e c h a n i s m s  a n d  a c t i o n s  o f  t h e s e  p e r i p h e r a l  
s i g n a l s  h a v e  b e e n  d e s c r i b e d  i n  a  n u m b e r  o f  e x c e l l e n t  a n d  d e t a i l e d  r e v i e w s ,  f o r  e x a m p l e  
( C u m m i n g s  a n d  O v e r d u i n ,  2 0 0 7 ,  D r u c e  a n d  B l o o m ,  2 0 0 6 ,  D r u c e  e t  a l . ,  2 0 0 4 ,  H u d a  e t  
a l . ,  2 0 0 6 ,  K a r r a  a n d  B a t t e r h a m ,  2 0 1 0 ,  M u r p h y  a n d  B l o o o m ,  2 0 0 4 ,  N e a r y  e t  a l . ,  2 0 0 4 ,  
S t a n l e y  e t  a l . ,  2 0 0 6 ,  v a n  d e r  L e l y  e t  a l . ,  2 0 0 4 ,  W o o d s  a n d  D ' A l e s s i o ,  2 0 0 8 ,  W r e n  a n d  
B l o o m ,  2 0 0 7 ,  W y n n e  e t  a l . ,  2 0 0 5 ,  G a r d i n e r  e t  a l . ,  2 0 0 8 ) .
1.3.1.1 Short term peripheral signals of nutrient intake
G u t - d e r i v e d  h o r m o n e s  a r e  r e l e a s e d  a c u t e l y  i n t o  t h e  b l o o d s t r e a m  f r o m  v a r i o u s  p a r t s  o f  
t h e  g a s t r o i n t e s t i n a l  t r a c t  ( G I T )  f o l l o w i n g  a  m e a l  i n  r e s p o n s e  t o  t h e  e n t r y  o f  n u t r i e n t s  
i n t o  t h e  g u t  l u m e n .  T h e s e  h o r m o n e s  a c t  b o t h  l o c a l l y ,  f o r  e x a m p l e  t o  i n f l u e n c e  g a s t r i c  
e m p t y i n g ,  a n d  c e n t r a l l y  ( s e e  s e c t i o n  1 . 3 . 2 ) .
T a b l e  1 . 1  s u m m a r i s e s  t h e  m a i n  g u t  p e p t i d e s  i d e n t i f i e d  t o  d a t e ,  t h e i r  s i t e s  o f  p r o d u c t i o n  
a n d  t h e i r  m a i n  m o d e s  o f  a c t i o n .  A s  s u m m a r i s e d ,  g h r e l i n  i s  o n l y  k n o w n  e n d o g e n o u s  
p e r i p h e r a l  o r e x i g e n i c  h o r m o n e  ( a p p e t i t e  e n h a n c i n g )  a n d  it p o w e r f u l l y  i n c r e a s e s  f o o d  
i n t a k e .  A l l  t h e  o t h e r  k n o w n  g u t - d e r i v e d  p e p t i d e s ,  f o r  e x a m p l e  p e p t i d e  Y Y  ( P Y Y ) ,  
c h o l e c y s t o k i n i n  ( C C K ) ,  g l u c a g o n - l i k e  p e p t i d e  1  ( G L P - 1 ) ,  p a n c r e a t i c  p o l y p e p t i d e  ( P P )  
a n d  o x y n t o m o d u l i n  ( O x m ) ,  a r e  a n o r e x i g e n i c  ( a p p e t i t e  s u p p r e s s i n g )  ( C u m m i n g s  a n d  
O v e r d u i n ,  2 0 0 7 ,  D r u c e  a n d  B l o o m ,  2 0 0 6 ,  D r u c e  e t  a l . ,  2 0 0 4 ,  H u d a  e t  a l . ,  2 0 0 6 ,  K a r r a  
a n d  B a t t e r h a m ,  2 0 1 0 ,  M u r p h y  a n d  B l o o o m ,  2 0 0 4 ,  N e a r y  e t  a l . ,  2 0 0 4 ,  S t a n l e y  e t  a l . ,  
2 0 0 6 ,  v a n  d e r  L e l y  e t  a l . ,  2 0 0 4 ,  W o o d s  a n d  D ' A l e s s i o ,  2 0 0 8 ,  W r e n  a n d  B l o o m ,  2 0 0 7 ,  
W y n n e  e t  a l ,  2 0 0 5 ,  G a r d i n e r  e t  a l . ,  2 0 0 8 ) .
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1.3.1.2 Long term peripheral signals of adiposity
In addition to peripheral signals produced acutely in response to food intake, appetite 
and energy homeostasis is also regulated by longer term signals o f adiposity: insulin, 
leptin and adiponectin. Insulin and leptin are anorexigenic signals that act centrally 
crossing the BBB to enter the hypothalamus by a saturable, receptor mediated 
mechanism, in concentrations proportional to circulating levels. Mechanisms by which 
adiponectin acts are less well understood.
Produced by pancreatic B cells, insulin was the first described adiposity signal 
(Schwartz et al., 1992). Plasma insulin concentrations are largely determined by degree 
o f  insulin sensitivity, which are in turn related to total adipose tissue mass and 
distribution. Circulating plasma insulin concentrations are therefore proportional to 
adiposity levels, particularly visceral (Porte Jr et al., 2002).
Insulin is also rapidly released in a biphasic pattern in response to ingestion. 
Central administration dose-dependently reduces food intake acutely and decreases B W  
chronically in rodents and primates (Ikeda et al., 1986, Woods et al., 1979, Menendez 
and Antrens, 1991). Effects o f peripheral insulin administration are more difficult to 
investigate due to inducing hypoglycaemia during administration, which confounds 
interpretation. When glucose concentrations are controlled, acute peripheral 
administration decreases food intake in rodents and baboons (Nicolaidis and Rowland, 
1976, Woods et al., 1984). In normal and overweight humans, a meta-analysis o f 
appetite studies concluded postprandial insulin but not glucose may be associated with 
short-term appetite regulation (Flint et al., 2007).
Leptin is derived from the ob gene, expressed primarily in white adipose tissue, with 
circulating levels directly proportional to total fat mass (M affe i et al., 1995). As well as
Julia Darzi Thesis
being determined by energy stores, leptin concentrations are also suppressed with 
restricted food intake, and elevated during overeating (Frederich et al., 1995, M affei et 
al., 1995), although unlike insulin, leptin is not acutely influenced by food intake. 
Central and peripheral leptin administration to rodents acutely decreases food intake 
(Ahima et al., 1996), and chronically decreases B W  and fat mass (Halaas et al., 1995). 
Leptin also appears to modulate EE in rodents (Halaas et al., 1995, Pelleymounter et al., 
1995), but not in humans. The classical ob/ob mouse, which has a mutation in the ob 
gene, is leptin deficient, hyperphagic, hyperinsulinaemic, has a low  EE and is very 
obese, all o f which may be normalised with leptin administration (Campfield et al., 
1995, Halaas et al., 1995, Pelleymounter et al., 1995).
A lso secreted from adipose tissue, circulating plasma adiponectin concentrations are 
approximately 1000 times greater than circulating insulin and leptin concentrations 
(Tsao et al., 2002). Although exact functions and mechanisms are unknown, adiponectin 
appears to have a role in energy homeostasis. Circulating concentrations are inversely 
proportional to adipose tissue mass in rodents, primates and humans (Arita et al., 1999, 
Hotta et al., 2001, Hu et al., 1996), and significantly increased fo llow ing food restriction 
in rodents (Berg et al., 2001) and humans (Hotta et al., 2000). Peripheral administration 
attenuates B W  gain by increasing EE, with no effect on actual intake (Fruebis et al., 
2001, Yamauchi et al., 2001).
1.3.2 Central processes in appetite regulation
The hypothalamus is pivotal in appetite regulation and ensuring long-term food intake 
adjusts over time thus stabilising energy levels stored as fat (i.e. promoting energy 
homeostasis), by integrating incoming hormonal and neuronal signals (Morton et al., 
2006, Wynne et al., 2004). The majority o f receptors involved in integrating energy
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homeostasis signals are located within the A R C  o f the hypothalamus. The A R C  is 
located at the base o f the hypothalamus near the median eminence, where there is an 
incomplete blood brain barrier (B BB ) allowing easy access by various circulating 
peptides and hormones (Broadwell and Brightman, 1976). Gut peptides including P Y Y  
and GLP-1, are able to cross the BBB via a nonsaturable mechanism, while others such 
as leptin and insulin are transported via a saturable mechanism (Stanley et al., 2006, 
Wynne et al., 2005).
The A R C  includes two distinct neuronal populations that integrate signals to either 
inhibit or stimulate food intake, secreting PO M C (proopiomelanocortin) or NPY/AgR P 
(neuropeptide Y  and Agouti-related protein) respectively (Cone et al., 2001). W hile 
originating in the ARC , these neuronal populations both project into other areas within 
the hypothalamus and other central areas, often in parallel (W oods and D'Alessio, 
2008).
The group o f neurones that secrete PO M C activate catabolic mechanisms, 
inhibiting food intake, increasing EE and promoting body fat loss. When secreted, 
PO M C is cleaved to form an anorectic peptide a-melanocyte stimulating hormone (a- 
M SH). a-M SH exerts its actions primarily via activation o f melanocortin 3 and 
melanocortin 4 receptors (M C 3R  and M C 4R ) located on neurons in the hypothalamus 
and elsewhere in the brain. Central administration o f a~MSH inhibits food intake and 
reduces BW . Leptin is known to stimulate the neurones directly to release PO M C and 
P Y Y  3-36 is also thought to stimulate PO M C release, with peripheral administration 
increasing PO M C expression (Neary et al., 2004, Woods and D'Alessio, 2008).
The group o f neurones secreting A gR P  and N P Y  activate anabolic mechanisms, 
stimulating food intake and body fat synthesis. As an antagonist o f  M C3R and M C4R, 
A gR P  blockades via actions o f  a-MSH, thus opposing the inhibition o f food intake.
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Central A gR P  administration acutely increases food intake with relatively long-lasting 
effects (up to a week), with chronic administration leading to sustained hyperphagia and 
consequently obesity. N P Y  is one o f the most potent orexigenic ligands and stimulates 
food intake via activation o f Y  receptors. Central administration o f N P Y  acutely 
stimulates feeding although these effects are far shorter-lived than those o f AgRP. 
Chronic central administration leads to sustained hyperphagia and weight gain in 
rodents. Prior to eating episodes N P Y  concentrations increase rapidly and remain 
elevated until eating commences, suggestive o f a role for N P Y  in meal initiation, which 
is interlinked to the finding that ghrelin activates NPY/AgRP neurons. It is also known 
that both leptin and insulin inhibit N PY/AgR P neurons. P Y Y  3-36 is thought to 
additionally inhibit NPY/AgR P release, with central administration directly into the 
A R C  reducing food intake, with this effect being abolished in Y 2  receptor knockout 
mice (Neary et al., 2004, W oods and D'Alessio, 2008).
In addition to direct action in the A R C , satiety signals also act indirectly via afferent 
fibres o f the vagal nerve to the brain stem. Within the brain stem, N TS  neurones such as 
GLP-1 neurones project into the P V N  and lateral hypothalamus, and serotoninergic 
neurones project into the A R C , thus connecting the brain stem to the hypothalamus. In 
addition to GLP-1, C C K  and PP are also known to exert actions via vagal activation. 
Vagal activation appears to regulate short-term feeding, while the hypothalamus is 
involved in longer-term energy homeostasis mechanisms (W oods and D'Alessio, 2008).
1.4 Experimental approaches to assess appetite
Due to the complex and diverse factors that can influence ingestive behaviour, as 
discussed in section 1.3, experimentally it is not straightforward to assess appetite and 
there is no single ideal method to follow . Factors regulating appetite include both
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objective (i.e. unconditioned or physiological) and subjective (i.e. conditioned or 
learned) components. Debates about the most valid, reproducible and robust methods 
are ongoing, controversial and subject to various reviews (Kissileff, 1985, Stubbs et al., 
1998, Stubbs et al., 2000, Booth, 2009b, Booth, 2009a).
1.4.1 What is the most appropriate setting in which to assess appetite? 
The assessment o f appetite in a laboratory setting allows the investigator to control the 
intervention, experimental environment (such as excluding eating cues) and outcome 
measures, and ensures participants fo llow  the specified protocol (Stubbs et al., 1998). 
However this control creates an artificial environment resulting in a lack o f external 
validity in relation to normal eating behaviour (Meiselman, 1996, Stubbs et al., 1998), 
although the internal validity o f  this type o f study is generally good (Stubbs et al., 1998) 
and could be advantageous in assessing the internal drive to eat (de Graaf et al., 2004).
An alternative is to conduct intervention studies in free-living conditions, for 
example by monitoring intake with the use o f  food diaries and/or food frequency 
questionnaires (FFQs) and asking participants to complete subjective appetite 
questionnaires. Free living studies have more external validity than controlled 
laboratory conditions, however it is not possible to unequivocally ascertain desired 
protocol has been adhered to, food diaries are subject to reporting bias (for example 
under-reporting and under-eating (Poslusna et al., 2009)) and other errors such as 
misinterpretation o f portion sizes during food diary analysis. It is also not possible to 
control for external, potentially confounding factors that could affect subjective results 
(for example stress, availability o f food, going out for meals or drinks, etc).
It has been suggested that the best approach is to carry out studies in both 
laboratory controlled and free-living conditions (Stubbs et al., 1998).
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1.4.2 Experimental design of laboratory based appetite studies
The most common experimental approach to investigate the influence o f a treatment 
(e.g. N D C  supplement) on appetite is the “preload-test meal”  paradigm in which 
participants are presented with a standard “preload” that includes the treatment under 
investigation or placebo (PL ). Follow ing this, the motivation to eat is usually 
subjectively assessed (section 1.4.3), then participants are presented with a “ test meal” 
in which E l is measured (section 1.4.4) (Stubbs et al., 1998). This method allows 
assessment o f the effects o f the treatment on subsequent eating behaviour (Kissileff, 
1985), and is best conducted as a within-subjects repeated measures design (Stubbs et 
al., 1998). An important consideration is that preload-delivered treatment effects tend to 
decrease as the time interval between preload and test meal increases (Rolls et al., 
1991). However this depends upon the treatment being investigated. For example the 
influence o f an N D C  supplement may occur later due to the time taken to reach the 
colon for fermentation.
1.4.3 Use of subjective rating scales
Visual Analogue Scales (V A S ) are the most commonly used systems to subjectively 
assess appetite. V A S  comprise a straight line, often 100mm long, with each end 
describing the most extreme positive and negative sensations o f the attribute under 
investigation. For example when asked “How  hungry do you feel?” , the two extremes 
are usually “ not at all hungry”  and “ I have never been more hungry”  (Stubbs et al., 
2000). Participants are asked to mark the point on the line that best represents their 
sensation o f the attribute at that time and a temporal profile o f the attribute is generated 
by repeating the V A S  measurement at various timepoints.
V A S  were initially designed to assess pain and were then developed for use in 
appetite regulation research. A  variety o f questions are usually asked to encompass the
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multidimensional aspects o f  appetite (Mattes et al., 2005), with the original battery o f 
six questions used summarised in Table 1.2 (H ill and Blundell, 1982). Further questions 
have since been added including assessing appetite for specific food groups, for 
example “Would you like to eat something sweet?” (Stubbs et al., 1998).
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Table 1.2. Y A S  questions designed for use in appetite research. W ith the phases
Question Negative Extreme Positive extreme
H ow  hungry do you feel? N ot at all hungry As hungry as I have ever felt
H ow  fu ll do you feel? N ot at all full As fu ll as I  have ever felt
H ow  strong is your desire to eat? V ery  weak Very  strong
H ow  much do you think you could 
eat right now?
Nothing at all A  large amount
Urge to eat N o  urge to eat
Strong, want to eat now, 
waiting is very uncomfortable
V A S  offer a quick, easy to use and easily interpreted method to assess appetite in a 
standardised way allowing comparisons between different studies (Stubbs et al., 2000). 
However the reliability o f  V A S  in appetite research is debated, not least due to 
difficulties in objectively validating their use. Stubbs et al. (2000) suggested V A S  
reliability can be assessed by considering their:
(a ) Ability to predict eating behaviour (e.g. food  intake): Studies have shown 
variable results in the ability o f  V A S  to predict food intake. In free-living conditions, 
significant but small correlations between subjective hunger ratings and subsequent 
self-recorded E l over a 7 d period have been reported (de Castro and Elmore, 1988, 
Mattes, 1990). Mattes found this was true only on week days, not weekend days, and 
within-subjects analysis found no association between hunger ratings and subsequent E l
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in the follow ing hour (Mattes, 1990). However free-living conditions may not be 
relevant to preload-test meal studies, and food diaries are vulnerable to mis-reporting. 
When carried out under controlled conditions, ad libitum  food intake was significantly 
and positively correlated to pre-meal hunger, desire to eat and prospective consumption 
ratings and negatively correlated to fullness ratings in older subjects (65-85 years). 
However in younger subjects (18-35 years) this correlation was only significant for 
fullness and prospective consumption (Parker et al., 2004). Drapeau and colleagues 
found the 1 h A U C  for fullness ratings fo llow ing a standard breakfast were also a good 
predictor o f ad libitum  E l fo llow ing the same standard breakfast provided on a different 
day (Drapeau et al., 2005). Furthermore, mean appetite ratings collected for 4.5 h prior 
to an ad libitum  lunch were more strongly correlated with subsequent E l than were pre­
meal ratings, and were significant for hunger, fullness, prospective food consumption 
and satiety ratings (Flint et al., 2000).
Results have therefore been variable, with stronger correlations seeming to occur 
in controlled rather than free-living conditions. Therefore overall hunger ratings do not 
necessarily appear to predict food intake, while fullness ratings may have a stronger 
relationship with subsequent El.
(b ) Sensitivity to experimental manipulations: There is some evidence V A S  are 
sensitive to experimental manipulations such as changes in diet composition and 
administration o f appetite stimulating and inhibiting drugs (Stubbs et al., 2000). 
However Stubbs et al. (2000) observed V A S  are not necessarily sensitive to relatively 
modest manipulations.
(c ) Reproducibility: Variable results have been found for within-subject test- 
retest-reliability o f V A S  ratings. Similar postprandial temporal profiles have been found
Julia Darzi Thesis
15
follow ing the same standard meal on different days (Flint et al., 2000, Nair et al., 2009). 
However considerable variation is observed, probably from combination o f true 
biological day-to-day variation and methodological variation (Flint et al., 2000, Raben 
et al., 1995), and possibly from conditioned effects o f having previously experienced 
the same meal (Raben et al., 1995). Flint et al. reported relatively low  reproducibility 
for fasting and peak ratings, and better reproducibility for mean 4.5 h ratings, 
particularly prospective consumption (r2 = 0.76 and 0.72 with and without previous 
standard diet) and fullness (r2 = 0.66 and 0.58 with and without previous standard diet) 
(Flint et al., 2000).
Between-subject reliability is more difficult to assess as differences in scores 
may arise from inter-individual differences in interpretation o f the V A S  (Stubbs et al.,
2000). It was found that in order to detect a 5 mm difference in mean 4.5 h fullness 
ratings, 20 participants should be recruited for a crossover study, while 120 participants 
are required per group in a parallel design study (Flint et al., 2000), highlighting the 
weakness o f parallel studies in appetite research.
Thus overall a number o f limitations and weaknesses in the use o f  V A S  to assess 
appetite have been highlighted by the validation studies, reflecting the difficulties in 
conducting research into appetite regulation. This is largely because data generated by 
V A S  is a measure o f the participant’ s interpretation o f their sensations and motivations 
regarding the attribute being investigated rather than an absolute outcome o f an 
underlying physiological response (Stubbs et al., 2000, Stubbs et al., 1998).
These limitations do not mean V A S  are not useful and valid for use in appetite 
research, but rather they should be carefully interpreted in combination with other 
measures o f appetite such as food intake data, within a crossover study design.
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Within the “preload-test meal”  paradigm, quantitative assessment o f preload influence 
on subsequent appetite is made by measuring E l at an ad libitum  test meal. Participants 
are presented a pre-weighed meal in a quantity far exceeding the usual portion size and 
are asked to eat until they feel comfortably full after which the meal is re-weighed to 
determine E l and macronutrient intake (H ill et al., 1995).
Ad libitum  meals are served either as a homogenous single meal or a mixed item buffet. 
The former can only assess effects on E l while a mixed buffet also assesses effects on 
macronutrient selection. However the variable intake o f macronutrients during a mixed 
item buffet may confound results due to differing satiating properties, as protein appears 
to be more satiating than fat and CHO (Gregersen et al., 2008).
Despite being w idely used in appetite studies, the reproducibility o f E l in ad libitum  
meals has not been extensively investigated. Good correlation was found in E l and 
macronutrient intake on two separate occasions when participants were presented a 
mixed 31 item cold buffet meal 4 h fo llow ing a standard preload. The inter- and intra­
subject coefficient o f variations (C V ) for E l were 35.1% and 8.2% respectively, 
demonstrating a high degree o f variability between subjects, again highlighting the 
strength o f a crossover design. The authors concluded the mixed buffet test meal is a 
reproducible method to assess macronutrient preferences (Arvaniti et al., 2000), 
however the sample size was not large (n=14) and participants only attended two 
sessions. Nair and colleagues reported E l o f  a mixed 18 item cold buffet provided on 
three study occasions was highly reproducible within subjects, although macronutrient 
reproducibility was more variable, being good for protein, moderate for fat and low  for 
CHO. The C V  was not reported (Nair et al., 2009).
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Similarly E l o f a homogenous ad libitum  buffet test meal (m ix o f pasta, minced meat, 
vegetable and cream) provided on two occasions 4.5 h follow ing a standard preload was 
significantly correlated between each test day (Gregersen et al., 2008). A  similar intra- 
individual C V  to the Arvanti study o f 8.9% was found, although this study was better 
powered (n=55). The authors concluded 17 participants are required to detect a 500 lcJ 
difference in E l with prior diet standardisation in a crossover study with a power o f  0.8 
(Arvaniti et al., 2000).
Overall, evidence to date indicates an ad libitum  test meal fo llow ing a preload is a 
reproducible method to assess El, with a homogenous meal being easier and less 
laborious to prepare, less expensive and wasteful, and removing the potentially variable 
satiating effects o f a mixed buffet. M ixed buffet may also lack external validity, as 
presenting participants with a wide food choice is not representative o f everyday life  
and may result in over-eating (H ill et al., 1995), as found by Arvanti and colleagues.
Whether E l o f an ad libitum  test meal reflects appetite is controversial. Many factors 
(e.g. hedonic food properties, cognitive factors, environment) influence the relationship 
between appetite and food intake (de Graaf et al., 2004). It is advisable to standardise 
test meal conditions by using the same room, with constant light, and free from 
distractions and to separate subjects to avoid social interaction (K issileff, 1985). De 
Graaf and colleagues conclude that when directly measured under standardised 
conditions, actual food intake may serve as a post-hoc indicator o f appetite (de Graaf et 
al., 2004).
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1.5 Fibre and non-digestible carbohydrates (NDC)
1.5.1 Defining dietary fibre
Dietary fibre (D F ) was originally defined to describe the non-digestible components o f 
plant cell walls (Hipsley, 1953) and was further expanded to “ the skeletal remains o f 
plant cells that are resistant to digestion (hydrolysis) by enzymes o f  man” (Trowell, 
1972). This was amended to “ dietary fibre consists o f the plant polysaccharides and 
lignin which are resistant to hydrolysis by digestive enzymes o f man” (Trowell et al., 
1976) to account for plant cell components other than the cell wall being hydrolysis 
resistant.
Since then, the definition o f DF has been under debate by various committees 
and organisations, with contrasting definitions in use worldwide, some based on 
analytical methods to isolate DF, and others based on chemical or physiological 
properties (Panel on the Definition o f Dietary Fiber et al., 2001).
Efforts are being made to reach consensus on a universal definition to avoid confusion. 
A  joint expert consultation o f W H O  and the FAO  (FAO  o f the U N, 1998) recommended 
carbohydrates (CHO ), including DF, should be classified according to their chemical 
divisions, namely sugars, oligosaccharides, polysaccharides and appropriate subgroups. 
It was considered ‘dietary fibre’ should only describe components with well established 
health benefits, in particular vegetable, fruit and wholegrain cell wall polysaccharides, 
and should not include synthetic, isolated or purified oligosaccharides and 
polysaccharides that do not have well established physiological effects. The Scientific 
Update therefore proposed DF should be defined as “ intrinsic plant cell wall 
polysaccharides”  (Mann et al., 2007), which could include the non-starch 
polysaccharides (NSPs) cellulose, hemicellulose and pectin, and resistant starch (FA O  
o f the UN, 1998). However it was acknowledged that while this definition facilitates
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easy measurement and therefore clear food labelling, it does not easily translate into 
nutritional effects (Mann et ah, 2007).
For this reason, the Codex Committee on Nutrition and Foods for Special Dietary Uses 
(CCNFSDU ), which sets global food standards, revisited the issue and agreed a new 
definition for DF in 2008 to include isolated and synthetic polysaccharides:
“Dietary fib re  means carbohydrate polymers with ten o r more monomeric units, which 
are not hydrolysed by endogenous enzymes in small intestine o f  human beings and 
belong to the fo llow ing categories:
• Edible CH O polymers naturally occurring in food  as consumed
• CH O polymers, which have been obtained from  raw material in food  by 
physical, enzymatic, o r chemical means and which have been shown to have 
physiological effect, o f  benefit to health by generally accepted scientific 
evidence to competent authorities
• Synthetic CH O polymers, which have been shown to have physiological effect 
o f  benefit to health by generally accepted scientific evidence to competent 
authorities” (Cummings et al., 2009, Codex Alimentarius Commission, 2008)
The definition included a footnote that the inclusion o f hydrolysis resistant CHO with 3 
to 9 monomeric units (i.e. oligosaccharides) should be at the discretion o f national 
authorities (Codex Alimentarius Commission, 2008, Harris and Pijls, 2009).
In view  o f the complex definition for DF, reference w ill often be made to Non- 
Digestible Carbohydrates (N D C ) in this thesis, which w ill be used to include any 
hydrolysis resistant CHO, regardless o f  molecular size.
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1.5.2 Defining prebiotics
It is also important to define the term ‘prebiotics’ when considering DF. Prebioties are 
non-digestible compounds that upon reaching the colon are selectively fermented to 
stimulate activity and/or growth o f health-enhancing indigenous colonic microflora, 
such as Bifidobacterium  and other lactic acid-producing bacteria (Kelly, 2008, 
Roberfroid, 2007). Inulin-type fructans are the most widely studied prebiotics, with 
galactooligosaccharides (G O S) also fulfilling the inclusion criteria (Roberfroid, 2007). 
Various other products have also been suggested as prebiotics, but further research is 
required to ascertain i f  they meet the prebiotic inclusion criteria (Kelly , 2008).
1.5.3 Inulin-type fructans
Inulin-type fructans are linear oligo- and polysaccharides with prebiotie properties that 
include mainly |3-(2->l) fructosyl-fructose glycosidic linkages (Roberfroid, 2005a). As 
digestive enzymes are specific for a-glycosidic bonds, inulin-type fructans resist 
enzymatic hydrolysis in the small intestine, and therefore proceed undigested to the 
colon where they are fermented (Kelly, 2008).
Inulin-type fructans are considered long chain with a degree o f  polymerisation 
(D P ) >10, medium chain with a DP o f 5-9 and short chain with D P o f 2-4. They are 
often termed inulin, oligofructose (O F ) or fructooligosaccharides (FOS) respectively, 
although these terms are not consistently used (Kelly , 2008).
Natural food sources include onions, leeks and garlic, with Jerusalem artichokes and 
chicory being rich sources (contain >15 % )  (Franck, 2002). The dietary intake o f inulin- 
type fructans is estimated to be 2 - 12 g per day in the U K  (van Loo et al., 1995).
Commercially, inulin-type fructans are isolated by extraction from chicory root 
or synthesis from smaller molecules (e.g. sucrose) (Kelly, 2008). Commercial inulin-
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type fructan preparations are a non-homogenous mixture with varying DP, and are 
described by the average DP (D Pave) and DP range. This can be further processed to 
change product composition and therefore properties, as summarised in Table 1.3 
(Franck, 2002, Kelly, 2008).
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Table 1.3. Properties of commercial inulin-type fructan preparations extracted 
from chicory. Adapted from (Franck, 2002) ________________ ______________
Standard inulin Inulin HP Oligofructose
D P  range 2 to 60 10 to 60 2 to 7
DPave 12 25 4
Appearance White powder White powder White powder
Taste Neutral Neutral Moderately sweet
W ater solubility (g/1) 120 25 >750
Use in foods Fat replacer Fat replacer Sugar replacer
The DP appears to influence the site o f  fermentation in the colon and side-effects. 
Fermentation o f shorter chain fructans occur more proximally while longer chain 
fructans appear to resist proximal fermentation and are fermented more distally. 
Furthermore FOS and OF tend to be associated with more gastrointestinal side effects 
than standard inulin at the same dose (Kelly , 2008).
1.6 Short-chaim fatty acids
1.6.1 Definition of short-chain fatty acids
Short-chain fatty acids (S C FA ) are organic fatty acids formed in the colon when N D C  
resist digestion and absorption in the small intestine, instead proceeding to the colon to 
undergo bacterial fermentation. SC FA  comprise 1 to 7 carbon (C ) units, with acetate (2 
C units), propionate (3 C units) and butyrate (4 C units) being the predominant anions in 
the colon (Cummings et al., 1987, Topping and Clifton, 2001), accounting for 
approximately 90-95% o f total colonic SCFA (Dass et al., 2007). The abundance o f the
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major colonic SCFA is normally acetate > propionate > butyrate (Cummings et al., 
1987), with daily colonic production estimated to be approximately 100 to 200 mmoles
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(Cook and Sellin, 1998). Figure 1.4 shows the chemical structure o f  the main SCFA.
o 0 0
Acetate Propionate Butyrate
Figure 1.4. Chemical structures of the SC FA  acetate, propionate and butyrate.
1.6.2 The fermentation process in the large intestine
The main routes by which N D C  are fermented are summarised in Figure 1.5.
Figure 1.5. Main routes of C H O  fermentation by colonic microflora in the colon.
Adapted from (Macfarlane and Macfarlane, 2003).________________________________________
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Once they arrive in the colon, NDC-derived polysaccharides, oligosaccharides and 
disaccharides are hydrolysed to monosaccharides. The monosaccharides are 
metabolised within colonic bacteria cells to pyruvate and acetyl CoA , predominantly via 
the Krebs cycle, and to a lesser extent via the pentose phosphate pathway (FAOAVHO, 
1997, Topping and Clifton, 2001). Pyruvate and acetyl C oA  are then further 
metabolised via a range o f intermediate fermentation products to SCFA (particularly 
acetate, butyrate and propionate), and gaseous by-products including hydrogen (Ho) and 
carbon dioxide (C 0 2) and in some individuals methane (CH 4). Heat is also released in 
this exothermic process (Macfarlane and Macfarlane, 2003, Topping and Clifton, 2001).
1.6.3 Fate of SCFA
Figure 1.6 provides an overview o f the fate o f the SCFA once generated in the GIT.
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Figure 1.6. Summary of fates of colonic acetate, propionate and butyrate.
3. Liver
Acetate: -50-70% extracted 
Propionate: -90%  extracted 
Butyrate: majority extracted
4. General Peripheral 
Circulation
Very little butyrate (~4pM) & 
propionate (~5pM) remaining. 
Acetate (-70pM) present in 
higher levels
2. Portal vein
Carries most of the colon derive 
acetate & propionate & any 
butyrate not utilised by coloncyt<
1. Colon
0-95% SCFAs rapidly absorbed. 
Majority of butyrate utilised as 
colonocyte fuel
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SCFA are efficiently absorbed, with only 5-10 % o f generated SCFA  excreted within 
faeces (Cummings et al., 1987, Roberfroid, 2005b). Human intubation studies have 
demonstrated butyrate, propionate and acetate are rapidly absorbed at similar rates along 
various regions o f the large bowel in a concentration-dependent manner (Ruppin et al., 
1980). Large quantities are metabolised by the large intestinal epithelium (Bergman, 
1990), with their oxidation supplying around 60-70% o f colonocyte energy needs 
(Topping and Clifton, 2001, Roediger, 1995). O f the three main SCFA, butyrate is the 
preferred colonocyte fuel (Bergman, 1990, Topping and Clifton, 2001, Roediger, 1995).
The majority o f acetate and propionate produced are absorbed across the colonic 
epithelium, with only relatively small amounts oxidised within colonocytes. Acetate and 
propionate, along with any residual butyrate not oxidised by colonocytes, are 
transported via the portal vein to the liver (Topping and Clifton, 2001), with 
approximately 90% o f propionate and 50-70% o f acetate extracted by the liver during a 
single pass (W ong et al., 2006, Roberfroid, 2005b). The fraction o f  acetate, propionate 
and butyrate not absorbed or utilised by the liver is distributed to the other body organs 
and tissues for metabolism via the general circulation, although very little propionate 
and butyrate is remaining at this point.
Data from sudden death victims demonstrates this progressive reduction in 
SCFA concentrations as they progress from portal to peripheral circulations (Table 1.4).
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Table 1.4. Mean SC F A  concentrations in human blood taken from portal, hepatic 
and peripheral sources. Samples from sudden death victims (n=6) within 4 h o f death 
(Cummings et al., 1987)
Total SCFA* Acetate Propionate Butyrate
Blood Source pmol/1 pmol/1 % total* pmol/1 %  total* pmol/1 % total*
Portal 375 258 69 88 23 29 7
Hepatic 148 115 78 21 14 12 8
Peripheral 79 70 89 5 6 4 5
* Total concentration o f  acetate +  propionate +  butyrate
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1.6.4 Factors influencing SCFA production
The exact molar ratios and quantities o f SC FA  are dependent on a number o f factors 
including the fermentable ND C substrate (Cook and Sellin, 1998, W ong et al., 2006), 
the colonic microflora composition and quantity (Roberfroid, 2005b, W ong et al., 2006) 
and the gut transit time (Cook and Sellin, 1998, W ong et al., 2006, M iller, 2004).
(a ) Fermentable substrate: Studies have demonstrated that the fermentation o f 
different ND C  sources result in distinct SCFA profiles, in terms o f both overall quantity 
and molar ratios o f SCFA  produced (Macfarlane and Macfarlane, 2003). This variability 
may arise from particular substrates favouring the growth o f particular colonic bacteria 
(Nyman, 2002) and the substrate solubility, with more soluble ND C  being more easily 
accessed by hydrolytic enzymes (FAO/W HO, 1997). However some soluble fibres, for 
example alginates and carragheenans, are poorly fermented (FAO/W HO, 1997).
(b ) Colonic M icro flo ra : The human colon is resided by a vast bacterial 
population, estimated to be at least 1010 to 1011 cfu/g wet weight (H ill, 1995) with over 
50 genera and greater than 400 species o f  bacteria having been identified in human 
faeces (Gibson and Roberfroid, 1995, H ill, 1995, Savage, 1986, Topping and Clifton,
2001), although microbial diversity within the human gut is thought to be grossly 
underestimated at present (Blaut et al., 2002). Anaerobes, which include the 
Bacteroides, Bifidobacterium , Eubacterium, Streptococcus and Lactobacillius species, 
are the predominant microflora. O f these, Bacteroides are generally present in the 
greatest numbers, often comprising over 30% o f the colonic microfloral population 
(Gibson and Roberfroid, 1995, Topping and Clifton, 2001). There is marked inter­
individual variation in microbial composition (Hopkins et al., 2002), which w ill impact 
on SC FA  production profiles.
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Fermentation end-products vary with different microbes (Macfarlane and Macfarlane, 
2003). Furthermore even within the same microbe, end-products can vary with the 
amount o f CHO substrate available and the microbe growth rate (Macfarlane and 
Macfarlane, 2003).
(c )  Gut Transit Time (G T T ): The G TT  (time taken for food eaten to travel along 
the G IT  from the mouth to the anus) greatly influences bacterial physiology and 
metabolism, and thus the fermentation process. When G TT  is slower (by ingesting 
senna or cisapride) significantly increased fecal SCFA concentrations are observed, 
while when the G TT  is faster (by ingesting operamide) significantly lower fecal SCFA 
levels are observed. This may be due to the slower transit time allowing greater 
opportunity for substrate fermentation (El Oufir et al., 1996, Lew is and Heaton, 1997).
1.7 SCFA G-protein coupled receptors (GPR)
In 2003 two G-protein coupled receptors, GPR41 and GPR43 (also known as FFA3 and 
FFA2 respectively), were identified as being activated by SCFA  (Brown et al., 2003, Le 
Poul et al., 2003). Interest in GPR41 and GPR43 is increasing and a number o f papers 
regarding these receptors have now been published (X iong et al., 2004, Tazoe et al., 
2009, Tazoe et al., 2008, Samuel et al., 2008, Le Poul et al., 2003, Karaki et al., 2008, 
Karaki et al., 2006, Hong et al., 2005, Dass et al., 2007, Covington et al., 2006, Brown 
et al., 2003), although their physiological relevance is not yet resolved.
GPR43 is equally sensitive to activation by propionate, butyrate and acetate, while 
sensitivity for GPR41 is in the order propionate >  butyrate > acetate (Tazoe et al., 2008, 
Brown et al., 2003, L e  Poul et al., 2003, X iong et al., 2004). Acetate is more selective 
for GPR43 than GPR41 (Tazoe et al., 2008).
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1.7.1 GPR patterns of expression
GPR41 and GPR43 are expressed in a variety o f tissues including adipose and the GIT. 
Initial studies indicate GPR41 is primarily expressed in adipose (Brown et al., 2003, Le 
Poul et al., 2003, Xiong et al., 2004) while GPR43 is more w idely distributed 
throughout many tissues, including immune cells, adipose tissue and the G IT  (Brown et 
al., 2003, Le Poul et al., 2003, Covington et al., 2006).
Both GPR41 and GPR43 are expressed in the human colon (Karaki et al., 2008, 
Tazoe et al., 2009). GPR43 is more abundant and widely distributed than GPR41, with 
cell counts o f 0.33+0.01 and 0.01+0.01 per crypt respectively. Western blot analysis 
suggests both receptors are located only in the mucosa, with neither detected in either 
submucosa or muscle (Karaki et al., 2008, Tazoe et al., 2009). Evidence to date 
indicates both receptors are expressed in enteroendocrine L-cells containing the 
anorexigenic gut peptides P Y Y  and GLP-1. A ll PYY-immunoreactive cells were 
immunoreactive for GPR43, however only low  levels o f GPR41 immunoreactivity were 
found in PYY-immunoreactive cells (Karaki et al., 2008, Tazoe et al., 2009), indicating 
all PYY-expressing cells also express GPR43 but do not necessarily express GPR41. 
Furthermore, double-immunostaining indicates GPR41 and GPR43 are not colocalised 
in the same enteroendocrine cells (Tazoe et al., 2009).
1.7.2 Role of GPR41 and GPR43 in adipose tissue
In vitro  and in vivo evidence from murine models indicates activation o f GPR41 and 
GPR43 by SCFA ligands may mediate leptin expression (Covington et al., 2006, Xiong 
et al., 2004) and inhibit lipolysis (Ge et al., 2008, Hong et al., 2005) respectively.
In vitro, leptin expression was upregulated follow ing treatment o f murine 
adipocytes with SCFA solutions, while oral provision o f propionate to mice in vivo led 
to elevated circulatory leptin concentrations. Propionate was the most potent ligand in
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vitro, and the stimulatory effects o f propionate treatment were abolished in cells 
infected with a virus that targeted GPR41 m RNA, suggesting GPR41 is the relevant 
receptor (X iong et al., 2004). However these findings are not corroborated by Hong and 
colleagues who did not detect GPR41 in adipose tissue (Hong et ah, 2005).
A  role for GPR43 in adipocyte functionality is indicated by an observed up-regulation 
o f GPR43 expression in mice fed a high fat diet (41 % fat) relative to a normal fat diet 
(8.5 % fat) (Hong et al., 2005). In  vitro treatment o f isolated adipocytes with propionate 
significantly elevated GPR43 expression (Hong et al., 2005), with acetate and 
propionate treatment inhibiting lipolysis (Hong et al., 2005, Ge et al., 2008). This 
inhibition was abolished when treating adipocytes isolated from GPR43 K O  mice (Ge et 
al., 2008), suggesting this effect is mediated via GPR43 activation. Oral provision o f 
acetate in vivo to live mice significantly suppressed plasma free fatty acids (FFA ), while 
no suppression was observed fo llow ing similar treatment o f GPR43 K O  mice (Ge et al., 
2008).
Thus SCFA may have a role in energy homeostasis via GPR41 activation to stimulate 
leptin expression, and may suppress N E F A  release via GPR43 activation to inhibit 
lipolysis.
1.7.3 GPR41 and GPR43 and gut peptides
The discovery that GPR41 and GPR43 receptors are co-localised with the anorexigenic 
‘ ileal brake’ gut peptide P Y Y  in enteroendocrine L-cells in the rodent and human colon 
(Karaki et al., 2006, Karaki et al., 2008, Tazoe et al., 2009) indicates luminal colonic 
SCFA  may have a role in appetite regulation. In addition to expressing and releasing 
P Y Y , L-cells also produce the anorexigenic gut peptides GLP-1 and Oxm, although
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studies have not determined i f  these gut peptides are co-localised with GPR41 and 
GPR43 receptors.
When administered in vitro  to a vascularly infused rat colon lumen, solutions o f 
propionate, butyrate, but not acetate stimulate P Y Y  secretion (Plaisancie et al., 1996), 
with no significant release o f GLP-1 (Plaisancie et al., 1995). In vivo, luminal 
administration o f SCFA  solutions in live rats increases subsequent blood P Y Y  
concentrations and reduces upper G I motility, an effect reproduced with a P Y Y  infusion 
(Cherbut et al., 1998). Similarly, in live large white pigs, ileal infusion o f an SCFA 
solution results in a significantly higher postprandial P Y Y  release than infusing with 
saline, with no significant effect on GLP-1 (Cuche and Malbert, 2000) (Figure 1.7).
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Figure 1.7. Postprandial plasma a) P Y Y  and b ) GLP-1 concentrations during ileal 
infusion of SCFA  (— G— ) or saline (— A — ). P Y Y  A U C  was significantly higher with 
SCFA  treatment (p<0.05). GLP-1 was not significantly influenced. Results shown as 
mean with error bars representing the SEM  (n=5). From (Cuche and Malbert, 2000)
A  limited number o f infusion investigations have been carried out in human volunteers, 
although these studies were less conclusive.
Caecal infusion o f a mixed SCFA  solution (54 and 90 mmol/180ml, 70% acetic, 
20% propionic, 10% butyric acid) delivered over 1 h to human volunteers did not 
significantly influence subsequent GLP-1 or P Y Y  concentrations relative to saline, 
although proximal gastric tone was significantly decreased, suggesting an ileal brake 
effect (Ropert et al., 1996). However the study design was flawed with infusions 
delivered in a non-random order, and at different times o f the day, thus confounding
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interpretation o f these data. Saline was infused on the morning o f day 1, 90 mmol SCFA 
solution infused on the afternoon o f day 1, and 54 mmol SCFA solution infused on the 
morning o f day 2.
In a separate 4-way crossover study, acetate solution was administered per 
rectum (60 mmol / 300ml) and intravenously (i.v.) (20 mmol Na acetate / 100ml) and 
compared to per rectum water (300ml) and i.v. saline (100ml). Repeated measures 
A N O V A  analysis found acetate treatment and rectal delivery significantly increased 
plasma GLP-1 (p=0.01 and p<0.01 respectively) and P Y Y  (p<0.0001 for both). A  
significant treatment x time interaction for postprandial P Y Y  (p<0.001) but not GLP-1 
levels was found by two-way repeated measures A N O V A . The authors concluded these 
results indicate colonic fermentation may stimulate gut hormones via distension o f the 
colon and increasing SCFA concentrations (acetate vs. saline) (Freeland and Wolever, 
2010). However per rectum infusions are not replicating events in the colon, therefore 
this data should be interpreted with caution when considering fermentable ND C effects.
Overall from these studies, luminal SC FA  appear to activate P Y Y  (Cherbut et al., 1998, 
Cuche and Malbert, 2000, Freeland and W olever, 2010, Plaisancie et al., 1995, 
Plaisancie et al., 1996) and possibly GLP-1 (Freeland and W olever, 2010) release, 
implicating SCFA may have a role in regulating appetite. As sensitivity to stimulation 
in vitro is in the order propionate >  butyrate »  acetate for P Y Y  secretion (Plaisancie et 
al., 1996) GPR41 is implicated as the responsible receptor for modulating these effects.
1.7.4 SCFA in the GIT and intestinal motility
Both in vitro and in vivo evidence indicates luminal SCFA influence intestinal motility 
via interactions with the lumen mucosa, suggesting a possible role for SCFA  in eliciting 
the ileal brake effect.
Julia Darzi Thesis
31
In animal models propionate and butyrate dose-dependently elicit phasic and tonic 
contractions when applied in vitro to the lumen colon muscle strips isolated from rats, 
while no contractions are observed with acetate (Mitsui et al., 2005, Yajima, 1988). 
These contractions are accompanied by an increase in electrical current (indicating 
colonic electrical activity) when the submucosal nerve is intact (Yajima, 1988).
Propionate-induced effects are attenuated by Ach and 5-HT4 receptor 
antagonists and cyclooxygenase (C O X ) inhibitor, implicating cholinergic motor 
neurones, 5-HT4 receptors and C O X  products (e.g prostglandins) as eliciting these 
effects (Mitsui et al., 2005). Tazoe and colleagues hypothesise GPR41 rather than 
GPR43 are responsible for mediating these effects as the sensitivity o f  responses appear 
to occur in the order propionate >  butyrate »  acetate (Tazoe et al., 2009).
Luminal administration o f SCFA  solutions in vivo to the proximal colon in 
conscious rats significantly accelerated colonic transit. This effect disappeared with 
prior vagotomy or pre-treatment with a 5-HT3 antagonist, indicating 5-HT3 receptors 
and sensory neurons in the colonic mucosa mediated these effects (Fukumoto et al.,
2003). Ileal infusion o f an SCFA  solution into conscious large white pigs decreased the 
amplitude but increased the frequency o f distal and terminal contractions compared to a 
infusion o f saline (Cuche and Malbert, 2000).
SCFA solutions have also been reported to alter G IT  motility in human volunteers. Ileal 
infusion o f an SCFA  solution (66% acetate, 24% propionate, 10% butyrate) over 1 h 
significantly increased the number o f  motor events follow ing infusion than when air or 
saline were administered (Kamath et al., 1988). In a separate study, proximal gastric 
tone was significantly decreased by ileal SCFA  administration (Ropert et al., 1996).
However, infusion o f an SC FA  solution (67.5% acetate, 17.2% propionate, 9.2% 
butyrate, 1.9% isobutyrate, 3% isovalerate, 1.2% valerate) into the duodenum o f
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intubated volunteers (n=8) over 12 h, did not differ significantly alter the motility index 
as compared to saline. The authors concluded SCFA do not alter jejunal motility in 
contrast to previous work (Masliah et al., 1992).
Overall from these studies, it appears that luminal SCFA influence gastrointestinal 
motility in the ileum and colon, and may therefore have a role in the ileal brake effect. 
This may be via interaction with either GPR41 and/or GPR43 and secretion o f P Y Y . 
Although GPR43 is present in higher levels in the G IT  than GPR41, GPR41 is 
implicated as being the responsible receptor for modulating these effects as sensitivity 
to stimulation in vitro is in the order propionate >  butyrate »  acetate (Mitsui et al., 
2005, Tazoe et al., 2009, Yajima, 1985, Yajima, 1988).
1.8 SCFA and appetite
As outlined in section 1.7.3, the SCFA-activated receptor GPR43 is co-localised 
luminally in enteroendocrine L-cells alongside the anorexigenic gut hormone P Y Y , 
which is suggestive o f  a role for SCFA  in appetite regulation. The effect o f SCFA on 
appetite have been investigated both via oral provision o f SCFA (see section 1.8.1) and 
by colonic delivery o f SCFA  via fermentable ND C  such as inulin-type fructans (see 
section 1.8.2) as discussed below.
1.8.1 Oral provision of SCFA and appetite
A  limited number o f studies investigating the effect o f orally ingested SCFA, in 
particular acetate (delivered as vinegar) (H lebowicz et al., 2008, Mettler et al., 2009, 
Ostman et al., 2005) and propionate (delivered as sodium (Na) propionate) (Frost et al., 
2003, Liljeberg and Bjorclc, 1996, Liljeberg et al., 1995) on subsequent satiety have 
been published, as summarised in Table 1.5.
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First considering propionate and effects on appetite, two studies from the same group 
examined the acute effects o f a bread baked with added Na propionate when consumed 
as part o f a mixed meal for breakfast. These studies report Na propionate significantly 
increases rated satiety, particularly when a high dose o f propionate is used (Liljeberg 
and Bjorck, 1996, Liljeberg et al., 1995). The actual dose was not reported by the 
authors, but is calculated as 15 and 45 mmol for low  and high dose breads respectively.
However, conclusions regarding effects on satiety were solely based on 
subjective data generated from a single bipolar rating scale, and no quantitative 
assessment o f appetite was made. The rating scale used fairly confusing language, with 
one extreme representing extreme hunger (score -10) and the other extreme representing 
extreme satiety (score +10). Although satiety and hunger could be considered to lie at 
polar opposite ends o f appetitive sensation scales, satiety is not simply the absence o f 
hunger (Mattes et al., 2005) and it is therefore confusing and inappropriate to have them 
on the same rating scale.
Furthermore in both studies, the statistical tests used were inappropriate for the 
data. W ilcoxon signed ranks test was used for comparisons at each timepoint (rather 
than repeated measures A N O V A  for comparisons over time) and to compare the A U C  
(rather than repeated measures A N O V A  or Friedman’ s A N O V A  to compare >2 
groups). It is therefore difficult to comment on the validity o f these conclusions.
By contrast, when mixed into a pasta meal consumed at breakfast, Na propionate (3g, 
~ 31 mmol) combined with polyunsaturated fat (PU FA, provided as 30 g sunflower oil) 
did not significantly alter subjective appetite ratings, or E l o f an ad libitum  test meal 
served 4 h postprandially (Frost et al., 2003). There was however a significantly 
increased GLP-1 IA U C  and significantly delayed gastric emptying with Na propionate 
treatment. A  significant increase in nausea was also observed. However as PU FA  was
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delivered alongside the propionate, it is not possible to determine i f  the observed effects 
are attributed to the added PU FA, propionate, or both and i f  the higher energy content 
o f the PUFA/propionate test meals had an effect.
Looldng now at effects o f  acetic acid, a dose-response increase in satiety ratings were 
reported follow ing the provision o f  bread soaked with 0 g (PL ), 18 g, 23 g and 28 g 
vinegar (equivalent to 0, 18, 23 and 28 mmol acetic acid) for breakfast (Table 1.6), with 
a significantly higher A U C  follow ing the 28 g dose relative to P L  (Ostman et al., 2005).
Tab le 1.6. Satiety score A U C  (0-120 minutes) following test breakfast o f white bread 
(containing 50 g CH O ) soaked in vinegar. Taken from (Ostman et al., 2005).
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Amount of 
vinegar (g)
N Satiety Score A U C
Mean SEM
0 10 210a 45
18 10 363ab 38
23 11 435ab 75
28 11 512b 105
ab Mean values marked with different letters significantly different (Wilcoxon signed-ranks test).
By contrast, a crossover study by the same group investigated the effects o f vinegar 
(28g =  28 mmol acetic acid) and form o f grain (i.e. refined, milled or wholegrain). The 
postprandial satiety score A U C  was significantly higher follow ing wholegrain + vinegar 
relative to the other 3 treatments, with none o f the other treatments altering satiety 
(H lebowicz et al., 2008). As wholegrain bread without added vinegar was not 
investigated it is not possible to conclude i f  the increased satiety arose from the 
wholegrain structure o f the bread alone or it was an additive effect o f  the grain structure 
with the vinegar. As satiety scores did not differ between white bread with and without 
vinegar, vinegar did not appear to influence appetite in this study.
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Both these previous studies (H lebowicz et al., 2008, Ostman et al., 2005) again used the 
single rating bipolar scale to assess appetite used by the same group to investigate Na 
propionate effects (L iljeberg and Bjorck, 1996, Liljeberg et al., 1995).
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A  2 x 2 crossover study by a different group investigating the additive effects o f acetic 
acid (28 mmol) and cinnamon mixed into a glucose drink and milk rice pudding found 
the satiety IA U C  did not significantly differ between treatments, although a main effect 
o f acetic acid approaching significance (p=0.064) was found (Mettler et al., 2009). 
Satiety was assessed with a single fixed point scale, rather than a variety o f VA S , 
although the exact wording used on the questionnaire was not reported.
The effects o f long-term supplementation with vinegar on anthropometric measures was 
reported in a recently published parallel study (Kondo et al., 2009) (Table 1.7).
Table 1.7. Mean [SD ] anthropometric and metabolic variables follow ing daily 
consumption o f a drink containing 0, 15 or 30ml apple cider vinegar (PL, Low , High 
respectively) for 12 wk. Taken from (Kondo et al., 2009).1,2 _____
Jawnwn-MTH—r—n— jgagaBeaaaaaKBB ■ — — i n ■nm..................................       i n inn  —  mg i—■■mm ■ nm arm ■ t ■ ■ iawaaaaM— — a w — n— I   1 i
P L
W eek 0 
Low High P L
W eek 12 
Low High
BW  (kg) 74.2 [11.0] 74.9 [10.1] 73.1 [8.6] #a 74.6 [11.3] #b 73.7 [10.3] #c 71.2 [8.3]
B M I
(kgm‘2)
26.9 [1.6] 27.2 [1.8] 27.0 [1.7] #a 27.1 [1.8] #b 26.8 [2.0] #c 26.3 [1.6]
% body fat
(% )
29.9 [6.8] 30.3 [7.2] 30.2 [7.6] * 29.9 [6.9] #b 29.6 [7.1] ,fb 29.3 [7.5]
Waist circ 
(cm)
90.2 [6.8] 90.8 [6.4] 90.5 [6.5] a 90.4 [6.9] #b 89.4 [6.5] #h 88.6 [6.3]
TAGs
(mmol/1)
1.71 [0.50] 1.70 [0.60] 1.78 [0.55] “ 1.68 [0.67] #b 1.39 [0.58] * b 1.31 [0.54]
Total chol 
(mmol/1)
5.53 [0.82] 5.31 [0.82] 5.70 [0.83] a 5.45 [0.87] #b 4.99 [0.82] f,ab 5.37 [0.83]
LD L-C
(mmol/1)
3.39 [0.83] 3.12 [0.73] 3.48 [0.74] 3.44 [0.73] 3.00 [0.76] 3.37 [0.77]
HDL-C 1.36 [0.24] 1.35 [0.32] 1.41 [0.34] 1.38 [0.26] 1.38 [0.34] 1.41 [0.33]
Values marked with different letters significantly different (by A N C O VA with post-hoc Bonferroni). 
2 Mean values at week 12 marked # are significantly different from the value at baseline (week 0).
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Healthy obese volunteers were randomised to P L  (n=58, 50 completed), low  dose 
(n=59, 54 completed), or high dose (n=58, 51 completed) treatment, consuming a 
beverage containing 0, 15 or 30 ml apple cider vinegar respectively (equivalent to 0, 
12.5 and 25 mmol acetic acid) daily for 12 wk. A t the end o f the intervention, those in 
both the low and high dose treatment groups had a significantly lower BW , BM I, % 
body fat, waist and hip circumference, waist to hip ratio, visceral fat area (V F A ), 
subcutaneous fat area (S F A ) and T A G  concentrations relative to P L  (Table 1.7 shows 
selected data). Additionally total fat area and systolic blood pressure were significantly 
lower in the high dose group relative to PL.
From the above studies, there is some evidence that SCFA may acutely effect appetite. 
However there were a number o f  methodological weaknesses, particularly in terms o f 
limitations in the methods to investigate appetite, and the use o f inappropriate statistical 
analyses. Studies to date have not measured quantitative effects, effects on gut peptides 
or subjective effects using validated V A S , except in one study (Frost et al., 2003), 
however PU FA  was delivered alongside the propionate in that study. The potentially 
confounding effects o f palatability on appetite have also been over-looked. It is 
therefore difficult to draw firm conclusions regarding the effect o f  oral SCFA  on 
subsequent appetite and satiety, although these findings warrant further investigation.
1.8.2 Colonic SCFA via NDC and appetite
There is growing evidence to indicate DF and other ND C may have a role in B W  
regulation, with a number o f studies suggesting intake o f DF and/or wholegrains are 
inversely associated with B W  and/or B M I (Burton-Freeman, 2000, Delzenne and Cani, 
2005, Howarth et al., 2001, Koh-Banerjee et al., 2004, Koh-Baneijee and Rimm, 2003, 
Melanson et al., 2006, Pereira and Ludwig, 2001, Slavin, 2005, Harland and Garton,
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2008, Good et al., 2008, McICeown et al., 2009, Rose et al., 2007, Lutsey et al., 2007). 
DF and other ND C may therefore potentially have a role in the prevention and treatment 
o f obesity.
Furthermore various studies have demonstrated DF may enhance satiety and 
reduce appetite, thus helping to control subsequent food intake (Berti et al., 2005, 
Burton-Freeman, 2000, Delzenne and Cani, 2005, Howarth et al., 2001, Pereira and 
Ludwig, 2001, Slavin, 2005). However the mechanisms by which this may occur are not 
fully understood. It is possible that SCFA generated during colonic fermentation may 
mediate effects on appetite via interaction with the SCFA activated receptors GPR41 
and GPR43 in colonic enteroendocrine L-cells, and GPR41 in adipocytes to modulate 
P Y Y  and leptin production respectively (see sections 1.7.2 and 1.7.3).
Focusing on the fermentable N D C  inulin-type fructans, which as well as being 
classified as a DF are also prebiotics (see section 1.5.2), initial rodent model studies 
gave evidence that inulin-type fructans may enhance satiety (Cani et al., 2006b, Cani et 
al., 2004, Cani et al., 2007, Daubioul et al., 2002, Kok et al., 1998, Cani et al., 2005). 
Chronic OF supplementation in rodents significantly decreases E l (Cani et al., 2004, 
Cani et al., 2005, Cani et al., 2007), suppresses B W  gain (Cani et al., 2005, Cani et al., 
2006b, Cani et al., 2007) (although not in all cases (Kok et al., 1998, Cani et al., 2004)) 
and suppresses fat mass gain (Cani et al., 2004, Cani et al., 2005, Cani et al., 2006b, 
Cani et al., 2007), increases proximal colon GLP-1 (7-36) amide (K ok  et al., 1998, Cani 
et al., 2004, Cani et al., 2005, Cani et al., 2006b, Cani et al., 2007), increases portal 
plasma GLP-1 (7-36) (Cani et al., 2004, Cani et al., 2005, Cani et al., 2007) and G IP 
(Kok et al., 1998) concentrations, reduces plasma ghrelin concentrations (Cani et al.,
2004) and increases the caecum mass (K ok  et al., 1998, Cani et al., 2004, Cani et al., 
2007). Most studies examined OF (low  DP inulin-type fructan), with few  investigating
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higher DP inulin-type fructans (e.g. inulin HP). Supplementing rats diets with Synergy 1 
(mixture o f low  and high DP inulin-type fructans) resulted in significantly suppressed 
B W  gain (Daubioul et al., 2002) and fat mass gain (Cani et al., 2004), reduced E l 
(Daubioul et al., 2002, Cani et al., 2004), reduced proximal colon GLP-1 (7-36) 
concentrations (Cani et al., 2004) and reduced caecum mass (Cani et al., 2004). 
Furthermore, supplementation with inulin HP (high DP inulin-type fructan) 
significantly suppressed B W  gain and increased caecum mass, but did not influence 
proximal colon GLP-1 (7-36) concentrations or fat mass gain (Cani et al., 2004).
Follow ing on from this promising data from animal models, a few  human studies have 
investigated acute (summarised in Table 1.8) and more have investigated chronic 
(summarised in Table 1.9) effects o f supplementing with inulin or OF on appetite and/or 
anthropometries. The results from these are variable and difficult to draw firm 
conclusions from, partly due to study limitations.
As summarised in Table 1.8, acute supplementation with Raftilose P95 (a low  DP OF) 
found no significant influence o f OF on satiety ratings nor ad libitum  food intake 
(Peters et al., 2009). The satiety ratings were completed in a free-living setting rather 
than under controlled conditions. It is therefore possible that participants may not have 
complied with the protocol, for example eating extra foods, and external conditions 
could have varied in between treatments potentially confounding the results.
Furthermore acute supplementation with inulin HP (high DP inulin-type fructan) 
significantly reduced 24 h E l relative to PL, although satiety ratings were not 
significantly altered (Archer et al., 2004), and the investigators did not assess effects on 
ad libitum  intake in a controlled setting.
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Similarly consumption o f a yogurt containing inulin (inulin used not specified) 
significantly decreased subsequent ad libitum  E l in a controlled setting relative to “ no 
preload”  (PL ), although the overall E l including the preload and the ad libitum  intake 
was more than the “ no preload” condition (Perrigue et al., 2009). Fullness ratings were 
significantly increased by yogurt containing inulin relative to yogurt with no added 
inulin (Perrigue et al., 2009), although it was unclear from the paper i f  hunger and the 
desire to eat had been significantly altered by inulin.
A  greater number o f chronic supplementation studies using OF (e.g. Raftilose P95) or 
mixed DP inulin-type fructans (e.g. Synergy-1) have been published investigating 
effects on appetite (summarised in Table 1.9), again with variable results and study 
limitations. There are no published studies investigating high DP inulin (e.g. inulin HP).
Looking first at chronic effects o f  OF on subjective and quantitative appetite measures. 
In a 2-way crossover study, daily supplementation with 16 g Raftilose P95 for 2 wk was 
found to significantly increase satiety ratings after breakfast and dinner, and reduce 
hunger and prospective consumption ratings follow ing dinner compared to PL. Ad  
libitum  E l was significantly reduced at breakfast and lunch but not dinner, and mean 
daily E l was significantly lower during the OF supplementation period (Cani et al., 
2006a). However as the preload test meals were provided ad libitum  rather than being a 
fixed, standardised preload, data generated postprandially is meaningless. It further 
appears from the paper that conditions were not controlled as participants were free to 
leave and eat (provided they noted it down) in between each ad libitum  meal (at 
breakfast, lunch and dinner).
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By contrast, Parnell and Reimer found satiety ratings and E l were not significantly 
altered by daily supplementation for 12 wk with 21 g OF (Raftilose P95) relative to P L  
(Parnell and Reimer, 2009), contradicting the results from Cani and colleagues (2006). 
However this parallel study, while having a fairly high sample size (n=48), was not 
sufficiently powered to assess subjective appetite effects being far lower than the 120 
participants per group suggested by Flint and colleagues (2000).
Finally, a recent parallel study conducted by a Hungarian group reported 
supplementation with 14 g Jerusalem Artichoke concentrate (containing OF) daily for 
12 wk reduced rated hunger and significantly reduced B M I and %  body fat levels (Antal 
et al., 2008). However the paper was difficult to critically review as it was in Hungarian, 
it was unclear i f  effects on hunger were significant.
Looking now at effects o f mixed inulin-type fructans on subjective and quantitative 
appetite measures, Whelan and colleagues found supplementation for 2 wk significantly 
increased daily mean and minimum fullness and minimum satiety ratings in a crossover 
study (Whelan et al., 2006). However it was not clear from the paper i f  appetite V A S  
were completed in controlled or free-living conditions and as pea fibre was also 
included in the active treatment, observed results may not have been solely due to the 
inulin-type fructans.
In a separate parallel study Cani found supplementation with Synergy-1 did not 
influence postprandial subjective appetite ratings follow ing a meal tolerance test preload 
(Cani et al., 2009). However this study was flawed in design. It was vastly 
underpowered (only 5 participants per treatment) and the meal tolerance test preload 
was ad libitum  rather than fixed which confounds interpretation o f postprandial data.
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Studies have also found contradictory evidence regarding effects on gut peptides. 
Raftilose P95 supplementation for 7 d significantly increased postprandial plasma GLP- 
1 A U C  with no effect on P Y Y  or C C K  in GERD patients (Piche et al., 2003), while in 
healthy volunteers supplementation for 2 wk significantly increased the P Y Y  A U C  with 
no influence on GLP-1 (Parnell and Reimer, 2009).
Supplementation with Orafti Synergy 1 was also found to increase the 
postprandial GLP-1 and P Y Y  response (Cani et al., 2009) however as noted above this 
study had a number o f design flaws. The study was underpowered, and postprandial 
measures were made fo llow ing an ad libitum  rather than fixed meal tolerance test 
preload. Furthermore significant results for plasma data were only found when reported 
relative to baseline, and capillary rather than venous plasma was collected, the use o f 
which has not been validated for gut peptide analysis (although authors did note this and 
values were reported to be comparable to venous values).
Less compelling is anthropometric and food intake data from chronic intervention 
studies, although these were not the main outcomes o f interest for all studies except two 
(Antal et al., 2008, Parnell and Reimer, 2009), so these studies were not designed 
specifically to explore these outcomes. None o f the studies except two (Antal et ah, 
2008, Parnell and Reimer, 2009) found a significant influence o f  inulin-type fructan 
supplementation on B W  post intervention (A lles et al., 1999, Antal et al., 2008, 
Davidson et al., 1998, Forcheron and Beylot, 2007, Giacco et al., 2004, Jackson et al., 
1999, Luo et al., 1996, Luo et al., 2000) or on food intake during the intervention (A lles 
et al., 1999, Giacco et al., 2004, Pedersen et al., 1997, Forcheron and Beylot, 2007). The 
study by Antal and colleagues reported daily supplementation with 14 g Jerusalem 
Artichoke concentrate (containing OF) for 12 wk significantly reduced B M I and % 
body fat levels (Antal et al., 2008).
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Therefore overall, while a number o f  studies have investigated the influence o f 
supplementation with inulin-type fructans on markers o f appetite in humans, the results 
to date are contradictory making it difficult to draw firm conclusions. This is in part due 
to variable dosages and differing choices o f  inulin-type fructan supplements and various 
confounding factors introduced by flawed study designs. Furthermore few  studies have 
investigated the high DP inulin-type fructans specifically.
1.9 SCFA and metabolic response
The idea SCFA may have a role in influencing metabolic mechanisms is strengthened 
by the discovery o f the SCFA  activated receptors GPR41 and GPR43, possibly 
influencing lipolysis and leptin release and ileal brake mechanisms (summarised in 
section 1.7). Effects o f SC FA  on the metabolic response and associated mechanisms 
have been investigated both via oral provision o f SCFA (see section 1.9.1) and colonic 
delivery o f SCFA via fermentable N D C  such as inulin-type fructans (see section 1.9.2) 
as discussed below.
1.9.1 Oral SCFA and metabolic response
There is increasing evidence to indicate that in addition to possibly influencing appetite, 
oral SCFA ingestion may blunt glycaemic and insulinaemic responses.
Early evidence for this was the finding that intragastric co-administration o f a starch and 
acetic acid solution to rats (n=6) significantly blunted the glycaemic response relative to 
no acetic acid (Ebihara and Nalcajima, 1988). Furthermore, consumption o f a sucrose 
drink containing 60 ml strawberry vinegar, by human volunteers (n=7) lowered the 
postprandial insulin A U C  by 20 %  relative to P L  (no added vinegar), although no 
differences in the glycaemic response were found (Ebihara and Nakajima, 1988).
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Since then, a number o f studies investigating the acute effects o f  oral SCFA 
supplementation have been conducted, primarily with acetate (supplied as vinegar) and 
propionate and also lactate. Most studies investigated effects on postprandial glycaemia 
and insulinaemia, but some considered other metabolic parameters.
Table 1.10 summarises findings from these studies. Evidence to date appears to support 
the idea that oral supplementation with acetate (given as vinegar) and propionate acutely 
influences postprandial insulin responses in healthy volunteers (Torsdottir et al., 1992, 
Liljeberg and Bjorck, 1996, Liljeberg et al., 1995, Darwiche et al., 2001, Frost et al., 
2003, Johnston et al., 2004, Ostman et al., 2005, Johnston and Buller, 2005, Ebihara and 
Nakajima, 1988).
The picture for the glycaemic response is less clear with some studies suggesting oral 
SCFA blunt the glycaemic response (Liljeberg and Bjorck, 1998, Torsdottir et al., 1992, 
Brighenti et al., 1995, Liljeberg and Bjorck, 1996, Sugiyama et al., 2003, Ostman et al., 
2005), while others did not find a significant effect in healthy volunteers (Ebihara and 
Nakajima, 1988, Darwiche et al., 2001, Johnston et al., 2004, Leeman et ah, 2005, 
H lebowicz et al., 2008) or were inconclusive (Liljeberg et al., 1995, Frost et al., 2003).
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Looking in more detail at a study investigating propionate, Liljeberg and Bjorck found 
that providing volunteers (11= 12) with a mixed breakfast made using bread with added 
Na propionate significantly reduced the postprandial glucose and insulin A U C  relative 
to bread matched for CHO levels (50g) with added lactic acid or with no additive (PL ) 
(Liljeberg and Bjorck, 1996) (Figure 1.8). However, the A U C  were compared by 
W ilcoxon signed ranks analysis, which is an inappropriate test for >2 treatments.
A) Blood glucose B) Serum insulin
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Figure 1.8. Incremental A ) blood glucose and B ) serum insulin response following 
breakfast made with P L  wholemeal bread ( V  W M B ) or W M B  with added Na  
propionate (O  W M B -p ) or lactic acid ( □  W M B-la ). Points with different letters 
differ significantly as assessed by W ilcoxon signed ranks test. Values shown as mean 
with error bars representing the SEM (n=12). Taken from (Liljeberg and Bjorck, 1996).
When investigating the acute effects o f vinegar supplementation Ostman and colleagues 
found a dose-dependent drop in postprandial glycaemia and insulinaemia follow ing 
provision o f bread soaked in 0 g (PL ), 18 g, 23 g and 28 g vinegar (equivalent to 0, 18, 
23 and 28 mmol acetic acid) for breakfast (n=12). The highest dose (28 mmol acetic 
acid) resulted in the lowest responses (Ostman et al., 2005).
SCFA may also improve long-term glycaemic control and other metabolic markers. 
Table 1.11 summarises published chronic oral supplementation studies, most o f which 
investigated fasting parameters, with only a few  considering postprandial effects.
52
Ta
bl
e 
1.
11
. 
Su
m
m
ar
y 
of 
st
ud
ie
s 
in
ve
st
ig
at
in
g 
th
e 
in
flu
en
ce
 
of 
sh
or
t 
& 
lo
ng
 
ter
m 
or
al
 
su
pp
le
m
en
ta
tio
n 
wi
th
 
ac
et
at
e 
or 
pr
op
io
na
te
 
on 
m
et
ab
ol
ic
 
m
ar
ke
rs
. 
An
y 
va
lu
es
 
qu
ot
ed
 
are
 
th
e 
m
ea
n 
va
lu
es
 
__
__
__
__
__
__
__
__
__
__
__
__
__
__
__
__
__
_
Daily supplementation with acetate (provided as vinegar) for 12 wk was reported to 
significantly reduce H b A lC  concentrations in T2D M  patients (Johnston et al., 2009) but 
not in obese volunteers (Kondo et al., 2009) relative to PL. However the H b A lC  
concentrations were already low  in the obese volunteers, with a mean baseline H b A lC  
o f 5.29 [SD 0.45] to 5.34 [SD 0.46] %, relative to the clinical target for diabetic patients 
o f  <6.5% or <7.0% (Goodall et al., 2007, The Diabetes Control and Complications Trial 
Research Group, 1993, Landgraf, 2004). H b A lC  is a marker o f  medium-term glycaemic 
concentrations, used to monitor patients with diabetes, with H b A lC  concentrations 
increasing with increasing plasma glucose concentrations.
Daily vinegar supplementation for 12 wk also significantly reduced fasting T A G  
and TC  concentrations in obese (Kondo et al., 2009) but not in T2D M  volunteers 
(Johnston et al., 2009), reduced SBP in obese volunteers (Kondo et al., 2009) and 
reduced fasting plasma glucose in T2D M  volunteers (White and Johnston, 2007). No 
effects on fasting plasma glucose, insulin, LD L-C  or HDL-C  were observed in obese 
volunteers (Kondo et al., 2009).
Supplementation with 7.5g Na propionate was reported to significantly increase HDL-C  
and maximum insulin increment (although this was not defined) relative to PL, and 
reduce fasting glucose and increase fasting T A G  relative to baseline. N o significant 
effects on postprandial glucose and insulin A U C  follow ing an O G TT  or on fasting 
insulin, TC, LD L-C  or N E FA  were observed, with the authors concluding the results 
may indicate improved insulin sensitivity (Venter et al., 1990) - an ambitious claim 
considering the lack o f effect on the postprandial glucose and insulin AUC .
However, daily consumption o f bread with 9.9 g added Na propionate for 1 wk 
significantly decreased the postprandial glucose A U C  at an acute 50 g bread challenge, 
relative to PL. Fasting lipid parameters were not significantly influenced, although as
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the supplementation period was short, plasma lipids were unlikely to have been 
influenced by the intervention (Todesco et al., 1991).
Therefore overall evidence for an effect o f chronic SCFA  supplementation on 
metabolic parameters is fairly inconclusive, with limited data available, mostly from 
parallel rather than crossover studies.
It has been suggested that the observed effects on the glycaemic and insulinaemic 
response and possibly appetite may arise from oral SCFA delaying the rate o f gastric 
emptying. As summarised in Tables 1.10 and 1.11, various researchers have 
investigated this with the majority o f studies reporting the GER is delayed follow ing 
acetate (Liljeberg and Bjorck, 1998, H lebowicz et al., 2007) and propionate (Liljeberg 
and Bjorck, 1996, Darwiche et al., 2001) relative to PL, with the exception o f 
Hlebowicz and colleagues who found no effect on the GER follow ing an acute 
challenge with vinegar (H lebowicz et al., 2008).
However none o f the studies investigating the GER used the ‘ gold standard’ for 
GER assessment (scintigraphy), instead using either the paracetamol absorption test 
(Liljeberg and Bjorck, 1996, Liljeberg and Bjorck, 1998) or real-time ultrasonography 
(Darwiche et al., 2001, H lebowicz et al., 2008, Hlebowicz et al., 2007). Recent reviews 
suggest the ultrasonography method requires further validation and standardisation, 
although good correlations to scintigraphy and stable isotope methods are reported 
(Szarka and Camilleri, 2009, Bratten and Jones, 2006). Paracetamol absorption has been 
found to have moderate to good correlation with scintigraphy in the liquid phase, 
although further standardisation is suggested for use in research (W illem s et al., 2001).
As vinegar and propionate both have a strong taste and smell that may exert an 
influence during the cephalic phase o f ingestion, it is possible that test product
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palatability may have triggered the observed effects on the metabolic response and 
satiety (reviewed below, see 1.10). Breads with propionate and lactic acid had 
significantly lower acceptability score than P L  (Liljeberg et al., 1995) and meals 
containing PU FA  and Na propionate induced higher subjective nausea ratings than 
meals that were unadulterated (Frost et al., 2003).
1.9.2 Colonic SCFA via NDC and metabolic response
As indicated by the presence o f SC FA  receptors in the colon, it is conceivable that 
fermentable ND C  may also influence the metabolic response via the generation o f 
colonic SCFA follow ing microflora mediated fermentation.
Focusing on the prebiotic inulin-type fructans, the effects o f their ingestion on plasma 
glucose (Kelly, 2009, Kaur and Gupta, 2002) and lipids (Beylot, 2005, Williams, 1999, 
Williams and Jackson, 2002, Kelly, 2009, Roberfroid, 2005a, Kaur and Gupta, 2002) 
have been reviewed. From these reviews, data from studies in rats is promising, 
indicating inulin-type fructans may decrease postprandial glycaemia and insulinaemia 
(Kaur and Gupta, 2002) and decrease fasting and postprandial TAG s (Beylot, 2005, 
Roberfroid, 2005a, W illiams and Jackson, 2002, Kaur and Gupta, 2002). However 
studies in human participants have generated conflicting results.
Table 1.12 summarises findings from chronic intervention studies ranging from 14 d to 
6 mo, in which human participants were supplemented with inulin, OF, or a mixture o f 
the two.
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Table 1.12. Summary of human clinical studies investigating chronic effects of 
inulin-type fructan supplementation on the metabolic response. A ll crossover 
studies separated intervention periods with a washout unless otherwise stated. 1
Study Design Dose Results
(Yamashita 
et al., 1984)
Parallel (n=28) 
Poorly  controlled 
N ID D M  patients
D aily  for 14 d:
- 8 g FOS (n=18) or
- 5 g sucrose (PL , 
n=10)
FOS sig I  fasting glu, TC , LD L -C  
levels.
N o  sig effects on H D L-C , T A G , 
N E F A
(Luo et al., 
1996)
Crossover (n=12) 
19-32 y 
Norm al weight &  
healthy
D aily  for 4 wk:
- 20 g FOS or
- 20 g sucrose (P L ) 
Baked in cookies
FOS sig I  basal hepatic glu, but 
total-body glu disposal, or post- 
absorptive hepatic glu not altered 
during hyperinsulinemic clamp. 
N o  sig effects on fasting glu, 
insulin, T A G , T C  or HD L-C .
(Pedersen 
et al., 1997)
Crossover (n=66) 
20-36 y 
Norm al weight &  
healthy
D aily for 4 wk low-fat 
spread containing:
- 14 g inulin Raftiline 
LS  or
- no inulin (P L )
N o  sig effects on fasting plasma 
TC , LC L -C , H D L-C , TAG s.
Glu &  insulin not assessed.
(Davidson 
et al., 1998)
Crossover (n=21) 
30-75 y 
B M I <32 lcgm'2
D aily  for 6 wk:
- 18 g inulin/OF 
Raftiline ST  or
- no inulin (P L )
T C  &  LD L -C  sig I  during 
inulin/OF compared to PL. N o  sig 
effects on fasting T A G .
Glu &  insulin not assessed.
(Alles et 
al., 1999)
Crossover (n=20) 
Patients with 
T 2 D M  
(N o  washout)
D aily  for 20 d:
- 15 g FOS or
- 4 g glucose (P L ) 
M ixed  in yogurt
N o  sig effects on fasting blood glu, 
or serum acetate, T C , HD L-C , 
LD L -C  or T A G .
(van
Doldcum et 
al., 1999)
Crossover (n=12) 
23 [SD  3] y 
Normal weight &  
healthy
D aily  for 21 d:
- 15 g inulin
- 15 g FOS or
- no N D C  (P L )
N o  sig effects on fasting TC , H D L- 
C, LD L-C .
N o sig effects on postprandial 
glucose or insulin fo llow ing O G TT .
(Jackson et 
al., 1999)
Parallel (n=54) 
20-32 lcgm"2 
M oderately 
raised plasma T C  
(&  T A G )
D aily  for 8 wk:
- 10 g inulin H P  (n=27) 
or
- 10 g  M D  (P L , n=27) 
Fo llow  up at 12 wk
Inulin sig j  fasting insulin at wk 4, 
but not at wk 8 or wk 12.
Inulin sig j  fasting T A G  over entire 
study.
N o  sig effects on fasting glu, TC , 
H D L-C , LD L -C , glu: insulin ratio.
(Causey et 
al., 2000)
Crossover (n=12) 
27-49 y 
Patients with 
mild hyper 
cholesterolemia
D aily  for 3 wk:
- 20 g inulin or
- sucrose (P L ) 
M ixed  in ice cream 
N o  washout
Inulin sig [  fasting T A G , | insulin 
1 h fo llow ing  O G T T  (p=0.07).
N o  sig effects on fasting insulin, 
glu, TC , H D L-C , L D L -C  or on 
postprandial glucose or c-peptide 
fo llow ing O G TT .
(Olesen and 
Gudmand- 
H0yer, 
2000)
Parallel (n=75) 
18-70 y 
Patients with IBS
D aily  for 12 wk:
- 10 g O F (n=38) or 
- lO g  glu (P L , n=37)
N o  sig effects on fasting plasma 
lipids (lipids not specified).
Glu &  insulin not assessed.
(Luo et al., 
2000)
Crossover (n=10) 
57 [SD  2] y 
Patients with 
T2D M
D aily  for 4 wk:
- 20 g FOS or
- 20 g sucrose (P L )
N o  sig effects on H b A lC , fasting 
glu, insulin, T A G , TC , H D L-C , 
insulin binding to erythrocytes or 
on basal hepatic glu production or 
glue disappearance during ITT .
‘M D = Maltodextrin, OF = Oligofructose, glu = glucose, ITT  = insulin tolerance test, M TT  = mixed 
meal tolerance test
57
Julia Darzi Thesis
Table 1.12 Cont.1
Study Design Dose Results
(Letexier et 
al., 2003)
Crossover (n=8) 
23-32 y 
Normal weight &  
healthy
D aily  for 6 wk:
- 10 g inulin H P  or 
-1 0  g M D  (P L )
Inulin sig f  fasting T A G .
N o  sig effects on fasting glu, 
insulin, TC , H D L-C , LD L-C .
(Giacco et 
al., 2004)
Crossover (n=30) 
46 [SD  10] y 
Overweight with 
mild hyper 
cholesterolemia
D aily  for 2 mo: 
- 10.6 g FOS or 
-15  g M D  (P L )
N o  sig effects on fasting insulin, 
glu, N E FA , TC , H D L-C , L D L -C  or 
on postprandial glu, insulin, N E FA , 
T A G  for 5 h fo llow ing standard 
high fat meal
(Boutron- 
Ruault et 
al., 2005)
Open pilot study 
W ith colorectal 
adenoma (n=44) 
v,?.. no adenoma 
(n=30)
D aily  for 3 mo:
- 10 g FOS
Outcomes measured at 
baseline &  post­
intervention
N o  sig effects on fasting insulin, 
glu, TC , T A G  or H D L-C  post­
supplementation in either group 
compared to baseline (i.e. no proper 
control group)
(Daubioul 
et al., 2005)
Crossover (n=7) 
Patients with 
non-alcoholic 
steatohepatitis
D aily  for 8 wk: 
-1 6  g FOS or 
- 16 g M D  (P L )
N o  sig effects on fasting insulin, 
glu, N E F A , TC , HD L-C , LD L-C .
(Forcheron 
and Beylot, 
2007)
Parallel (n=17) 
A g e  &  B M I not 
specified
D aily  for 6 mo:
- 10 g inulin/OF 
mixture (n -9 ) or
- 10 g unspecified P L  
(n=8)
Inulin/OF trend for f  TC , L D L -C  &  
f  H D L-C  but not sig different from  
P L  group.
N o  sig effects on fasting plasma 
glu, insulin, glucagons, N E F A  or 
T A G  or on postprandial glu or 
insulin fo llow ing O G T T
(Parnell
and
Reimer,
2009)
Parallel (n=48, 
n=39 completed) 
20-70 y 
Overweight &  
obese
D aily for 12 wk:
- 21 g OF Raftilose P95 
or
- M D  equicaloric (P L )
S ig time x diet interaction for 
postprandial insulin fo llow ing 
M T T .
Postprandial sig fg lu  in OF &  fg lu  
in P L  groups relative to baseline. 
N o  sig effects on postprandial 
serum lipids.
(Cani et 
al., 2009)
Parallel (n=10) 
21-38 y 
Norm al weight &  
healthy
D aily  for 2 wk:
- 16 g Orafti Synergy or 
-1 6  g M D  (P L )
Inulin/OF sig j  postprandial plasma 
glu A U C .
N o  sig effects on fasting plasma glu 
or insulin.
'MD = Maltodextrin, OF = Oligofructose, glu = glucose, ITT  = insulin tolerance test, , M TT = meal 
tolerance test
Most studies examined effects o f supplementation with inulin-type fructans on fasting 
parameters, with mixed findings, particularly for lipid parameters.
Many o f the studies found no effect on fasting plasma lipids (A lles et al., 1999, 
Daubioul et al., 2005, Giacco et al., 2004, Luo et al., 1996, Luo et al., 2000, Olesen and 
Gudmand-H0yer, 2000, Parnell and Reimer, 2009, Pedersen et al., 1997, van Dokkum 
et al., 1999). However, supplementation significantly reduced fasting plasma T A G
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concentrations in two studies (Causey et al., 2000, Jackson et al., 1999) and 
concurrently reduced plasma TC  and LD L-C  concentrations in three studies (Davidson 
et al., 1998, Forcheron and Beylot, 2007, Yamashita et al., 1984).
The majority o f studies reported no effects on fasting plasma or blood glucose 
(A lles et al., 1999, Boutron-Ruault et al., 2005, Cani et al., 2009, Daubioul et al., 2005, 
Forcheron and Beylot, 2007, Giacco et al., 2004, Jackson et al., 1999, Letexier et al., 
2003, Luo et al., 1996, Luo et al., 2000, Causey et al., 2000), with the exception o f one 
study (Yamashita et al., 1984), nor on fasting insulin concentrations (Boutron-Ruault et 
al., 2005, Cani et al., 2009, Causey et al., 2000, Daubioul et al., 2005, Forcheron and 
Beylot, 2007, Giacco et al., 2004, Letexier et al., 2003, Luo et al., 1996, Luo et al., 
2000) except one study in which inulin H P significantly reduced fasting plasma insulin 
concentrations in the early stages o f  the intervention (Jackson et al., 1999).
Fewer studies have examined effects o f  chronic supplementation with inulin-type 
fructans on postprandial metabolites. Postprandial glycaemia was unchanged by 
supplementation in three studies (Causey et al., 2000, Forcheron and Beylot, 2007, van 
Dokkum et al., 1999), with only one reporting concentrations to be significantly lower 
in the OF group and higher in the P L  group compared to baseline levels (Parnell and 
Reimer, 2009). Tw o studies reported postprandial plasma insulin concentrations were 
reduced significantly (Parnell and Reimer, 2009) and with a trend approaching 
significance (p=0.07) (Causey et al., 2000) follow ing OF and inulin treatment 
respectively, although two other studies found no effect on insulinaemia (Forcheron and 
Beylot, 2007, van Dokkum et al., 1999). Postprandial lipid responses were not altered 
by supplementation in the only study to report postprandial lipid responses (Parnell and 
Reimer, 2009).
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Insulin sensitivity fo llow ing OF supplementation was examined in two studies. 
Supplementation o f 20 g OF per d for 4 wk in healthy volunteers significantly reduced 
basal hepatic glucose production during a hyperinsulinaemic clamp, although total body 
glucose disposal and post-absorptive hepatic glucose were not altered (Luo et al., 1996). 
However in patients with T2DM , no measures were altered during an insulin tolerance 
test follow ing supplementation'with 20 g OF per d for 4 wk (Luo et al., 2000).
Only one study examined acute effects on postprandial metabolites and found 20 g 
inulin/OF (with no macronutrients supplied) significantly lowered glycaemic A U C  and 
glucose and insulin mean peak concentrations, relative to 20 g fructose (Rumessen et 
al., 1990). However, fructose is an unsuitable PL  as fructose is rapidly absorbed from 
the G IT. Additionally, 10 g inulin/OF ingested alongside wheat bread (with 50 g starch) 
significantly lowered the glucose IA U C  relative to the same wheat bread with no 
inulin/OF (Rumessen et al., 1990), due to hypoglycaemia from 90 min postprandially.
1.10 The Cephalic Phase Response
1.10.1 Overview of the Cephalic Phase Response
Physiological responses to eating episodes are divided into three phases, referring to the 
part o f the digestive system being stimulated by food: namely the cephalic, gastric and 
intestinal phases. The cephalic phase relates to pre-absorptive effects while gastric and 
intestinal phases relate to post-ingestion effects o f food intake (Giduck et al., 1987, 
Zafra et al., 2006).
The cephalic phase response is initiated by food-related sensory stimuli including the 
thought, sight, smell, taste and chewing o f  food, and occurs before and during the first 
moments o f an eating episode (Feldman and Richardson, 1986, Te ff, 2000). These
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effects arise from vagal cholinergic signalling and have been shown to initiate a variety 
o f autonomic and endocrine responses linked to digestion, absorption and metabolism 
(summarised in Table 1.13).
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Table 1.13. Overview of the main physiological responses triggered during the 
cephalic phase. Adapted from (Robertson, 2009), (Zafra et al., 2006) and (Power and 
Schulkin, 2008)
Site Response(s) Cephalic Function(s)
Oral cavity f  salivation •Lubricate food, start starch & fat digestion (amylase 
& ligual lipase in saliva), dissolve food particles to be 
transported to taste buds
Stomach t  gastric acid secretion 
t gastric motility 
t  gastrin levels 
f  pre-prandial ghrelin levels
t  leptin mucosal secretion
• Hydrolysis & breakdown o f food
• tgastric emptying rate -> regulate food passage
• Stimulate gastric acid secretion
•Rise stimulates appetite. However postprandial 
suppression rapidly follows (i.e. inhibit appetite)
•M ay inhibit CHO absorption, promote small peptide 
absorption, reduce appetite
Small t  intestinal motility • Regulate food passage
intestine t absorption water, glucose 
t motilin
• Feed-forward mechanism 
•Stimulate intestinal motility
Large t intestinal motility •Regulate food passage
intestine t  neurotensin • Unknown
Pancreas t insulin release • Anticipatory metabolic role
f  digestive enzymes ©Digest protein, CHO, fat
t  bicarbonate secretion • Neutralise stomach acid
t  glucagon release ©Unknown. May t  postprandial thermogenesis & or
prevent CPIR induced hypoglycaemia
t  PP release • Cephalic phase role unknown
Liver t  V LD L levels • Cephalic phase role unknown
1 NEFA levels (suppressed by 
CPIR)
•M ay enhance glucose metabolism in insulin sensitive 
tissues
Adipose
Tissue
t  LPL expression (stimulated 
by CPIR)
•Probably in preparation for imminently incoming 
nutrients
Vasculature t  intestinal blood flow •Probably in preparation for imminently incoming 
nutrients
t  cardiac output, heart rate •Cephalic phase role unknown
Other t  cephalic phase 
thermogenesis
•M ay arise from actions o f cephalic phase hormones 
(e.g. insulin, glucagon)
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The cephalic response is thought to be a “ feed-forward” effect “ priming” the G IT  and 
metabolic processes in preparation for imminently incoming nutrients (Robertson, 2009, 
Zafra et al., 2006). Cephalic initiated responses are more rapid in onset, shorter-lived 
and lower in magnitude than gastric and intestinal phase responses (Robertson, 2009, 
Zafra et al., 2006).
The concept o f cephalic phase responses were first introduced in the classical 
experiments o f Pavlov, who documented anticipatory salivary and gastric secretions 
occurring in response to the sight and smell food or even just the expectation o f feeding 
in dogs (Pavlov, 1902).
Experimentally, sham feeding and modified sham feeding (M SF) are the most 
commonly used methods to investigate cephalic phase responses. In early sham feeding 
experiments, animals were fitted with a gastric or oesophageal fistulae allowing food to 
be eaten but not absorbed from the small intestine. These studies have provided much 
evidence regarding cephalic phase processes, however this model does not allow 
researchers to differentiate between responses arising from receptors in the mouth, or 
further down in the oesophagus or stomach (Robertson, 2009, Zafra et al., 2006).
The M SF (or “ chew-and-spit” ) technique, which involves chewing and tasting but not 
swallowing food, was developed to investigate cephalic phase responses in humans 
(Richardson et al., 1977). The M SF technique allows researchers to selectively 
investigate oral vagal activity, avoiding pharyngeal and oesophageal receptors 
(Robertson, 2009). However as food is not swallowed the influence o f cephalic 
responses on subsequent nutrient handling is not so clear (T e ff, 2000). To  overcome 
this, M SF is often coupled with intragastric nutrient delivery or intravenous glucose 
(Teff, 2000, LeBlanc, 2000).
Julia Darzi Thesis
62
Saliva is the first cephalic secretion and is secreted into the oral cavity both prior to 
eating in response to visual and olfactory stimuli and also once food is being tasted and 
chewed (Giduck et al., 1987, Robertson, 2009), with taste and chewing inducing higher 
secretion levels (Mattes, 1997). Indeed, as demonstrated by Pavlov, salivary output 
increases even at the mere thought o f  food (Pavlov, 1902), and favourite foods are often 
described as being “mouth watering”  (Mattes, 2000). The quantity o f saliva produced 
in anticipation o f a meal has been found to be correlated with hunger ratings and the 
rated palatability o f the food (W oo ley  and W ooley, 1973).
Saliva acts as a lubricant and protects the oral mucosa during chewing, aiding 
mastication, bolus formation and swallowing. In addition, saliva contains enzymes such 
as amylase and lingual lipase for initial digestion o f starch and fats respectively (Mattes, 
2000, Pedersen et al., 2002). O f importance, saliva acts as a solute so nutrients are 
dissolved allowing them to be transported to taste buds to stimulate taste receptor cells, 
thereby facilitating taste perception (Pedersen et al., 2002).
Taste is important in identifying potentially harmful and toxic compounds and, 
in addition to mastication and swallowing, is the main stimulant o f salivary production 
(Pedersen et al., 2002, Mattes, 2000). The type o f gustatory stimulus influences saliva 
volume and composition, with a sour/acidic (e.g. lemon ju ice) or bitter (e.g. quinine) 
taste potently stimulating salivary flow  and a sour/acidic taste increasing protein levels 
in saliva (Davenport, 1982, Robertson, 2009). Increased salivary flow  in response to 
bitter or acidic tastes may have evolved as a protective mechanism to dilute or clear 
potential toxins, irritants or other dangerous substances from the mouth (Robertson, 
2009, Mattes, 2000).
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1.10.3 Cephalic phase insulin release (CPIR)
Various studies have demonstrated insulin is secreted from the pancreas in response to 
taste stimuli (Bellisle et al., 1985, Bruce et al., 1987, Lucas et al., 1987, T e ff and 
Engelman, 1996, T e ff et al., 1993a, T e ff  et al., 1991, T e ff et al., 1993b), a phenomenon 
termed cephalic phase insulin release (CPIR ). Similarly, early insulin peaks alongside 
an increase in C-peptide have been observed during eating episodes within a few  min o f 
meal initiation and prior to a postprandial rise in plasma glucose concentrations. During 
CPIR, insulin concentrations generally rise within 2 min o f the oral stimulus, reaching 
maximal levels after 4 min and returning to baseline by 10 min post-stimulation (Teff, 
2000) (Figure 1.9A ). The CPIR  magnitude and profile are similar post M SF and post 
actual food ingestion (T e ff  et al., 1993a).
CPIR  appears to be necessary for normal glucose homeostasis. The postprandial 
plasma glucose A U C  follow ing gastric infusion o f a glucose solution, thereby by­
passing oral stimulation, was significantly lower when preceded by an M SF episode 
than with no prior cephalic stimulation (Figure 1.9B) (T e ff and Engelman, 1996).
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Fig 1.9A: CPIR. Effect o f M SF on 
plasma insulin concentrations (M SF, 
- ■ - )  relative to no stimlus (PL, -A - ).  
Values shown as mean with error bars 
representing the SEM (n=12). Taken 
from (Teff, 2000) ______
Tim o (m in )
Fig 1.9B: Postprandial plasma glucose.
Following intras gastric infusion o f 75 g 
glucose with (MSF, - • - )  and without (PL, - 
A - )  prior MSF. Values shown as mean with 
error bars representing the SEM (n=8). Taken 
from (T e ff and Engelman, 1996)_______________
The amplitude o f CPIR may be related to meal palatability. Higher C PIR  concentrations 
are reported to occur fo llow ing exposure to foods rated as highly palatable than
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follow ing exposure to those with lower palatability ratings (Bellisle et al., 1985, Lucas 
et al., 1987), although this is not a consistent finding (T e ff and Engelman, 1996).
1.10.4 Cephalic gastric secretions
As demonstrated in Pavlov ’ s experiments, gastric acid is secreted in substantial 
quantities during the cephalic phase (Pavlov, 1902), accounting for approximately one- 
third o f total secretion levels (Robertson, 2009). Cephalic gastric acid secretion occurs 
via vagal activation triggering Ach release, in turn stimulating gastric acid production 
(Robertson, 2009).
The thought o f appetising food has been shown to induce gastric acid 
production, although levels produced are lower than during M SF when food is also 
seen, smelt, tasted and chewed (Feldman and Richardson, 1986), showing gustation has 
an important role in cephalic gastric secretion (Zafra et al., 2006). However as it is 
difficult to separate thoughts o f  food from tasting food, it is difficult to quantify the 
influence o f taste (Mattes, 1997). In an early human study, gastric acid secretions were 
found to be lower in response to an M SF unpalatable meal (gruel) in comparison to a 
palatable meal (freely selected preferred meal) (Janowitz et al., 1950). However in dogs 
gastric acid secretion was only suppressed when presented with “ inedible” meals 
(Robertson, 2009).
1.10.5 Cephalic phase intestinal motility
Evidence from various studies indicates gastric and intestinal motility is influenced 
during the cephalic phase. Intragastric delivery o f a soup, thereby bypassing the oral 
cavity, resulted in a significantly higher rate o f gastric emptying than when the same 
soup was administrated orally (Cecil et al., 1998). Furthermore, gastric emptying o f a
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fat load was significantly faster with prior vagal stimulation via MSF, compared to 
ingestion alone (Heath et al., 2004).
Oral vagal stimulation has also been shown to influence the migrating motor 
complex (M M C ), which comprises recurring waves o f activity propagating motility 
along the length o f the G IT  between meals to remove debris and prevent microfloral 
overgrowth. The M M C  occurs in three phases: Phase I (inactive), Phase II (irregular 
motility similar to postprandial motility) and Phase III (strong, frequent contractions) 
(Robertson, 2009). Sham feeding during phase III appears to disrupt antroduodenal 
motility and inhibit the propagation o f contractions in the duodenum (Pouderoux et al., 
1995) to be replaced by antral contractions (Katschinski et al., 1992).
Colonic motility also appears to be influenced during the cephalic phase, and is 
stimulated even by the mere smell, sight and thought o f food as well as by oral 
stimulation via sham feeding (Robertson, 2009).
1.10.6 Effects on appetite during the cephalic phase
Sham fed animals fitted with a fistula do not become satiated and continue to eat while 
food is available, providing the first evidence that intestinally released hormones are 
necessary for satiation (Robertson, 2006, Robertson, 2009). Furthermore, early studies 
in humans found that removing cephalic stimuli with nose-clips and topical anaesthesia 
in the mouth (to block olfactory and taste stimuli respectively) significantly influenced 
satiation (Geliebter, 1979). It is now known that some gut peptides are released during 
cephalic phase vagal stimulation, including ghrelin, leptin, gastrin, neurotensis and 
motilin, whereas others are only released post-ingestively, including CCK, G IP and 
GLP-1 (Robertson, 2009).
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Plasma ghrelin, the ‘hunger hormone’ , is elevated during fasting promoting the urge to 
eat and falls postprandially suppressing the urge to eat (reviewed in section 1.3.1.1). 
Cephalic stimulation with a palatable meal via M SF results in significantly increased 
pre-prandial plasma ghrelin concentrations, even during the anticipatory stage o f a meal 
(i.e. the sight, thought and smell) (Simonian et al., 2005, Heath et al., 2004). Alongside 
this, PP concentrations are also increased during MSF, suggesting efferent vagal 
activation (Simonian et al., 2005). M SF induced cephalic stimulation appears to 
accentuate the postprandial ghrelin response when preceding an oral fat load, 
significantly enhancing the speed and magnitude o f suppression, as compared to no 
M SF prior to eating (Heath et al., 2004), suggesting a role for cephalically stimulated 
ghrelin in enhancing satiation.
In addition to being expressed in adipose tissue, leptin is also expressed in 
gastric mucosa and released fo llow ing vagal stimulation (Sobhani et al., 2002), 
suggesting gastric-derived leptin is released during the cephalic phase. Leptin receptors 
are located in jejunal and ileal mucosa, indicating a role for leptin in mediating nutrient 
digestion and absorption. For example leptin has been shown to enhance small peptide 
absorption (Sobhani et al., 2002) and may inhibit CHO absorption (Robertson, 2009).
M SF elicited cephalic phase activation appears to reduce subjective hunger ratings in 
human subjects (LeBlanc and Soucy, 1996, Smeets and Westerterp-Plantenga, 2006b). 
Subjective appetite ratings for fullness and desire to eat were increased to a significantly 
greater level follow ing M SF with sandwiches (nutritive material) relative to chewing a 
latex dummy (non nutritive material) for a similar length o f time. However ad libitum  
E l 85 min post-MSF did not differ significantly between treatments, suggesting only a 
short time effect o f the cephalic phase (Stratton et al., 1999).
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Direct administration o f  nutrients or foods into the G IT  allows investigation o f 
responses in the absence o f cephalic stimulation. Hunger ratings remained significantly 
elevated fo llow ing intragastric infusion o f a soup relative to oral ingestion o f the same 
soup (Cecil et al., 1998), suggesting a role for cephalic mechanisms in amplifying 
gastrointestinal satiety signals. Furthermore, while hunger ratings were reduced to a 
similar level follow ing intragastric infusion o f  isocaloric soups high in fat or CHO, oral 
administration resulted in significantly lower hunger ratings fo llow ing the high fat soup 
relative to oral administration o f the high CHO soup (Cecil et al., 1999).
Taken together, this data suggests not only do orosensory signals enhance 
appetite suppression, but information gained at the cephalic phase allows discrimination 
between nutrients (e.g. fat and CHO ). This in turn influences the appetite response, with 
oral fat loads suppressing appetite to a greater extent than oral CHO loads.
1.11 Influence of palatability on appetite and metabolic response
As reviewed in section 1.10, the cephalic phase o f digestion appears to influence 
subsequent appetite and metabolic processes, with sensory factors governing meal 
palatability appearing to influence some cephalic responses. It is therefore reasonable to 
postulate that palatability may influence appetite and the metabolic response.
1.11.1 Defining palatability and sensory-specific satiety
Defining palatability is not straightforward and has been the cause for debate by many 
researchers with no single definition having yet been assigned (Yeomans, 1998, 
Ramirez, 1990, Yeomans et al., 2004). Palatability has been defined as the ability o f 
sensory factors to increase food intake, however this can give rise to a circular 
argument, as it is then not possible to determine i f  alterations in intake arise from 
palatability (Yeomans, 1998).
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Iii addition to taste, sensory factors that may influence perceptions o f palatability 
include texture, odour, temperature and appearance (Grinlcer, 1990). Grinker also noted 
palatability is influenced by previous exposure and experience o f the food, time o f day, 
season, variety (o f foods on offer), expectation o f the food, metabolic status (e.g. 
hungry or satiated), location o f the meal (e.g. home or restaurant) and E density and 
nutrient quality o f the food, suggesting palatability is not only a function o f intrinsic 
properties but also o f exposure and experience (Grinker, 1990).
In a quest to clarify and standardise the definition o f palatability, a review by 
Yeomans concluded current data supports the idea o f Le Magnen that palatability 
should be defined as the “ hedonic evaluation o f orosensory food cues under 
standardised conditions” (L e  Magnen, 1987, Yeomans, 1998).
The complexity o f factors influencing palatability suggest palatability is not a fixed 
attribute, but is a variable property (Yeomans, 1998), as demonstrated by the 
observation that ratings o f meal pleasantness generally decrease as a meal progresses 
(Hetherington et al., 1989, Rolls et al., 1981a, Yeomans and Symes, 1999).
Sensory-specific satiety (SSS) refers to the decline in rated pleasantness o f the sensory 
characteristics o f a food relative to uneaten foods when consumed to satiety during a 
single eating episode (Hetherington et al., 1989, Nolan and Hetherington, 2009, Rolls et 
al., 1981a, Sprensen et al., 2003). It has also been found that sensory ratings can 
decrease without reaching satiety (Smeets and Westerterp-Plantenga, 2006a). The 
greatest decline in pleasantness during SSS occurs immediately during the first 20 min 
o f consumption, indicating SSS is related to sensory factors accompanying ingestion 
rather than post-ingestive or post-absorptive effects (Smeets and Westerterp-Plantenga, 
2006a, Rolls et al., 1981a, Sprensen et al., 2003). SSS has been demonstrated to occur
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with vagal stimulation via MSF, demonstrating post-ingestive feedback is not necessary 
for SSS to occur (Nolan and Hetherington, 2009, Smeets and Westerterp-Plantenga, 
2006a), further supporting SSS as a sensory phenomenon. The concept o f SSS 
demonstrates the complexity and importance o f palatability influences.
1.11.2 Measurement of palatability
Palatability is generally measured with hedonic ratings using continuous V A S  scales or 
fixed point scales (FPS) (Yeomans, 1998, Sprensen et al., 2003). Participants are asked 
questions such as “ How pleasant is the appearance/taste/texture o f this food right now?” 
(Krai et al., 2004), or “How  palatable is this meal right now?”  (Flint et al., 2000).
However as Yeomans points out, it is important to interpret palatability ratings with 
caution, as seemingly small differences in the way a question is asked w ill influence the 
outcome (Yeomans, 1998). The terms palatability and pleasantness have been used by 
investigators interchangeably, which may cause difficulties due to differing 
interpretations o f what palatability means (Sprensen et al., 2003). For example, separate 
ratings to assess meal pleasantness and palatability found that while pleasantness ratings 
declined from the start to the end o f the meal, changes in the palatability were more 
variable. Two-thirds o f participants rated palatability and pleasantness similarly, while 
one-third rated palatability as being constant from the start to the end o f the meal 
despite pleasantness ratings declining across the meal (Yeomans and Symes, 1999).
This in combination with the different scales (V A S  and FPS) used means there is 
considerable variation in the format o f palatability ratings in palatability research.
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1.11.3 Palatable food and hedonistic mechanisms
Appetite is regulated by a complex physiological feedback system involving central and 
peripheral hunger and satiety signals to control E balance (reviewed in section 1.3). 
However palatable food can override these homeostatic mechanisms by activating the 
reward system (hedonistic mechanisms), with gratification being the main motivator to 
eat rather than correcting negative E balance (Saper et al., 2002, Erlanson-Albertsson,
2005). Activation o f the reward system triggers a behaviour to “ come back for more” , 
so that in an environment with free access to palatable foods (K elley  et al., 2002), 
overeating beyond homeostatic requirements can occur (Erlanson-Albertsson, 2005). 
This overeating is usually characterised by a lengthened eating episode duration due to 
hedonistic mechanisms over-riding satiation signals (Erlanson-Albertsson, 2005).
The relationship between ingesting palatable food and reward has many similarities to 
the relationship between drug addiction and reward (K elley  et al., 2002, Erlanson- 
Albertsson, 2005). As the consumption o f palatable food is associated with the release 
o f opioids and dopamine in the reward system, and central administration o f opiates and 
dopamine stimulates food intake, it is argued a vicious cycle may result from the 
consumption o f palatable foods invoicing a reinforcing mechanism. In addition, 
consumption o f  palatable food may blunt responses to satiety signals, possibly by the 
reward centre interacting with hypothalamic appetite-controlling neurones (Erlanson- 
Albertsson, 2005).
One criticism that can be made o f the research is that the term palatable has not been 
defined. For example Erlanson-Albertsson describes palatable food as being “ foods high 
in fat and sugar” , but no assessment or measurement o f palatability is actually 
discussed.
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Studies investigating the link between sensory properties o f food and appetite suggest 
sensory properties influence food choice and quantities consumed (Sprensen et al., 
2003). A  pooled analysis o f data from food palatability manipulation studies concluded 
there was a strong linear relationship between the change in rated palatability and 
difference in food intake follow ing food manipulation (Figure 1.10) (Yeomans, 2007).
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Figure 1.10. Relationship between change in palatability ratings and food intake
when palatability is manipulated. Each data point represents a published study. Taken
from (Yeomans, 2007).
As summarised in Table 1.14, investigators have manipulated taste and palatability in 
various ways, including varying the amount o f acid and salt added to sandwiches 
(Hellemann and Tuorila, 1991), adding citric acid to tomato soup (de Graaf et al., 1999), 
varying the concentration o f oregano added to pasta (Yeomans, 1996, Yeomans et al., 
1997), adding cumin to a banana colada frozen yogurt drink (B obroff and Kissileff, 
1986), adding quinine sulphate to impart a bitter taste (Nisbett, 1968) and offering stale 
popcorn in comparison to fresh.
In general these palatability m an ipu lation  studies have found ad libitum  intake 
o f the manipulated test product is inversely correlated to product palatability (Bobroff 
and Kissileff, 1986, de Graaf et al., 1999, Hellemann and Tuorila, 1991, Nisbett, 1968, 
Yeomans, 1996, Yeomans et al., 1997). The effect on subsequent satiety is less clear
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and has not been extensively investigated. The addition o f citric acid to a tomato soup 
preload did not significantly influence subsequent ad libitum  intake o f  a buffet meal 
regardless o f the intepneal time interval (de Graaf et al., 1999).
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Table 1.14. Summary of studies investigating the effect of taste manipulation on 
satiation
Study Design Test products Results
(Nisbett,
1968)
Parallel
n=14
Ice-cream:
- with added quinine 
sulphate
-no additives (PL)
- Ad libitum intake & subjective taste 
ratings of quinine ice-cream sig [  than 
PL ice cream
- Linear relationship between taste 
ratings and ad libitum intake
(Bobroff and
Kissileff,
1986)
Banana colada:
- with added cumin
- no additives (PL)
- Ad libitum intake & subjective taste 
ratings of cumin colada sig | than PL 
colada
- Time taken to eat cumin colada sig f 
than for PL colada
(Hellemann 
and Tuorila, 
1991)
12-way 
crossover 
n=27
Sandwiches made using: 
-3 types of bread 
-4 types of spread 
each with varying levels 
of acid & salt
- Number of sandwiches consumed 
correlated with pleasantness ratings
(Yeomans,
1996)
Parallel
n=54
Pasta & tomato
- with oregano 0.27 % 
(palatable) & 0.54 % 
(strong, unpleasant)
- no oregano (bland)
- Ad libitum intake of palatable was 
significantly higher than of strong
- Eating rate of palatable was 
significantly faster than of strong
(Yeomans et 
al., 1997)
Crossover
n=16
Pasta & tomato
- with oregano 0.27 % 
(palatable)
- no oregano (bland)
- Ad libitum intake of palatable was 
significantly t than of bland
- Hunger ratings f during initial stages 
of palatable but not bland
(de Graaf et 
al., 1999)
Crossover
n=35
Tomato soup
- with 7.5g (less pleasant) 
& 15g (unpleasant) citric 
acid per kg soup
- no additives (PL)
- Sig I ad libitum intake of ‘less 
pleasant’ & unpleasant than PL
- No effect of taste on ad libitum intake 
at subsequent buffet meal 15 or 90 min 
following soup preload
(Wansink 
and Kim, 
2005)
Parallel
n=158
Popcorn:
- 14 d old (Stale)
- Fresh (PL)
- Ad libitum intake of stale popcorn was 
sig I than fresh popcorn
A  relatively new area o f appetite research is Sensory Specific Satiety (SSS) (defined in 
1.11.1), further indicating the importance o f sensory properties in influencing satiety. 
As SSS appears to be specific to sensory properties o f an individual food, it is proposed 
that when a variety o f  foods are offered together then overall intake should be higher 
than i f  a single food item is served alone (Rolls et al., 1981b, Rolls et al., 1984).
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Studies appear to support this concept, (reviewed in (Sprensen et al., 2003)). For 
example, when participants were offered one hors d’ oeuvres (no variety) or 3 different 
types o f  hors d’ oeuvres (variety) (Pliner et al., 1980), or a 4 course meal with different 
foods in each course (variety) or the same foods in each course (no variety) (Rolls et al., 
1984), or served sandwiches with different fillings (variety) or one filling (no variety) 
(Rolls et al., 1981b, Bellisle and Le Magnen, 1981), or provided three different yogurts 
that differed in taste, texture and colour (variety) compared to just the participants 
favourite yogurt flavour (no variety) (Rolls et al., 1981b), to name a few  examples, 
overall intake was higher in the variety condition.
Furthermore, when exposed to a cheese sandwich (either ingested or M SF), 
more sandwiches were consumed subsequently when offered ham ( ‘variety’ ) than when 
offered cheese ( ‘no variety’ )  fillings, suggesting that SSS may occur even when the 
food is only tasted and chewed but not swallowed (via M SF) (Nolan and Hetherington, 
2009). However this study did not account for the fact some participants may prefer 
ham rather than cheese sandwiches, thus confounding the data.
1.11.5 Palatability and metabolic response
Food palatability may also influence the metabolic response. For example, consumption 
o f a highly palatable meal resulted in significantly higher oxygen consumption 
(LeBlanc and Brondell, 1985, Sawaya et al., 2001) and postprandial plasma insulin 
(LeBlanc and Brondell, 1985) and glucose (Sawaya et al., 2001) response compared to 
the same meal blended, then desiccated into a biscuit form (unpalatable meal). Plasma 
noradrenaline concentrations also increased alongside the palatable, but not the 
unpalatable blended meal, suggesting vagal involvement (LeBlanc and Brondell, 1985).
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Furthermore, as discussed in section 1.10.3, CPIR  concentrations may be related to 
meal palatability, with higher responses occurring follow ing highly palatable foods 
(Bellisle et al., 1985, Lucas et al., 1987).
Gastric motility also appeal's to be influenced by food palatability and taste, which w ill 
in turn influence the metabolic response. For example, when an orally ingested liquid 
test meal was preceded by M SF o f a modified bitter tasting Slim-Fast bar, gastric 
emptying was significantly delayed compared to prior M SF o f a regular Slim-Fast bar 
(P L ) (W icks et al., 2005). In a separate study, gastric myoelectric activity was decreased 
by sham feeding an unappetising food (cold tofu frankfurters) as compared to an 
appetising food (cooked frankfurters), suggesting a lack o f cephalic phase vagal 
stimulation with the ‘unappetising’ treatment (Stem et al., 2001), however this was a 
parallel rather than a crossover study. As would be expected, the influence o f  taste on 
gastric emptying appears to occur at the cephalic phase o f digestion, as demonstrated by 
intragastric infusion o f a bitter solution having no influence on the gastric emptying rate 
as compared to water (Little, 2009).
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1.12 Aims and objectives
The aim o f the work presented within this thesis is to elucidate further the role SCFA 
may have in regulating appetite and the metabolic response in humans, looking at both:
° Oral delivery o f SCFA - via the provision o f vinegar as a source o f acetate and the 
provision o f propionate 
• Colonic delivery.of SCFA  - via the provision o f NDC.
Within this, the influence o f product palatability, which was over-looked in previous 
studies, is to be considered. This w ill be achieved by the follow ing objectives:
A . To  investigate the acute effects o f including a palatable propionate-rich sourdough 
bread as a component o f one meal on postprandial subjective measures o f appetite, 
prospective consumption at a subsequent ad libitum  meal, 24 h intake and 
postprandial metabolite concentrations compared to a visually and nutritionally 
identical P L  bread o f equal palatability (Chapter 3).
B. To  examine the acute effects o f acetic acid ingestion (sweetened drink containing 
vinegar) delivered in an unpalatable (Unpal) and more palatable (Pal) form 
consumed alongside a standard breakfast preload on postprandial subjective 
measures o f appetite, prospective consumption at a subsequent ad libitum  meal, 24 h 
intake and postprandial metabolite concentrations compared to a visually identical 
P L  (sweetened drink with no added vinegar) (Chapter 4).
C. To investigate the acute effects o f  orosensory stimulation with acetic acid (delivered 
in a drink containing vinegar) via M SF follow ing a standard breakfast preload on 
postprandial subjective measures o f appetite, prospective consumption at a
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subsequent ad libitum  meal, 24 h intake and postprandial metabolite concentrations 
as compared to M SF with P L  (drink with no added vinegar) (Chapter 5).
D. To  evaluate i f  inulin propionyl ester (IPE ), a modified form o f inulin HP with 
propionate tethered to the inulin scaffold, is able to enhance colonic propionate 
production by investigating the acute dose-response effects o f  IPE on subsequent 
colonic propionate production, assessed by determining 24 h urinary SCFA  levels 
during the 24 h period fo llow ing supplementation (Chapter 6).
E. To investigate the effect o f inulin, IPE, and L-Rha follow ing a 1 wk run-in period, 
as a component o f breakfast and lunch, on postprandial subjective measures o f 
appetite and gastrointestinal symptoms, prospective consumption at a subsequent ad 
libitum  meal, 24 h intake and postprandial metabolite concentrations and breath 
hydrogen levels as compared to P L  (Chapter 7).
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Chapter 2: General methods
The follow ing chapter outlines the general methods followed during the conduct o f the 
Clinical Studies reported in Chapters 3-7 and subsequent analysis o f biological samples.
2.1 Screening
A t the start o f each study, interested participants were invited to attend a screening 
session at the Clinical Investigation Unit (C IU ) in the University o f Surrey to assess 
their suitability for inclusion in the study. During screening, volunteers were asked to 
complete a Medical and Lifestyle Questionnaire (example questionnaire given in 
Appendix B) that included a self-certificate medical questionnaire and the Dutch Eating 
Behaviour Questionnaire (DEBQ, see 2.1.1 and Appendix C )
Anthropometric measurements (height, BW , % body fat and waist 
circumference) were taken and body mass index (B M I) was calculated. Blood pressure 
(B P ) was measured in triplicate (mean value reported) and a small blood sample was 
collected by fingerpriclc and analysed for glucose concentrations using the HemoCue 
Glucose 201+ (see section 2.6.3.3). In studies where blood samples were collected via 
an indwelling cannula (Chapters 3 and 7) blood haemoglobin (Hb) concentrations were 
also measured using the HemoCue Hb 201+ (see section 2.6.9).
2.1.1 Dutch Eating Behaviour Questionnaire (DEBQ)
During screening, participants completed a DEBQ to assess eating behaviour 
(questionnaire is given in Appendix C). The DEBQ was developed by van Strien and 
colleagues as a tool to enhance understanding o f the complex eating behaviour patterns 
exhibited by obese individuals (Van Strien et al., 1986). It measures three dimensions o f 
eating behaviour, restraint, emotional and external, and comprises a 33 item
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questionnaire, 10 items each to assess restrained and external eating behaviour, and 13 
items to assess emotional eating behaviour. Each item has a five-point response format, 
never, seldom, sometimes, often and very often, scored 1, 2, 3, 4 and 5 respectively for 
each item except question 26, where a reverse scoring is applied. There is also a “ not 
relevant”  category for items presented in a conditional format, designated a score o f 0.
The score for each eating behaviour dimension is calculated by determining the 
sum o f the scores from each item regarding that particular eating dimension divided by 
the number o f items assessing that particular dimension. This division factor is reduced 
by the number o f items for which the ‘not relevant’ response is chosen. For example, 
the restraint score is calculated as shown below:
S Scores from questions regarding restrained eating
Restraint Score =  — ------------   —-—— --------------------- -10 — number of not relevant answers
Thus the score for each dimension ranges from 1 to 5, with a higher score implying a 
stronger tendency towards displaying that eating behaviour dimension.
2.2 Anthropometry, body composition and blood pressure (BP)
2.2.1 Apparatus and equipment
• Harpenden stadiometer
• Tanita TBF-300A body composition analyser (Tanita Europe BV, Netherlands)
• Flexible tape measure
• Omron M X3 BP monitor (Omron Healthcare U K  Ltd, Milton Keynes, U K )
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Anthropometric measures and BP were measured at screening sessions and on study 
days. On study days, these were performed in the morning after a 12 h fast.
Height was measured using a Harpenden stadiometer without shoes. Participants stood 
erect, facing ahead in a horizontal plane with their back to the stadiometer with their 
heels, buttocks, shoulder blades and back o f  the head touching the wall, ankles together, 
knees straight and arms by their side. The measuring bar was gently lowered to touch 
the top o f the participant’ s head and height was recorded to the nearest 0.1 cm.
B W  and % body fat were measured non-invasively using the Tanita TBF-300A body 
composition analyser (Tanita Europe BV , Netherlands). Participants were asked to not 
apply body lotion and to urinate immediately prior to taking measurements, and 1.0 to
1.5 kg was subtracted to allow for the weight o f clothes (depending on clothes worn).
The Tanita TBF-300A assesses body composition indirectly by bioimpedance 
analysis (B IA ) through the lower half o f the body. A  safe electrical signal is sent 
through the body via the pressure contact foot pad electrodes which participants are 
asked to step onto in bare feet. The Tanita directly measures B W  and the bioelectric 
impedance (defined as the strength and speed o f an electrical signal travelling through 
the body, measured in Ohms) using the conductive properties o f  the legs. %  body fat, 
fat free mass and other parameters are then calculated on the basis o f measured B W  and 
bioelectric impedance and other variables including age, height, gender and body type 
(standard or athletic). The use o f  the Tanita to assess %  body fat has been previously 
validated and found to be highly correlated with the gold standard assessment method, 
duel energy x-ray absorptiometry (D E X A ) in non-obese individuals (Boneva-Asiova 
and Boyanov, 2008).
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Waist circumference was measured with a flexible tape measure, with the participant 
standing erect and their arms relaxed by their sides. The measurement was taken under 
clothes and around the navel for standardisation. Participants were asked to breathe out 
gently and the measurement was recorded at the end o f expiration to the nearest 0.5 cm.
BP was measured in triplicate using the Omron M X3 BP monitor (Omron Healthcare 
U K  Ltd, M ilton Keynes, U K ) with the participant in a relaxed sitting position. The cuff 
was wrapped tightly but without extensive pressure (so an index finger could be inserted 
between the cu ff and arm) around the upper non-dominant arm. The participant was 
asked to remain relaxed and refrain from movements during the measurements.
2.3 Subjective and quantitative assessment of appetite and palatability
2.3.1 Visual Analogue Scales to assess appetite and palatability
Effects o f the nutrition interventions reported in this thesis on appetite were subjectively 
assessed by asking participants to complete V A S  regarding hunger sensations, 
prospective food consumption, feelings o f fullness, the desire to eat something sweet, 
salty, savoury or fatty, and for some studies the desire to eat a meal or snack (H ill and 
Blundell, 1982). The reliability and validity o f using V A S  as a tool to subjectively 
assess appetite has been reviewed in Chapter 1 (section 1.4.3)
Participants completed a set o f V A S  at baseline (in duplicate), and then every 30 min 
follow ing the test preload until the end o f the study, generating a temporal profile for 
each attribute under investigation. The V A S  comprised a 100 mm line with each end 
representing the most extreme sensation associated with the attribute (Figure 2.1 and 
Appendix D). Participants were asked to mark the point on the line that they felt best 
represented their feelings o f  the attribute under investigation at the time. Each set o f
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V A S  were presented as an individual booklet for each timepoint, with each question 
presented on a separate page. A  new booklet was provided for each timepoint. For 
analysis, ratings were converted into scores in mm taking the left anchor as the origin.
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Nothing at all
H ow  much do you think you can eat?
A  lot
Not at all full
H ow  fu ll do you feel?
Extremely
full
F igure 2.1. Example V A S  to assess sensations regarding appetite.
V A S  were also used to assess palatability o f test products used in clinical investigations. 
These were again presented as booklets with each question on a separate page. 
Attributes investigated included pleasantness o f taste, texture and aftertaste.
2.3.2 A d libitum pasta based test meal
Quantitative assessment o f appetite was carried out follow ing the “preload-test meal” 
paradigm (reviewed in Chapter 1, section 1.4.2 and 1.4.4), investigating the impact o f 
the preload under investigation on subsequent E l at an ad libitum  test meal.
The ad libitum  test meal used in all appetite studies reported in this thesis comprised a 
homogenous pasta dish made to a standard recipe. The meal was made by cooking 
Tesco Fusilli Pasta Twists (400 g dry weight) for 12-15 min which was then drained and 
mixed with Ragu Original Pasta Sauce (500 g), Tesco M ild Cheddar (100 g) and Tesco
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Vegetable O il (30 g). The dish supplied 9750 kJ (2330 kcal), 81.5 g protein, 339.1 g 
CHO, 70.0 g fat, 15.9 g fibre and had a mean weight o f 1517 [SD 45] g and E density o f 
6.4 [SD 0.19] lcJ/g, which far exceeds a usual portion size. The weight and E density 
varied due to differing amounts o f water absorbed by the pasta during cooking, which 
was accounted for when calculating EI.
The ad libitum  test meals were served to participants seated in isolated booths 
free from distraction. The pasta meal was presented on a tray in a large serving bowl 
pre-weighed prior to serving along with a smaller dish and a 250 ml glass o f tap water. 
Participants were instructed to serve themselves from the large serving bowl into the 
smaller dish, and to eat until they were comfortably full. They were informed any 
leftovers could be taken home to discourage them from over-eating. The amount 
consumed was determined by re-weighing the meal after the participant had eaten, and 
the corresponding EI and macronutrient intake was calculated.
2.33 24 h intake
Food and drink diaries were completed for the remainder o f the day on study days to 
determine 24 h intake and were analysed for EI, macronutrient and fibre intake using 
WinDiets Professional 2005 (The Robert Gordan University, Aberdeen, U K ). The Food 
Standards Agency (F S A ) Food Portion Sizes book was used as a guide when actual 
quantities were not described (Food Standards Agency, 2002), with a medium portion 
assumed when the portion size was not given. When actual brands were given, the 
nutritional values for the products were input into the program and used. In this thesis 
values for fibre intake are based on non-starch polysaccharide quantities from Windiet.
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2.4 Breath hydrogen analysis
2.4.1 Equipment
e Gastrolyzer 2 portable hand held breath hydrogen (H 2) monitor (Bedfont Scientific 
Ltd, Rochester, U K )
• Disposable T-pieces (Bedfont Scientific Ltd, Rochester, U K )
• Universal disposable cardboard mouthpieces (Bedfont Scientific Ltd, Rochester, U K )
• 200 ppm H2 in air calibration gas (Bedfont Scientific Ltd, Rochester, U K )
2.4.2 Method
During the ND C supplementation study, breath H 2 concentrations in expired breath 
were monitored at baseline and at regular time intervals postprandially as outlined in the 
study protocol (reported in Chapter 7) using a Gastrolyzer 2 breath H2 monitor (Bedfont 
Scientific Ltd, Rochester, U K ).
Disposable cardboard mouthpieces were connected to the Gastrolyzer via a 
disposable T-piece, and it was ensured that all connections were pushed firm ly in place 
to prevent sample loss. To  operate, the ‘G o ’ button on the Gastrolyzer was pressed 
which initiated a 15 second countdown period. During this time participants were asked 
to inhale and then hold their breath. A t the end o f the countdown, participants slowly 
and gently exhaled into the Gastrolyzer via the cardboard mouthpiece, emptying the 
lungs as far as possible. The Gastrolyzer then analysed the exhaled breath to determine 
the breath H2 concentration (in parts per million, ppm).
The Gastrolyzer was calibrated at least once per month to 200 ppm using 200 
ppm H 2 in air calibration gas.
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2.5 Blood sampling
2.5.1 Venous blood sample collection
2.5.1.1 Equipment and consumables
• Centrifuge Labfuge 400R (Kendro Laboratory Products, Germany)
• Cannulae Y-can 19G and 21G with syringe valve (Beldigo SA, Marche, Belgium)
• 1 ml, 2 ml, 5 ml, 10 ml, 20 ml syringes (BD Plastipalc, Devon, UK)
• White card sample collection trays (Southern Syringe Supplies)
• 1 ml & 2 ml Fluoride oxalate tubes with screw cap (Teklab Ltd, Durham, UK)
«> 2 ml, 5 ml & 10 ml Dipotassium EDTA polystyrene tubes with screw cap (Teldab Ltd, 
Durham, UK)
• 6 ml plain red topped serum tubes (Southern Syringe Supplies)
° 5 ml Lithium Heparin tube with wadded cap (Teklab Ltd, Durham, UK)
*0.5 ml and 1.5 ml Apex plus microtubes (Alpha Laboratories, Hampshire, UK)
• Apex plus screw caps in various colours (Alpha Laboratories, Hampshire, UK)
2.5.1.2 Reagents
• 500 ml bag sodium chloride (NaCl) 0.9% IV solution (Royal Surrey County Hospital)
«50 ml vial Trasylol Aprotinin 10,000 KIU / ml (Bayer) -  used for study in chapter 3
«100 mg vial Aprotinin from bovine lung, A1153 2-8 TIU / mg solid (Sigma-Aldrich 
Company Ltd, Gillingham, Dorset, UK) -  used to prepare aprotinin solution (10,000 
KIU /  ml sodium chloride 0.9% solution) for study in chapter 7
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Venous blood samples were regularly collected from an indwelling intravenous cannula 
inserted into an antecubital vein as detailed in individual study protocols during clinical 
investigation days for the studies in Chapters 3 and 7.
Blood was collected from the cannula by syringe (disposing of the first 1-2 ml to 
account for dead-space in the cannula and to remove NaCl solution). Following blood 
collection from the cannula, 2 ml NaCl solution was injected into the cannula to keep 
the line patent.
Collected blood was immediately decanted into fluoride oxalate tubes for 
glucose analysis, dipotassium EDTA-coated tubes for insulin, non-esterified fatty acid 
(NEFA), and triglyceride (TAG) analysis, dipotassium EDTA-coated tubes with added 
aprotinin (200 klU/ml whole blood) for gut peptide (for example GLP-1, PYY, PP and 
Ghrelin) analysis and into plain serum (Chapter 3) or lithium heparin (Chapter 7) tubes 
for SCFA analysis.
Following collection, blood samples in serum tubes were allowed to clot for one 
hour at room temperature (RT) prior to separation of the serum. All other collected 
blood samples were gently mixed then stored at 4 °C to reduce degradation until 
processed. Samples were centrifuged at 1750 g (3000 rpm) for 10 min to separate the 
plasma from the red blood cells. Plasma and serum samples were aliquoted into 1.5 ml 
and 0.5 ml microtubes and stored at -20 °C until analysis. In order to minimize inter­
assay variability, samples were batch analysed at the end of each study.
2.5.2 Capillary blood sample collection
2.5.2.1 Equipment and consumables
• Centrifuge Labfuge 400R (Kendro Laboratory Products, Germany)
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* Glucose / Fluoride Microvette 300 pi tubes (Starstedt Ltd, Beaumont, Leicester, UK)
«0.5 ml Apex plus microtubes & screw caps (Alpha Laboratories, Hampshire, UK)
<» Accu-Chelc Softclix Pro finger pricker pen & lancets (Roche Diagnostics Ltd, Burgess 
Hill, UK)
2.S.2.2 Method
Capillary blood samples were collected by fingerprick at screening sessions and regular 
time intervals during the clinical investigation days for the studies in Chapters 4 and 5.
For the study detailed in Chapter 4 and during screening, collected blood 
samples were immediately analysed for blood glucose concentrations using the 
HemoCue 201+ (see 2.6.3.3). Blood samples were also analysed for blood Hb 
concentrations at screening using the HemoCue Hb 201+ (see 2.6.9).
For the study detailed in Chapter 5, capillary samples were collected into 300 pi 
glucose / fluoride microvette tubes for glucose and insulin analysis and were gently 
mixed then stored at 4 °C until processed. The samples were centrifuged at 1750 g 
(3000 rpm) for 10 min to separate the plasma from the red blood cells. The plasma was 
aliquoted into 0.5 ml microtubes and stored at 4 °C until analysed for plasma glucose 
concentrations using the YSI 2300 Stat Plus Glucose Analyser (see 2.6.3.2). Glucose 
analysis was carried out on the same day as blood collection. The remaining plasma was 
stored at -20 °C until analysis of plasma insulin concentrations. To minimize inter-assay 
variability, samples were batch analysed for insulin levels at the end of the study.
2.6 Blood, plasma and serum biochemical analysis
All frozen plasma samples were defrosted at 4 °C on the day of analysis, vortex mixed 
and then centrifuged at 1750 g (3000 rpm) for 5 min to separate the plasma from any 
fibrin that could be present and would otherwise interfere with accuracy of the assay.
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All samples batch analysed at the end of the clinical study were re-aliquoted into new 
microtubes prior to analysis.
2.6.1 Equipment
• ILAB 650 (Instrumentation Laboratory, Milan, Italy)
• Y S I2300 Stat Plus Glucose Analyser (YSI Incorporated, Yellow Springs, Ohio, USA)
• HemoCue Glucose 201 Plus (HemoCue Ltd, Sheffield, UK)
• Microplate Washer AW1 (Anthos Labtec Instruments, Wals, Austria)
• Microplate Luminometer LB 960 Centro (Berthold Technologies, Wildbad, Germany)
• Gamma Counter - Wizard with Multicalc level 4.M software (Wallac International, 
Turku, Finland)
• HemoCue Hb 201 Plus (HemoCue Ltd, Sheffield, UIC)
• Pipetman P20, P100, P200, P1000, P5000 & tips (Gilson Inc, Middleton, USA)
• Positive displacement C250 pipette & tips (Anachem Ltd, Luton, UK)
2.6.2 Consumables and reagents
• LP3 and LP4 test tubes (L.I.P. Ltd, Shipley, UK)
• Hemocue Glucose 201 microcuvettes (HemoCue Ltd, Sheffield, UK)
• Hemocue Hb 201 microcuvettes (HemoCue Ltd, Sheffield, UK)
• GlucoTrol 2.4, 6.0 and 9.7 mmol/1 for QC (HemoCue Ltd, Sheffield, UK)
• Glucose (Oxidase) analysis kit (Instrumentation Laboratory Co., Lexington, USA)
• Triglycerides analysis kit (Instrumentation Laboratory Co., Lexington, USA)
• NEFA analysis kit (Randox Laboratories Ltd, Co. Antrim, UK)
• Cholesterol analysis kit (Instrumentation Laboratory Co., Lexington, USA)
• Direct HDL-CholesteroI analysis kit (Instrumentation Laboratory Co., Lexington, 
USA)
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«Human insulin-specific RIA kit HI-14K (Millipore, Missouri, USA)
• Immuno-chemiluminometric insulin assay kit (Invitron Ltd, Monmouth, UK)
• Luminometer detection reagent kit (Invitron Ltd, Monmouth, UK)
• Insulin controls (Invitron Ltd, Monmouth, UK)
2.6.3 Analysis of plasma and whole blood glucose
Three different methods were adopted to analyse glucose concentrations:
2.6.3.1 ILAB 650
Plasma glucose concentrations of samples collected from the studies in Chapters 3 and 7 
were analysed by an enzymatic colorimetric method using the enzyme glucose oxidase 
(Instrumentation Laboratory Co., Lexington, USA) on the ILAB 650 (Instrumentation 
Laboratory, Milan, Italy). Glucose oxidase catalyses the oxidation of glucose to produce 
gluconic acid and hydrogen peroxide (H2O2).
D-Glucose + 0 2 + H20  -----------------------► Gluconic Acid + H20 2
All H2O2 generated then reacts with phenol and 4-aminoantipyrene, catalysed by 
peroxidase, leading to the production of red quinoneimine and water.
Peroxidas q
2 H20 2 + phenol + 4-aminoantipyrine----------------------- ► Red quinoneimine + 4 H20
The concentration of red quinoneimine generated is determined by measuring the 
absorbance at 510 nm. The concentration of red quinoneimine generated is directly 
proportional to the amount of glucose in the sample.
QCs were included at the start and end of each assay. Intra-assay coefficients of 
variation (CV) were <2.0 %  and <2.5 %  and inter-assay CV were 1.3 % and 2.5 % at 
5.31 mmol/1 and 14.0 mmol/1 respectively.
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2.6.3.2 Y S I 2300 Stat Plus Glucose Analyser
Plasma glucose concentrations of samples collected from the study in Chapter 5 were 
analysed using the YSI 2300 Stat Plus Analyser (YSI Incorporated, Yellow Springs, 
Ohio, USA), which uses an immobilized enzyme biosensor. The enzyme glucose 
oxidase is immobilised between two membrane layers, one comprising polycarbonate 
and the other cellulose acetate. As the injected sample enters the membrane layer, 
glucose oxidase catalyses the oxidation of glucose contained in the sample, with H2O2 
generated as a by-product.
Glucose oxidase
D-Glucose + 0 2  ► D-glucono-o-lactone + H20 2
Once generated, H2O2 passes through the cellulose acetate membrane into a platinum
anode. This catalyses H20 2 oxidation to generate electrons. The resultant current is
proportional to the glucose concentration of the injected sample.
_  Platinum anode ^ _
H20 2  ► 2 H+ + 0 2 + 2 e*
A 10 mmol/1 QC was included at the start and end of a run of samples for each 
participant. The intra-assay CV was <2 % and inter-assay CV was 1.2 %.
2.63.3 HemoCue Glucose 201 Plus
Glucose concentrations of whole blood capillary samples collected by fingerpriclc for 
the study in Chapter 4 and during screening were analysed with the HemoCue Glucose 
201 Plus (HemoCue Ltd, Sheffield, UK). The HemoCue Glucose 201 Plus is a portable 
photometric system which uses a glucose dehydrogenase photometric method.
The first drop of capillary blood drawn following fingerpriclc was wiped away 
and the next drop of blood was loaded directly from the fingertip onto a HemoCue 
microcuvette, with the correct volume of blood being drawn onto the cuvette by
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capillary action. Excess blood was wiped from the cuvette, then the cuvette was placed 
into the cuvette holder.
The microcuvette contains dried reagents saponin, nicotinamide-adenine 
dinucleotide (NAD), methylthiazolyldiphenyl tetrazolium (MTT), propylene glycol, 
ammonium chloride and sodium fluoride and an enzyme mix of glucose dehydrogenase, 
diaphorase and mutarotase. Once blood is introduced to the microcuvette, erythrocytes 
are haemolysed under the action of saponin to release their contents, including a-D- 
glucose which undergoes mutarotase catalysed conversion to (3-D-glucose. Glucose 
dehydrogenase (which is specific for (3-D-glucose) catalyses (3-D-glucose oxidation, 
generating NADH in quantities equimolar to available glucose.
Glucose dehydrogenase 
(3-D-Glucose + NAD+ --------------------  *  (3-D-Gluconolactone + NADH
In the presence of generated NADH, diaphorase catalyses the conversion of MTT to 
form a coloured formazan which is quantified photometrically at 660 nm and 840 nm. 
The formazin concentrations are directly proportional to sample glucose concentrations.
Diaphorase
MTT + NADH ---- -------► Formazan + NAD+
The HemoCue offers the advantage of being portable, providing instant results and only 
requiring a very small quantity of blood. The reliability and accuracy of the HemoCue 
system is reported to be good (Ashworth et al., 1992, Stork et al., 2005, Voss and 
Cembrowslci, 1993), although this finding is not unanimous (Torjman et al., 2001), 
particularly in neonates (Dahlberg and Whitelaw, 1997).
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Plasma TAG concentrations were analysed using an enzymatic colorimetric method 
(Instrumentation Laboratory Co., Lexington, USA) on the ILAB 650 (Instrumentation 
Laboratory, Milan, Italy). In this method, H20 2 is generated from TAG in 3 steps.
In the first step glycerol is generated from the lipoprotein lipase catalysed 
hydrolysis of TAG. The glycerol is then phosphorylated with adenosine triphosphate 
(ATP) to form glycerol-3-phosphate and adenosine diphosphate (ADP), catalysed by 
glycerol kinase. Glycerol-3-phosphate oxidase then catalyses the oxidation of glycerol- 
3-phosphate to generate dihydroxy acetone and H20 2.
Lipoprotein Lipase 
t a g _ L A  L > G lycero l+ FFA
Glycerol kinase
Glycerol + A TP-----------------------> Glycerol-3-P + ADP
Glycerol-3-P oxidase
Glycerol-3-P + 0 2 -----------------------► Dihydroxyacetone phospate + H20 2
Finally peroxidase catalyses the oxidative coupling of 4-chlorophenol and 4- 
aminophenazone in the presence of the generated H20 2 to form a quinoneimine red dye 
complex. The concentration of the generated quinoneimine complex is quantified by 
measuring absorbance at 510 nm and is directly proportional to the sample TAG 
concentration.
Peroxidase
H20 2 + 4-chlorophenol + 4-aminophenazone-----------------------► Red quinoneimine + H20
QCs were included at the start and end of each assay. Intra- and inter-assay CV were 
< 2 % and 1.25 % at 1.5 mmol/1 and <1 %  and 0.99 %  at 2.5 mmol/1 respectively.
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2.6.5 Analysis of plasma NEFA
Plasma NEFA concentrations were analysed using an enzymatic colorimetric method 
(Randox Laboratories Ltd, Co. Antrim, UK) on the ILAB 650 (Instrumentation 
Laboratory, Milan, Italy). In this assay, H2O2 is generated from NEFA in a two-step 
reaction. In the first step, the coupling of NEFA to Coenzyme A (CoA) is catalysed by 
Acetyl CoA Synthetase in the presence of ATP. The resultant Acyl CoA is then oxidised, 
catalysed by Acyl CoA Oxidase, to generate 2,3-trans-Enoyl-CoA and H2O2 .
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Acyl CoA Synthetase „  ___
NEFA + ATP + CoA  ------- ----------► Acyl CoA + AMP + PPi
Acyl CoA Oxidase
Acyl CoA + 0 2  ► 2,3-trans-Enoyl-CoA -1- H2Q2
Peroxidase then catalyses the oxidative coupling of N-ethyl-N-(2-hydroxy-3- 
sulfopropyl)-m-toluidine (TOOS) and 4-aminophenazone (4-AAP) in the presence of 
the generated H2O2 leading to the formation of a purple adduct.
Peroxidase
2 H20 2 + TOOS + 4 -A A P  ► Purple adduct + 4H20
The concentration of the purple adduct is quantified by measuring the absorbance at 550 
nm and is directly proportional to the concentration of NEFA in the sample.
QCs were included at the start and end of each assay. Intra- and inter-assay CV were 
respectively <3 % and 4.3 %  at 1.09 mmol/1 and <3.5 %  and 4.2 % at 1.11 mmol/1.
2.6.6 Analysis of plasma total cholesterol
Plasma total cholesterol concentrations were analysed 0 11 the ILAB 650 
(Instrumentation Laboratory, Milan, Italy) using a three-step enzymatic colorimetric 
method (Instrumentation Laboratory Co., Lexington, USA). In the first step, cholesterol
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esterase catalyses the hydrolysis of cholesterol ester. In the next step, the resultant free 
cholesterol is oxidised, catalysed by cholesterol oxidase, to generate H20 2. Finally, 
peroxidase catalyses the oxidative coupling of 4-aminoantipyridine (4-AA) with phenol 
in the presence of the generated H20 2, to form quinoneimine, a red dye complex.
Julia Darzi Thesis
Cholesterol esterase 
Cholesterol ester + H20  — -........ -....► Cholesterol + FFA
Cholesterol oxidase 
Cholesterol + 0 2 ------------------------► Cholest-4-en-3-one + H20 2
Peroxida so
H20 2 + 4-AA + p h en o l----------------------- ► Quinoneimine (red adduct) + 4H20
The concentration of generated quinoneimine is directly proportional to the 
concentration of total cholesterol in the original sample, and is quantified by measuring 
absorbance at 500 nm.
QCs were included at the start and end of each assay. Intra- and inter-assay CV were 
< 2 %  and2.2 % a t2 .4 mmol/1 and<1.5 % and 1.1 % a t5.1 mmol/1 respectively.
2.6.7 Analysis of plasma HDL-cholesterol
Plasma HDL-cholesterol concentrations were also analysed on the ILAB 650 
(Instrumentation Laboratory, Milan, Italy) using an enzymatic colorimetric method 
(Randox Laboratories Ltd, Co. Antrim, UK) that consists of two distinct reaction steps. 
In the first step, cholesterol esterase and cholesterol oxidase then catalase catalyse the 
elimination of chylomicron and VLDL- and LDL-cholesterol.
Cholesterol esterase 
Cholesterol ester + H20   ► Cholesterol + FFA
Cholesterol oxidase 
Cholesterol +  0 2  ► C holest-4-en-3-one + H20 2
Catalase
2H20 2  ► 2H20  + 0 2
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Following this elimination, surfactants activate the release of HDL-cholesterol. 
Cholesterol esterase then catalyses the hydrolysis of the released cholesterol ester to 
free cholesterol which is then oxidised to generate H2O2 .
Peroxidase catalyses the oxidative coupling of 4-aminoantipyridine (4-AA) with 
N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline (HDAOS) in the presence of the 
generated H20 2, forming a quinine imine dye complex (quinone pigment). During this 
second step, sodium azide inhibits catalase (used in the first step).
Peroxid
2H20 2 + 4-AA + HDAOS -------------------► Quinone pigment + 4H20
The concentration of generated quinone pigment is directly proportional to the sample 
cholesterol concentration, and is quantified by measuring absorbance at 600 nm.
QCs were included at the start and end of each assay. Intra- and inter-assay CV were 
<2 % and 0.18 % at 0.82 mmol/1, <2 %  and 0.21 % at 1.32 mmol/1 and <1.5 %  and 
0.10 %  at 1.88 mmol/1 respectively.
2.6.8 Analysis of plasma insulin
2.6.8.1 Radioimmunoassay
Plasma insulin concentrations for samples collected from the studies in Chapters 3 and 7 
were analysed using a Human Insulin Specific radioimmunoassay (RIA) kit (Millipore, 
St. Charles, Missouri). This assay determines plasma insulin concentrations by the 
double antibody / PEG technique, utilising human insulin antiserum raised in guinea pig 
and 125I-labelled human insulin.
The assay is 100 % specific for human insulin, <0.2 % specific for human 
proinsulin and des 31-32 split proinsulin, 76 % specific for des 64-65 split proinsulin, 
100 % specific for porcine and canine insulin, 62 %  specific for bovine insulin and 0.1
Julia Darzi Thesis
95
%  specific for rat insulin. There is no cross reactivity with insulin growth factor, 
glucagon, Somatostatin and PP. The lowest level of detection is 2 pU/ml and the limit 
of linearity is at a concentration of 200 pU/ml with a 100 pil sample. There is no cross­
reactivity with human proinsulin, therefore measuring true insulin concentrations.
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This is a two day assay. On day 1, plasma samples were defrosted at 4°C, then vortex 
mixed and centrifuged at 1750 g (3000 rpm) for 5 min to separate the plasma from any 
fibrin that could be present and would interfere with accurate pipetting. Samples were 
set up in duplicate in LP3 tubes in the order outlined in Table 2.1.
The 125I-insulin was hydrated by adding the entire contents of the supplied label 
hydrating buffer (containing Normal Guinea Pig serum as a carrier) and allowed to set 
at RT for at least 30 min, with occasional gentle mixing.
Table 2.1. Insulin R IA  protocol. Based on the Manufacturers information booklet 
(Millipore, Missouri, USA)
D a y ! Day 2
1 2 3 4 5 6 7 8
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Count
1,2 - - 100 pi - 1.0 ml
NSB 3,4 300 pi - 100 pi - 1.0 ml
Ref 5,6 300 pi - 100 pi 100 pi 1.0 ml
Standards 7-20 300 pi 100 pi 100 pi 100 pi 1.0 ml
QC 1 21,22 300 pi 100 pi 100 pi 100 pi 1.0 ml
QC 2 23,24 300 pi 100 pi 100 pi 100 pi 1.0 ml
Samples 25-n 300 pi 100 pi 100 pi 100 pi 1.0 ml
To start, assay buffer was added to all tubes except Total Count tubes, adding 300 pi to 
the non-specific binding (NSB) tubes, 200 pi to the zero-standard Reference (Ref) tubes 
and 100 pi to all remaining tubes, including standards, QC samples and plasma samples,
96
using an Eppendorf multipipette. The purpose of the NSB tube is to determine non­
specific binding of the label to assay tubes.
Next, 100 pi standard, QC or plasma samples were accurately dispensed in 
duplicate to relevant tubes using a positive displacement pipette. Purified recombinant 
human insulin standards were provided with the kit in the following concentrations: 2, 
5, 10, 20, 50, 100 and 200 pU/ml. When samples were available in only small volumes, 
50 pi of sample was added to the tube then an additional 50 pi buffer was also added.
Following this, 100 pi hydrated 125I-insulin was added to all tubes using a an 
Eppendorf multipipette, then 100 pi human insulin antibody was added to all tubes 
except Total Count tubes and NSB Tubes. The tubes were then covered, vortex mixed 
and incubated overnight at RT for 20-24 h.
On day 2 of the assay, 1.0 ml cold (4 °C) precipitating (ppt) reagent (Goat anti-Guinea 
Pig IgG serum containing 3% PEG) was added to all tubes except Total Count tubes. 
The tubes were covered, vortex mixed and incubated for 20-30 min at 4 °C, then 
centrifuged for 40 min at 4 °C at 1750 g (3000 rpm).
The supernatant was immediately aspirated under vacuum from all tubes, taking 
care not to disrupt the solid pellet. The pellet, containing the bound fraction, was 
counted on a gamma counter (Wallac Wizard 1470 with Multicalc level 4.M software). 
Insulin concentrations of each plasma and QC sample were determined by the Multicalc 
software based on the standard curve, Total Counts and NSB readings.
QCs were included at the start and end of each assay. Intra- and inter-assay CV were 
respectively 10.1 % and 8.4 % for QC level 1 (expected range 5.9 to 12.3 pU/ml) and
5.6 %  and 8.1 % for QC level 2 (expected range 20.4 - 42.4 pU/ml).
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Plasma insulin concentrations in capillary samples collected for the study reported in 
Chapter 5 were analysed using a Human Insulin Specific immunochemiluminometric 
assay (Invitron Ltd, Wyastone Business Park, Monmouth, UK). This is a two-site 
immunoassay which employs an insulin-specific solid phase antibody immobilised in 
mitrotitre plate wells, and a soluble chemiluminescent-labelled antibody. This assay 
requires only small plasma volumes (25pi per well), making it suitable to analyse 
capillary plasma samples collected by fingerprick.
Plasma samples were defrosted, and all kit components and samples were brought to 
RT. Samples were vortex mixed then centrifuged at 1750 g (3000 rpm) for 5 min at RT 
to separate the plasma from any fibrin that could be present. Standards supplied with the 
kit (ranging from 0 to 200 mU/1) were reconstituted by the addition of deionised water 
(1 ml), allowed to set for 5 min, then mixed gently to ensure all solids were in solution. 
Working strength chemiluminescent-labelled antibody solution was prepared by 
accurately pipetting labelled antibody concentrate (900 pi) into a bottle of antibody 
diluent, and working strength wash buffer was prepared by diluting 1 part wash buffer 
concentrate with 9 parts deionised water.
Working strength chemiluminescent-labelled antibody solution (100 pi) was 
accurately pipetted into each mitrotitre plate well being used, followed by 25 pi 
standard, QC or sample. All standards, QCs and samples were analysed in duplicate. 
The plate was sealed with the supplied plate sealers and was incubated at 37 °C for 2 h. 
Following incubation, the plate sealers were removed and the plate was washed with 
working strength wash buffer in triplicate using an automatic plate washer, Microplate 
Washer AW1 (Anthos Labtec Instruments, Wals, Australia). The luminescence of the
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bound label was quantified using a microtitre plate luminometer, Microplate 
Luminometer LB 960 Centro (Berthold Technologies, Wildbad, Germany).
This assay cross-reacts 100% with insulin, 1.2% with intact proinsulin, 1.6% with 32-33 
split proinsulin, 0.8% with des 31-32 split proinsulin, 23% with 65-66 split proinsulin 
and 44% with des 64-65 split proinsulin and does not cross react with C-peptide.
QCs were included at the beginning of each assay. Intra and inter-assay CV were 5.8 % 
and 22.3 % at 12.5 pmol/1, and 11.3 % and 26.9 % at 162 pmol/1 respectively.
2.6.9 Analysis of blood haemoglobin
Hb concentrations of whole blood capillary samples collected by fingerprick during 
screening were analysed with the HemoCue Hb 201 Plus (HemoCue Ltd, Sheffield, 
UK), utilising a modified azidemethemoglobin photometric method.
The first drop of capillary blood drawn following fingerprick was wiped away 
and the next drop of blood was loaded directly from the fingertip onto a HemoCue 
microcuvette, with the correct volume of blood being drawn onto the cuvette by 
capillary action. Excess blood was wiped from the cuvette, then the cuvette was placed 
into the cuvette holder.
The microcuvette contains dried reagents sodium deoxycholate, sodium nitrite 
and azide. Sodium deoxycholate activates the disintegration of erythrocyte membranes 
to release Hb. Iron within the Hb is then oxidised from the ferrous to the ferric state 
under the action of sodium nitrite, to form methemoglobin, which is then coupled with 
azide to form azidmethemoglobin, a dye complex. The concentration of generated 
azidmethemoglobin is quantified photometrically at 570 nm and 880 nm and is directly 
proportional to the Hb concentration in the sample.
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2.7 Urinary SCFA biochemical analysis
Dr Douglas Morrison at SUERC analysed the urine samples collected in the study 
reported in Chapter 6 by GC-MS (gas chromatography-mass spectrometry) to quantify 
SCFA levels. Prior to analysis the urine samples were thawed defrosted at 4 °C, purified 
and derivatised as previously described (Morrison et al., 2004) and outlined below.
2.7.1 Equipment
• GC-MS (Hewlett Packard 5890 II GC; Optic II temperature programmable injector; 
Fisions Instruments A200S autosampler; VG Trio-1000 quadrupole MS with electron 
ionisation)
• GC column Rtx-5MS 30m x 0.25 mm x 0.25 pm (Thames Restelc, Saunderton, UK)
• Solid phase extraction (SPE) manifold (International Sorbent Technology, UK)
2.7.2 Consumables and reagents
• Amicon Centriplus YM-30 centrifugal filter device (Millipore Ltd., Watford, UK)
• SPE Bakerbond SDB-2 disposable cartridges 200 mg, 3 ml capacity (Mallinclcrodt 
Baker UK, Milton Keynes, UK)
• 2 ml crimp-cap and 1 ml tapered vials (Chromacol, Welwyn Garden City, UK)
• 3-methylvaleric acid (3-MV) internal standard (IS) (Sigma Aldrich, Poole, UK)
• ferf-butyldimethylsilyl chloride (/BDMS-C1) (Flulca Chemical Co., Poole, UK)
2.7.3 Sample preparation and GC-MS analysis
Thawed 2.5 ml aliquots of urine or deionised water (for process blank), 4 M NaCl 
solution (2.5 ml) and IS (400 nM 3-methylvaleric acid solution in 0.15 M NaOH) were 
added to 25 ml plastic universal bottles and vortex mixed. When necessary 0.15 M
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NaOH solution was added to adjust to pH 7-8. This mixture was applied to a centrifugal 
filter device (Amicon Centriplus YM-30) and centrifuged at 3000 g for 2 h to remove 
proteins and other high molecular weight materials by ultrafiltration.
The resultant ultrafiltrate was acidified with 6M HC1 to pH 2-2.5 then loaded 
onto Bakerbond SDB-2 SPE cartridges (Mallinckrodt Baker, UK) mounted in a SPE 
manifold (International Sorbent Technology, UK), that were pre-conditioned with 2 x 2  
ml methanol (MeOH), then 1 x 2 ml distilled water then 1 x 2 ml 0.1M HC1. SCFA in 
the urine sample were eluted with 2 x 500 pi MeOH into 100 pi 1M NaOH in 2 ml 
crimp cap vials (Chromacol, UK) to form stable, non-volatile Na salts of the SCFA. The 
vial contents were mixed and dried overnight at 55 °C. Vials were capped and stored at 
RT until ready for analysis.
On the day of analysis the SCFA Na salts were acidified with 4 M HC1 (50 pi) then 
extracted into diethyl ether (400 pi). An aliquot of the ether extract (50 pi) was 
transferred to a 1 mL tapered vial (Chromacol, UK) containing dry acetonitrile (100 pi) 
and /BDMS-C1 (Fluka Chemical Co., UK) and heated at 60 °C for 1 h to form SCFA 
/BDMS esters (which are easily identified by MS).
Samples were analysed by GC-MS on the day of derivatisation following the 
program sequence previously described (Morrison et al., 2004). The method was 
calibrated with the use of external SCFA standard solutions relative to IS.
2. 8 Estimation of insulin sensitivity
2.8.1 Fasting insulin sensitivity
Fasting insulin sensitivity (Si) was assessed by Homeostasis Assessment Model 
(HOMA) using the HOMA2 Calculator Version 2.2 (University of Oxford, Oxford, 
UK). The HOMA model estimates steady state (3-cell function (%B), insulin sensitivity
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(%S), and insulin resistance (HOMA IR), which is the reciprocal of %S (100/%S) from 
paired fasting plasma glucose and plasma insulin (or C-peptide) concentrations (Levy et 
al., 1998, Matthews et al., 1985, Wallace et al., 2004).
2.8.2 Postprandial insulin sensitivity
Postprandial insulin sensitivity (Oral Si) was assessed using the minimal model index 
method (Caumo et al., 2000), which was designed to mathematically describe how 
exogenous glucose reaches the systemic circulation. It is essentially assessing non­
insulin dependent glucose disposal.
In this model, Oral Si is estimated following ingestion of CHO, based on the CHO load 
within the specific meal, basal and postprandial plasma glucose and insulin 
concentrations at each timepoint and the individual’s BW, using the following equation 
in Figure 2.2.
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Figure 2.2. Equation used to estimate Oral Si. Taken from (Caumo et al., 2000)
A U C
AUcT&Wn ~ GB' AUC [As(T>/s(t)
Oral 5/ — f  • IW  AUC [M t )]
Where: f  = fraction of ingested CHO to reach peripheral circulation as glucose
(a nominal value of 1 was used for f  for all participants in all studies) 
Dorai = dose of ingested CHO per unit BW (mg/kg BW)
GE = glucose effectiveness (fixed at 0.024 dl/kg.min)
AUC = area under curve calculated from time zero until test end for glucose
(g(t)) and insulin (i(t))
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This equation is used when postprandial glucose concentrations remain above basal 
glucose levels, with an adapted equation being used when postprandial glucose 
concentrations fall below basal levels (Caumo et al., 2000). The model assumes total 
glucose disposal from the system is equal to the amount o f glucose entering the 
peripheral circulation when basal levels are reached, allowing for first pass extraction 
by the liver, and that the rate o f  GE is constant for the entire study period (Caumo et al., 
2000).
2.9 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0 (SPSS Inc., 
Chicago, U S A ) as described within the methods section o f individual chapters, with 
statistical significance assumed at p<0.05 unless otherwise stated.
A ll data was first tested for normality using the Kolmogorov-Smirnov test. Data was 
assumed to be normally distributed i f  the p value was not significant. Data was 
compared using parametric tests when normally distributed and non-parametric tests 
when not normally distributed, as stated within individual chapters.
The A U C  for temporal data such as postprandial plasma metabolites and subjective 
V A S  ratings were calculated using the trapezoidal rule.
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Chapter 3Az Sensory evaluation of propionate-rich sourdough 
bread to assess suitability for use in appetite studies
3.1 Introduction
It has previously been found that product palatability can influence appetite and the 
metabolic response to nutrients (reviewed Chapter 1, section 1.11). Therefore, in order 
to eliminate the potential confounder o f product palatability in appetite investigations it 
is necessary to ensure test and placebo (P L ) products are equally palatable.
Therefore, prior to commencing the study reported in Chapter 3B, a sensory evaluation 
o f the propionate-rich SOUR bread test product was carried out to determine i f  the 
sensory attributes o f the bread were acceptable and appropriately matched to the P L  
bread product. The sensory evaluation was carried out fo llow ing well established 
methodology reported in British Standard documents (ISO, 1992, ISO, 2003, ISO, 2004, 
ISO, 2005b, ISO, 2005a, ISO, 2006) and included the paired test, triangle test, ranking 
and rating tests and the use o f  Hedonic Scales. The SOUR bread was initially 
manufactured using three different levels o f starter culture (1 ,2  and 3% domani starter 
culture), so the sensory evaluation tests were designed to investigate the acceptability o f 
the bread products at each level o f  starter culture.
3.2 Aims
The sensory evaluation therefore aimed to investigate the sensory attributes o f a novel 
propionate-rich SOUR bread made using either 1, 2 or 3% domani starter culture in 
comparison to a visually identical P L  bread (made without starter culture) in order to 
assess i f  the novel SOUR bread would be acceptable to volunteers in further studies.
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3.3 Methods 
3.3.1 Participants
Fourteen healthy participants (four male, ten female) aged between 25 and 45 y were 
recruited from the student and staff population at the University o f Surrey by e-mail 
advertisement. To  assess suitability for inclusion participants completed a Lifestyle and 
Medical Questionnaire and DEBQ (see section 2.1) prior to participating.
For inclusion, participants were required to have a restraint score o f  <3.5 
(assessed using the DEBQ ) and have been stable weight for at least 3 months. Exclusion 
criteria included currently pregnant or breast feeding, on a weight reducing diet, history 
o f  gastrointestinal disorders, history o f eating disorders, drug or alcohol abuse in the last 
2 y, current habitual smoker or high habitual alcohol intake (>20 units per week).
The mean participant age was 29.1 [SD 6.4] y and mean DEBQ restraint, 
emotional and external cue scores were 2.3 [SD 0.6], 2.0 [SD 0.5] and 2.7 [SD 0.6] 
respectively.
3.3.2 Ethics
A ll participants gave written consent prior to commencing the study. Approval for the 
study was granted by the University o f Surrey Ethics Committee on 14th March 2007 
(EC/2007/18/SBMS), and the study took place during March and April 2007 in the C IU  
at the University o f Surrey.
3.3.3 Study protocol
Participants attended in the mid-afternoon at approximately 14.30 h on one occasion 
follow ing a 2 h fast. The sensory evaluation questionnaires were designed to be self- 
explanatory, therefore upon arrival fo llow ing a short brief participants were seated in
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individual cubicles free from external noise, smells and other potential distractions, and 
away from other participants.
Once seated in the cubicle, participants were presented the sensory evaluation 
questionnaire, which comprised six separate tests (see 3.3.5). Tests were presented to 
participants three at a time (i.e. Tests 1, 2 and 3, then Tests 4, 5 and 6), with 15 min 
allowed per three tests. Boiled and cooled water was provided as a palate cleanser to 
rinse the mouth in between each test. Once all six tests were completed, participants 
were free to leave the CIU.
Bread samples were identified by a random three digit number between 001 and 999 
unique to each sample test to avoid samples in previous tests being identified as the 
same bread. The numbers used were also unique to each questionnaire for each 
participant. Samples were presented in plain cake cases labelled with the sample 
number and placed on disposable paper plates labelled with the corresponding test 
number.
3.3.4 Test products
The SOUR and P L  bread test products were manufactured and supplied by Holgran (a 
trading name for R H M  Group Limited). The SOUR bread was made using a starter 
culture, Domani, containing microflora that favour the production o f propionate. The 
Domani culture was used at a level o f 1 %, 2 % and 3 %, resulting in SOUR bread 
containing increasing quantities o f propionate (Table 3.1). The non-sourdough P L  bread 
was made using yeast.
The SOUR and P L  breads were visually identical (white sliced bread) and well 
matched for energy, macronutrient and fibre content (Chapter 3A, Table 3.7).
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Table 3.1. Propionate concentrations in non-sourdough P L  bread and SO U R  
bread made using 1%, 2% and 3% Domani starter culture.
Propionate levels determined by analysis by Holgran
Bread Propionic acid Calcium propionate T O T A L
mg/kg mmol/kg mg/kg mmol/kg mg/kg mmol/kg
P L 31 0.42 39 0.21 70 0.63
1% SOUR 855 11.55 1077 5.78 1932 17.33
2% SOUR 1675 22.64 2111 11.34 3786 33.98
3% SOUR 2365 31.96 2980 16.00 5345 47.96
3.3.5 Sensory evaluation questionnaire
Six different tests were included in the sensory evaluation questionnaire (see Appendix 
F), all designed follow ing British Standard Guidelines (ISO, 1992, ISO, 2003, ISO, 
2004, ISO, 2005b, ISO, 2005a, ISO, 2006) as outlined in Table 3.2.
Table 3.2. Procedure for tests used in sensory evaluation.
Test Procedure
Paired Test 
( Test 1)
Participants were presented with 2 bread samples (3% domani 
SOUR and P L ) and asked to indicate which sample they preferred 
(ISO, 2005b).
Triang le  
D ifference Test
(Test 2)
Participants were presented with 3 bread samples (two samples o f 
3% domani SOUR and one sample o f P L  or vice versa) and asked 
to indicate which sample differs from the others (ISO, 2004).
R anking  Test 
(Test 3)
Participants were presented with 4 bread samples (1 ,2  and 3 %  
domani SOUR and P L ) and asked to rank them in order o f 
preference (ISO, 2006).
Acceptability Test 
(Test 4)
Participants were presented with 4 bread samples (1, 2 and 3% 
domani SOUR and P L ) and asked to indicate how much they like 
each sample using a 9 Point Hedonic Scale (ISO, 2003).
R ating  Tests 
(Tests 5 &  6)
Participants were presented 2 bread samples (3%  domani SOUR 
and P L ) for each attribute being assessed (Test 5 -  aftertaste, and 
Test 6 - acidic taste) and asked to evaluate the intensity o f each 
attribute using quantitative dynamic response scales (ISO, 2003).
107
In order to minimise bias, bread samples were presented in different permutations for 
each participant. For example in the Paired and Rating Test where two samples were 
presented (SOUR 3% and PL ), samples were given in the order SOUR, P L  for some and 
PL, SOUR for others.
3.3.6 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0. Differences in 
the proportions o f participants indicating preference between P L  and 3 %  domani 
SOUR in the paired test and in proportions o f participants correctly identifying the odd 
sample out in the triangle difference test were compared using the chi-square goodness 
o f  fit test.
Ranking and acceptability scores for the P L  and 1 %, 2 % and 3 %  domani SOUR bread 
samples were compared by Friedman’ s A N O V A  analysis. Rating scores for aftertaste 
and acid taste o f  P L  and 3 % domani SOUR bread samples were compared using paired 
samples t-test analysis.
Differences were considered significant at a level o f p<0.05.
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3.4.1 Paired test
64% o f participants (9 out o f 14) indicated they preferred the 3 % domani SOUR bread 
to the PL. This was a non-significant finding when analysed using the chi-square 
goodness o f fit test.
3.4.2 Triangle difference test
The odd sample was correctly identified from a choice o f three samples (odd one out 
plus two identical samples) by 64 % o f participants (9 out o f 14). This was a non­
significant finding when analysed using the chi-square goodness o f  fit test.
3.4.3 Ranking & acceptability tests
As Table 3.3 shows, the rank scores for each o f the three types o f  SOUR bread (made 
using 1 %, 2 % and 3 % domani starter culture) and non-sourdough P L  bread did not 
differ significantly between bread types when analysed by Friedman’ s A N O V A .
Similarly, the acceptability scores for each o f the three types o f SOUR bread and 
P L  bread did not differ significantly between bread types when analysed by Friedman’ s 
A N O V A .
Table 3.3. Sum rank score and mean [SD ] acceptability score following sensory 
evaluation of P L  and SO U R  (1 % , 2 % &  3 % domani) breads
Comparisons carried out by Friedman’ s A N O V A  analysis (n=14)
P L  SO U R  P
1% 2% 3%
Sum rank score 36 34 39 31 NS
Mean acceptability score 5.6 [1.3] 5.9 [1.5] 5.9 [1.7] 6.2 [1.5] NS
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The ratings for both aftertaste and the level o f acidic taste did not differ significantly 
between the P L  non-sourdough bread and SOUR bread made using 3% domani starter 
culture (Table 3.4).
Table 3.4. Ratings of aftertaste and acidic taste following sensory evaluation of P L  
and SO U R  (3% domani) breads
Comparisons carried out by paired samples t test (n=14)
P L  SO U R  P
Mean SD Mean SD
Aftertaste 4.9 2.2 5.0 2.2 NS
Acidic taste 3.3 2.2 3.5 2.1 NS
3.5 Conclusion
The sensory evaluation found no significant differences in preference between P L  and 
3% domani SOUR breads. There were also no significant differences in identifying the 
odd one out when presented with two samples o f P L  and one o f 3% domani SOUR or 
vice versa. Furthermore, the sum rank scores o f  preference and the mean acceptability 
scores did not differ significantly between P L  and SOUR breads made using 1%, 2% 
and 3% domani starter. In addition, ratings for level o f  acid taste and aftertaste did not 
differ significantly between P L  and 3% domani SOUR.
These results indicate that the SOUR bread is equally acceptable to and
indistinguishable from PL, and is therefore suitable for use in appetite studies.
Furthermore, the SOUR bread made using the highest level o f domani starter culture
(3% ) can be used in these studies.
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Chapter 3B: Acute effects of a propionate-rich sourdough 
bread on appetite, food intake and metabolic response
3.6 Introduction
The provision o f Na propionate baked into bread is reported to significantly increase 
subsequent satiety (Liljeberg and Bjorck, 1996, Liljeberg et al., 1995). Additionally it 
acutely reduces postprandial glycaemia (Todesco et al., 1991, Liljeberg and Bjorck, 
1996, Liljeberg et al., 1995) and insulinaemia (Liljeberg et al., 1995, Liljeberg and 
Bjorck, 1996, Darwiche et al., 2001) (reviewed in sections 1.8.1 and 1.9.1), suggesting 
propionate rich bread may be a promising functional food product. Possible 
mechanisms include delayed gastric emptying (Liljeberg and Bjorck, 1996, Darwiche et 
al., 2001), and via activation o f the SCFA receptors GPR41 and GPR43 expressed in 
adipocytes which are reported to stimulate leptin release (Covington et al., 2006, X iong 
et al., 2004) and inhibit lipolysis (Ge et al., 2008, Hong et al., 2005) respectively when 
activated (see section 1.7). Postprandial effects on plasma N E F A  and T A G  have not yet 
been investigated.
There were however various weaknesses with the study design in previous studies, 
particularly in investigating effects on appetite. Appetite in humans is regulated by a 
complex array o f  stimuli within a psychobiological system (Blundell et al., 1994, 
Blundell and Halford, 1994), therefore the study design for investigations into effects on 
appetite require careful consideration. In previous studies (Liljeberg and Bjorck, 1996, 
Liljeberg et al., 1995), conclusions regarding effects o f oral propionate ingestion on 
satiety were based solely on results from a single bipolar rating scale that used 
confusing language (reviewed in section 1.8.1), with no quantitative assessment made, 
thus warranting further investigation. Instead, a set V A S  would be more suitable to
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assess appetite ratings. V A S  are w idely used in appetite research and although not 
without limitations, have been found to generate reproducible results (see section 2.2.3).
The previous studies also did not control for the palatability effects o f  the test products. 
Compared to PL, propionate-containing bread had a lower acceptability score (Liljeberg 
et al., 1995), and a meal with added propionate induced higher subjective nausea ratings 
(Frost et al., 2003). It is therefore conceivable that the propionate test products triggered 
differing cephalic phase responses from P L  due to their unpleasant taste, resulting in the 
observed metabolic and appetite effects.
In order to determine i f  observed effects following propionate ingestion are a 
physiological effect o f propionate in the G IT  or i f  they merely arise due to the 
orosensory properties o f propionate-containing products, it is necessary to control for 
palatability as far as possible.
A  sourdough starter culture (Domani) containing microflora favouring propionate 
production has been developed, resulting in a sourdough bread (SO U R ) naturally rich in 
propionate. Prior to carrying out the present investigation, the sensory attributes o f 
SOUR were evaluated relative to PL. SOUR was found to be acceptable and 
indistinguishable from P L  (reported in Chapter 3A ).
3.7 Aims
The aim o f this study was, therefore, to investigate the acute effects o f including 
sourdough bread (SOUR, made with Domani starter culture), as a component o f one 
meal, on appetite V A S  ratings, prospective food intake at a subsequent meal, 24 h 
intake and metabolic response compared to a visually and nutritionally identical placebo 
bread (PL, made without starter culture) o f equal palatability.
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3.8.1 Sample size calculations
This study was powered to look at the acute effects o f consuming a preload containing 
the SOUR on a main outcome o f ad libitum  intake 3 h postprandially. As it has 
previously been reported that 17 participants are required to detect a 500 kJ difference 
in E l in a crossover design study with a power o f  0.8 (Arvaniti et al., 2000) provided 
intake on the previous evening is standardised, we aimed to recruit a similar number to 
this study.
3.8.2 Participants
The study was conducted in twenty young, healthy participants (nine male, eleven 
female) aged between 18 and 35 y recruited from the student population at the 
University o f Surrey by e-mail advertisement. To assess suitability for inclusion 
participants completed a Lifestyle and Medical Questionnaire and DEBQ, and a fasting 
blood sample was collected by fingerprick to measure blood glucose and Hb levels at an 
initial screening session (see section 2.1).
For inclusion, participants were required to have a B M I o f 19 to 27 kgmf2, fasting blood 
glucose <6.0 mmol/1, Hb in the normal range, restraint score o f <3.5 (assessed using the 
DEBQ) and have been stable weight for at least 3 months. Exclusion criteria included 
currently pregnant or breast feeding, on a weight reducing diet, history o f  coronary heart 
disease, diabetes mellitus, gastrointestinal disorders, anaemia, clinical depression and 
other psychological disorders or o f  eating disorders, drug or alcohol abuse in the last 2 
y, current habitual smoker, high habitual alcohol intake (>20 units per week) and taking 
selected current regular medications (excluding contraceptives).
Julia Darzi Thesis
3.8 Methods
113
One participant used an asthma inhaler during acute episodes and another participant 
used migraine pain relief when required, 5 participants were taking oral contraceptives, 
one used a Mirena coil and one was fitted with a contraceptive implant.
Table 3.5 outlines the baseline participant characteristics. The mean participant age was 
25.1 [SD 4.6] y and B M I was 23.1 [SD 2.4] kgm'2. The mean age, B M I and BP did not 
differ significantly between genders, while the waist circumference, %  body fat and 
DEBQ restraint scores did.
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Table 3.5. Baseline participant characteristics1
Overall (n=20) Male (n=9) Female (n==11)
Mean SD Range Mean SD Range Mean SD Range
A g e / y 25.1 4.6 18-35 25.8 3.6 21-32 24.5 5.4 18-35
B M I/k g m '2 23.1 2.4 19.0-27.2 23.4 2.4
20.3-
27.3 22.8 2.7
19.0-
26.3
** Waist 
circumference / cm 78.3 3.4
64.3-
95.6 84.6 7.2
76.0-
95.6 73.1 5.3
64.3-
82.8
* *  Body fat /% 22.6 8.3 10.0-36.8 16.0 4.2
10.0-
22.0 28.0 6.8
13.3-
36.8
Systolic BP / mmHg 116 9.7 102-133 120 12.4 102-133 113 5.7 104-124
Diastolic BP / mmHg 69 5.6 59-77 67 5.3 59-75 70 5.8 62-77
*  DEBQ Restraint
.... / .. . .. .. .
2.1 0.67 1.0-3.4 1.8 0.72 1.0-3.4 2.4 0.50 1.7-3.1
Characteristics that differed significantly (p<0.05) and very highly significantly (p<0.001) between 
genders are denoted by (*) and (**) respectively
3.8.3 Ethics
A ll participants gave written consent prior to commencing the study. Approval for the 
study was granted by the University o f  Surrey Ethics Committee on 25th July 2007 
(EC/2007/50/SBMS), and the study took place during September to November 2007.
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3.8.4 Study protocol
Acute postprandial effects on plasma metabolites and appetite (assessed by subjective 
ratings and subsequent E l) in response to two breakfast preloads containing either 
propionate-rich SOUR bread or identical non-sourdough P L  bread were investigated 
using a randomised single-blind crossover study design.
Participants attended on two occasions at least one week apart and were assigned 
to the experimental condition (SO U R vs P L  containing breakfast preload, see 3.8.5 for 
further details), in a counter-balanced randomly assigned order (using randomizer.org). 
The breakfast preloads provided a total o f 6.0 and 0.1 mmol propionate respectively.
In addition, to control for hormonal variations throughout the menstrual cycle, 
female participants not using contraceptive methods that regulate hormonal levels (e.g. 
oral contraceptive, contraceptive implant) attended at approximately the same point o f 
the follicular phase in their menstrual cycle for each study day.
To  reduce within-subject variability, participants were instructed to refrain from 
unaccustomed exercise and alcohol during the 24 h preceding each study day and to 
approximately replicate their 24 h intake prior to each study day. A  standardised 
evening meal (low  fibre ready meal and dessert selected by participant) was provided 
and 24 h intake was recorded.
A ll study days took place at the Clinical Investigation Unit (C IU ) at the University o f 
Surrey. Participants were required to stay in the C IU  for the entire duration o f the study, 
although they were allowed to read, write, work on their computers or watch television 
(avoiding programmes with food cues).
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Figure 3.1 shows a timeline for the study day protocol.
On each study day, participants arrived at the C IU  at approximately 08.00 h follow ing 
an overnight fast o f  at least 12 h. Initially anthropometric measurements (%  body fat, 
weight, BM I, waist circumference) and BP were recorded. An intravenous cannula was 
then inserted into an antecubital vein and two fasting blood samples were taken (at time 
-30 and -5 min). Tw o initial V A S  to subjectively assess appetite (see 2.3.1) were 
completed follow ing each blood sample.
Participants were then provided with the breakfast preload (jam sandwiches 
made with SOUR or P L  bread, see 3.8.5) at time = 0 min which they were asked to 
consume within 15 min. The time taken to consume the test breakfast (satiation time) 
was recorded. Following breakfast, participants completed V A S  regarding the 
palatability and pleasantness o f the breakfast (see 2.3.1).
Blood samples were taken every 15 min for the first hour postprandially and half hourly 
for the follow ing two hours until lunch. In addition a set o f V A S  for fullness, hunger, 
prospective food consumption, desire to eat sweet / savoury / salty / fatty were 
completed at half hourly intervals. A fter removing the cannula, a large ad libitum  
homogenous pasta meal was served in a confined individual booth 180 min fo llow ing 
the breakfast preload, and participants were instructed to eat until comfortably full.
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Further details about the ad libitum  buffet meal and the conditions under which it was 
served are described in Chapter 2 (section 2.3.2).
Once the participants had finished their lunch they were free to leave and were asked to 
complete a food and drink diary for the remainder o f the day until 09.00 h the follow ing 
morning.
3.8.5 Test products and breakfast
The SOUR and P L  bread test products were manufactured and supplied by Holgran (a 
trading name for R H M  Group Limited). SOUR bread was made using a starter culture, 
Domani, containing microflora that favour the production o f propionate, while the PL  
bread was made using yeast. Apart from this, both breads were made using the same 
ingredients in the same quantities and the breads were visually identical. As shown in 
Table 3.6, the resultant SOUR bread contained higher levels o f  propionate (48 mmol per 
kg) than P L  (0.8 mmol per kg)
Table 3.6. Propionate levels in the SO UR  and non-sourdough P L  breads.
Propionate levels determined by analysis by Holgran
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Bread Propionic acid Calcium propionate T O T A L
mg/kg mmol/kg mg/kg mmol/kg mmol/kg
P L 31 0.42 39 0.35 0.77
SOUR 2365 31.96 2980 16.00 47.96
In a sensory evaluation (n=14) no significant differences in preference, odd one out, 
acceptability, ranking and rating tests were found between the SOUR and PL  bread 
(Chapter 3A), suggesting the SOUR is suitable for use in appetite studies.
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The preload breakfast provided 011 study mornings comprised jam sandwiches made 
using 126 g o f  the SOUR or P L  bread (equivalent to approximately 3 slices o f bread), 
24 g O livio spread and 45 g Tesco strawberry, plum or apricot jam. A ll ingredients were 
weighed to the nearest 0.1 g. In addition participants were served either 250 g water 01* 
Robinson’s Sugar Free orange, lemon or blackcurrant and apple squash. The jam and 
drink were selected by the participant at screening, and the same jam and drink were 
served on each occasion.
Table 3.7 summarises the nutritional and propionate content for the test 
breakfast made using either bread, demonstrating that SOUR and P L  breads are well 
matched for energy, macronutrient and fibre content. The nutritional analysis for the 
bread was determined by Holgran using samples taken from the actual batch used in the 
present study.
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Table 3.7. Nutritional content of the test breakfast. Samples analysed by Holgran
Energy CHO Protein Fat Fibre Propionate
kcal kJ g g g g mmol
PL 495 2082 77.1 9.4 16.3 3.5 0.1
SOUR 503 2116 79.0 9.6 16.3 3.2 6.0
3.8.6 Blood sampling and analysis
Blood samples were analysed for glucose, T A G , NEFA  and total and H D L cholesterol 
concentrations by an enzymatic calorimetric method using the IL A B  650 analyser 
(Instrumentation Laboratory, Milan, Italy) and insulin concentrations were analysed by 
R IA . Sufficient blood was also collected for gut peptide and SCFA  analysis although 
this was not carried out. More detailed descriptions o f the blood sample collection and 
analysis procedures are given in Chapter 2 (sections 2.5 and 2.6).
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3.8.7 Food diary analysis
Food and drink diaries were completed on the day before and the day o f the study. 
These diaries were analysed for EI, macronutrient and fibre intake using WinDiets 
Professional 2005 (The Robert Gordan University, Aberdeen, U K ). See Chapter 2 
(Section 2.3.3) for further details.
3.8.8 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0. Data was tested 
for normality using the Kolmogorov-Smirnov test. Differences in anthropometric 
variables between male and female participants were assessed non-parametrically using 
the Mann-Whitney test.
Differences in the effects o f consuming breakfast made with SOUR compared to P L  
bread on palatability V A S  scores, satiation times, EI at the buffet meal, EI and 
macronutrient intake during the 24 h preceding the study day and during the 24 h o f the 
study day were assessed by paired samples t-test i f  normally distributed, and by 
W ilcoxon signed-ranks test i f  not normally distributed.
The influence o f bread type on subjective appetite V A S  ratings and the postprandial 
metabolic responses were assessed by two-way (bread treatment x time) repeated 
measures A N O V A  and by comparison o f the A U C  and IA U C  using paired samples t- 
test. The A U C  for postprandial plasma metabolites and subjective appetite ratings were 
calculated using the trapezoidal rule.
Differences were considered significant at a level o f p<0.05.
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Figure 3.2 shows the mean V A S  scores in answer to the questions “ How pleasant is the 
taste o f this meal right now?”  and “ How pleasant is this meal right now?” . Paired 
samples t-test analysis determined bread type did not significantly influence the 
perception o f the pleasantness o f taste (mean score 70 [SD 17] mm for PL  and 67 [SD 
17] mm for SOUR) nor the palatability (75 [SD 14] mm for PL and 69 [SD 21] mm for 
SOUR).
Julia Darzi Thesis
3.9 Results
3.9.1 Palatability VAS scores
E xtrem ely
pleasant
a ) Pleasant taste
T  100
tZ! 40
20
N ot at all 
pleasant
SOUR
Extrem ely
palatable
b) M eal palatablity
C/3 40
> 20
Extrem ely
unpalatable
SOUR
Figure 3.2a. VAS ratings in answer to 
‘How pleasant is the taste of this meal 
right now?’
The bread type did not influence the 
ratings for taste.
Figure 3.2b. VAS  ratings in answer to 
‘How palatable is this meal right now?’
The palatability did not differ significantly 
between bread type.
Analyses conducted by paired-samples t- 
test. Results shown as mean with error 
bars representing the SEM (n=20)._________
Analyses conducted by paired-samples t- 
test. Results shown as mean with error 
bars representing the SEM (n=20).__________
The satiation time at breakfast also did not significantly differ between bread type, with 
participants taking 522 [SD 110] seconds to eat the SOUR breakfast and 504 [SD 133] 
seconds to eat the PL  breakfast.
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Selected subjective appetite ratings time-course curves as assessed by V A S  are shown 
in Figure 3.3.
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3.9.2 Subjective appetite ratings
a) How hungry do you feel?
c) How much do you think you can eat?
Yes, very much
Time (min)
e) Would you like to eat something savoury?
Time (min)
Extremely full
- r  loo-
b) How fu ll do you feel?
Yes, very much
Time (min)
d) Would you like to eat something sweet?
Time (min) 
f )  Would you like to eat something fatty?
Figure 3.3. Subjective appetite ratings following PL  ( - •  - ) and SO U R  ( - ▲ - )
SOUR treatment did not significantly influence any subjective appetite ratings except 
desire to eat sweet (p=0.024). Analyses were carried out by two-way repeated measures 
A N O V A . Results shown as mean with error bars representing the SEM (n=20).
Two-way repeated measures A N O V A  analysis found no significant effects o f treatment 
on hunger, fullness, prospective consumption, desire to eat something savoury, desire to 
eat something fatty or desire to eat something salty (graph not shown). However, the 
desire to eat something sweet was found to be significantly lower (p=0.024) follow ing
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the SOUR breakfast compared to PL. In addition, a significant treatment x time 
interaction was found for the desire to eat something fatty (p=0.010).
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Comparison o f the A U C  (Table 3.8) and IA U C  (data not shown) for the V A S  appetite 
ratings from 0 to 180 min found no significant differences between SOUR and P L  
treatment for all V A S  questions except the A U C  for the desire to eat something sweet 
(p=0.022, paired samples t-test, n=20). Differences between SOUR and P L  were 
compared by paired t-test when normally distributed or W ilcoxon signed-ranks test 
when not normally distributed.
Table 3.8. A U C  (0-180 min) for VA S  appetite ratings after P L  and SO U R  preloads
N o significant differences between preloads found except for the desire to eat something 
sweet. Analysis was carried out by paired-samples t-test or W ilcoxon signed-ranks test 
as appropriate. Values are mean [SD ] (n=20).
VA S rating PL SO U R
Mean SD Mean SD P
Hunger 7193 2564 6449 2519 NS
Fullness 8279 3178 8834 2503 NS
Prospective consumption 8186 2927 7755 2718 NS
Desire for sweet 7483 3998 5745 3596 0.022
Desire for savoury 9521 2944 8370 3847 NS
Desire for fatty 6503 4025 5377 3842 NS
Desire for salty 6722 4209 5939 4158 NS
When the data was sub-divided by gender, no significant treatment effects were found 
within either sub-group for any o f the appetite ratings.
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3.9.3 Quantitative appetite assessment
3.9.3.1 Intake at the ad libitum test meal
Figure 3.4 shows the mean El o f the ad libitum  pasta meal 3 h following the test 
breakfast preload. The mean intake follow ing PL  breakfast preload (527 [SD 188]g, 
3438 [SD 1225] kJ) did not differ significantly from the mean intake following the 
SOUR breakfast (531 [SD 163] g, 3469 [SD 1078] kJ), when analysed by paired sample 
t-test. Differences in intake were also non significant when sub-divided by gender.
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Male (n=9) Female (n = ll) OVERALL (n=20)
Figure 3.4. E l of ad lib itum  pasta test meal provided 3 h postprandially
Bread type did not significantly influence intake within the overall sample (n=20) or 
within male (n=9) or female (n= 11) sub-groups. Analyses were carried out by paired 
samples t-test. Results shown as mean with error bars representing the SEM._____________
Additionally, the mean satiation time at the ad libitum lunch did not differ between PL 
(639 [SD 170] seconds) and SOUR (632 [SD 164] seconds) treatment. Again 
differences in satiation time were also non significant when sub-divided by gender.
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3.93.2 Intake during 24 h period following preload
The mean E l and macronutrient intake for the entire study day (including food provided 
during the study morning) follow ing P L  and SOUR based preloads is shown in Table 
3.9. Mean E l follow ing the SOUR breakfast was over 500 kJ lower than follow ing PL, 
however this difference was non significant. When intake from alcohol was removed 
from the analysis, the difference in E l between treatments remained non significant. 
There were also no significant differences between treatments for macronutrient and 
alcohol intakes when analysed using paired-samples t-test for parametric data and 
W ilcoxon signed-ranlcs test for non-parametric data.
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Table 3.9. Energy and macronutrient intake 24 h after PL  and SO U R  preloads
N o significant effect o f bread treatment on energy and macronutrient intake was found. 
Analysis was carried out by paired-samples t-test or W ilcoxon signed-ranlcs test as 
appropriate (n=20).
PL SO UR
PMean SD Mean SD
Energy (kJ) 9751 2076 9208 2375 NS
Fat (g) 78.8 22.3 71.1 30.7 NS
Protein (g) 75.0 19.2 71.9 22.6 NS
C H O  (g) 320.0 77.2 307.2 65.9 NS
Fibre (g) 15.7 4.5 15.4 3.7 NS
Alcohol (g) 4.8 12.5 5.2 20.4 NS
There was also no difference in % contribution o f macronutrients and alcohol to the 
total 24 h E l between P L  and SOUR (Table 3.10).
Table 3.10. % contribution to E l by each macronutrient and alcohol 24 h after PL  
and SO U R  preloads. N o significant effect o f  bread treatment was found when analysed 
by paired-samples t-test (n=20).
P L SO UR
PMean SD Mean SD
Fat % E I 30.3 4.9 28.7 6.3 NS
Protein % E I 12.9 2.1 13.1 1.9 NS
C H O  % E I 55.2 7.1 56.9 7.2 NS
Alcohol % E I 1.5 4.0 1.2 5.0 NS
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3.9.4 Postprandial plasma metabolites
3.9.4.1 Glycaemic response
The mean postprandial glycaemic response following consumption o f the PL  and SOUR 
breakfast is shown in Figure 3.5. Ingestion o f the SOUR breakfast led to a higher mean 
plasma glucose peak than PL  at 30 min. A  second increase in plasma glucose occurred 
at 120 min after both breads. Two-way repeated measures A N O V A  analysis found no 
significant treatment effects o f SOUR compared to PL  and no significant time x 
treatment effect.
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Time (min)
Figure 3.5. Postprandial plasma glucose concentrations
No significant influence o f SOUR treatment found by two-way repeated measures 
A N O V A  analysis. Results shown as mean with error bars representing the SEM (n=20)
Comparison o f the A U C  and IA U C  by paired t-test analysis also found no significant 
difference between SOUR and PL  treatment (data not shown).
Similarly no significant differences were found when sub-divided by gender.
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As shown in Figure 3.6, the mean postprandial plasma insulin response following 
ingestion o f the SOUR preload remained elevated above PL  from 45 to 90 min 
postprandially. Two-way repeated measures A N O V A  analysis indicated there was a 
treatment x time effect with a trend approaching significance (p=0.061) for the entire 
180 min, which was significant for the 60 min postprandially (p=0.033). However the 
overall treatment effect o f SOUR treatment was non significant compared to PL.
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3.9.4.2 Insulinaemic response
Tim e (m in )
Figure 3.6. Postprandial plasma insulin concentrations
N o significant effect o f SOUR treatment found by two-way repeated measures A N O V A  
analysis, although there was a treatment x time interaction with a trend approaching 
significance (p=0.061). Results shown as mean with error bars representing the SEM 
(n=20).______________________________________________________________________________________
Comparison o f the A U C  and IAU C  by paired t-test or W ilcoxon signed-ranks test 
analysis also as appropriate found no significant difference between SOUR and PL 
treatment (data not shown).
Similarly no significant differences were found when sub-divided by gender.
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The mean postprandial plasma N E FA  response is shown in Figure 3.7. Two-way 
repeated measures A N O V A  analysis found a significant treatment effect (p=0.025), 
although the treatment x time effect was not significant.
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3.9.4.3 NEFA response
Time (min)
Figure 3.7. Postprandial plasma N E FA  concentrations
No significant effect o f SOUR treatment was found by two-way repeated measures 
A N O V A  analysis. Results shown as mean with error bars representing the SEM (n=20).
As shown in Table 3.11, the mean A U C  for the postprandial N E FA  response was 
significantly higher follow ing SOUR than for PL  (p=0.007), although the IAU C  did not 
differ between treatments for the overall sample. When subdivided by gender these 
differences were significant for the female sub-group (p=0.048, n=l 1) and with a trend 
approaching significance for the male sub-group (p=0.054, n=9) (data not shown).
Table 3.11. A U C  and IA U C  of N EFA  response following PL  and SO UR  preloads
A U C  follow ing SOUR preload was significantly higher than PL  (paired-samples t-test). 
The IAU C  did not differ between treatments (W ilcoxon signed-ranks test) (n=20).
PL SOUR
Mean SD Mean SD P
A U C  180 37.3 10.0 41.4 9.4 0.007
IA U C  180 -56.2 38.4 -58.7 40.4 NS
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As shown in Figure 3.8, the postprandial plasma TA G  response was not significantly 
influenced by bread treatment when analysed by two-way repeated measures A N O V A . 
The treatment x time interaction was also non significant.
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3.9.4.3 TAG response
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Figure 3.8. Postprandial plasma T A G  concentrations
Bread treatment did not significantly influence postprandial T A G  concentrations when 
analysed by two-way repeated measures A N O V A . Results shown as mean with error 
bars representing the SEM (n=20).
Additionally, comparison o f the AUCs and IAUCs by paired t-test analysis also found 
no significant difference between bread types (data not shown).
Similarly there were also no significant differences when sub-divided by gender.
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As shown in Table 3.12, the fasting insulin sensitivity, (3-cell function and insulin 
resistance as estimated by Homeostasis M odel Assessment (H O M A ) (Levy  et al., 1998, 
Wallace et ah, 2004, Matthews et ah, 1985) (see section 2.8.1 for further details) were 
not significantly different at the start o f  each study day.
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3.9.5 Indices of insulin sensitivity
Postprandially, neither the oral insulin sensitivity as estimated using the minimal model 
method (Caumo et ah, 2000) (see section 2.8.2 for further details) nor the insulin to 
glucose A U C  ratio (for 0-180 min) differed significantly between SOUR and PL.
Table 3.12. Indices of insulin sensitivity at baseline and following consumption of 
P L  or SO U R  preload1’2’3
N o significant difference between treatments was found by paired-samples t-test / 
W ilcoxon signed ranks comparison as appropriate (n=20).
PL SO U R
PMean SD Mean SD
H O M A  % S 1 78.6 22.8 75.2 20.1 NS
H O M A  %  B 1 122.8 21.1 122.8 23.9 NS
H O M A  I R 1 1.4 0.46 1.5 0.44 NS
Insulintglucose A U C  2 7.5 3.08 8.0 3.18 NS
Oral S i3 2.18 1.21 1.82 0.97 NS
1 HOM A %S, fasted oral insulin sensitivity, HOM A %B, p-cell function and HOM A IR, insulin 
resistance all estimated by homeostasis model assessment.
2 AUC 0-180 mins
3 Oral S! values are x 10"3 dl glucose / kg.min / (iU insulin.ml. Calculated by minimal model.
Comparisons were carried out by paired t-test when normally distributed and by 
W ilcoxon signed-ranlcs test when non-parametric.
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As shown in Table 3.13, the mean energy, macronutrient and fibre intake during the 24 
h period prior to participating in each study day did not differ significantly between P L  
and SOUR treatment when analysed by W ilcoxon signed-ranks test.
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3.9.6 Intake 24 h preceding study
Additionally, the food diaries indicated that all participants had adhered to the required 
10-12 h fast prior to coming in for the study day, had consumed the supplied standard 
meals and had not consumed any alcohol during the 24 h period preceding the study.
Table 3.13. Energy and macronutrient intake 24 h prior to study day
N o significant differences were found between treatments when analysed by W ilcoxon 
signed-ranks test (n=20).
PL SO U R
PMean SD Mean SD
Energy (kJ) 7666 1856 7422 1654 NS
Fat (g) 77.9 26.9 73.2 28.5 NS
Protein (g) 64.8 18.4 66.8 14.5 NS
C H O  (g) 228.7 48.5 216.7 14.5 NS
Fibre (g) 13.2 4.3 12.4 4.2 NS
Alcohol (g) 0 0 0 0 NS
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3.9.7 Anthropometric and clinical measures on each study leg
The mean baseline anthropometric measurements, clinical measurements and fasting 
plasma results taken at the start o f  each study day are summarised in Table 3.14. None 
o f these parameters differed significantly between treatments.
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Table 3.14. Fasting plasma, anthropometric &  clinical measures on each study day
N o significant difference between treatments was found by paired-sample t-test analysis 
(n=20).
PL SO U R
PMean SD Mean SD
Fasting plasma metabolites
TC  / mmol/1 4.0 0.6 4.1 0.7 NS
HDL-C / mmol/1 1.2 0.3 1.2 0.3 NS
T A G  / mmol/1 0.97 0.35 1.05 0.35 NS
NEFA/mmol/1 0.52 0.25 0.56 0.24 NS
Glucose / mmol/1 5.0 0.4 5.0 0.4 NS
Insulin / mmol/1 56.4 19.6 57.5 18.6 NS
Anthropometrics/CIinical
B M I/k gm '2 22.6 2.4 22.7 2.4 NS
% body fat / % 22.5 8.3 22.6 8.3 NS
Waist circumference / cm 78.2 8.3 78.3 8.6 NS
BP systolic / mmHg 116 9 114 15 NS
BP diastolic / mmHg 68 6 69 7 NS
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The present investigation found a mixed meal that included a palatable propionate-rich 
SOUR bread providing 6.0 mmol propionate did not improve the postprandial insulin 
response compared to a non-sourdough P L  bread. Indeed it may have a detrimental 
effect on insulinaemia as evidenced by a treatment x time effect with a trend 
approaching significance (p=0.061), which was significant for the first 60 min 
(p=0.033). The postprandial N E F A  response A U C  was also significantly higher 
follow ing SOUR (p=0.007), however postprandial glycaemic and T A G  responses were 
not significantly influenced by bread type.
A  further important finding was that appetite was not significantly influenced 
follow ing ingestion o f the propionate-rich SOUR bread as part o f a mixed meal preload, 
with no effects on ad libitum  E I 3 h postprandially, on postprandial 24 h intake or on 
subjective appetite ratings except the desire to eat sweet.
To  our knowledge, this is the first study in which propionate has been delivered 
as part o f a meal in a palatable form that would be considered a ‘real’ unmodified food 
that can be purchased and incorporated into the diet, albeit delivering propionate in 
lower quantities than previous studies. The amount o f propionate in the SOUR bread in 
present study was however what could be naturally incorporated without influencing 
product palatability and represents what is commercially available.
These findings are in contrast to previous studies that found ingestion o f Na propionate 
baked into bread acutely reduced rather than increased the glycaemic (Liljeberg and 
Bjorck, 1996, Liljeberg et al., 1995, Todesco et al., 1991) and insulinaemic (Darwiche 
et al., 2001, Liljeberg and Bjorck, 1996, Liljeberg et al., 1995) response and 
significantly increased subjective satiety ratings relative to P L  (see in section 1.9.1).
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3.10 Discussion
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One o f the major differences between the present study and previous studies (Darwiche 
et al., 2001, Liljeberg and Bjorck, 1996, Liljeberg et al., 1995, Todesco et al., 1991) is 
that the unpleasant taste o f Na propionate was not controlled for in previous studies and 
was therefore a potential cofounder. It may be postulated that the results from the 
previous studies were elicited by the unpleasant taste o f the Na propionate rather than a 
physiological effect o f propionate. There is now a large body o f evidence suggesting 
that even at the cephalic (pre-absorptive) phase o f ingestion metabolic responses can 
occur that can influence metabolic handling at later stages. For example vagal 
stimulation via M SF has been shown to initiate insulin release (C P IR ) (Bellisle et al., 
1985, Bruce et al., 1987, Lucas et al., 1987, T e ff  and Engelman, 1996, T e ff  et al., 1991, 
T e ff et al., 1993b, Robertson et al., 2001, Just et al., 2008) and gastric secretions 
(Feldman and Richardson, 1986, Pavlov, 1902, Robertson, 2009, Zafra et al., 2006), to 
suppress N E FA  release (Robertson et al., 2001) and alter intestinal motility (Heath et 
al., 2004, Katschinski, 2000, Pouderoux et al., 1995) amongst others (reviewed in 
Chapter 1 , 'section 1.10). Postprandial lipaemia is also enhanced when preceded by 
vagal stimulation (Robertson et al., 2002) and CPIR appears to be necessary for normal 
glucose homeostasis (T e ff  and Engelman, 1996).
It is therefore reasonable to postulate that the sensory properties o f  a food could 
influence subsequent metabolic responses, a possibility that has been investigated by 
various researchers. For example when product palatability was modified by the 
addition o f a bitter taste (quinine), subsequent gastric emptying was significantly 
delayed compared to the same product without added quinine (W icks et al., 2005). 
Additionally, gastric myoelectric activity was decreased when volunteers were sham fed 
an unappetising food (cold tofu frankfurters) as compared to an appetising food (cooked 
frankfurters), suggesting a lack o f cephalic phase vagal stimulation with the
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‘unappetising’ treatment (Stern et al., 2001). It is highly likely that altered gastric 
motility would influence postprandial metabolite responses.
Furthermore, eliciting cephalic phase response by M SF has been found to increase 
ghrelin concentrations (Heath et al., 2004, Simonian et al., 2005) and reduce subjective 
hunger ratings (LeBlanc and Soucy, 1996, Smeets and Westerterp-Plantenga, 2006b) in 
human subjects. It is therefore also reasonable to postulate that unpleasant tasting food 
could also influence subsequent satiety. Yeomans found a strong linear relationship 
between the change in rated palatability and differences in food intake when data was 
pooled from studies in which palatability was manipulated (Yeomans, 2007). For 
example, intake and taste ratings o f an ice-cream adulterated with a bitter tastant were 
significantly lower than the unadulterated ice cream (Nisbett, 1968). This suggests an 
unpleasant taste influences satiation.
Based on this it can be postulated that the reduced postprandial insulinaemic and 
glycaemic responses (Darwiche et al., 2001, Liljeberg and Bjorck, 1996, Liljeberg et al., 
1995, Todesco et al., 1991) and delayed gastric emptying (Darwiche et al., 2001, 
Liljeberg and Bjorck, 1996) and increased satiety (Liljeberg and Bjorck, 1996, Liljeberg 
et al., 1995) observed in previous studies fo llow ing oral propionate ingestion arose as a 
result o f the unpleasant taste o f the Na propionate breads. Indeed acceptability ratings 
for the Na propionate breads used in a previous studies were significantly lower than P L  
(Liljeberg et al., 1995). By contrast, in the present study prior sensory evaluation 
determined participants were unable to distinguish the propionate rich SOUR bread 
from the P L  bread. This could also explain why the findings o f the present study do not 
replicate the results from these previous studies.
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Furthermore, as discussed in the introduction, conclusions from previous studies that 
propionate-containing bread can increase subsequent satiety were based solely on 
results from a single bipolar rating scale (Liljeberg and Bjorck, 1996, Liljeberg et al., 
1995), and a quantitative assessment o f appetite was not made. The validity o f their 
conclusions can therefore be questioned. The bipolar scale was anchored by extreme 
hunger at one end and extreme satiety at the other. However although satiety and hunger 
could be considered to lie at polar opposites, satiety is not simply the absence o f hunger. 
It is therefore inappropriate to have satiety and hunger on the same rating scale (Mattes 
et al,, 2005). In the present study our conclusions were based on a combination o f  data 
generated from appetite V A S , EI at an ad libitum  meal and 24 h intake, which is a more 
valid way to investigate appetite based on current thinking (see section 1.4).
It still remains to be explained why in the present study the propionate-rich SOUR 
bread may be detrimental to postprandial insulinaemia. To our knowledge this is the 
first time that such an observation has been made follow ing oral administration o f 
propionate in humans. A  possible explanation is that the orally ingested propionate 
elicited a gluconeogenic response in the present study.
W olever and colleagues reported rectal administration o f a propionate solution 
significantly increased subsequent blood glucose levels in man while rectal acetate and 
saline infusions did not. As these solutions were rectally infused, the taste o f propionate 
was eliminated, and as no CHO source was given, the observed increase in glucose 
must have occurred due to the infused propionate. The authors o f this study postulate 
propionate is gluconeogenic in humans, based on the fact that animal studies appear to 
suggest propionate is converted to glucose via succinate and oxaloacetate (W olever et 
al., 1991). However gastric infusion o f a propionate solution administered at levels
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similar to that generated by 30g fibre per day did not influence hepatic glucose 
production (Laurent et al., 1995), although the sample size for this study was low (n=6).
Propionate is well known to be gluconeogenic in ruminants, and is the primary 
glucose source via hepatic metabolism. As much lower quantities o f propionate are 
supplied to the non-ruminant liver, propionate is not an important gluconeogenic 
precursor in non-ruminants, although the non-ruminant liver is capable o f propionate 
metabolism (A llen  et al., 2009).
Based on this it may be postulated that in the present study, propionate was 
absorbed from the G IT  and traversed to the liver via the portal vein. In the liver it may 
have been metabolised to glucose, which in turn could have enhanced insulin secretion. 
However, i f  gluconeogenesis explains the observed effects on insulin response in the 
present study, why did this not occur in previous studies using Na propionate bread? It 
is possible that in previous studies while gluconeogenesis may have occurred, the 
cephalic phase effects arising from the sensory properties o f the Na propionate bread 
out-weighed gluconeogenic effects.
Postprandial plasma N E FA  concetrations were also significantly influenced by 
treatment (p=0.025) in the present study, with a significantly higher A U C  with SOUR 
treatment than P L  (p=0.007). However this result needs to be interpreted with caution, 
as the mean fasting N E FA  concentrations were higher than PL, although not 
significantly so, and by 120 min postprandially concentrations were almost identical 
between treatments. This is suggestive that SOUR may have suppressed N E FA  
concentrations to a greater degree than did PL. Plasma T A G  concentrations were not 
significantly influenced. To  our knowledge this is the first study to investigate the 
postprandial effects o f oral propionate ingestion as part o f a mixed meal on postprandial 
lipid responses.
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It should also be considered that the SOUR bread in the present study delivered lower 
quantities o f propionate (6.0 mmol) than in the previous studies (Darwiche et al., 2001, 
Liljeberg and Bjorck, 1996, Liljeberg et al., 1995, Todesco et al., 1991), which may be 
an alternative explanation for a lack o f  effect in the present study. The amount delivered 
in these studies is not given and not clear, but by calculation it seems to be 
approximately 15 mmol and 45 mmol from low  and high dose breads respectively. 
These quantities were sufficient to significantly reduce acceptability rating scores (45 
mmol) (Liljeberg et al., 1995) and increase nausea ratings (30 mmol) (Frost et al., 
2003), thus representing a product that could not be marketed.
In the present study we did not analyse gut peptide concentrations due to the observed 
lack o f effect on subjective and quantitative proxy measures o f  appetite. W e had also 
intended to analyse serum SCFA concentrations to confirm propionate levels had been 
modulated after ingesting SOUR, giving a more complete picture o f  events taking place. 
However analysis o f serum SCFA concentrations is not straightforward, largely due to 
the low  concentrations present in the peripheral circulation, and we were unable to 
successfully set up and validate the method for their analysis.
Finally, some recently published studies have found sourdough products can acutely 
reduce postprandial glycaemia and insulinaemia (De Angelis et al., 2007, Lioger et al., 
2009, M aioli et al., 2008, Najjar et al., 2009), satiety ratings (L ioger et al., 2009) and 
GLP-1 and G IP concentrations (Najjar et al., 2009) relative to PL. In these studies a 
lactobacilli sourdough starter was used which promotes lactic acid production rather 
than Domani starter used in the present study that contains propionate producing 
mieroflora. The differing organic acid compositions o f the resulting sourdough products
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may explain the differences in observed results, suggesting the findings from the present 
study are specific to the SCFA propionate.
3.11 Conclusion
In summary, we found oral ingestion o f a propionate-rich palatable sourdough bread 
(providing 6.0 mmol propionate) did not influence appetite, postprandial glucose or 
T A G  concentrations and that it may even worsen postprandial insulinaemia, in contrast 
to previous findings. W e propose that the results from the previous studies (Darwiche et 
al., 2001, Liljeberg and Bjorck, 1996, Liljeberg et al., 1995, Todesco et al., 1991) may 
have resulted from the unpleasant taste o f  the test bread rather than physiological effects 
o f propionate. The increased postprandial insulin concentrations in the present study 
may have arisen from a gluconeogenic effect o f  propionate in the liver.
Alternatively it is possible that the lack o f effect was simply due to a lower dose 
o f  propionate being provided than in the previous studies. However, while the bread 
used in this study was rated as being palatable (see Chapter 3A ) and is commercially 
available, the Na propionate breads used in previous studies containing higher doses 
were rated as not acceptable and associated with increased nausea.
To  our knowledge, this is the first study in which propionate has been delivered 
as part o f a meal in a palatable form using a test product that would be considered a 
‘real’ unmodified food that can be purchased and incorporated into the diet. Prior 
sensory evaluation confirmed that participants were unable to distinguish the PL  from 
SOUR and that the SOUR was no less preferable than the P L  bread (see Chapter 3A).
Overall, our results do not support the promotion o f propionate-rich sourdough bread as 
a functional food product (D iplock et al., 1999), as we do not consider it likely to reduce 
disease risk or confer additional health benefits.
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Chapter 4: Acute effects of acetic acid supplementation on 
appetite, food intake and glycaemic response
4.1 Introduction
Following on from the study reported in the previous chapter, which considered the 
influence o f oral ingestion o f the SCFA propionate on the postprandial metabolic 
response and satiety, the present study was designed to investigate the oral provision o f 
acetic acid (provided within vinegar) on postprandial glycaemia and satiety.
The provision o f vinegar (as a source o f acetic acid) has been linked with a 
reduced acute glycaemic and insulinaemic response in healthy volunteers (Brighenti et 
al., 1995, Liljeberg and Bjorck, 1998, Ostman et al., 2005, Sugiyama et al., 2003, 
Johnston and Buller, 2005, Liljeberg and Bjorck, 1996) and in individuals with insulin 
resistance and T2D M  (Johnston et al., 2004), as reviewed in Chapter 1 (sections 1.8.1 
and 1.9.1). Possible mechanisms for this include delayed gastric emptying (Liljeberg 
and Bjorck, 1998, H lebowicz et al., 2007) and a decreased rate o f starch digestion 
(Ogawa et al., 2000). Oral ingestion o f vinegar has also been reported to significantly 
increase subsequent satiety (H lebowicz et al., 2008, Ostman et al., 2005), and 
supplementation for 12 wk significantly lowered BMI, % body fat and waist and hip 
circumference (Kondo et al., 2009). The SCFA  receptor proteins GPR41 and GPR43 
may also be implicated in modulating effects (see Chapter 1, section 1.7).
However, there were problems in the study design o f the previous studies investigating 
oral vinegar provision, particularly in investigating appetite. In common with previous 
propionate studies, studies that found a significant effect o f  vinegar ingestion on satiety 
(H lebowicz et al., 2008, Ostman et al., 2005) based their conclusions on results 
generated from a single bipolar' rating scale using confusing language with no 
complementary quantitative assessment o f appetite, Ostman and co-workers (2005)
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additionally excluded data from participants whose satiety ratings were lower 
postprandially than at fasting, which could be argued to be data manipulation.
As with the propionate studies, palatability effects o f vinegar were also not controlled 
for. W hile the acceptability o f the vinegar test products were not rated, both studies used 
large quantities o f vinegar (between 18g and 28g) which were supplied to participants 
soaked in bread. When tested in our laboratories during the study development stage, 
vinegar served in this way was found to be highly unpleasant and nauseating to eat. It is 
therefore possible that the observed effects 011 satiety and the metabolic response were a 
cephalic phase effect due to the unpleasant orosensory properties o f the test products, 
particularly in view  o f the results from our previous study that found no effect on satiety 
with oral ingestion o f the SCFA  propionate in a palatable form (see Chapter 3), 
although far lower quantities o f SCFA  were used in that study.
The present study was therefore designed to further investigate the influence o f vinegar 
ingestion on appetite using validated methodology (appetite V A S  ratings, food intake at 
a subsequent ad libitum  meal and 24 h intake), and to explore the influence o f the 
palatability o f the test products. Palatability effects were assessed by supplying vinegar 
within a drink (sugar-free orange squash) in a more palatable form (diluted across the 
entire drink) and a less palatable form (diluted in part o f the drink, thus supplying the 
vinegar in a more concentrated form). W e hypothesised that reduced product 
palatability, whilst controlling for the amount o f acetic acid consumed, would result in 
increased satiety and reduced postprandial glycaemia.
Julia Darzi Thesis
140
4.2 Aims
The primary aim was to investigate the acute effects o f acetic acid ingestion (in a 
sweetened drink containing vinegar) delivered in an unpalatable (Unpal) and more 
palatable (Pal) form when consumed alongside a standard breakfast preload on 
subsequent appetite ratings, prospective food intake at a subsequent meal, 24 h intake 
and plasma glucose response compared to a visually identical P L  (sweetened drink 
without added vinegar).
4.3 Methods
4.3.1 Sample size calculations
This study was a pilot study. As it has previously been reported that 17 participants are 
required to detect a 500 lcJ difference in E I in a crossover design study with a power o f 
0.8 (Arvaniti et al., 2000) provided intake on the previous evening is standardised, we 
aimed to recruit a similar number to this study.
4.3.2 Participants
Sixteen healthy participants (3 male, 13 female) aged between 21 and 33 y were 
recruited from the student population at the University o f Surrey by e-mail 
advertisement. To  assess suitability for inclusion participants completed a Lifestyle and 
Medical Questionnaire and DEBQ, and a blood sample was collected by fingerprick to 
measure fasting blood glucose levels at an initial screening session (see section 2.1).
For inclusion, participants were required to have a B M I o f 19 to 27 kgm'2, 
fasting blood glucose <6.0 mmol/1, restraint score o f <3.5 (assessed using the DEBQ) 
and have been stable weight for at least 3 months. Exclusion criteria included currently 
pregnant or breast feeding, on a weight reducing diet, history o f  coronary heart disease,
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diabetes mellitus, gastrointestinal disorders, anaemia, clinical depression and other 
psychological disorders or o f eating disorders, drug or alcohol abuse in the last 2 y, 
current habitual smoker, high habitual alcohol intake (>20 units per week) and taking 
selected current regular medications (excluding contraceptives).
Nine participants were talcing oral contraceptives and one was fitted with a 
contraceptive implant, but no other medications were prescribed to participants.
Table 4.1 outlines the baseline participant characteristics. The mean participant age was 
22.2 [SD 3.0] y and B M I was 22.1 [SD 2.4] lcgm"2. None o f the characteristics 
significantly differed between genders except the waist circumference and % body fat.
Table 4.1: Baseline participant characteristics
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Overall (n=16) Male (n=3) Female (n=13)
Mean SD Range Mean SD Range Mean SD Range
A ge/y 22.2 3.0 21-33 22.0 1.0 21-23 22.2 3.3 21-33
BMI / ltgm'2 22.1 2.4 18.5-27.0 23.9 3.5 20.1-27.0 21.7 2.1 18.5-25.1
:,!Waist 
circumference / cm 74.6 8.6 62.4-94.0 88.0 7.9 79.0-94.0 71.5 5.2 62.4-80.0
*Body fat / % 23.6 6.3 9.7-33.9 15.3 4.9 9.7-18.8 25.5 4.9 15.1-33.9
Systolic BP / mrnHg 122 13.3 103-147 134 18.2 113-147 119 11.1 103-137
Diastolic BP / mrnHg 74 9.6 61-94 73 9.4 62-80 74 10.0 61-94
DEBQ Restraint 1.9 0.7 1.1-3.5 2.0 0.5 1.5-2.4 1.9 0.7 1.1-3.5
DEBQ Emotion 2.6 0.7 1.7-4.1 2.9 1.1 1.7-3.9 1.9 0.7 1.8-4.1
DEBQ External 2.6 0.7 1.3-3.8 1.7 0.4 1.3-2.1 2.5 0.5 2.0-3.8
Characteristics that differed significantly (p<0.05) between genders are denoted by ( * )
4.3.3 Ethics
A ll participants gave written consent prior to commencing the study. The study was 
approved by the University o f  Surrey Ethics Committee on 11th October 2007 
(EC/2007/76/FHMS), and took place from November 2007 to December 2008.
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4.3.4 Study protocol
Acute postprandial effects on blood glucose and appetite (assessed by subjective ratings 
and subsequent E l) in response to a standard breakfast preload alongside either an 
unpalatable (Unpal) or more palatable (Pal) vinegar-containing drink or P L  drink were 
investigated using a randomised single-blind crossover study design.
Participants attended on three occasions at least 2 d apart and were assigned to 
the experimental condition (Unpal vs. Pal vs. PL, see 4.3.5 for further details), in a 
counter-balanced randomly assigned order.
To  reduce within-subject variability, participants were instructed to refrain from 
unaccustomed exercise and alcohol during the 24 h preceding each study day and to 
approximately replicate their 24 h intake prior to each study day. A  standardised 
evening meal (low  fibre ready meal and desert selected by participant) was provided 
and 24 h intake was recorded.
A ll study days took place at the C IU  at the University o f Surrey. Participants were 
requested to stay in the C IU  during the study, although they could to read, write, work 
on their computers or watch television (avoiding programmes with food cues).
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On each study day, participants arrived at the C IU  at approximately 08.00 h follow ing 
an overnight fast o f at least 12 h. Upon arrival, two initial fasting capillary blood 
samples were taken by fingerprick at time =  -30 and -5 min and analysed for glucose 
concentrations (see 2.3.6), and participants were asked to complete two initial V A S  to 
subjectively assess appetite, nausea and other attributes unrelated to appetite (see 2.3.1) 
follow ing each blood sample.
Participants were then provided with the standard breakfast preload (jam 
sandwiches) alongside the test drinks (Unpal vinegar, Pal vinegar or PL ) divided 
between 2 glasses (see 4.3.5) at time = 0 min. It was requested that participants ingested 
the breakfast within 15 min and consume the first o f  the two test drinks alongside the 
first sandwich quarter and the remaining drink before completing the breakfast. 
Following breakfast, participants completed V A S  regarding the palatability and 
pleasantness o f the breakfast and drinks (see 2.3.1).
Blood samples were taken every 15 min for the first hour fo llow ing breakfast and half 
hourly for the fo llow ing 2 h until lunch. In addition a set o f V A S  for fullness, hunger, 
prospective food consumption, desire to eat sweet / savoury / salty / fatty and nausea 
plus additional V A S  unrelated to appetite such as calmness, happiness, tiredness, 
boredom and anxiety were completed at half hourly intervals. Participants were not 
informed this study was investigating effects on appetite which is why the additional 
V A S  questions were included to distract from the purpose o f the study.
180 min follow ing breakfast, a large ad libitum  homogenous pasta meal was 
served in a confined individual booth, and participants were instructed to eat until 
comfortably full. The difference in intake fo llow ing PL, Pal and Unpal test drinks was 
determined. Further details about the ad libitum  buffet meal and the conditions under 
which it was served are described in Chapter 2 (section 2.3.2).
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Once the participants had finished their lunch they were free to leave and were asked to 
complete a food and drink diary for the remainder o f the day until 09.00 h the follow ing 
morning.
4.3.5 Test breakfast
On the study mornings participants were provided with a test breakfast comprising jam 
sandwiches cut into quarters and the test drink that the participant had been randomised 
to on that occasion (ingredients given in Table 4.2), either:
a) Placebo drink with no added vinegar - P L
b ) M ore palatable drink with 25 g added vinegar (=  25 mmol acetic acid) - Pal
c ) Unpalatable drink with 25 g added vinegar (=  25 mmol acetic acid) -  Unpal
A ll test drinks were made using Robinson’ s Sugar Free Orange Squash, and the vinegar 
used was Tesco White W ine Vinegar which contains 6% acetic acid.
Table 4.2. Ingredients used to make the test drinks.
Once prepared, drinks (a) P L  and (b) Pal were equally divided between 2 glasses (175g 
per glass) and chilled, (c) Unpal drinks were prepared separately (Drink 1 and 2) and 
were kept at R T  until serving
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Ingredient a) P L b) Pal
Drink 1
c) Unpal 
Drink 2 Total
Squash /g 75 75 25 50 75
V inegar/g - 25 25 - 25
W ater / g 275 250 100 150 250
Total amount / g 350 350 150 200 350
On the first study morning participants were provided with 7 quarters o f jam 
sandwiches (equivalent to three and a half slices bread, with each slice weighing 38 g) 
for the test breakfast. Participants were asked to consume a minimum o f 4 full quarters 
(equivalent to 2 slices o f bread). On subsequent study days participants were provided
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with the same number o f quarters as consumed on the first study occasion. This 
procedure allowing participants to eat to their desired intake has been previously 
reported (Westatrate and van Amelsvoort, 1993) and used in our group (Bodinham et 
al., 2010).
The sandwiches were made using 8 g O livio spread and 16 g Tesco strawberry 
jam per 38 g slice o f Kingsmill Everyday Soft Bread. Table 4.3 summarises the 
nutritional content o f the test breakfast for 4, 5, 6 and 7 quarters (equivalent to 2, 2.5, 3 
and 3.5 slices o f  bread respectively).
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Table 4.3. Nutritional content of the test breakfast
Number Number Portion size (g ) Energy Protein CHO Fat Fibre
sandwich
quarters
slices
bread
Bread Spread Jam kcal kJ g g g g
4 2 76 16 32 345 1454 6.9 54.5 12.4 2.2
5 2.5 95 20 40 431 1817 8.7 68.2 15.4 2.8
6 3 114 24 48 518 2180 10.4 81.7 18.5 3.4
7 3.5 133 28 56 605 2543 12.3 95.4 21.7 3.9
4.3.6 Blood sampling and glucose analysis
Capilliary blood samples were taken by fingerprick (for method, see section 2.5.2) and 
analysed immediately using a HemoCue Glucose 201+ system (for method, see section
2.6.3.3). Participants were invited to a session to familiarise them with the fingerprick 
method prior to commencing the study, to minimise effects on appetite during the study.
4.3.7 Food diary analysis
Food and drink diaries were completed on the day before and the day o f the study. 
These diaries were analysed for El, macronutrient and fibre intake using WinDiets 
Professional 2005 (The Robert Gordan University, Aberdeen, U K ). See Chapter 2 
(Section 2.3.3) for further details.
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4.3.8 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0. Data was tested 
for normality using the Kolmogorov-Smirnov test. Differences in anthropometric 
variables between male and female participants were assessed non-parametrically using 
the Mann-Whitney test.
Differences in the effects o f vinegar treatment on palatability V A S  scores, EI at 
the buffet meal, E I and macronutrient intake during the 24 h preceding the study day 
and during the 24 h o f the study day were assessed by one-way repeated measures 
A N O V A  with post-hoc Bonferroni i f  normally distributed, and by Friedman’s A N O V A  
with post-hoc W ilcoxon signed-ranks test i f  not normally distributed.
The influence o f vinegar treatment on postprandial subjective V A S  ratings and 
glycaemic response was assessed by two-way (vinegar treatment x time) repeated 
measures A N O V A . The A U C  and IA U C  were compared by one-way repeated measures 
A N O V A  with post-hoc Bonferroni. The A U C  for postprandial plasma metabolites and 
subjective appetite and nausea ratings were calculated by the trapezoidal rule.
As well as analysing the blood glucose response over the entire study morning 
(180 min), analysis was carried out for the first 120 min to allow direct comparison with 
previous investigations.
Data was pooled from all study days to examine the relationship o f palatability V A S  
ratings and nausea A U C  with subjective appetite AU C , EI 3 h postprandially and 24 h 
EI by correlation analysis. Analysis was carried out by 2-tailed Pearson’ s product- 
moment (parametric) and Spearman’ s rho (non-parametric) as appropriate.
Differences were considered to be significant at p<0.05 except the post-hoc W ilcoxon 
signed-ranks test, where significance was set at a level o f p<0.0167 (=0.05/3).
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4.4 Results
Figure 4.2 shows the mean palatability V A S  ratings. Vinegar treatment significantly 
influenced the rated pleasantness o f taste o f the drinks (pcO.OOl) (Figure 4.2a) and 
palatability o f breakfast (p<0.001) (Figure 4.2b) with one-way repeated measures 
A N O V A  analysis. The mean ratings for both were highest for PL  and lowest for Unpal.
Post-hoc bonferroni analysis revealed the taste ratings for both the Pal and 
Unpal drinks were significantly lower than PL  (pcO.OOl), and the Unpal drink was rated 
as less pleasant than the Pal drink with a trend approaching significance (p=0.055). For 
the breakfast palatability, the ratings were significantly lower when consumed with Pal 
and Unpal drinks (p=0.020 and 0.002 respectively) than with PL, and the Unpal 
treatment rating was significantly lower than during Pal treatment (p=0.022, n=16).
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4.4.1 Palatability VAS ratings
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Figure 4.2a: VAS  ratings in answer to 
‘How pleasant was the taste of the 
drink?’
Vinegar treatment significantly reduced 
the pleasantness o f the drink (p<0.0001). 
Columns showing the same symbol denote 
significant differences between treatments: 
Ap<0.0001, *p<0.000l, ~p=0.055.
Analyses conducted by one-way repeated 
measures A N O V A  with post-hoc 
Bonferroni. Results shown as mean with 
error bars representing the SEM (n=16).
Ill
ely PL Pal UnpalExtremely
unpalatable
Figure 4.2b: VAS ratings in answer to 
‘How palatable was the breakfast?’
Vinegar treatment significantly influenced 
the breakfast palatability (p<0.0001). 
Columns showing the same symbol denote 
significant differences between treatments:
Ap=0.020, *p<0.002, ~p=0.022.
Analyses conducted by one-way repeated 
measures A N O V A  with post-hoc 
Bonferroni. Results shown as mean with 
error bars representing the SEM (n=16).
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As summarised in Figure 4.3, vinegar treatment significantly influenced postprandial 
subjective appetite ratings for fullness (p<0.0001, n=16), hunger (p=0.045, n=16) and 
prospective food consumption (p=0.036, n=16) when analysed by two-way repeated 
measures A N O V A  analysis. Additionally, the desire to eat something sweet was 
influenced with a trend towards significance (p=0.058, n=16), and a significant vinegar 
treatment x time interaction was observed for prospective consumption (p=0.009). 
Subjective ratings for the desire to eat something savoury, salty and fatty were not 
significantly influenced by vinegar treatment (data not shown).
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4.4.2 Subjective appetite ratings
a) How full do you feel.f Never been b) How hungry do you feel?
c) How much do you think you can eat? d) Would you like to eat something sweet?
Figure 4.3. Subjective appetite ratings following PL  (- #  -), Pal (- ■  -) and Unpal 
(- A  -) drinks.
Vinegar treatment significantly influenced (a) fullness (p<0.0001), (b ) hunger (p=0.045) 
and (c) prospective consumption (p=0.036) and influenced (d ) desire to eat something 
sweet with a trend towards significance (p=0.058). Analyses were carried out by two- 
way repeated measures A N O V A . Results shown as mean with error bars representing 
the SEM (n=16).
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Figure 4.4 shows the A U C  o f subjective appetite ratings from 0 to 180 min. Vinegar 
treatment significantly lowered the A U C  for fullness (p<0.0001), prospective food 
consumption (p=0.048) and desire to eat something sweet (p=0.048) by one-way 
repeated measures A N O V A  analysis. In addition, hunger was lowered with a trend 
towards significance (p=0.067). A U C  for the desire to eat something savoury, salty and 
fatty were not significantly influenced by vinegar treatment (data not shown).
Post-hoc analysis found the A U C  for fullness was significantly lower for PL  
than for both Pal (p=0.023) and Unpal (p=0.007), and the A U C  for the desire to eat 
something sweet was significantly higher for PL  than Unpal (p=0.035). No other 
significant differences by post-hoc analysis were found for the other appetite ratings.
a) Fullness b ) Hunger
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P L  Pal Unpal P L  Pal Unpal
c) Prospective consumption d ) Desire to eat sweet
P L  Pal Unpal P L  Pal Unpal
Figure 4.4. A U C  (0-180 min) for subjective appetite ratings
Vinegar treatment significantly influenced the A U C  for (a) fullness (p<0.0001) and (c) 
prospective consumption (p=0.048) and influenced (b) hunger (p=0.067) and (d) desire 
to eat something sweet (p=0.051) with a trend towards significance.
Columns showing the same symbol denote significant differences between treatments 
by post-hoc analysis for: a) fullness Ap=0.023 (P L  vs Pal) and *p=0.007 (P L  vs Unpal) 
and d) desire to eat something sweet for $p=0.055 (Pal vs Unpal).
Analyses were carried out by one-way repeated measures A N O V A  with post-hoc 
Bonferroni. Results shown as mean with error bars representing the SEM (n=16).
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4.4.3 Quantitative appetite assessment
4.4.3.1 Intake at the ad libitum test meal
When analysed for the overall sample (n=16), the mean intake ad libitum  intake o f pasta 
did not differ between treatments as shown in Figure 4.5.
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a) Intake (g) b) Intake (kJ)
1 4000-1
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PL Pal Unpal PL Pal Unpal
Figure 4.5. Intake of ad lib itu m  pasta meal in (a ) grammes &  (b ) kJ
Intake did not differ signficantly between treatments. Results shown as mean with error 
bars representing the SEM (n=16).
However, box-plot analysis o f intake o f the buffet meal provided 3 h postprandially 
identified one outlier in the dataset, with an intake value >3 SD over the mean intake 
during Unpal treatment (Figure 4.6). The ad libitum  intake o f the pasta meal was 
therefore also re-analyses follow ing the removal o f  all data from this participant, with 
analyses carried out on the remaining 15 participants.
Figure 4.6. Dot-plot graph of ad lib itu m  E l 3 h postprandially
An outlier was identified with a value >3SD over the mean. Results shown as mean 
with error bars representing the SD (n=16).
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The mean ad libitum  intake o f pasta after removal o f the outlier (n=15) is shown in 
Figure 4.6. The mean intake fo llow ing Unpal was the lowest (2797 [SD 888] kJ), 
followed by Pal (3034 fSD 851] kJ), with the highest mean intake occurring with PL  
treatment (3430 [SD 1010] kJ). Follow ing removal o f the outlier, vinegar treatment 
significantly influenced intake o f the ad libitum  meal both in grammes and in kJ 
(p=0.022 for both g and kJ, n=15) when analysed by Friedman’ s A N O V A  test. Post-hoc 
W ilcoxon analysis (with the level o f significance assumed at p=0.0167) found the 
difference in mean intake between PL  and Unpal approached significance (p=0.023 for 
both g and kJ, n=15), although there was no significant difference between PL  and Pal 
or Pal and Unpal.
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Figure 4.7. Intake of ad lib itu m  meal in (a ) grammes &  (b ) kJ with outlier removed
Vinegar treatment significantly influenced the intake (p=0.022 for both g and kJ) with 
post-hoc identifying a difference approaching significance between intake follow ing PL  
and Unpal (*p=0.023 for both g and kJ).
Analyses were carried out by Friedman’ s A N O V A  with post-hoc W ilcoxon. Results 
shown as mean with error bars representing the SEM (with outlier removed, n=15).
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The mean 24 h energy and macronutrient intake post ingestion o f PL, Pal and Unpal 
preloads is shown in Table 4.4. Data from two participants was excluded due to 
incomplete 24 h intake dietary records, therefore analyses were carried out on the 
remaining 14 participants.
As Table 4.4 shows, the highest intake o f energy and o f all macronutrients was 
fo llow ing PL, followed by Pal then Unpal. Energy (p=0.021, n=14) and CHO (p=0.010, 
n=14) intakes were both significantly influenced by vinegar treatment when analysed by 
one-way repeated measures A N O V A . The significance for E I remained when alcohol 
was removed from the contributions to E I (p=0.010, n=14). There was also a vinegar 
treatment effect with a trend towards a lower intake o f fat and protein follow ing Unpal 
(p=0.059).
Table 4.4. E I and macronutrient intake 24 h after PL, Pal and Unpal treatment1
Vinegar treatment was found to significantly influence energy (p=0.021) and CHO 
intake (p=0.010) and to influence fat and protein intakes with a trend towards 
significance (both p=0.059). A ll analyses carried out by one-way repeated measures 
A N O V A  with post-hoc Bonferroni (n=14).
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4.4.3.2 Intake during 24 h period following preload
P L Pal Unpal
PMean SD Mean SD Mean SD
Energy (k j) A 9515 2560 8565 2710 A 7475 2092 0.021
EI excluding alcohol (k j) #9001 1992 "8259 2316 #~7081 1954 0.010
Fat (g) 72.2 22.9 66.5 25.8 53.7 22.5 0.059
Protein (g) 70.2 10.6 * 70.9 19.8 * 59.4 19.1 0.059
CHO (g) # 308.3 75.9 273.5 79.5 # 242.7 63.3 0.010
Alcohol (g)
i * « _____,
17.4 40.6 12.4 22.3 13.2 21.8 NS
Mean values marked with the same symbol denote significant differences between treatments following 
post-hoc analysis *p<0.05, Ap<0.02, #p<0.005, or trend approaching significance ~p=0.054.
Post-hoc analysis revealed E I and CHO intake was significantly lower fo llow ing Unpal 
than P L  treatment (p=0.017 and p=0.004 respectively). Furthermore, protein intake was
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lower with a trend towards significance follow ing Pal than PL  (p=0.023). When alcohol 
was removed from the contribution to El, El following Unpal was significantly lower 
than PL  (p=0.002) and lower than Pal with a trend towards significance (p=0.054).
As shown in Figure 4.8, there was no difference in % contribution o f macronutrients 
and alcohol to the total 24 h El between PL, Pal and Unpal treatment when analysed by 
one-way repeated measures A N O V A .
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Fat Pro CHO EtOH
Figure 4.8. % contribution to 24 h E l by each macronutrient and alcohol
No significant difference between treatments was found for any o f the macronutrients or 
alcohol by one-way repeated measures A N O V A  analysis. Results shown as mean with 
error bars representing the SEM (n=14).
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The mean postprandial glycaemic response follow ing the different treatments is shown 
in Figure 4.9. Vinegar ingestion alongside the standard breakfast resulted in a lower and 
later glucose peak than PL. A  significant effect o f vinegar treatment on the glycaemic 
response was found for 180 min (p=0.022, n=16) and 120 min (p=0.003, n=16) 
postprandially by two-way repeated measures A N O V A  analysis. In addition there was a 
significant vinegar x time interaction (p<0.0001 and p=0.012 for 180 and 120 min 
postprandially respectively, n=16) and a significant effect o f time (p<0.0001 for both 
180 and 120 min postprandially, n=16).
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4.4.4 Postprandial glycaemic response
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Figure 4.9. Postprandial blood glucose concentrations
Vinegar treatment significantly influenced the glycaemic response (p=0.022, two-way 
repeated measures A N O V A  analysis). Results shown as mean with error bars 
representing the SEM (n=16).
The A U C  and IA U C  for the blood glucose response from 0 to 120 and to 180 min is 
shown in Table 4.5. Vinegar treatment significantly influenced the A U C  (both 0 to 120 
and 180 min) and the IA U C  from 0 to 120 min, when analysed by one-way repeated 
measures A N O V A .
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Post-hoc analysis found that the A U C  and IA U C  from 0 to 120 min fo llow ing Pal was 
significantly lower than P L  (p=0.006 and 0.011) and the A U C  from 0 to 180 min was 
lower fo llow ing Pal than fo llow ing P L  with a trend towards significance (p=0.079). 
There was no significant difference between Unpal and P L  or between Pal and Unpal 
A U C  and IAU C .
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Table 4.5. A U C  &  IA U C  for blood glucose response 120 and 180 min 
postprandially following PL, Pal and Unpal1
Vinegar treatment significantly influenced the A U C  180 and 120 and IA U C  120. A ll 
analyses carried out by one-way repeated measures A N O V A  with post-hoc Bonferroni 
(n=16).
PL Pal Unpal
PMean SD Mean SD Mean SD
A U C  180 "1019.6 84.8 "956.9 82.0 987.2 67.6 0.047
120 a727.5 75.6 a662.1 56.4 688.2 59.4 0.013
IA U C  180 184.9 71.9 140.7 86.4 168.8 97.0 NS
120
1 *TT^  ‘TVATTO
*171.0 73.4 *118.0 58.5 142.6 77.7 0.027
AUC & IAUC mean values marked with the same symbol denote significant differences between 
treatments (Ap=0.006, *p=0.011) or a trend approaching significance (~p=0.079)
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Figure 4.10 shows the V A S  ratings for nausea. Vinegar treatment was found to 
significantly influence nausea ratings (p=0.001) when analysed by two-way repeated 
measures A N O V A . In addition there was a significant vinegar x time interaction 
(pcO.OOOl).
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4.4.5 Subjective nausea ratings
Extremely
Figure 4.10. Postprandial VA S  ratings for feelings of nausea
Vinegar treatment significantly influenced nausea (p=0.001, two-way repeated 
measures A N O V A  analysis). Results shown as mean with error bars representing the 
SEM (n=16).______________________________________________________________________________
The mean A U C  and IA U C  from 0 to 180 min for the nausea appetite ratings are shown 
in Figure 4.11. A  significant effect o f  vinegar treatment on both the A U C  (p=0.001) and 
the IAU C  (p=0.009) was found by one-way repeated measures A N O V A  analysis.
Post-hoc bonferroni analysis found the A U C  and IAU C  for nausea were significantly 
higher follow ing Pal than PL  (p=0.024 and p=0.037 respectively) and follow ing Unpal 
than PL  (p=0.007 and p=0.014 respectively). The mean nausea A U C  and IAU C  
follow ing Unpal was higher than follow ing Pal, although this difference was not 
significant.
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Figure 4.11. Subjective nausea ratings A U C  and IA U C
Vinegar treatment significantly influenced nausea ratings (a) A U C  (p=0.001) and (b) 
IA U C  (p=0.009). Values marked with the same symbol denote significant differences 
between treatments (p<0.05).
Analyses were carried out by one-way repeated measures A N O V A  with post-hoc 
Bonferroni. Results shown as mean with error bars representing the SEM (n=16).
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Table 4.6 summarises the relationship o f palatability ratings and nausea A U C  with 
appetite parameters (postprandial subjective appetite A U C  and actual E l). Correlation 
analysis was carried out on pooled data from all study days using Pearson’ s product- 
moment correlation to examine relationships with breakfast palatability V A S  ratings 
and nausea A U C  (normally distributed) and Spearman rho correlation to examine 
relationships with drink pleasantness V A S  ratings (not normally distributed).
A  large inverse correlation was found between breakfast palatability ratings and 
the nausea A U C  (r=-0.557, n=48, pcO.OOl) and a medium inverse correlation was found 
between drink pleasantness ratings and the nausea A U C  (r=-0.408, n=48, p=0.004).
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4.4.6 Correlations of palatability and nausea with appetite parameters
Table 4.6. Correlations of palatability &  nausea measures with appetite measures.
Bivariate correlation coefficients for palatability V A S  ratings and postprandial nausea 
A U C  compared to postprandial appetite V A S  A U C  &  quantitative appetite measures 1-5
Pleasant Taste 2Palatable 2Nausea
Rating Rating A U C
r P r P r P
3V A S  A U C  
Fullness -0.528 <0.001 -0.447 0.001 0.155 NS
Hunger 0.313 0.030 0.540 <0.001 -0.247 NS
Prospective consumption 0.394 0.006 0.640 <0.001 -0.387 0.007
Desire to eat savoury 0.316 0.029 0.613 <0.001 -0.138 NS
Desire to eat sweet 0.239 NS 0.618 <0.001 -0.148 NS
Desire to eat fatty 0.194 NS 0.391 0.006 0.052 NS
Desire to eat salty 0.223 NS 0.402 0.005 0.093 NS
Nausea -0.408 0.004 -0.557 <0.001 -
Energy Intake
4Ad libitum  test meal E l 0.449 0.002 0.452 0.002 -0.313 0.037
_____________  524 h E l 0.428 0.005 0.262 NS  -0.279 0.073
Correlation analysis carried out by Spearman rho correlation
2 Correlation analysis carried out by Pearson’ s product moment correlation 
3Analyses for the AUC VAS were carried out on the entire dataset (n = 3x16 = 48)
4Analyses for ad libitum test meal E l were carried out after outlier was removed (n = 3x15 =  45)
5Analyses for 24 h E l was carried out after missing data from 2 participants was removed (n = 3x14 = 42)
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Breakfast palatability ratings were additionally significantly and positively correlated 
with all appetite A U C  except fullness with medium to large correlations (ranging from 
t-0.391 to 0.618, n=48, p = <0.001 to 0.006) and were significantly and negatively 
correlated to fullness A U C  (r=-0.447, n=48, p=0.001) when examined by Pearson 
correlation. The breakfast palatability ratings were also significantly and positively 
correlated with the ad libitum test meal E l (r=0.449, n=45, p=0.002) and 24 h E l 
(1-0.428, n=42, p=0.005).
Correlations between drink pleasantness ratings and subjective appetite A U C  
were not as strong. Spearman rho analysis found a strong inverse significant correlation 
with the fullness A U C  (r=-0.528, n=48, p<0.001) and medium positive significant 
correlation with hunger, prospective intake and desire to eat savoury (r=0.313 to 0.394, 
p=0.006 to 0.030). There was also a significant medium positive correlation between the 
drink pleasantness ratings and ad libitum  test meal E l (r=0.449, n=45, p-0.002) and 24 
h E l (1-0.487, n=42, p=0.001).
Selected correlations are displayed in Figure 4.12.
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1a) Pleasant drink rating & fullness AUC 2a) Pleasant drink rating & nausea AUC 3a) Pleasant drink rating & ad libitum El
1b) Palatable breakfast & fullness AUC 2b) Palatable breakfast & nausea AUC 3b) Palatable breakfast & ad libitum El
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Figure 4.12. Correlations of 1. drink taste pleasantness and 2. breakfast 
palatability ratings with (a) fullness A U C , (b ) nausea VAS  and (c) ad lib itu m  test 
meal E l
160
As shown in Table 4.7, differences between the mean energy and macronutrient intake 
during the 24 h period prior to participating in each study day were not significant as 
determined by one-way repeated measures A N O V A  analysis.
Additionally, the food diaries indicated that all participants had adhered to the required 
10-12 h fast prior to coming in for the study day and had not consumed any alcohol 
during the 24 h period preceding the study.
Table 4.7. Energy and macronutrient intake 24 h prior to study days.
N o significant differences were found between treatments for energy and macronutrient 
intake during the 24 h time-period preceding study days by one-way repeated measures 
A N O V A  analysis (n=16).
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4.4.7 Intake 24 h preceding study
P L Pal Unpal
PMean SD Mean SD Mean SD
Energy (k j) 7335 1449 7612 2700 7527 2500 NS
Fat (g) 62.0 21.4 63.0 24.2 59.4 23.4 NS
Protein (g) 75.1 20.6 71.8 18.7 71.8 20.9 NS
CHO (g) 229.7 50.8 247.7 110.8 250.9 111.3 NS
Alcohol (g) 0 0 0 0 0 0 NS
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The present study found that ingestion o f  25 mmol acetic acid (supplied in 25 g white 
wine vinegar containing 6 % acetic acid) alongside a mixed meal significantly increases 
satiety postprandially. Vinegar treatment significantly increased subjective fullness 
ratings (p<0.0001) and decreased prospective consumption (p=0.036) and hunger 
ratings (p=0.045) and significantly lowered the EI over the 24 h period follow ing the 
vinegar preload (p=0.021). Additionally, E I o f  ad libitum  test meal provided 3 h 
postprandially was significantly lower (p=0.022) follow ing the removal o f an outlier.
These findings agree with previous studies that had concluded vinegar ingestion 
significantly increased satiety (H lebowicz et al., 2008, Ostman et al., 2005), with a 
dose-response effect on satiety ratings having been observed (Ostman et al., 2005). 
However in these previous studies, the methodology to investigate effects on satiety was 
weak and the statistical tests used were inappropriate for the data, making the 
conclusions questionable. In the present study, appetite was investigated with the use o f 
subjective V A S  ratings and measurement o f  prospective food intake o f a pre-weighed 
ad libitum  meal. To our knowledge this is the first time that the influence o f vinegar 
ingestion on appetite has been investigated in this way.
Similar doses o f vinegar were supplied in the previous studies (18, 23 and 28 g 
vinegar supplying 18, 23 and 28 mmol acetic acid respectively (Ostman et al., 2005) 
and 28g vinegar supplying 28 mmol acetic acid (H lebowicz et al., 2008)) to the present 
study (25g vinegar supplying 25 mmol acetic acid). A ll studies also used similar types 
o f vinegar (white wine vinegar containing 6% acetic acid).
The present study also found ingestion o f vinegar alongside a mixed meal significantly 
reduced the glycaemic response (p=0.022). The influence o f vinegar ingestion on
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postprandial glycaemia has been extensively investigated (Brighenti et al., 1995, 
Liljeberg and Bjorck, 1998, Ostman et al., 2005, Sugiyama et al., 2003, Johnston and 
Buller, 2005, Liljeberg and Bjorck, 1996), and findings from the present study agree 
with previous results.
In addition to investigating the influence o f vinegar ingestion on subsequent appetite 
using more robust methodology, we also aimed to determine i f  palatability had an 
influence on outcomes.
Ideally to investigate the role o f palatability, palatability ratings for P L  and Pal 
treatments would not differ significantly. However both the Pal and Unpal drinks were 
rated as significantly less pleasant than PL, and both the Pal and Unpal breakfasts were 
rated as significantly less palatable than PL, which means that we were not successful in 
making Pal to a similar level o f  acceptability as PL. The Unpal breakfast was however 
rated significantly less palatable than Pal and the Unpal drink was less pleasant than Pal 
with a trend towards significance, so we successfully made Pal more acceptable than 
Unpal treatment. It is interesting to note there were large differences between mean 
ratings for pleasantness and palatability, indicating that the wording o f  questions can 
greatly influence responses, which has previously been indicated in the literature 
(Sprensen et al., 2003, Yeomans, 1998).
It was found that E l decreased in the order PL, Pal and Unpal for the entire 24 h 
o f the study day. Futhermore, follow ing the removal o f an outlier E l o f  the ad libitum  
test meal provided 3 h postprandially also decreased in the order PL, Pal and Unpal, 
although it may be argued that this is not an appropriate analytical approach. Post-hoc 
analysis found that while the difference in E l between P L  and Unpal treatments 
approached significance for the ad libitum  meal (p=0.023, W ilcoxon analysis) and was 
significant for 24 h intake (p=0.017, Bonferroni analysis), differences between P L  and
Julia Darzi Thesis
163
Pal and between Pal and Unpal were not significant. When alcohol was removed from 
contributions to 24 h El, in addition to a significant difference between P L  and Unpal 
(p=0.002) E l differed between Pal and Unpal with a trend approaching significance.
So what are the implications o f  these findings? The Pal and Unpal drinks delivered 
exactly the same dose o f  vinegar (25 g, equivalent to 25 mmol acetic acid) in exactly the 
same total volume o f liquid alongside an identical breakfast. As Unpal treatment 
decreased subsequent E l (at both the ad libitum  meal 3 h postprandially and over the 
entire 24 h period) while the Pal drink did not, this provides support for the hypothesis 
that preload palatability had an influence on subsequent appetite.
Added to this, post-hoc analysis o f  appetite ratings in the present study found the 
fullness A U C  was significantly higher follow ing Unpal than P L  and higher with a trend 
towards significance fo llow ing Pal than PL. As the palatability ratings for Unpal were 
significantly lower than Pal, this still fits with our hypothesis that palatability may 
influence appetite, although it does not exclude the possibility that the acetic acid itself 
may have a physiological effect. N o other post-hoc differences between PL, Pal and 
Unpal for appetite ratings were found, except the desire to eat sweet A U C  (significantly 
higher follow ing Pal than Unpal), despite vinegar treatment also significantly 
influencing hunger and prospective consumption. The lack o f significant findings may 
simply be due to the study having insufficient power to detect significant differences in 
the post-hoc analyses. Flint and co-workers suggest at least 20 participants should be 
recruited for a crossover study in order to detect a 5mm difference in mean 4.5h fullness 
ratings (Flint et al., 2000).
When data was pooled from all the study days, medium to strong correlations 
were found between the palatability V A S  ratings and all appetite V A S  A U C , ad libitum  
test meal E l and 24 h El. Drink pleasantness ratings were correlated to fullness, hunger,
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prospective intake and desire to eat savoury A U C  and to ad libitum  test meal and 24 h 
EI. W hile correlations do not imply causality and do not indicate which variable is 
causing the other to change (Field, 2009), these findings are certainly interesting in 
supporting our hypothesis that decreased palatability o f test products is associated with 
decreased appetite / increased satiety.
It has previously been shown that palatability manipulation may influence appetite. For 
example, the addition o f  citric acid to soup was found to increase satiation in a dose- 
response manner, with ad libitum  intake o f the soup and palatability ratings both 
significantly decreasing with increasing levels o f citric acid (de Graaf et al., 1999). 
However the relationship is not straightforward, as this study found E I at a postprandial 
ad libitum  buffet meal was not significantly influenced by treatment, leading the authors 
to conclude there was no effect on subsequent satiety. Other previous studies have also 
found an influence o f palatability on satiation (Hellemann and Tuorila, 1991, Nisbett, 
1968, Yeomans, 1996, Yeomans et al., 1997). The lack o f  effect o f palatability on 
satiety in the study by de Graaf and co-workers (1999) is in contrast to the findings o f 
the present study where we did find an influence on satiety. However the fact that 
researchers have found an influence o f palatability on satiation (Hellemann and Tuorila, 
1991, Nisbett, 1968, Yeomans, 1996, Yeomans et al., 1997, de Graaf et al., 1999) adds 
some weight to our hypothesis that palatability has an influence on appetite.
With this in mind, it may be interesting to additionally investigate ad libitum  
intake o f vinegar-containing test products to determine the influence o f vinegar on 
satiation. The test drinks used in the present study would not be suitable due to the 
minimal energy content o f  the drinks, but this could be investigated for example with 
the addition o f vinegar to soup at different level o f  concentration.
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Conversely, Freeland and W olever have recently reported that rectal and intravenous 
infusion o f acetate (thereby bypassing cephalic responses) increased postprandial P Y Y  
and GLP-1 concentrations providing some evidence that acetate may have a 
physiological influence on appetite aside from a cephalic response (Freeland and 
Wolever, 2010). However the study was only small (n=6), no subjective or quantitative 
appetite measures were reported and it needs to be remembered that rectal infusion 
stimulates a different part o f the G IT  in comparison to oral delivery. Blood was not 
collected for gut peptide analysis in the present study so it is not possible to directly 
compare results.
Looking now at the metabolic results, the postprandial glycaemia A U C  was highest 
following PL, followed by Unpal then Pal. Post-hoc analysis found the A U C  following 
Pal was significantly lower than P L  during the first 120 min but did not differ 
significantly between P L  and Unpal and between Pal and Unpal. The difference 
between Pal and P L  was not significant during the full 180 min (p=0.079), despite a 
significant overall treatment effect o f vinegar (p=0.047).
A  possible explanation for Pal significantly lowering glycaemia while Unpal did 
not is that participants were observed to consume the Unpal drink as quickly as possible 
to ‘get it over with’ , whereas the Pal drink took much longer to drink as it was spread 
throughout a larger volume, meaning participants were consuming the vinegar drink for 
the entire duration o f the test breakfast with Pal but not Unpal treatment. Interpretation 
o f these results in relation to palatability effects is therefore difficult, as Unpal did not 
significantly lower glycaemia while Pal did. W e therefore feel our results are 
inconclusive regarding the influence o f  vinegar treatment on the glycaemic response.
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One limitation o f the study was that as blood analyses were carried out at the point o f 
sample collection on each study day (the HemoCue 201+ analyser provides immediate 
results from a simgle drop o f blood), error w ill have been introduced due to day-to-day 
variability in the analysis. QCs were however run at the start o f each study day and the 
same HemoCue analyser was used on each occasion. As the main study outcome was 
appetite, we chose to use the HemoCue system as the amount o f blood required was 
minimal, thus reducing the invasiveness o f the blood collection procedure and reducing 
confounding influences o f this procedure on appetite.
Another limitation in the present study is that we did not control for the effects 
o f hormonal variations throughout the menstrual cycle. However, o f  the 13 female 
participants, 9 were using oral contraceptives and one was fitted with an implant, so 
only three participants were not using hormonal preparations that would have helped to 
moderate hormonal fluctuations.
W e also did not carry out a sensory evaluation o f the test products prior to 
carrying out the present investigation, which could have helped us in improving the 
palatability o f the Pal treatment in relation to PL, although making a palatable product 
that contains vinegar in the quantities being investigated is challenging and probably 
impossible.
4.6 Conclusion
To our knowledge this is the first study that has investigated the influence o f oral 
vinegar ingestion on subjective appetite V A S  ratings and on quantitative measures o f 
appetite, and the first study to attempt to investigate the influence o f palatability on 
these outcome measures.
Our results indicate the unpleasant taste o f vinegar test products influence 
postprandial appetite as indicated by effects on subjective appetite ratings and
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quantitative appetite measures being greater follow ing Unpal treatment compared to Pal 
treatment. In addition there were medium to strong correlations between palatability 
ratings and appetite parameters. It is not possible to ascertain i f  palatability is the sole 
cause o f observed effects in the present study as we were only partially successful in 
producing a more palatable (Pal) and less palatable (Unpal) vinegar containing test 
product. Furthermore correlations do imply causality. The influence o f palatability on 
postprandial glycaemia was less clear.
Further work is required to investigate the influence o f the palatability in 
appetite and metabolic responses fo llow ing vinegar ingestion.
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Chapter 5: Orosensory effects of vinegar on appetite, food 
intake and metabolic response
5.1 Introduction
In the previous study (Chapter 4) it was reported that oral ingestion o f vinegar (as a 
source o f the SCFA acetic acid) acutely reduced glycaemia and increased satiety 
postprandially, and that these effects may have arisen from the palatability o f  the 
vinegar-containing test products.
However results from the previous study were not conclusive, mainly due to the 
difficulty in producing a vinegar-containing test product that does not differ in 
palatability from a non-vinegar containing PL. W e produced a more ‘palatable’ and an 
‘unpalatable’ vinegar-containing test drink that delivered equimolar quantities o f 
acetate. W hile our ‘unpalatable’ test drink was rated as having a significantly less 
pleasant taste than the ‘palatable’ test drink, the ‘palatable’ drink also had a significantly 
lower taste rating than PL, so it was not possible to separate the orosensory properties o f 
the test product from additional physiological effects acetate may have.
Therefore although we found significant correlations between the palatability o f 
the breakfast and appetite, our findings from the previous study were not conclusive.
Following on from this, the present study was designed to investigate the orosensory 
effects (taste, smell, thought, etc) o f  vinegar on appetite and postprandial glycaemia and 
insulinaemia. A  method that can be adopted to investigate orosensory effects o f a 
product is the modified sham feeding (M SF), or “ spit-and-chew”  technique, which has 
been used extensively to investigate cephalic phase responses (see Chapter 1, section 
1.10). In this technique, the food under investigation is tasted and chewed but not 
swallowed, instead being expectorated, thus separating the orosensory properties o f  the 
food from physiological effects that it’ s constituents may have fo llow ing ingestion.
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5.2 Aims
The aim o f this study was, therefore, to investigate the acute effects o f orosensory 
stimulation with acetic acid (delivered in a drink containing vinegar, V IN ) follow ing a 
standard breakfast preload on appetite V A S  ratings, prospective food intake at a 
subsequent ad libitum  test meal 3 h postprandially, 24 h intake and glycaemic and 
insulinaemic response as compared to stimulation with PL  (drink with no added 
vinegar). Orosensory stimulation was achieved using the M SF technique.
5.3 Methods
5.3.1 Sample size calculations
This study was a pilot study. As it has previously been reported that 17 participants are 
required to detect a 500 lcJ difference in E l in a crossover design study with a power o f 
0.8 (Arvaniti et al., 2000) provided intake on the previous evening is standardised, we 
aimed to recruit a similar number to this study.
5.3.2 Participants
Fourteen healthy participants (6 male, 8 female) aged between 20 and 42 y were 
recruited from the student population at the University o f Surrey by word o f mouth 
during June to July 2009. To assess suitability for inclusion participants completed a 
Lifestyle and Medical Questionnaire and DEBQ, and a blood sample was collected by 
fingerpriclc to measure fasting blood glucose concentrations at an initial screening 
session (see section 2.1).
For inclusion, participants were required to have a B M I o f 19 to 28 kgm '2, 
fasting blood glucose <6.0 mmol/1, restraint score o f <3.5 (assessed using the DEBQ) 
and have been stable weight for at least 3 months. Exclusion criteria included currently
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pregnant or breast feeding, on a weight reducing diet, history o f  coronary heart disease, 
diabetes mellitus, gastrointestinal disorders, anaemia, clinical depression and other 
psychological disorders or o f  eating disorders, drug or alcohol abuse in the last 2 y, 
current habitual smoker, high habitual alcohol intake (>20 units per week) and talcing 
selected current regular medications (excluding contraceptives). One participant was 
prescribed an asthma inhaler to use during acute episodes, but no other medications 
were prescribed to participants.
Table 5.1 outlines the baseline participant characteristics. The mean participant age was 
27.5 [SD 5.4] y and B M I was 22.7 [SD 3.2] lcgm'2. None o f the characteristics 
significantly differed between genders except the % body fat, systolic and diastolic BP 
and fasting blood glucose.
Table 5.1: Baseline participant characteristics
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Overall (n=14) Male (n=6) Female (n=8)
Mean SD Range Mean SD Range Mean SD Range
Age / years 27.5 5.4 20-42 24.8 3.7 20-31 29.5 5.9 24-42
BMI/kgm'2 22.7 3.2 18.1-28.2 24.0 3.5 20.9-28.2 21.7 2.8 18.1-25.0
Waist circumference / 
cm 81.4 9.4 68.0-95.0 84.7 8.7 76.0-95.0 79.1 9.8 68.0-91.5
*Body fat / % 21.7 8.9 10.3-33.9 16.1 5.8
10.3-
22.2 25.8
O
O
O
O 11.3-33.9
*:|iSystolic BP / imnHg 108 10.9 95-127 118 7.9 108-127 101 5.6 95-113
^Diastolic BP / mrnHg 67.7 5.6 60-78 72 4.8 65-78 65 4.6 60-74
DEBQ Restraint 2.2 0.7 1.2-3.2 2.2 0.6 1.6-2.9 2.3 0.8 1.2-3.2
DEBQ Emotion 1.9 0.7 1.0-3.1 1.8 0.4 1.2-2.3 2.1 0.8 1.0-3.1
DEBQ External 2.9 0.4 2.1-3.7 2.9 0.3 2.5-3.3 3.0 0.5 2.1-3.7
!|:Fasting blood
n l i i e A c n
4.7 0.4 4.3-5.5 4.5 0.3 4.3-5.0 4.9 0.4 4.5-5.5glucose
Characteristics that differed significantly (p<0.05) and very highly significantly (p<0.00J) between 
genders are denoted by (* )  and (* * )  respectively
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5.3.3 Ethics
A ll participants gave written consent prior to commencing the study. Approval for the 
study was granted by the University o f Surrey Ethics Committee on 29th September 
2008 (EC/2008/70/FHMS), and the study took place from June until August 2009 in the 
Clinical Research Centre (C R C ) at the University o f Surrey.
5.3.4 Study protocol
Acute postprandial effects on appetite (assessed by subjective ratings and subsequent 
E I) and plasma glucose and insulin in response to a standard milkshake preload 
followed by a M SF phase with either a vinegar-containing (V IN ) or P L  drink were 
investigated using a randomised balanced crossover study design. Participants attended 
on two occasions separated by at least 2 d and were assigned to the experimental 
condition (V IN  or PL, see 5.3.5 for further details), in a counter-balanced randomly 
assigned order.
To  reduce within-subject variability, participants were instructed to refrain from 
unaccustomed exercise and alcohol during the 24 h preceding each study day and to 
approximately replicate their 24 h intake prior to each study day. A  standardised 
evening meal (low  fibre ready meal and desert selected by participant) was provided 
and 24 h intake was recorded.
A ll study days took place at the CRC at the University o f Surrey. Participants were 
requested to stay in the CRC during the study, although they were allowed to read, write 
or work on their computers.
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Figure 5.1 shows a timeline for the study day protocol.
On each study day participants arrived at the CRC at approximately 08.30 h follow ing 
an overnight fast o f at least 12 h. Upon arrival, anthropometric measurements (%  body 
fat, weight, B M I) were taken. Tw o fasting capillary blood samples were then collected 
by fingerpriclc (time -30 and -5 min) and two initial V A S  to subjectively assess appetite, 
nausea and other attributes unrelated to appetite (see 2.3.1) were completed fo llow ing 
each blood sample.
Participants were then provided the breakfast preload (Nurishment milkshake, 
see 5.3.5), which they were asked to consume within 5 min. A t t =  6 min, the M SF 
phase was commenced (see 5.3.5 for details) with either V IN  or P L  treatment, which 
took approximately 5 min. Follow ing breakfast, participants completed V A S  regarding 
the pleasantness o f M SF drink and the milkshake (see 2.3.1).
Blood samples were taken every 15 min for the first hour fo llow ing breakfast and half 
hourly for the fo llow ing 2 h until lunch. In addition a set o f V A S  for fullness, hunger, 
prospective food consumption, desire to eat meal / snack / sweet / savoury / salty / fatty 
and nausea plus additional V A S  unrelated to appetite such as calmness, happiness, 
tiredness, boredom and anxiety were completed at half hourly intervals. Participants
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were not informed this study was investigating effects on appetite which is why the 
additional V A S  questions were included to distract from the purpose o f the study.
180 min following the start o f the preload milkshake, a large ad libitum  homogenous 
pasta meal was served in a confined individual booth, and participants were instructed 
to eat until comfortably full. The difference in intake follow ing V IN  and PL  treatment 
was determined. Further details about the ad libitum  buffet meal and the conditions 
under which it was served are described in Chapter 2 (section 2.3.2).
Once the participants had finished their lunch they were free to leave and were asked to 
complete a food and drink diary for the remainder o f the day until 09.00 h the follow ing 
morning.
5.3.5 Test breakfast and MSF drinks
The standard breakfast preload provided at t = 0 min was 420 g Nurishment milkshake 
(chocolate, vanilla or strawberry flavour). Participants were given the same flavour on 
each visit and were asked to drink the milkshake within 5 min. Each milkshake supplied 
1804 kJ (428 kcal), 21.0 g protein, 60.0 g CHO and 12.6 g fat.
A t t = 6 min (i.e. 6 min follow ing the start o f the milkshake preload), participants were 
asked to commence the M SF phase randomised to on that occasion, either P L  (water 
with no added vinegar) or V IN  (water with added vinegar at a level o f  16.7 g vinegar / 
100 g total volume, equivalent to 160 mmol/1 acetic acid which is the same 
concentration as the Unpal drink used in Chapter 4). The vinegar used was Tesco White 
W ine Vinegar (6% acetic acid). The ingredients used to make the test drinks are 
summarised in Table 5.2.
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Table 5.2: M SF test drinks. Once prepared, the drink was divided equally between 10 
small taster cups
Product a) PL b) V IN
Tesco White W ine Vinegar (6% acetic acid) - 30g
Tap water 180g 150g
T O T A L 180g 180g
The M SF drinks were divided equally between 10 small taster cups. During the MSF 
phase o f the study, participants were asked to sip from one cup at a time and to hold the 
drink in their mouth for 25 seconds without swallowing any o f the provided drink. They 
then expectorated the drink into a pre-weighed receptacle and 5 seconds later were 
asked to sip from the next cup and so on. This sequence continued until all 10 cups had 
been sham fed, which took approximately 5 min. The pre-weighed receptacle was then 
re-weighed in order to determine the recovery following the M SF sequence. The MSF 
protocol is outlined in Figure 5.2.
Figure 5.2: M SF protocol
mm mm iiiiiii mimi iiiiiii mum nmm iiiiiiii mm mm
Key 25 seconds -  hold MSF drink in month 
5 seconds -  expectorate the MSF drink
5.3.6 Blood sampling and analysis
Capilliary blood samples (approximately 300pl per timepoint) were collected by 
fingerprick into fluoride microvette tubes (Starstedt Ltd, Beaumont, Leicester, U K ) (see 
section 2.5.2). Glucose concentrations were analysed immediately on fresh plasma 
samples using the YS I 2300 Stat Plus Glucose Analyser (Y S I Incorporated, Yellow  
Springs, Ohio, U S A ) (see section 2.6.3.2). The remaining plasma was stored at -20°C 
until analysed for insulin concentrations using an immunochemiluminometric ELISA
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ldt (Invitron Ltd, Wyastone Business Park, Monmouth, U K ) (see section 2.6.8.2). 
Samples from the same participants were analysed on the same plate.
Participants were invited to a session to familiarise them with the fingerprick 
method prior to commencing the study, to minimise effects on appetite during the study.
5.3.7 Food diary analysis
Food and drink diaries were completed on the day before and the day o f the study. 
These diaries were analysed for EI, macronutrient and fibre intake using WinDiets 
Professional 2005 (The Robert Gordan University, Aberdeen, U K ) (see section 2.2.3).
5.3.8 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0. Data was tested 
for normality using the Kolmogorov-Smirnov test. Differences in anthropometric 
variables between male and female participants were assessed non-parametrically using 
the Mann-Whitney test.
Differences in the effects o f V IN  compared to P L  on palatability V A S  scores, EI 
at the buffet meal, EI and macronutrient intake during the 24 h preceding the study day 
and during the 24 h o f the study day were assessed by paired samples t-test i f  normally 
distributed, and by W ilcoxon signed-ranks test i f  not normally distributed.
The influence o f V IN  treatment compared to PL  on postprandial subjective V A S  
ratings, glycaemia and insulinaemia was assessed by two-way (V IN  treatment x time) 
repeated measures A N O V A . The A U C  and IA U C  were compared by paired samples t- 
test or W ilcoxon signed-ranks test as appropriate. The A U C  was calculated using the 
trapezoidal rule.
Differences were considered significant at a level o f p<0.05.
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5.4 Results
Figure 5.3 shows the mean V A S  scores in answer to the questions “ How pleasant was 
the taste o f the M SF drink?” and “ How pleasant was the taste o f the milkshake?” .
The M SF drink containing vinegar (Figure 5.3a) was rated as significantly less pleasant 
than PL  (p<0.0001) when analysed by paired t-test, with mean scores o f 22.4 [SD 22.5] 
mm and 73.0 [18.7] mm respectively.
By contrast, V IN  treatment did not significantly influence the perception o f the 
pleasantness o f taste o f the milkshake relative to PL  (Figure 5.2b).
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5.4.1 Palatability VAS scores
E xtrem ely  
pleasant 1Q0
& 4 0
N o t at all 
pleasant
a) MSF drink E xtrem ely  
pleasant 1()()
£  4 0
b) Milkshake
N ot at all 
pleasant
V IN
Figure 5.3a. VAS ratings in answer to 
‘How pleasant was the taste of the M SF  
drink?’
V IN  significantly reduced the pleasantness 
o f the M SF drink relative to P L  (pcO.OOOl).
Figure 5.3b. VAS ratings in answer to 
‘How pleasant was the taste of the 
milkshake?’
V IN  did not significantly influence 
pleasantness o f the milkshake relative to PL.
Analyses conducted by paired samples t-test. 
Results shown as mean with error bars 
representing the SEM (n=14)._________________
Analyses conducted by paired samples t-test. 
Results shown as mean with error bars 
representing the SEM (n=14)._________________
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Recovery o f the V IN  drink follow ing sham feeding was found to be significantly higher 
than P L  recovery (p=0.001) when analysed by the W ilcoxon signed-ranks test (Table
5.3). The mean recovery was 97 [SD 5] % follow ing PL  and 107 [SD 4] %  following 
V IN , and recovery o f drinks was >90 %  in all cases except one.
5.4.2 Recovery of the MSF drink following sham feeding
Table 5.3. % recovery of the M SF  drinks following sham feeding protocol1
Recovery o f  the vinegar M SF drink was found to be significantly higher than recovery 
o f the P L  M SF drink (n=14)
% Recovery
PNo PL VIN
1 98 108
2 99 105
3 99 116
4 82 104
5 98 107
6 99 104
7 100 111
8 98 114
9 101 106
10 100 101
11 99 104
12 91 109
13 101 107
14 100 108
*MEAN *97 *107
SD 5 4
1 Mean % recovery differed significantly between treatments (*p=0.001,'Wilcoxon signed-ranks test)
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The mean V A S  rating time-course curves were lower following V IN  for all appetite 
ratings except fullness (Figure 5.4).
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5.4.3 Subjective appetite ratings
b) How hungry do you feel? Extremely b) How strong is your desire to eat a meal?
Extremely c) How strong is your desire to eat a snack ? d) How much would you like to eat?
e) Would you like to eat something savoury? f )  Would you like to eat something salty?
Figure 5.4. Subjective appetite ratings following PL  (- •  -) and V IN  (- A  -)
V IN  treatment did not significantly influence any V A S  ratings over the entire study 
period. A  significant treatment effect over part o f  the study was found for (a) hunger (0- 
150 min, p=0.044), (b ) desire to eat (0-90 min, p=0.050) &  (d) prospective consumption 
(0-60 min, p=0.034). Analyses were carried out by two-way repeated measures 
A N O V A . Results shown as mean with error bars representing the SEM (n=14).
V IN  treatment did not have a significant influence when looking at the entire acute 
study period (from 0 to 180 min) when analysed by two-way repeated measures 
A N O V A . There was however a significant treatment x time effect for hunger (p=0.009) 
and the desire to eat something salty (p=0.002).
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V IN  treatment reduced the mean A U C  and IA U C  from 0 to 180 min for all appetite 
ratings except fullness (Table 5.4). However this was only to a significant level for the 
IA U C  for hunger (p=0.024), desire to eat a snack (p=0.010) desire to eat salty (p=0.006) 
and with a trend towards significance for the A U C  for hunger (p=0.052).
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Table 5.4. A U C  and IA U C  from 0-180 min and A U C  from 0-90 min for selected 
VAS appetite ratings after P L  and V IN  treatment
A U C  and IA U C  were lower for all ratings fo llow ing V IN . This was significant over 
entire study duration for desire to eat a snack A U C  and for hunger and desire to eat salty 
IA U C  and trend towards significance for hunger AUC . Analysis was carried out by 
paired-samples t-test or W ilcoxon signed-ranks test as appropriate (n=20).
VAS rating P L V IN
Mean SD Mean SD P
A U C  (0-180)
Hunger 9013 3452 7158 2733 0.052
Prospective consumption 9089 3275 8124 2813 NS
Desire to eat a meal 9198 3482 8134 2495 NS
Desire to eat a snack 8867 4109 7653 3262 0.010
Desire to eat salty 7680 3966 6754 3439 NS
IA U C  (0-180)
Hunger 553 3331 -1918 3651 0.024
Prospective consumption -46 2446 -1274 3301 NS
Desire to eat a meal -670 2550 -1448 2470 NS
Desire to eat a snack 516 2245 -1514 2694 NS
Desire to eat salty -73 1535 -1976 2414 0.006
A U C  (0-90)
Prospective consumption -376 1422 -1026 1476 0.041
Desire to eat a meal -596 1409 -1163 1641 0.045
W hile it is not statistically appropriate to do so, it is interesting to note that during the 
earlier part o f the study, two-way repeated measures A N O V A  found V IN  treatment 
significantly reduced hunger ratings from 0 to 150 min (p-0.044) and the desire to eat 
from 0 to 90 min (p=0.050). Prospective consumption was influenced with a trend 
towards significance from 0 to 90 min (p=0.051). Significant treatment x time 
interactions were also observed for desire to eat a snack (p=0.024) from 0 to 150 min. 
V IN  significantly reduced the A U C  for hunger (p=0.028) from 0 to 150 min and for 
prospective consumption (p=0.045) and desire to eat a meal (p=0.041) from 0 to 90 min.
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5.4.4 Quantitative appetite Assessment
5.4.4.1 Intake at the ad libitum test meal
Figure 5.5 shows the mean intake o f the ad libitum  pasta meal 3 h follow ing the 
milkshake preload. The mean intake was higher follow ing M SF with V IN  (562 [SD 
290] g, 3636 [SD 1909] kJ) than follow ing M SF with PL  (534 [SD 180] g, 3392 [SD 
1119] kJ) treatment. Comparative analysis using the paired sample t-test determined the 
difference in intakes were non significant.
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a) Intake (g) b) Intake (k j)
PL VIN PL VIN
Figure 5.5. Intake of ad lib itu m  pasta meal in (a ) grammes and (b ) k j
No significant influence o f V IN  treatment on pasta meal intake in grammes or kJ. 
Analyses were carried out by paired samples t-test. Results shown as mean with error 
bars representing the SEM (n=14).
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The mean energy and macronutrient intake for the entire study day follow ing P L  and 
V IN  treatment is shown in Table 5.5. Mean EI follow ing V IN  treatment (9576 [SD 
2079] 1<J) was higher than fo llow ing P L  (9394 [SD 2866] Id ), however this difference 
was non significant. There were also no significant differences between treatments for 
macronutrient and alcohol intakes when analysed using paired-samples t-test for 
parametric data and W ilcoxon signed-ranks test for non-parametric data.
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S.4.4.2 Intake during 24 h period following preload
Table 5.5. E I and macronutrient intake 24 h following PL  and V IN  treatment
N o significant effect o f  V IN  treatment was found. Analysis was carried out using 
paired-samples t-test or W ilcoxon signed-ranks test when appropriate (n=14).
PL V IN
PMean SD Mean SD
Energy (k j) 9304 2866 9576 2079 NS
E I excluding alcohol (k j) 9054 2379 9574 2081 NS
Fat (g) 74.7 31.5 79.5 20.0 NS
Protein (g) 93.8 31.0 89.0 24.0 NS
C H O  (g) 281.5 55.3 305.9 69.2 NS
Fibre (g) 11.6 3.4 11.8 3.4 NS
Alcohol (g) 8.5 31.8 0.1 0.3 NS
As shown in Table 5.6, there was also no difference in % contribution o f macronutrients 
and alcohol to the total 24 h E I between P L  and V IN  treatment when analysed by 
paired-samples t-test.
Table 5.6. %  contribution to E I by each macronutrient and alcohol 24 h after PL  
and V IN  treatment
N o significant effect o f V IN  treatment was found. Analysis carried out by paired- 
samples t-test (n=14).
PL V IN
PMean SD Mean SD
Fat % E I 29.3 5.7 31.2 3.9 NS
Protein % E I 16.9 2.9 15.5 2.6 NS
C H O  % EI 52.3 7.4 53.2 2.1 NS
Alcohol % E I 1.6 5.9 0.0 0.1 NS
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The mean postprandial glycaemic and insulinaemic responses for the different 
treatments are shown in Figure 5.6. No influence o f V IN  treatment on either the 
glycaemic or insulinaemic responses was found when analysed by two-way repeated 
measures A N O V A . Additionally the treatment x time interactions were non significant.
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5.4.5 Postprandial plasma metabolites
a) Plasma glucose b) Plasma insulin
T im e  (m in )  T im e  (m in )
Figure 5.6. Postprandial plasma (a) glucose &  (b ) insulin concentrations following 
PL  (- #  -) and V IN  (- ▲  -) treatment
No significant influence o f V IN  treatment on either metabolite was found. Analyses 
were carried out by two-way repeated measures A N O V A . Results shown as mean with 
error bars representing the SEM (n=14).
Comparison o f the A U C  and IAU C  using the paired t-test analysis also determined there 
was no significant difference between V IN  and PL  treatment for both postprandial 
plasma glucose and insulin concentrations (data not shown).
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As shown in Table 5.7, the fasting insulin sensitivity, p-cell function and insulin 
resistance as estimated by Homeostasis M odel Assessment (H O M A ) (Levy  et al., 1998, 
Wallace et al., 2004, Matthews et al., 1985) (see section 2.8.1 for further details) were 
not significantly different at the start o f each study day.
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5.4.6 Indices of insulin sensitivity
Postprandially, neither the Oral Si as estimated using the minimal model method 
(Caumo et a l, 2000) (see section 2.8.2 for further details) nor the insulin to glucose 
A U C  ratio (for 0-180 min) differed significantly between V IN  and PL.
Table 5.7. Indices of insulin sensitivity at baseline and following milkshake 
preload1,2,3
N o significant difference between V IN  and P L  treatments was found by paired-samples 
t-test / W ilcoxon signed ranks comparison as appropriate (n=14).
PL V IN
PMean SD Mean SD
H O M A  % S 243.33 38.99 236.34 64.88 NS
H O M A  %  B 58.01 16.55 65.88 30.66 NS
H O M A  IR 0.45 0.11 0.52 0.32 NS
Insulin:glucose A U C  (1) 3.46 1.91 3.23 2.06 NS
Oral S i (2) 37.03 25.16 53.66 71.54 NS
1 HOM A %S, fasted oral insulin sensitivity, HOM A %B, (3-cell function and HOM A IR, insulin 
resistance all estimated by homeostasis model assessment.
2 AUC 0-180 mins
3 Oral Sj values are x 10'3 dl glucose / kg.min / pU insulin.ml. Calculated by minimal model.
Comparisons were carried out by paired t-test when normally distributed and by 
W ilcoxon signed-ranlcs test when non-parametric.
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Figure 5.7 shows the V A S  ratings for nausea. Analysis by two-way repeated measures 
A N O V A  found that although the mean nausea ratings were higher follow ing V IN  than 
follow ing PL, this difference was not significant. Additionally the treatment x time 
interactions were non significant.
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5.4.7 Subjective nausea ratings
Comparison o f the A U C  and IAU C  by paired-samples t-test also found no significant 
difference between treatments (data not shown).
Extremely
nauseous
Tim e (m in )
Figure 5.7. Postprandial VAS  ratings for feelings of nausea
No significant influence o f V IN  treatment was found by two-way repeated measures 
A N O V A  analysis. Results shown as mean with error bars representing the SEM (n=14).
Comparison o f the fasting nausea ratings by paired-samples t-test analysis determined 
that the nausea ratings were significantly higher during the V IN  condition than the PL  
condition.
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As shown in Table 5.8, the mean energy, macronutrient and fibre intake during the 24 h 
period prior to participating in each study day did not differ significantly between PL  
and V IN  treatment when compared by paired-samples t-test or W ilcoxon signed-ranks 
test as appropriate.
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5.4.8 Intake 24 h preceding study
Additionally, the food diaries indicated that all participants had adhered to the required 
10-12 h fast prior to coming in for the study day, had consumed the supplied standard 
meals and had not consumed any alcohol during the 24 h period preceding the study.
Table 5.8: Energy and macronutrient intake 24 h prior to study day
N o significant differences were found between treatments for the energy and 
macronutrient intake during the 24 h time-period preceding the study days when 
analysed by paired-samples t-test or W ilcoxon signed-ranks test as appropriate (n=14)
P L V IN
PMean SD Mean SD
Energy (k j) 6649 1617 6845 1639 NS
Fat (g ) 55.4 20.6 58.1 23.2 NS
Protein (g ) 69.7 20.5 68.2 18.4 NS
C H O  (g ) 202.7 59.9 211.0 73.0 NS
Fibre (g ) 16.3 7.6 16.3 7.7 NS
Alcohol (g ) 0 0 0 0 NS
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The present study found that orosensory stimulation with a vinegar containing drink 
follow ing a standard breakfast preload did not significantly alter postprandial 
glycaemia, insulinaemia and oral insulin sensitivity nor did it alter subsequent E l 3 h 
postprandially or E l over the entire 24 h period fo llow ing the preload. Some 
postprandial subjective appetite V A S  ratings were however significantly altered. In 
particular hunger was significantly reduced, indicating orosensory stimulation with 
vinegar may have transiently reduced appetite.
O f note, for all appetite ratings except fullness, the mean temporal curves follow ing 
V IN  treatment ran below the P L  curves, and the mean A U C  and IA U C  were lower 
following V IN  treatment than PL. When looking at the entire study duration (0 to 180 
min) these differences were only significant for hunger (treatment x time effect: 
p=0.009, AU C : p=0.052, IAU C : p=0.024), desire for a snack (A U C : p=0.010) and 
desire to eat salty (treatment x time: p=0.002, IAU C : p=0.006). However this is a pilot 
study and the study was underpowered to detect differences in V A S  ratings (Flint et al., 
2000).
W e did find significant differences when looking at earlier parts o f the study for 
prospective consumption (0 to 90 min), the desire to eat a meal (0 to 90 min), and the 
desire to eat a snack (0 to 150 min). It can be argued that statistically this is not the most 
appropriate way to look at the data due to the influence o f the data from later time- 
points, so these findings should be interpreted with caution. However these results are 
suggestive that there was a transient influence o f the orosensory properties on subjective 
appetite ratings, but that the orosensory effects did not last for the entire 180 min o f the 
study, therefore having no impact on E l at the buffet meal.
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5.5 Discussion
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Therefore from our results it seems that the orosensory properties o f vinegar-containing 
products do appeal' to have some influence on appetite. This influence is relatively 
short-lived and the effects on appetite are not as strong as when vinegar-containing 
products are ingested. It is possible that there may be an additive effect o f  the taste o f 
acetate in the oral cavity plus physiological effects o f SCFA in the G IT  upon ingestion. 
However the lack o f effect on appetite o f oral ingestion o f  propionate delivered in a 
palatable form (Chapter 3) in which there are no taste effects in the oral cavity does not 
back this idea up, although in this study the quantity o f propionate ingested (Chapter 3, 
6.0 mmol propionate) was much lower than when vinegar was ingested (Chapter 4, 25 
mmol acetic acid).
It is also possible that effects on appetite follow ing ingestion o f vinegar are 
partially modulated by feelings o f  nausea. Nausea ratings in the present study were not 
significantly reduced by M SF with V IN  relative to M SF with PL, in contrast to when 
V IN  was ingested in our previous study (Chapter 4). It is probable that merely 
stimulating the oral cavity does not trigger the same level o f nausea as triggered by 
ingesting the vinegar. I f  this is the case then this could explain why influences on 
appetite and the metabolic response were not as strong as the responses in the previous 
study.
A  further interesting possibility is that when vinegar is ingested, as well as activating 
taste cells in the oral cavity, it is ‘ tasted’ further down the GIT. It is now known that 
taste molecules are expressed in the G IT  (Young et al., 2009, Kokrashvili et al., 2009b), 
which suggests it is possible that the taste o f  ingested food can be sensed in the gut. It 
has further been shown that taste-signalling proteins are expressed on enteroendocrine L  
cells in the small intestine, the same cells that express the appetite gut peptides GLP-1 
and P Y Y  (Kokrashvili et al., 2009b, Kokrashvili et al., 2009a, Martin et al., 2009),
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suggesting taste sensing in the G IT  may have a role in modulating appetite and insulin 
release. Indeed, luminal sugars have been demonstrated to act on taste signalling 
proteins in L  cells to trigger GLP-1 release (Kolcrashvili et al., 2009b). The effect o f 
SCFA  on taste receptors has not been reported, however it is possible that they could 
also be ‘tasted’ by the gut lumen.
An important difference between the present study and the previous studies 
investigating the oral supplementation with SC FA  (Chapters 3 and 4) is that we 
provided volunteers with a milkshake preload whereas in other studies participants were 
given solid foods. W e chose to use milkshake because it can be consumed much quicker 
than a solid meal, allowing the M SF phase o f the study to commence at the earlier phase 
o f digestion and absorption o f the preload. However this also meant that the gut transit 
time o f the liquid breakfast preload in the present study was faster than in the previous 
studies follow ing solid breakfast preloads, as reflected in a sharper and faster glycaemic 
and insulinaemic response fo llow ing the liquid preload. Furthermore, the impact on 
subjective appetite was much less pronounced follow ing the liquid preload than solid 
preloads in the previous studies, which is unsurprising as it was recently reported that a 
semi-solid dessert is significantly more satisfying than an equicaloric drink (Zijlstra et 
al., 2009). In addition, consuming a liquid rather than a solid bypasses the need for 
mastication (which is the main reason that it is quicker to consume a liquid rather than a 
solid), which w ill alter cephalic responses.
Overall the use o f a liquid preload could make it more difficult to alter appetite 
and metabolic responses than when a solid preload is used, and it is possible that we 
may have observed stronger effects i f  the study had been carried out using a solid 
preload. It is also possibly the reason for the shorter-lived influence o f M SF with 
vinegar on appetite.
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Additionally, the timing o f vagal stimulation via M SF may have influenced the 
findings. W e chose to have the M SF phase after the preload rather than before so that 
the taste effects would occur at the stage o f digestion and absorption. However it has 
previously been found that vagal stimulation with an appetising meal gave rise to more 
significant effects when applied prior to a fat load than when applied after a fat load 
(Robertson et al., 2002).
Finally, it may have been worthwhile having a shorter study duration, as the 
effects on subjective appetite ratings occurred earlier in the study. For example i f  we 
had carried out a 90 minute postprandial study we may have observed effects on E l at 
the buffet meal as more V A S  appetite ratings were significantly altered at the point.
5.6 Conclusion
In conclusion, the results from this pilot study indicate orosensory stimulation with a 
vinegar-containing product may transiently reduce subsequent appetite ratings, however 
these effects are not a strong as effects when vinegar is ingested (Chapter 4). This is 
suggestive that while the taste o f the vinegar-product in the oral cavity does influence 
appetite, this may not be the only reason for a reduced appetite follow ing vinegar 
ingestion. Possible additional reasons for ingested vinegar having a stronger influence 
on appetite include feelings o f  nausea or ‘ tasting’ in the upper G IT  or both.
Further work is therefore required in order to ascertain the role o f palatability in 
influencing appetite. For example the oral cavity could be bypassed via gastric infusion 
o f an acetate solution vs. saline alongside a standard oral preload to determine i f  
observed effects on appetite and the metabolic response occur when there is no 
orosensory stimulation with acetic acid, thereby just observing the physiological effects 
o f SC FA  in the GIT.
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Chapter 6: Acute effects of supplementation with inulin 
propionyl ester on propionate production
6.1 Introduction
The previous studies in this thesis reported in Chapters 3-5 have considered the delivery 
o f specific SCFA (propionate in Chapter 3 and acetate in Chapters 4 and 5) to the upper 
G IT  via oral ingestion. An alternate approach to deliver SCFA to the body is by 
ingestion o f fermentable NDC to deliver SCFA further along the G IT  to the colon.
A  method to deliver specific SCFA to the colon is being developed in which 
specific SCFA (e.g. propionate) are tethered to an NDC scaffold such as inulin by 
chemical esterification (Figure 6.1).
Figure 6.1. Diagrammatic representation of inulin propionyl ester (IPE )
Propionate molecules are esterified to an insulin scaffold (N D C ) which resist digestion, 
thereby delivering propionate to the colon.
NDC SCFA esters such as an inulin acyl ester or starch acyl ester overcome the 
problems associated with the other modes o f  delivery to the body (e.g. via gastric 
infusion or oral delivery), as it non-invasively places the specific SCFA at the site o f 
interest (the colon) and overcomes palatability problems that occur when SCFA are 
added to food items.
Investigations are underway to determine if  NDC esters are able to deliver 
specific SCFA to the colon. To be suitable, NDC SCFA esters need to be able to resist 
digestion in the upper G IT  in order to reach the colon for fermentation. Lactulose mono­
acetate was found to resist digestion in vitro when incubated in conditions modelling the
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stomach (pH 1.2) and the small intestine (pancreatic enzymes), suggesting this NDC 
ester is able to resist digestion in the upper G IT  (Morrison et al., 2005). This is backed 
up by in vivo data from a recent study where ileostomy patients (n=7) were provided 
with 20 g cooked acetylated, propionylated, butyrylated starch as a single dose on 
separate occasions. Analysis o f 24 h stomal effluent determined significant quantities 
(73-76%) o f each starch acyl ester were recovered intact, implying these esters are able 
to resist digestion in the small intestine (Bajlca et al., 2006).
In addition to resisting digestion in the upper GIT, it is also necessary that the SCFA 
can be cleaved from the N D C  SCFA  ester once the N D C  SCFA ester reaches the colon. 
In  vitro incubation o f  lactulose mono-acetate in human batch faecal fermenters resulted 
in an increased acetate production, implying faecal microflora are able to release the 
acetate from the ND C ester. Furthermore, the provision o f acetylated, propionylated or 
butyrylated starch to rats for 14 d led to increased acetate, propionate and butyrate pools 
respectively in the caecum when compared to a control non-acylated starch (Annison et 
al., 2003). In rats, acylated starch also significantly increased overall large bowel SCFA 
pools (Annison et al., 2003, Bird et al., 2006, Morita et al., 2005) and butyrylated starch 
significantly increased portal venous plasma butyrate levels (Bajka et al., 2006).
There is only limited evidence in healthy humans. The provision o f lactulose mono- 
( 13C)acetate alongside 20 g OF to human volunteers (n=2) resulted in 85 % o f the 
( 13C)acetate (marked by 13C 0 2 production) being released alongside breath H2 
production from colonic fermentation. This suggests that the majority (-85 % ) o f the 
lactulose mono-acetate was delivered to the colon, with less than 15% absorbed from 
the small intestine (Morrison et al., 2005), particularly remembering some l3C is lost via 
equilibration with body bicarbonate pools.
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In a separate study, Morrison and co-workers (2007) provided volunteers (n=7) with 2 g 
inulin mono-(13C)-butyryl ester alongside 20 g OF. It was found >90 % o f the butyrate 
was released for oxidation only once it had reached the colon, as indicated by >90 % o f 
the 13C 0 2 being released follow ing a rise in breath I I2, suggesting >90 %  ( 13C)-butyrate 
was released follow ing colonic fermentation. The data further indicated most o f the 
butyrate was cleaved from  the inulin (Morrison and Preston, 2007).
The evidence to date indicates esterified N D C  may be able to deliver SCFA  to the colon 
for use in clinical studies, such as those investigating the effects o f  specific SCFA on 
appetite. The present study was designed to evaluate i f  inulin propionyl ester (IPE ), an 
inulin acyl ester with propionate as the tethered SCFA, is able to enhance colonic 
propionate production in humans, using 24 h urinary SCFA levels as a non-invasive 
proxy measure o f colonic SC FA  production.
Urinary SCFA levels have been used in initial stable isotope studies to 
determine the contribution o f exogenous acetate to whole-body acetate flux, with 
similar results to those obtained from regular blood sampling (Morrison et al., 2004). 
This initial study therefore indicates 24 h urinary SCFA levels can non-invasively 
assess colonic SCFA production.
6.2 Aims
This study therefore aimed to evaluate i f  IPE was able to enhance colonic propionate 
production by investigating the acute dose-response effects o f IPE  on subsequent 
colonic propionate production. Colonic propionate production was assessed by 
measuring 24 h urinary SCFA  levels during the 24 h period fo llow ing supplementation, 
to act as a non-invasive marker for large bowel SCFA production (Morrison and 
Preston, 2007).
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6.3.1 Participants
The study was conducted in twelve healthy participants (6 male, 6 female) aged 
between 24 and 44 y recruited from the student and staff population at the University o f 
Surrey by e-mail and poster advertisement during April 2007. Suitability for inclusion 
was assessed using a Lifestyle and Medical Questionnaire (see section 2.1).
For inclusion, participants were required to have a B M I o f  19 to 28 kgmf2 and have been 
a stable weight for at least 3 months. Exclusion criteria included currently pregnant or 
breast feeding, on a weight reducing diet, history o f coronary heart disease, diabetes 
mellitus, gastrointestinal disorders, anaemia, clinical depression and other psychological 
disorders or o f eating disorders, drug or alcohol abuse in the last 2 y, current habitual 
smoker, high habitual alcohol intake (>20 units per week) and taking selected current 
regular medications (excluding contraceptives).
Three participants were taking oral contraceptives, but no other medications were 
prescribed to participants.
Table 6.1 outlines the baseline participant characteristics. The mean participant age was
32.1 [SD 5.8] y and B M I was 21.9 [SD 2.4] kgm'2. None o f the characteristics 
significantly differed between genders.
Julia Darzi Thesis
6.3 Methods
Table 6.1: Baseline participant characteristics
Overall (n=12) Male (n=6) Female (n=6)
Mean SD Range Mean SD Range Mean SD Range
Age / years 32.1 5.8 24-44 32.2 5.4 27 - 42 32.0 6.7 24-44
BMI/kgm’2 21.9 2 4 18-5 - 
25.6
22.0 2 1 19-2'  
24.7
21.7 2.8
18.5-
25.6
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6.3.2 Ethics
A ll participants gave written consent prior to commencing the study. Approval for the 
study was granted by the University o f Surrey Ethics Committee on 26th March 2007 
(EC/2007/19/SBMS), and the study took place from April to July 2007 in the C IU  at the 
University o f Surrey.
6.3.3 Study protocol
The study was performed as a randomised double-blind balanced crossover study to 
investigate the acute dose-response effects o f  IPE on subsequent colonic SCFA 
production as assessed by 24 h urinary propionate levels.
Participants attended on five  occasions at least 1 wk apart and were assigned to the 
experimental condition (see 6.3.4 for further details) in a counter-balanced randomly 
assigned order, either:
® N o inulin or IPE supplement
• 15 g inulin
© 5 g IPE +10 g inulin
® 10 g IPE + 5 g inulin
• 15 g IPE
To reduce within-subject variability, participants were instructed to refrain from 
unaccustomed exercise and alcohol during the 24 h preceding each study day, to avoid 
high fibre food choices (advice was provided) and to approximately replicate their 24 h
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intake prior to each study day. A  standardised evening meal (low  fibre ready meal and 
desert selected by participant) was provided and 24 h intake was recorded.
On each study day participants arrived at the C IU  at approximately 08.30 h 
follow ing an overnight fast o f at least 12 h. Upon arrival participants were provided 
with a test breakfast containing the inulin / IPE dosage they had been randomised to for 
that visit mixed into a flavoured mousse (Angel Delight see 6.3.4 for further details).
Following breakfast, participants were supplied with a low fibre packed lunch prepared 
in-house with choices selected at screening, and also an evening meal (low  fibre ready 
meal and desert selected by participant). They were supplied with the same lunch and 
evening meal on each study day and were asked to complete a food and drink diary to 
monitor compliance. They were then free to leave and were asked to collect all urine 
passed during the 24 h period and dropped o ff the 24 h urine collections the follow ing 
morning (see 6.3.5). A ll food and drink diaries were analysed using Windiet.
6.3.4 Test breakfast and products
The inulin (Orafti Beneo Inulin HP, with a D Pave >23) was donated by Orafti Active 
Food Ingredients. The IPE was manufactured and donated by Dr Douglas Morrison and 
Dr Tom  Preston at the Scottish Universities Environmental Research Centre (SUERC). 
Prior to serving, it was crushed to a fine powder with the use o f a pestle and mortar.
On study mornings participants were provided with a standard breakfast o f 30g Rice 
Krispies served with 125 ml semi-skimmed milk and a mousse containing the assigned 
inulin and/or IPE dose (either no supplement, 15 g inulin, 5 g IPE + 10 g inulin, 10 g 
IPE + 5 g inulin or 15 g IPE).
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The mousse was made by whisking together Angel Delight powder (22 g butterscotch, 
20 g raspberry or 22 g chocolate flavour as chosen by participant) mixed with the 
assigned inulin and/or IPE dose with 100ml semi-skimmed milk. The mousse was left 
to set at R T  for 5 minutes and then stored at 4 °C until served. In total the breakfast 
supplied 1353 kJ, 10.4 g protein, 52.7 g CHO, 8.0 g fat and 0.8 g fibre (excluding the 
added ND C supplement) when a chocolate Angel Delight was served.
6.3.5 Urine collection and processing
Participants were supplied with two 3 L  Urisafe Urine Collection Containers (V W R  
International) with no added preservative, as preservatives interfere with the SCFA 
analysis. In addition female participants were supplied with 1 L  polypropylene beakers 
(Fisher Scientific U K ) to help with the urine collection.
Participants were requested to collect all urine passed during the 24 h period follow ing 
the test breakfast until the follow ing morning. The follow ing morning participants 
dropped o ff their 24 h urine collections at the CIU  which was stored at 4 °C until 
processing. The urine was always processed on the day o f receipt. T o  process, the 24 h 
urine was pooled and 10 ml aliquots were removed and stored at -20°C until ready to 
process for analysis. The total volume o f the 24 h urine was measured using a 500 ml 
measuring cylinder and recorded.
6.3.6 Urinary analysis
Dr Douglas Morrison at SUERC analysed the urine samples by GC-MS to quantify 
SCFA levels (Morrison et al., 2004) as decribed in section 2.7. A ll analyses were 
carried out blinded to treatment.
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A ll statistical analyses were conducted using SPSS for Windows 16.0. The urinary data 
was not normally distributed as assessed by the Kolmogorov-Smirnov test, so data was 
analysed non-parametrically. Dose-response effects were analysed by comparison o f 
mean values at each dose using the Friedman’ s A N O V A  test and also by correlation 
using the Spearman’ s rho test to compare the IPE / inulin dose to urinary results.
Differences were considered significant at a level o f p<0.05.
6.3.7 Statistical analyses
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Figure 6.2 shows the dose response effects o f supplementing with inulin and IPE on 
total 24 h urinary propionate levels for all participants (n=12) and also with an outlier 
removed (n= l 1). 24 h urinary propionate production did not differ significantly between 
each dose for the overall sample (n=12) nor when the outlier was removed (n=l 1) by 
Friedman’ s A N O V A  analysis. Furthermore doses did not correlate with 24 h propionate 
production by one-tailed Spearman’ s rho analysis for the overall sample (R 2=0.016, 
n=12) nor when the outlier was removed (R 2=0.008, n=l 1).
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6.4 Results
6.4.1 Dose response effects on 24 h urinary propionate parameters
A) Mean [SEM] n=12 B) n=l 1 (outlier removed)
C) Mean [SD] showing outlier
Figure 6.2. Total urinary propionate levels (mmol/24 h) at each IPE  dose (a) for all 
participants (n=12), (b ) after excluding an outlier (n = l l )  and (c) showing the 
outlying value (n=12)
N o significant effect o f treatment on 24 h urinary propionate was found by Friedman’ s 
A N O V A  and the dose was not significantly correlated to 24 h urinary propionate levels 
for all participants (n=12) and with the outlier removed (n= l 1). In = inulin.
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The mean nutritional intake on the study day and the day before each study day is 
shown in Table 6.2A and B respectively. Participants achieved a low  mean fibre intake, 
consuming 10.0 [SD 2.6] to 10.6 [SD 2.9] g and 8.7 [SD 1.6] to 9.1 [SD 1.6] g on the 
day before and the day o f each study day respectively.
Table 6.2. Mean [SD ] energy and macronutrient intake on (A ) study day and (B ) 
day before study for each dose level
N o significant differences between energy and macronutrient intake were found 
between each dose level for either day. Analysis carried out using one-way repeated 
measures A N O V A  or Friedman’ s A N O V A  analysis as appropriate (n=12).
6.4.2 48 h nutritional intake
(A ) Study day
Dose (g ) 
IP E  Inulin
Energy
kJ
Fat
g
Protein
g
C H O
g
Fibre
g
0 0 8727 [1213] 74.0 [17.5] 72.4 [12.9] 283.8 [42.0] 8.7 [1.6]
0 15 8561 [1256] 72.2 [18.5] 71.0 [11.6] 279.3 [46.1] 8.8 [1.8]
5 10 8680 [1336] 73.1 [19.1] 71.7 [12.7] 283.7 [44.9] 8.8 [1.7]
10 5 8683 [1320] 72.5 [17.8] 72.9 [13.3] 284.2 [49.5] 9.1 [1.6]
15 0 8570 [1211] 71.7 [18.0] 70.6 [11.9] 281.5 [44.6] 8.8 [1.7]
P  value NS NS NS NS NS
(B ) Day before study day
Dose (g ) 
IP E  Inulin
Energy
kJ
Fat
g
Protein
g
C H O
g
Fibre
g
0 0 7445 [1582] 66.2 [22.2] 69.1 [10.1] 230.8 [58.0] 10.2 [2.8]
0 15 7775 [2360] 70.3 [30.3] 74.3 [15.4] 236.7 [77.4] 10.3 [2.7]
5 10 7776 [2321] 67.9 [26.6] 72.7 [15.4] 243.8 [84.0] 10.3 [2.9]
10 5 7845 [1974] 71.1 [28.2] 73.6 [12.5] 239.5 [66.6] 10.6 [2.9]
15 0 7768 [1937] 70.9 [28.5] 70.8 [15.2] 237.4 [62.9] 10.0 [2.6]
P  value NS NS NS NS NS
Energy, macronutrient and DF intakes did not differ significantly between dose levels 
both on the day before and the day o f each study morning when analysed by dose level 
by within subjects one-way repeated measures A N O V A  (when normally distributed) or 
Friedman’ s A N O V A  analysis (when not normally distributed).
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The results from the current data are inconclusive. There did not appear to be an effect 
on 24 h urinary propionate levels with increasing doses o f IPE. However from the 
current dataset it is not possible to determine i f  this lack o f  effect is due to IPE being 
ineffective at enhancing colonic propionate levels, or i f  it is due to 24 h urinary 
propionate not being sufficiently sensitive to reflect colonic SCFA levels.
Certainly this dataset does not disprove the hypothesis that the IPE can enhance 
propionate delivery to the colon. One possibility is that the lack o f effect arose from 
participants having a ‘naive gut’ , as the colonic microflora are unlikely to have 
previously encountered IPE (and in many cases even inulin) in these quantities. It is 
therefore possible that a run-in period is required whereby a daily dose o f  the inulin / 
IPE is given to participants over a period o f  a week or two to introduce the ND C to the 
colonic microflora. It could also be worthwhile giving an increased dose, for example 
20 g rather than 15 g. Additionally there is much inter-individual variation in colonic 
microflora, which w ill have introduced biological noise that may have been reduced 
with a greater sample size.
Another problem with the present study was the fact that it was not possible to assess 
complete urine collection. A  commonly utilised tool to assess completeness is to 
measure para-aminobenzoic acid (P A B A ) excretion when ingested as 3 x 80 mg doses 
during the day o f urine collection (Bingham and Cummings, 1983). It was not used in 
the present study because P A B A  may interfere with SCFA metabolism, which would in 
turn influence the primary study outcome. Creatinine levels were used instead, however 
P A B A  is a more sensitive and reliable indicator (Bingham and Cummings, 1985). 
Therefore error may have been introduced due to incomplete 24 hurinary collection.
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Furthermore, the propionate concentrations being measured in the 24 h urine samples 
were low  (in the pmol range), so it is possible that at these low levels, any actual effects 
on propionate levels are lost in the background propionate ‘noise’ . Propionate w ill not 
have been generated in the first few  hours follow ing breakfast, as the orocaecal transit 
time for inulin generally takes approximately 5-6 h (Geboes et al., 2003), so an 
improvement could be to commence urine collection partway through day (for example 
4-5 h postprandially), to avoid diluting the collection with urine that w ill not contain 
propionate generated from fermentation. It is also uncertain exactly what the metabolic 
fate o f propionate is once it has reached the general circulation, and it is possible that 
metabolic demands for propionate vary from day-to-day, which may mask any effects 
o f enhanced propionate levels in the urine.
6.6 Conclusion
In summary, the results from the present study were inconclusive as it was not possible 
to determine i f  the lack o f  effect on 24 h urinary propionate levels arose from either:
• The IPE not being able to effectively raise colonic propionate production 
® The dose o f IPE being inadequate to modulate colonic propionate production 
®The urinary propionate analytical method not being sufficiently sensitive to detect 
urinary propionate in the concentrations present in urine 
®24 h urinary propionate not being a sufficiently sensitive proxy measure o f colonic 
propionate production.
The only way by which it is practically possible to determine i f  the IPE is able to 
enhance propionate production in humans is by taking postprandial peripheral blood 
samples throughout the day to monitor the appearance o f SCFA in the bloodstream.
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Chapter 7: The influence of don-digestible carbohydrate 
supplements on appetite, food intake and metabolic response
7.1 Introduction
In the previous chapters, the effects o f  orally delivered SCFA on appetite and the 
metabolic response were reported. Follow ing on from this, the present study was 
designed to investigate the effects o f colonically delivered SCFA, particularly 
propionate, via fermentable NDC.
The SCFA activated G-coupled protein receptors GPR43 and to a lesser extent GPR41 
are co-expressed in colonic enteroendocrine cells with the anorexigenic ‘ ileal brake’ gut 
peptide P Y Y  (Karaki et al., 2008, Tazoe et al., 2008), providing a rationale that 
colonically derived SCFA may be more effective than orally delivered SCFA  in 
influencing appetite and the metabolic response. Propionate is the most potent ligand for 
GPR41 (Tazoe et al., 2008). As sensitivity to stimulation in vitro for P Y Y  secretion is in 
the order propionate >  butyrate »  acetate (Plaisancie et al., 1996) GPR41 is therefore 
implicated as the responsible receptor for modulating P Y Y  despite being present in the 
colon in lower quantities than GPR43. This is suggestive o f a role for colonic 
propionate in influencing P Y Y  release and therefore appetite and metabolic effects. This 
is a possibility that the present study aimed to investigate.
A  novel ND C has been developed in which propionate molecules are tethered to an 
inulin scaffold (inulin propionyl ester, IPE ) to maximise the delivery o f propionate to 
the colon, making it a suitable product to investigate physiological effects o f colonic 
propionate. The effectiveness o f  IPE  in modulating propionate production was 
evaluated, although findings from this study were inconclusive (Chapter 6).
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In addition, the non absorbable sugar L-rhamnose (L-Rha) also appears to be suitable to 
investigate effects o f colonic propionate. L-Rha is reported to favour propionate 
production during in vitro fermentation (Fernandes et al., 2000), with increased serum 
concentrations occurring approximately 6 h follow ing an acute challenge (Vogt et al., 
2004b). W hile acute (V ogt et al., 2004a) and chronic (Vogt et al., 2006) effects o f L- 
Rha ingestion on metabolites have been previously investigated, albeit not extensively, 
effects on appetite have not.
L-Rha is a naturally occurring deoxy monosaccharide that is found in 
polysaccharides o f gums and mucilages (Schaffer, 1980), being found in foods such as 
oranges, french beans, winter cabbage and carrots (Cummings and Englyst, 1987). 
When ingested, it resists digestion and absoiption in the small intestine, to reach the 
colon intact so it is available for colonic fermentation (Vogt et al., 2004b). L-Rha 
cannot be categorised as a DF as it is a monosaccharide, so it w ill therefore be referred 
to as an ND C in this thesis.
Effects o f  supplementing with inulin-type fructans on appetite (reviewed in section 
1.8.2) have been more extensively investigated. However data is not conclusive, with 
contradictory results due to variable dosages, choice o f  inulin-type fructan, and 
confounding factors from study design limitationss. Furthermore, few  studies have 
investigated effects o f high DP inulin (e.g. inulin H P) on appetite. Previous studies have 
also explored the influence o f inulin-type fructan supplementation on plasma 
metabolites (reviewed in section 1.9.2), although only a few  considered postprandial 
effects, with some indication supplementation may reduce postprandial insulinaemia 
(Causey et al., 2000, Parnell and Reimer, 2009), although this finding was not universal 
(Forcheron and Beylot, 2007, van Doklcum et al., 1999). There is therefore still a need 
to further investigate effects o f high DP inulin on appetite and the metabolic response.
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7.2.1 Original aims (4 way crossover)
The present study originally aimed to investigate the effects o f IPE, following a 1 wk 
run-in period, as a component o f breakfast and lunch, on postprandial appetite and 
metabolic response, compared to a high DP inulin (inulin HP), L-Rha (positive control) 
and no ND C (PL, negative control).
However it was not viable to continue using the IPE due to supply and QC difficulties 
that occurred during the study. The study was therefore continued without the IPE leg, 
as the work was still novel particularly in terms o f investigating the effects o f L-Rha on 
appetite and satiety. The results are therefore presented as a 3 way crossover study.
7.2.2 Aims of present study (3 way crossover)
The present study therefore aimed to investigate the effect o f the fermentable NDC L- 
Rha and inulin HP follow ing a 1 wk run-in period, as a component o f breakfast and 
lunch, on postprandial subjective measures o f  appetite and gastrointestinal symptoms, 
prospective consumption at a subsequent ad libitum  meal, 24 h intake and postprandial 
metabolite concentrations and breath H2 concentrations as compared to PL.
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7.3.1 Sample size calculations
This study was a pilot study.
7.3.2 Participants
Sixteen healthy participants (8 male, 8 female) were initially recruited to this study from 
the student population at the University o f Surrey by e-mail advertisement during 
September 2008 to M ay 2009. O f these, one participant was excluded after the first 
study day due to commencing antibiotic therapy, one participant was excluded partway 
through the study due to poor compliance with study instructions, and one participant 
was removed from analyses at the end o f due to poor compliance with fasting on one 
study visit evidenced by plasma T A G  results.
Therefore at the end o f the study, analyses were carried out on thirteen participants (5 
male, 8 female) aged between 19 and 32 y.
To  assess suitability for inclusion participants completed a screening Lifestyle and 
Medical Questionnaire and DEBQ, and a fasting blood sample was collected by 
fingerpriclc to measure fasting blood glucose and Hb concentrations (see section 2.1).
For inclusion, participants were required to have a B M I o f  19 to 27 lcgm'2, fasting blood 
glucose <6.0 mmol/1, Hb in the normal range, DEBQ restraint score o f <3.7 and have 
been stable weight for at least 3 months. Exclusion criteria included currently pregnant 
or breast feeding, on a weight reducing diet, history o f coronary heart disease, diabetes 
mellitus, gastrointestinal disorders, anaemia, clinical depression and other psychological
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disorders or o f eating disorders, drug or alcohol abuse in the last 2 years, current 
habitual smoker, high habitual alcohol intake (>20 units per week) and talcing selected 
current regular medications (excluding contraceptives).
Six participants were taking oral contraceptives and one was fitted with a contraceptive 
implant, but no other medications were prescribed to participants.
Table 7.1 outlines the baseline participant characteristics (n=13). The mean participant 
age was 22.9 [SD 3.6] y and BM I was 22.1 [SD 1.6] kgm"2. None o f the characteristics 
significantly differed between genders except the waist circumference, % body fat and 
systolic BP.
Table 7.1. Baseline participant characteristics 1
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Overall (n=13) Male (n=5) Female (n=8)
Mean SD Range Mean SD Range Mean SD Range
Age / years 22.9 3.6 19-32 22.6 3.3 19-28 23.1 4.0 19-32
BMI/ltgm'2 22.1 1.6 19.5-24.7 23.0 1.5 21.4-24.7 21.5 1.5 19.5-24.2
** Waist 
circumference / cm 75.5 6.9 67.5-86.0 82.9 3.1 78.0-86.0 70.5 2.3 67.5-73.0
!i!:l!Body fat / % 21.9 6.5 11.4-29.4 15.5 3.4 11.4-19.6 26.0 4.1 16.6-29.4
:|!Systolic BP / mrnHg 115 8.5 103-130 120 6.5 114-130 110 7.5 103-121
Diastolic BP / mrnHg 68 7.7 60-84 67 5.6 63-77 69 9.3 60-84
DEBQ Restraint 2.1 0.8 1.1-3.6 2.2 0.9 1.4-3.6 2.1 0.7 1.1-2.8
DEBQ Emotion 2.3 0.6 1.5-3.5 2.4 0.2 2 .2-2.1 2.3 0.7 1.5-3.5
DEBQ External 3.5 0.5 3.0-4.4 3.8 0.6 3.0-4.4 3.4 0.3 3.0-3.7
Fasting blood 
glucose / mmol/1 4.3 0.5 3.6-5.0 4.4 0.5 3.6-5.0 4.2 0.4 3.7-5.0
Hb / g/dl 15.6 1.3 12.8-17.1 14.9 1.5 13.0-17.1 14.4 1.3 12.8-17.0
Characteristics that differed significantly between genders are denoted by *p<0.05 and *'*p<0.001
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7.3.3 Ethics
A ll participants gave written consent prior to commencing the study. Approval for the 
study was granted by the University o f Surrey Ethics Committee on 19th August 2008 
(EC/2008/53/FHMS), and the study took place from September 2008 until April 2009 in 
the C IU  at the University o f Surrey.
7.3.4 Description of test products
Tw o different N D C  supplements were used in the 3-way crossover study. A  high DP 
inulin (Orafti Beneo Inulin HP, which has a D Pave > 23) was donated by DKSH  Great 
Britain Limited, and L-Rha (food grade L-(+)-Rhamnose Monohydrate) was purchased 
from Vitanutrition Limited. These were supplied within carrier products (sugar free je lly  
and Angel Delight) as described in Sections 7.3.7 and 7.3.9. During the P L  leg, the 
carrier product only was consumed.
7.3.5 Study protocol
The study was performed as a randomised single-blind balanced crossover study. It was 
initially a 4-way crossover study where participants commenced four separate study 
periods in which they were randomised to either IPE, non-esterified inulin HP, L-Rha 
(positive control) or P L  (negative control, no fibre). Once the IPE leg was removed this 
became a 3-way crossover study with participants being randomised to either inulin HP, 
L-Rha or PL  (control, no fibre).
Follow ing screening, all participants who had not previously participated in an appetite 
study involving cannulation were invited to attend an initial ‘familiarisation’ study 
morning in order to familiarise them with the techniques being used (see 7.3.6).
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The overall study plan for the 3-way crossover is shown in Figure 7.1.
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Randomisation 
of supplements
Figure 7.1. Overall study plan for 4 way crossover
Once the inulin PE leg was removed, the study became a 3 way crossover with 3 study 
periods instead o f 4. w/o = washout period.
Participants were then randomised to commence the first study period. The timeline for 
each study period is given in Figure 7.2. Each study period comprised a 6 d run-in 
period during which time participants were asked to incorporate the supplement they 
were randomised to into their usual diet (see 7.3.7). On Day 7 o f the study period, 
participants attended a study day at the C IU  (see 7.3.8).
RUN-IN PERIOD » STUDY DAY
7 day Gastrointestinal Symptom Ratings
4 day Diet Diary---------------
 Target dose <Step up dose daily — ►
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6
2 day Diet Diary
^-Target dose-
Day 7 Day 8
Figure 7.2. Study period timeline
Following a washout period o f  at least one week, participants then commenced the next 
study period. Subsequent study periods were also separated by at least one week to 
allow for washout.
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In addition, in order to control for hormonal variations throughout the menstrual cycle, 
female participants not using contraceptive methods that regulate hormonal levels (e.g. 
oral contraceptive, contraceptive implant) attended at approximately the same point in 
their menstrual cycle during the early (luteal phase) for each study day.
7.3.6 Initial familiarisation study morning
A ll participants that had not previously participated in an appetite study with 
cannulation attended an initial study morning in order to reduce the confounding effects 
on appetite assessment that can arise from the unfamiliar procedures being used. A ll 
data and samples collected on these study morning were disposed of. Participants were 
told that this was a baseline study morning and were not informed o f the true purpose. 
A ll study mornings took place in the C IU  at the University o f Surrey.
The day before the study morning, participants were asked to refrain from 
unaccustomed exercise and alcohol and to fast overnight for 12 h. Upon arrival at the 
CIU, various anthropometric measurements (%  body fat, weight, B M I) were taken after 
which an intravenous cannula was inserted into an antecubital vein and a small initial 
blood sample was taken. V A S  to subjectively assess appetite and gastrointestinal 
symptoms were also completed (see section 2.3.1) and participants were also asked to 
collect two baseline breath samples to assess breath H2 concentrations (see section 2.4).
Participants were then provided with a standard breakfast (croissants with jam alongside 
an Angel Delight mousse -  see section 7.3.9). Following breakfast, V A S  were 
completed and breath samples were collected every 30 min and a few  small blood 
samples were collected. Three hours fo llow ing breakfast the cannula was removed, and 
participants were provided with a large pasta ad libitum  meal which they were asked to
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eat until they were comfortably full (see section 2.3.2). Once the participants had 
finished their lunch they were free to leave.
7.3.7 Run-in period (Days 1-6 of each study period)
During each 6 d run-in period, participants were asked to incorporate the ND C 
supplement (inulin or L-Rha) or P L  that they were randomised to into their diet. Table 
7.2 shows the daily quantities supplied for each supplement.
Table 7.2. Daily dose of inulin and L-Rha provided during run-in period (Days 1-6) 
and on study day (Day 7). Provided as a split dose within 2 jellies per d during run-in.
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Day Inulin L-Rha (98% )
1 7.5 8.5
2 11.2 12.8
3 14.9 17.0
4-6 22.4 25.5
7 (study day) 22.4 25.5
Total (g/week) 123.2 140.5
The daily dose provided was steadily increased during Days 1-3 to reach the target dose 
by Day 4. This daily stepped increase in dose has been used by another group who 
increased OF doses by 5 g per d for the first 3 d (A lles et al., 1999). In the present 
study, doses o f the different supplements were matched by pentose/hexose equivalents 
(see Appendix G ) and were chosen to match the dose provided in previous clinical 
studies using L-Rha (Vogt et al., 2004a, Vogt et al., 2004b).
The daily supplement doses were incorporated into two jellies (Hartley’ s Sugar 
Free Jelly in strawberry, raspberry, lemon and lime, blackcurrant and orange flavours) 
which participants were asked to consume alongside either breakfast or lunch and with 
their evening meal. When randomised to PL, participants were provided with jellies
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containing no additional supplement. Sugar-free je lly  was chosen as the vehicle to 
provide the supplement as did not contribute greatly to El, they disguised the 
supplement (or P L ) randomised to and they made it easy for the participant to consume 
the supplement as no additional preparation (such as mixing into a drink) was required.
Compliance was monitored with a daily diary in which participants were asked to note 
i f  and when they consumed the je lly  and to score the pleasantness o f taste o f  the jellies 
daily (page from diary shown in Appendix H). Using the same diary, gastrointestinal 
symptoms were also monitored (page from diary shown in Appendix H). The diary was 
designed to be easily completed by participants. Food intake was also monitored with 
the use o f a 4 d food and drink diary from Days 3 to 6 (see Section 2.3.3).
To  reduce within-subject variability, participants were instructed to refrain from 
unaccustomed exercise and alcohol during the 24 h preceding each study day (Day 6), 
to consume a low  fibre diet and to approximately replicate their 24 h intake prior to each 
study day. Participants were provided with low  fibre food items (e.g. white bread, low 
fibre breakfast cereal) and a low  fibre diet sheet (see Appendix H ) which gave an 
overview o f the main foods to avoid, low  fibre alternatives and some lunch suggestions.
A  standardised evening meal (pre-selected low  fibre ready meal and desert) was 
provided and 24 h intake was recorded.
7.3.8 Study day (Day 7 of study period)
Study days took place at the C IU  at the University o f  Surrey and participants were 
required to stay in the C IU  for the entire duration o f the study, although they were
Julia Darzi Thesis
212
allowed to read, write, work on their computers or watch television (avoiding 
programmes with food cues).
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Figure 7.3 gives the timeline for the study day.
On each study day, participants arrived at the C IU  at approximately 08.00 h follow ing 
an overnight fast o f  at least 12 h. Initially anthropometric measurements (%  body fat, 
weight, B M I) were taken, then an intravenous cannula was inserted into an antecubital 
vein and two fasting blood samples were taken (time -30 and -5 min). Tw o initial V A S  
to subjectively assess appetite (see section 2.3.1) were completed follow ing each blood 
sample, and an initial V A S  to subjectively assess gastrointestinal symptoms was 
completed follow ing the first blood sample. Additionally participants were asked to 
collect two baseline breath samples to assess breath H2 concentrations (see section 2.4).
A t time = 0 min, participants were provided with the breakfast preload, croissants with 
jam, sugar free squash or water and an Angel Delight mousse containing the ND C 
supplement under investigation or P L  (see 7.3.9), which they were asked to consume 
within 15 min. Follow ing breakfast, participants completed V A S  regarding the 
palatability and pleasantness o f the mousse (see section 2.3.1).
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Blood samples were taken every 15 min for the first hour postprandially and at 30 min 
intervals for the follow ing two hours until lunch. In addition a set o f V A S  for fullness, 
hunger, prospective food consumption, desire to eat meal / snack / sweet / savoury / 
salty / fatty and nausea were completed after blood samples at half hourly intervals. 
Gastrointestinal symptom V A S  were completed at hourly intervals and breath H2 
samples were collected hourly for the first hour and half hourly thereafter.
Three hours follow ing breakfast, a standard lunch was served, comprising sandwiches 
with a choice o f fillings, crisps, sugar free squash or water and an Angel Delight mousse 
containing the ND C supplement under investigation or PL  (see 7.3.9).
Following lunch, blood samples were collected every 15 min for the first hour and then 
half hourly for the next 3 h, appetite V A S  were completed half hourly, gastrointestinal 
symptom V A S  were collected hourly and breath samples were collected half hourly. 
Four hours follow ing lunch (7 h follow ing breakfast) the cannula was removed. 
Participants were provided a large pasta ad libitum  test meal which they were asked to 
eat until they were comfortably full (see section 2.3.2). Once the participants had 
finished they were free to leave and were asked to complete a 2 d food diary for the rest 
o f the day and for the next day (see section 2,3.3).
7.3.9 Study day meals
The standard breakfast provided on the initial study morning (see 7.3.6) and on the 
study day (see 7.3.8) comprised 66 g Tesco A ll Butter M ini Croissants (equivalent to 2 
small croissants) filled with 28 g Tesco strawberry or plum jam with either 250 g water 
or Robinson’ s Sugar Free orange, lemon or blackcurrant and apple squash (made using 
42 g squash and 208 g water). In addition participants were given an Angel Delight
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made by whisking together one-third o f a packet Angel Delight (22 g butterscotch or 
chocolate, 20 g strawberry or raspberry), 100 ml semi-skimmed milk and two-thirds o f 
the daily ND C  dose randomised to (14.9 g inulin or 16.8 g L-Rha) or P L  (no ND C 
supplement). On the initial study morning no ND C  supplement was added. Table 7.3 
shows the nutritional content o f the test breakfast with different Angel Delight flavours.
Julia Darzi Thesis
Table 7.3: Overall nutritional content of test breakfast made with strawberry jam  
and each Angel Delight flavour. Quantity o f  fibre excluding the N D C  supplements.
Angel Energy C H O Sugar Protein Fat Fibre
delight used kcal kJ g g g g g
Chocolate 495 2074 10.5 65.9 36.4 21.1 2.0
Butterscotch 496 2078 10.2 66.0 37.5 21.3 1.6
Strawberry 489 2049 10.2 64.1 35.7 21.4 1.5
Raspberry 487 2039 10.1 64.5 36.3 20.9 1.6
The standard study day lunch comprised sandwiches cut into quarters made using 
Kingsmill Everyday medium sliced bread, O livio spread and a choice o f  chicken (Tesco 
Light Choices Roast Chicken), ham (Tesco Light Choices Smoked Ham) or edam 
cheese (Tesco Edam Cheese Slices) filling. Participants were also given crisps selected 
for their low  fibre levels (choice o f  Frazzles, Tesco Ready Salted Crunchy Sticks, Tesco 
Salt and Vinegar Twirls or Tesco Onion Rings), Angel Delight (made with one-third 
packet Angel Delight and 100 ml semi skimmed milk, same as per breakfast), but this 
time with one-third o f the daily N D C  dose added (7.5 g inulin, 8.4 g L-Rha and no fibre 
for PL ) and a drink (water or sugar free squash, same as per breakfast).
On the first study day participants were provided with 8 sandwich quarters (i.e. made 
using four slices o f bread, with each slice bread weighing 38 g ) and 20 g crisps and 
were asked to consume at least 4 full sandwich quarters (equivalent to 2 slices o f bread) 
and as many crisps and they would like. They were required to consume the entire
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Angel Delight provided. Thereafter the participants were provided the same number o f 
quarters o f sandwiches and quantity o f crisps as consumed on the first study occasion. 
This procedure allowing participants to eat to their desired intake on the first visit then 
giving the same on subsequent occasions has been previously reported (Westatrate and 
van Amelsvoort, 1993) and used in our group (Bodinham et al., 2010).
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Table 7.4: Nutritional content of the test lunch. For 4, 6 or 8 quarters sandwich 
containing either ham, chicken or cheese filling plus 20g Frazzles and chocolate Angel 
Delight. Quantity o f  fibre excluding the N D C  supplements.
Bread Filling Portion size (g) Energy Protein CHO Fat Fibre
quarters
(slices) bread spread filling kcal 1<J g g g g
4 quarters Ham 76 12 44 534 2245 22.3 67.2 21.1 2.8
(2 slices) Chicken 76 12 44 539 2265 22.9 67.3 21.3 3.1
Cheese 76 6 32 556 2332 20.6 67.1 24.3 2.8
6 quarters Ham 114 18 66 679 2853 30.6 84.3 26.6 3.9
(3 slices) Chicken 114 18 66 685 2883 31.5 84.4 26.9 4.2
Cheese 114 9 48 711 2982 28.0 84.1 31.3 3.9
8 quarters Ham 152 24 88 823 3461 38.8 101.3 32.0 4.9
(4 slices) Chicken 152 24 88 832 3500 40.1 101.5 32.5 5.3
Cheese 152 12 64 867 3633 35.5 101.1 38.4 4.9
For the ham and chicken sandwiches, 22 g ham/chicken and 6 g spread were used per 
38 g slice o f bread and for the cheese sandwiches 16 g edam and 3 g spread were used 
per 38 g slice o f bread, with one slice o f  bread equating to 2 sandwich quarters. Table 
7.4 summarises the nutritional content o f  the test lunch.
The choice o f jam for breakfast, sandwich filling and flavour o f  crisps for lunch and 
drink and Angel Delight flavours for breakfast and lunch were selected by participants 
at screening, and the same choices were served on each occasion. A ll food ingredients 
were weighed to the nearest 1 g except the Angel Delight and fibre supplements which 
were weighed to the nearest 0.1 g.
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7.3.10 Blood sampling and analysis
Blood samples were analysed for glucose, TA G , N E FA  and total and H D L  cholesterol 
concentrations by an enzymatic calorimetric method using the IL A B  650 analyser 
(Instrumentation Laboratory, Milan, Italy) and insulin concentrations were analysed by 
R IA . More detailed descriptions o f the blood sample collection and analysis procedures 
are given in Chapter 2 (see section 2.5 and 2.6 respectively).
7.3.11 Statistical analyses
A ll statistical analyses were conducted using SPSS for Windows 16.0 (SPSS Inc., 
Chicago, U SA ). Data was tested for normality using the Kolmogorov-Smirnov test. 
Differences in anthropometric variables between male and female participants were 
assessed non-parametrically using the Mann-Whitney test.
Differences in the effects o f treatment on palatability V A S  scores, intake at the buffet 
meal, E l and macronutrient mean intake during the days preceding the study day and 
intake during the 24 h o f  the study day, H O M A  estimates, insulin sensitivity index 
estimates and participant characteristics on each study day were analysed parametrically 
by one way repeated measures A N O V A  with post-hoc bonferonni or non-parametrically 
using the Friedman test with post-hoc W ilcoxon signed ranks test.
Tim e course data was analysed by two-way (treatment x time) repeated measures 
A N O V A  o f all timepoints and also by comparison o f the A U C  and IA U C  using one 
way repeated measures A N O V A  with post-hoc bonferonni when parametrically 
distributed or Friedman test with post-hoc W ilcoxon signed ranks test when non- 
parametrically distributed. Tim e course data included postprandial subjective appetite 
and gastrointestinal symptom ratings, plasma metabolites (glucose, insulin, NEFA,
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TA G s) and breath H 2 concentrations on the study day, and daily taste and 
gastrointestinal symptom ratings during the run-in period.
Time course data collected on the study day was considered for the entire study duration 
(from 0 to 420 min) and also separately fo llow ing breakfast (from  0 to 180 min) and 
lunch (from 180 to 420 min). The A U C  for postprandial plasma metabolites and 
subjective appetite ratings were calculated for each individual using the trapezoidal rule 
and the IA U C  was calculated by subtracting the area below basal levels from the AU C .
Differences were considered to significant at p<0.05 with the exception o f the post-hoc 
W ilcoxon signed-ranks test, where significance was set at a level o f p<0.0167 (=0.05/3).
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Selected subjective appetite ratings time-course curves as assessed by V A S  are shown 
in Figure 7.4.
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7.4 Results
7.4.1 Subjective appetite ratings
Figure 7.4. Subjective appetite ratings following PL  ( - •  - ), inulin ( - ■  - )  and L - 
Rha (-A - )
No significant treatment effects were found for the entire study duration, during the 
morning (0-180 min) and after lunch (180-420 min). A  treatment x time interaction was 
found during the morning with a trend approaching significance for a) hunger (p=0.070) 
and to a significant level for d) meal desire (p=0.008), and during the afternoon for f) 
desire to eat sweet (p=0.036). Analyses were carried out by two-way repeated measures 
A N O V A . Results shown as mean with error bars representing the SEM (n=13).
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No significant treatment effects o f NDC supplementation were found for any o f the 
V A S  appetite ratings when analysed by two-way repeated measures A N O V A . This was
219
the case when considering the overall study day (from time 0 to 420 min) and when 
considering the morning (from time 0 to 180 min) and afternoon (from  time 180 to 420 
min) separately. A  significant treatment x time interaction was found during the 
morning (0-180 min) for meal desire (p=0.008) and approaching significance for hunger 
(p=0.070), and during the afternoon (180-420 min) for desire to eat sweet (p=0.036). N o 
other significant interactions were found for the V A S  appetite ratings.
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Comparison o f the A U C  and IA U C  o f the subjective appetite ratings (selected data in 
Table 7.5) determined there were no significant differences between inulin, L-Rha and 
P L  treatment for all V A S  questions, except the desire to eat sweet. Post-hoc analysis 
found the desire to eat sweet A U C  after lunch (180-420 min) was significantly lower 
follow ing L-Rha than P L  (p=0.048). Differences were compared by one-way within 
subjects repeated measures A N O V A  with post-hoc Bonferroni when normally 
distributed and Friedman test with post-hoc W ilcoxon when not normally distributed.
Table 7.5. A U C  for selected appetite VAS  ratings during the morning (0-180 min) 
and afternoon (180-420 min)1
N o significant differences were found between treatments for except a trend towards 
significance for the desire to eat sweet IAU C . Analyses carried out by one-way within 
subjects repeated measures A N O V A  or Friedman’ s as appropriate (n=13).
P L Inulin L-Rha
PMean SD Mean SD Mean SD
A U C  (0-180)
Hunger 
Meal desire 
Sweet desire
8254
9170
8022
2838
2646
3173
8997
9265
7017
2560
2247
3271
8259
9000
7077
2733
2588
3721
NS
NS
NS
A U C  (180-420)
Hunger 8106 3304 8947 3118 8817 3570 NS
Meal desire 9907 3704 9825 2951 9361 3119 NS
Sweet desire
U , _____i_______ i
*10086 4145 8175 4726 *8045 4383 0.071
Mean values marked with the same symbol denote significant differences between treatments following 
post-hoc analysis *p=0.048
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7.4.2 Quantitative appetite Assessment
7.4.2.1 Intake at the ad libitum test meal
Figure 7.5 shows the mean intake o f the ad libitum  pasta meal provided 4 h following 
the test lunch (and 7 h fo llow ing the test breakfast). No significant differences in mean 
intake between PL  (4204 [SD 1666] kJ), inulin (4089 [SD 1680] kJ) and L-Rha (4053 
[SD 1538] kJ) were found by one-way repeated measures A N O V A  analysis.
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a ) Intake (g ) b) Intake (kJ )
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Figure 7.5. Intake of ad lib itu m  pasta meal in a) grammes and b) kJ
N o significant influence o f NDC treatment on intake in grammes or the El was found. 
A ll analyses carried by one-way repeated measures A N O V A . Results shown as mean 
with error bars representing the SEM (n=13).
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Table 7.6 shows the mean energy and macronutrient 24 h intake on the study days, 
including all study food and drink in addition to all consumed follow ing the study. No 
significant differences between treatments were found for energy and macronutrient 
intakes when analysed by within subject one-way repeated measures A N O V A .
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7.4.2.2 Intake following breakfast &  lunch preloads
Table 7.6. E l and macronutrient intake 24 h after PL, inulin and L -R ha treatment.
N o significant differences between treatments were found. Analysis was earned out 
using within subjects one-way repeated measures A N O V A  (n=13).
P L Inulin L-Rlia
PMean SD Mean SD Mean SD
Energy (kJ) 12368 3128 11667 1930 12383 2656 NS
E l excluding alcohol (kJ) 11964 2162 11210 1765 11500 1245 NS
Fat (g) 101.5 15.2 93.3 16.6 103.2 16.4 NS
Protein (g) 101.3 20.9 96.4 20.5 97.5 15.5 NS
CHO (g) 382.8 80.4 368.6 55.7 368.3 56.0 NS
Alcohol (g) 13.7 43.8 11.4 27.3 23.1 54.6 NS
Comparison o f the %  contribution o f macronutrients and alcohol to E l found no 
significant difference between treatments when analysed by within subjects one-way 
repeated measures A N O V A  (Table 7.7).
Table 7.7. % contribution to E l by each macronutrient and alcohol 24 h after PL, 
inulin and L-Rha treatment.
N o significant differences between treatments were found. Analysis was carried out 
using within subjects one-way repeated measures A N O V A  (n=13).
P L Inulin L-Rha
Mean SD Mean SD Mean SD P
Fat % E I 31.6 3.3 30.3 2.9 32.9 2.6 NS
Protein % E I 13.9 1.8 13.8 1.3 13.6 1.5 NS
C H O  % E I 52.4 3.5 53.2 3.6 51.1 3.9 NS
Alcohol % E I 2.0 6.2 2.8 5.9 2.3 3.7 NS
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Table 7.8 shows the mean EI and macronutrient intake over the 4 d preceding the study 
(Days 3 to 6 o f run-in period), whilst loading up on inulin or L-Rha supplements or PL. 
N o significant differences were found between intakes follow ing the different 
treatments when analysed by within subject one-way repeated measures A N O V A .
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7.4.23 Intake during run-in period
Table 7.8. E I and macronutrient intake during the 4 d preceding the study day 
(Days 3-6 of run-in period).
N o significant differences between treatments were found. Analysis was carried out 
using within subjects one-way repeated measures A N O V A  (n=13).
P L Inulin L -R h a
PMean SD Mean SD Mean SD
E nergy  (k j ) 9078 1857 8730 2232 8691 2131 NS
E I  excluding alcohol ( k j ) 8822 1901 8266 1985 8138 1734 N S
F at (g ) 82.9 26.1 75.9 26.8 77.3 20.9 N S
P ro te in  (g ) 79.4 18.1 72.5 13.1 73.9 17.2 N S
C H O  (g ) 268.5 59.9 257.3 61.3 244.9 58.8 0.080
A lcoh o l (g ) 8.7 12.0 15.8 21.9 18.8 27.8 N S
Comparison o f the %  contribution o f macronutrients and alcohol to EI also found no 
significant difference between treatments when analysed by within subject one-way 
repeated measures A N O V A  (Table 7.9).
Table 7.9. % contribution to E I by each macronutrient and alcohol during the 4 d 
preceding the study day (Days 3-6 of run-in period)
N o significant differences between treatments were found. Analysis was carried out 
using within subjects one-way repeated measures A N O V A  (n=13).
P L Inulin L-Rha
PMean SD Mean SD Mean SD
Fat % E I 33.5 5.9 31.9 5.6 33.0 4.7 NS
Protein % E I 14.7 3.1 14.1 2.5 14.3 2.4 NS
C H O  % EI 49.0 5.2 49.3 7.2 47.4 7.8 NS
Alcohol % E I 2.9 4.0 4.7 5.8 5.3 7.9 NS
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Figure 7.6 shows the mean postprandial glycaemic response follow ing consumption o f 
either the inulin or L-Rha supplements or PL. Two-way repeated measures A N O V A  
analysis found no significant treatment effect when analysed over the entire study 
duration (T=0-420 min), just during the morning (T=0-180 min), nor when analysed 
after lunch (T = l80-420 min, p=0.070). Furthermore, no significant time x treatment 
effects were observed.
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7.4.3 Postprandial plasma metabolites
7.4.3.1 Glycaemic response
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Figure 7.6. Postprandial plasma glucose response
No significant treatment effects were found for the entire study duration, during the 
morning (0-180 min) and after lunch (180-420 min). Analyses were carried out by two- 
way repeated measures A N O V A . Results shown as mean with error bars representing 
the SEM (n=13).
Comparison o f the A U C  and IAU C  (Table 7.10) by one-way within subject repeated 
measures A N O V A  found a difference between treatments approaching significance for 
the A U C  after lunch (T=  180-420 min, p=0.06l). However, post-hoc bonferroni analysis 
found no significant differences between the 3 groups. There were no significant 
differences between the A U C  and IA U C  during the overall study day (T=0-420 min) or 
the study morning (T=0-180 min).
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Table 7.10. A U C  &  IA U C  for plasma glucose response during the morning (0-180 
min), afternoon (180-420 min) and full study day (180-420 min)
N o significant differences were found between treatments for the A U C  and IAU C  
except with a trend towards for the A U C  during the afternoon (180-420 min). Analyses 
were carried out by one-way within subjects repeated measures A N O V A  (n=13).
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PL Inulin L-Rha
PMean SD Mean SD Mean SD
A U C
0-180
180-420
0-420
970
1295
2265
173
145
303
970
1386
2356
134
153
252
973
1329
2302
123
98
188
NS
0.061
NS
IA U C
0-180 102 152 88 110 90 94 NS
180-420 193 123 213 142 165 135 NS
0-420 239 270 299 230 242 171 NS
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The mean postprandial plasma insulin response is shown in Figure 7.7. There was a 
significant influence o f NDC treatment found during the morning (T=0-180 min, 
p=0.051), although the treatment effect was not significant during the afternoon 
(T =  180-420 min) or for the overall study day (T=0-180 min). In addition, a significant 
NDC treatment x time interaction was found during the morning (T=0-180 min, 
p=0.024), afternoon (T =  180-420 min, p=0.026) and for the entire study day (T=0-420 
min, p=0.009).
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7.4.3.2 Insulinaemic response
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Figure 7.7. Postprandial plasma insulin response
Plasma insulin concentrations were significantly influenced by ND C treatment during 
the morning (0-180 min, p=0.051), but not after lunch (180-420 min) or for the entire 
study duration (0-420 min). A  significant treatment x time interaction was also found 
for the entire study duration (0-420 min, p=0.009), during the morning (0-180 min, 
p=0.024) and after lunch (180-420 min, p=0.026).
Analyses were carried out by two-way repeated measures A N O V A . Results shown as 
mean with error bars representing the SEM (n=13).
Table 7.11 summarises the IAU C  values for the postprandial insulin response curve 
(A U C  values not given). The mean A U C  and IAU C  were highest during PL  and lowest 
following L-Rha. As A U C  and IAU C  were not normally distributed, analyses were 
carried out using Friedman’ s A N O V A  with post-hoc W ilcoxon Signed Rank Test.
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The IA U C  for the entire study day (T=0-420 min) differed between treatments with a 
trend approaching significance (p=0.058), with L-Rha treatment lowering the IA U C  
with a trend approaching significance (p=0.023) relative to P L  by post-hoc analysis. 
The A U C  for the entire study day did not differ significantly between treatments.
During the morning, there was a significant treatment effect on the IA U C  (T=0- 
180 min, p=0.050 and T=0-120 min, p=0.037). Post-hoc analysis found the IA U C  was 
significantly lower follow ing L-Rha than P L  (p=0.011) from 0-120 min and lower with 
a trend towards significance follow ing L-Rha than P L  (p=0.033) from 0-180 min. There 
were no significant differences between P L  and inulin nor between L-Rha and inulin.
During the afternoon the IA U C  differed with a trend towards significance 
(p=0.058) during the first 180 min postprandially (180-360 min), although the 
differences were not significant from 180-420 min. Post-hoc analysis found no 
significant differences between treatments.
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Table 7.11. IA U C  for plasma insulin response during morning (0-180 min), 
afternoon (180-420 min) and full study day (180-420 min)1
Analyses earned out by Friedman’ s A N O V A  with post-hoc W ilcoxon (n=13).
PL  Inulin L-Rha
Mean SD Mean SD Mean SD P
0-120 A5374 3080 4426 2040 A3827 1412 0.037
0-180 *6255 4363 5357 3294 *4649 1984 0.050
180-360 6982 4163 6477 3975 6349 5356 0.058
180-420 6610 4100 6359 3983 6320 5977 NS
0-420 #15119 12128 13756 11304 #12373 8105 0.058
1 Mean values marked with the same symbol denote significant differences between treatments following 
post-hoc Wilcoxon analysis (Ap=0.011) or a trend approaching significance (*p=0.033, #p=0.023)
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The mean postprandial plasma T A G  response is shown in Figure 7.8. No significant 
treatment effects were found when analysed over the entire study duration (T=0-420 
min), during the morning (T=0-180 min), nor after lunch (T = l80-420 min) when 
analysed by two-way repeated measures A N O V A . However, there was a significant 
time x treatment effect for the full study day over the first 300 min (T=0-300 min, 
p=0.036) and for the study morning (T=0-180 min, p=0.006).
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Figure 7.8. Postprandial plasma T A G  response
No significant treatment effects were found for the entire study duration, during the 
morning (0-180 mins) and after lunch (180-420 mins). A  significant treatment x time 
interaction was found during the morning (0-180 min, p=0.006) and for the full study 
day until 300 min following breakfast (0-300 min, p=0.036) Analyses were carried out 
by two-way repeated measures A N O V A . Results shown as mean with error bars 
representing the SEM (n=13).
Between treatment comparisons o f the A U C  and IAU C  for the postprandial T A G  
response curve using one-way within subject repeated measures A N O V A  found no 
significant differences (data not shown).
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The mean postprandial plasma N E FA  response is shown in Figure 7.9. Two-way 
repeated measures A N O V A  analysis found no significant treatment effects when 
analysed over the entire study duration (T=0-420 min), just during the morning (T=0- 
180 min), or when analysed after lunch (T =  180-420 min). There was however a 
significant time x treatment effect during the study afternoon (T =  180-420 min, 
p=0.046), although time x treatment effects were not seen for the entire study day or 
during the study morning.
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7.4.3.4 NEFA response
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Figure 7.9. Postprandial plasma N E FA  response
No significant treatment effects were found for the entire study duration, during the 
morning (0-180 mins) and after lunch (180-420 mins). A  significant treatment x time 
interaction was found during the afternoon following lunch (180-420 min, p=0.046). 
Analyses were carried out by two-way repeated measures A N O V A . Results shown as 
mean with error bars representing the SEM (n=13).
Table 7.12 summarises the A U C  and IA U C  values for the postprandial N E FA  response 
curve. Between treatment comparisons using one-way within subject repeated measures 
A N O V A  found no significant differences in treatment effects on A U C  and IAU C  for 
the entire study day (T=0-420 min) or the study morning (T=0-180 min). The IAU C  
after lunch (T = l80-420 min) differed between treatments with a trend approaching
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significance (p=0.075), with the lowest mean IA U C  follow ing L-Rha, although post-hoc 
Bonferroni analysis found this difference was not significant.
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Table 7.12. A U C  &  IA U C  for plasma N E FA  response during morning (0-180 min), 
afternoon (180-420 min) and full study day (180-420 min)
Analyses carried out by one-way within subjects repeated measures A N O V A  (n=13).
P L Inulin L-Rha
Mean SD Mean SD Mean SD P
A U C
0-180
180-420
0-420
40.4
45.3
85.7
11.6
11.0
20.3
41.3
46.3 
87.6
13.7
17.1
30.0
36.9
39.6
76.5
6.8
10.9
15.0
NS
NS
NS
IA U C
0-180 66.0 28.6 67.8 41.3 74.1 48.0 NS
180-420 28.2 • 35.7 21.3 29.4 6.7 12.1 0.075
0-420 162.4 75.9 166.9 102.0 182.6 121.5 NS
230
As shown in Table 7.13, the fasting insulin sensitivity, P-cell function and insulin 
resistance as estimated by H O M A  (L evy  et al., 1998, Wallace et al., 2004, Matthews et 
al., 1985) (see section 2.8.1 for further details) were not significantly different at the 
start o f each study day.
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7.4.4 Insulin sensitivity
Table 7.13: Indices of fasting insulin sensitivity following consumption of inulin or 
L-R ha supplements or P L  during a 6 d run-in1
N o significant difference between treatments found by Friedman’ s A N O V A  (n=13).
PL Inulin L-Rha
PMean SD Mean SD Mean SD
H O M A  % S 89.6 46.2 83.0 37.2 78.6 34.5 NS
H O M A  % B 124.9 35.2 125.0 33.1 129.8 33.6 NS
H O M A  IR
T T tA ) *
1.4 0.5 1.4 0.6 1.5 0.7 NS
HOM A %S, fasted oral insulin sensitivity, HOM A %B, p-cell function and HOM A IR, insulin 
resistance all estimated by homeostasis model assessment.
Postprandially, neither the Oral Si as estimated using the minimal model method 
(Caumo et al., 2000) (see section 2.8.2) nor the insulin to glucose A U C  ratios differed 
significantly between treatments when compared by Friedman’ s A N O V A  analysis.
Table 7.14. Indices of postprandial insulin sensitivity following ingestion of inulin 
or L -R ha supplements or P L  1
N o significant difference between treatments found by Friedman’ s A N O V A  (n=13).
PL Inulin L-Rha
Mean SD Mean SD Mean SD P
Insulin:glucose A U C
0-180 8.6 5.2 7.5 3.4 7.0 2.6 NS
180-420 8.7 6.1 7.7 5.5 7.8 5.1 NS
0-420 8.6 5.7 7.6 4.5 7.5 3.9 NS
Oral S i1
0-180 21.7 16.5 26.3 17.6 33.6 40.1 NS
180-420 18.0 19.8 19.2 7.5 23.4 10.1 NS
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7.4.5 Breath hydrogen concentrations
The mean postprandial breath H2 concentrations are shown in Figure 7.10. Two-way 
repeated measures A N O V A  analysis found a significant effect o f NDC supplementation 
for the entire study day duration (T=0-420 min, p<0.001), during the morning (T=0-180 
min, p=0.010) and during the afternoon (t= 180-420 min, pcO.OOl). There was also a 
significant NDC treatment x time interaction for the entire study day, the morning and 
the afternoon (pcO.OOl for all cases).
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Figure 7.10. Postprandial breath H 2 concentrations
Breath H2 concentrations were significantly influenced by NDC treatment during the 
entire study duration (0-420 min, pcO.OOl), during the morning (0-180 min, p=0.010) 
and after lunch (180-420 min, pcO.OOl). Analyses were carried out by two-way repeated 
measures A N O V A . Results shown as mean with error bars representing the SEM 
(n=13).
Comparison o f the A U C  o f the postprandial breath H2 A U C  (Figure 7.12a) by 
Friedman’ s A N O V A  analysis found a significant difference between treatments for the 
entire study day (T=0-420 min, pcO.OOl), for the study morning (T=0-180 min, 
p=0.023, data not shown) and for the study afternoon (T = l80-420 min, pcO.OOl, data 
not shown). Post-hoc W ilcoxon analysis found consumption o f both inulin and L-Rha 
significantly increased the A U C  over the entire study duration (T=0-420 min, p=0.001 
and 0.009 respectively), during the morning (T=0-180 min, p=0.023 and 0.033
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respectively) and after lunch (T =  180-420 min, p=0.001 and 0.006 respectively) relative 
to PL. There was no significant difference between the AU C  for inulin and L-Rha.
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a) Breath H 2 A U C  (0-420) b ) Fasting breath H 2 concentration
p<0.001 p<0.001
Inulin L-Rha Inulin L-Rha
Figure 7.12a: Breath H 2 A U C (o-42o) 
NDC treatment significantly influenced 
the breath H 2 A U C  for entire study day 
(p=0.001, Friedman’ s A N O V A ). Post- 
hoc W ilcoxon found inulin and L-Rha 
A U C  were both significantly higher 
than PL  (*p=0.001 & Ap=0.009
respectively).
Figure 7.12b: Fasting breath H 2
NDC treatment significantly influenced 
the fasting breath H 2 concentrations 
(p=0.001, Friedman’ s A N O V A ). Post-hoc 
W ilcoxon found inulin significantly raised 
fasting breath H2 concentrations compared 
to both PL  (*p=0.011) and L-Rha
(Ap=0.002).
Columns showing the same symbol 
denote significant differences between 
treatments. Results shown as mean with 
error bars representing the SEM (n=13).
Columns showing the same symbol denote 
significant differences between treatments. 
Results shown as mean with error bars 
representing the SEM (n=13).______________
Comparison o f mean fasting breath H2 concentrations (Figure 7.12b) by Friedman’ s 
A N O V A  analysis found a significant difference between treatments, with post-hoc 
W ilcoxon finding the mean fasting breath H2 concentrations were significantly higher 
with inulin treatment (24 [SD 23] ppm) than PL  (7 [SD 7] ppm, p=0.011) and than L- 
Rha (5 [SD 7] ppm, p=0.002). The fasting breath H2 concentrations did not differ 
significantly between PL  and L-Rha.
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7.4.6.1 VAS ratings on study day
Figure 7.13 shows the mean V A S  scores regarding the taste, texture and aftertaste o f the 
Angel Delight mousses containing inulin or L-Rha or PL  at breakfast and lunch.
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7.4.6 Palatability
Figure 7.13. VAS ratings regarding palatability of the mousse
Analyses were carried out by one-way repeated measures A N O V A  with post-hoc 
bonferroni. Results shown as mean with error bars representing the SEM (n=13).
1. *H ow  pleasant was the taste o f  th is mousse? ’ NDC treatment significantly 
influenced V A S  score at breakfast (p=0.0l 1). Post hoc analysis found a difference with 
a trend approaching significance between PL  and L-Rha (p=0.059). There was no 
significant influence at lunch.
2. *How  pleasant was the texture o f  th is  mousse?’ NDC treatment influenced V A S  
rating significantly at lunch (p=0.050) and with a trend towards significance at breakfast 
(p=0.073). No significant differences found by post-hoc analysis except PL  and L-Rha 
differed with a trend approaching significance (p=0.056) at breakfast.
3. ‘D id  the mousse have an unpleasant aftertaste? ’ No significant influence o f NDC 
treatment on the aftertaste V A S  score was found at breakfast and at lunch.
NDC treatment significantly influenced the rated taste pleasantness o f the mousses at 
breakfast (p=0.011), but not at lunch when analysed by one-way repeated measures 
A N O V A  analysis. L-Rha had the lowest mean score while PL  had the highest at both 
breakfast and lunch (58 [SD 21], 73 [SD 20] and 75 [SD 21] mm at breakfast and 69
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[SD 20], 73 [SD 21] and 74 [SD 18] mm at lunch for L-Rha, inulin and PL  
respectively). Post-hoc bonferroni analysis found the taste ratings for the L-Rha mousse 
was lower with a trend approaching significance than P L  at breakfast (p=0.059), but no 
other post-hoc significant differences were found.
The rated pleasantness o f the mousse texture was significantly influenced by ND C 
treatment at lunch (p=0.050) and influenced with a trend towards significance at 
breakfast (p=0.073). Again, L-Rha had the lowest mean score at both breakfast and 
lunch (59 [SD 21], 72 [SD 21] and 69 [SD 21] mm at breakfast and 63 [SD 20], 72 [SD 
22], 73 [SD 21] mm at lunch for L-Rha, P L  and inulin respectively). However again 
post-hoc analysis found no significant differences between treatments at breakfast or 
lunch except a trend approaching significance between P L  and L-Rha (p=0.056) at 
breakfast.
The mean V A S  score regarding any aftertaste following consumption o f the mousse 
( “ Did the mousse have an unpleasant aftertaste?” ) was not significantly influenced by 
ND C treatment at either mealtime.
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Figure 7.13 shows the mean daily taste ratings for the jellies (PL, inulin or L-Rha) 
supplied during the run-in period, where 1 indicated ‘ like extremely’ and 9 indicated 
‘dislike extremely’ .
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7.4.6.2 Daily taste ratings during run-in period
It was found that neither the addition o f inulin nor o f L-Rha influenced taste ratings 
over time to a significant level as compared to PL.
Day
Figure 7.13. Daily taste ratings for jellies given during run-in.
NDC treatment did not significantly influence the taste. Analysis was carried out by 
one-way repeated measures A N O V A  with post-hoc bonferroni. Results shown as mean 
with error bars representing the SEM (n=13).
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7.4.7 Gastrointestinal symptoms
7.4.7.1 VAS ratings on study day
Selected subjective gastrointestinal symptom ratings time-course curves as assessed by 
V A S  on the study days are shown in Figure 7.14. Two-way repeated measures A N O V A  
analysis revealed that the only gastrointestinal symptom influenced by NDC treatment 
on the study days was the urge to defecate (p=0.013). Furthermore, no significant 
treatment x time interactions were observed for any symptom.
For all gastrointestinal symptoms rated, the mean scores were low at all 
timepoints (all were less than 25mm) and for all treatments, and the baseline scores did 
not differ significantly between treatments.
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a) Have you had the urge 
to defacate in the past hour?
Time (min)
b) Did you experience any 
stomach discomfort in the past hour?
Time (min)
c) Did you experience any 
bloating in the past hour?
Tim e (n iin )
d) Did you experience any 
flatulence in the past hour?
Tim e (m in )
Figure 7.14 Selected subjective gastrointestinal symptom ratings following 
PL  ( - •  - ), inulin ( -  ■  - )  and L-Rha ( -A - )  treatment
The urge to defacate was significantly influenced with NDC treatment (p=0.013). No 
other subjective gastrointestinal symptom ratings were significantly influenced by 
treatment. Analyses were carried out by two-way repeated measures A N O V A . Results 
shown as mean with error bars representing the SEM (n=13).
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Table 7.15 summarises the A U C  values for the postprandial gastrointestinal symptom 
ratings, which were compared by Friedman’ s A N O V A  analysis with post-hoc W ilcoxon 
as the data was not normally distributed.
The urge to defecate was significantly influenced by ND C treatment (p=0.046), 
with the A U C  follow ing L-Rha treatment being significantly higher than P L  (p=0.007) 
and higher than inulin with a trend towards significance (p=0.039). The P L  and inulin 
A U C  did not differ significantly.
The A U C  for stomach discomfort was also significantly influenced by ND C 
treatment for the first 315 min o f  the study (p=0.046), with post hoc analysis finding the 
A U C  with L-Rha treatment was higher than P L  with a trend approaching significance 
(p=0.041). The difference between PL  and inulin and between inulin and L-Rha was not 
significant.
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Table 7.15. A U C  for all gastrointestinal and headache symptom ratings over entire 
study day until pasta m eal1,2
Analyses carried out by Freidman’ s A N O V A  analysis with post-hoc W ilcoxon (n=13).
P L Inulin L-Rha
M ean SD M ean SD M ean SD P
A U C
Urge to defecate *1879 2003 #2811 3349 *#4163 4105 0.046
Diarrhoea 1171 1709 1154 1603 1432 1776 N S
Stomach discomfort A1595 1812 2054 2400 A2424 2129 0.046
Bloating 2122 2455 3258 3278 2872 3125 N S
Flatulence 2431 2325 4331 5926 3624 4241 N S
Heartburn 1284 1012 1963 2562 1808 2141 NS
Burp/belch 3190 2650 2926 2673 3199 3173 NS
Headache 
TTTT^ r  —
2613 3277 2934 3725 2456 2341 NS
AUC & IAUC mean values marked with the same symbol denote significant differences between 
treatments (*p=0.007) or a trend approaching significance (#p=0.039, Ap=0.041)
2 Data for AUC from 0-315 min
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Selected subjective daily gastrointestinal symptom time-course curves as assessed by a 
gastrointestinal symptom diary during the run-in period are shown in Figure 7.15. Data 
is shown for only 12 participants due to missing data for one participant.
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7.4.7.2 Daily ratings during run-in period (Days 1-6)
Figure 7.15. Selected daily gastrointestinal symptom ratings during 6 d run-in 
period with PL  ( - •  - ), inulin ( -  ■  - )  and L-Rha ( -A - )  treatment
Flatulence ratings were significantly influenced by NDC treatment (p=0.010), but none 
o f the other subjective gastrointestinal symptom ratings were significantly influenced. 
Analyses were carried out by two-way repeated measures A N O V A . Results shown as 
mean with error bars representing the SEM (n=12).
The ratings for flatulence were significantly influenced by treatment (p=0.010) as 
determined by two-way repeated measures A N O V A  analysis. Treatment x time 
interactions were significant for flatulence ratings (p=0.044) and approaching 
significance for stomach pain ratings (p=0.073). There were no significant treatment or 
treatment x time influences for any other subjective ratings.
Table 7.16 shows the main daily ratings for gastrointestinal symptoms during Days 4 to 
6 o f the run-in, when participants were consuming the target dose o f NDC supplements. 
The mean flatulence ratings were significantly influenced by treatment when analysed 
by Friedman’ s A N O V A  (p=0.007), with the mean rating during inulin supplementation 
being significantly higher than PL  (p=0.011) and L-Rha (p=0.012). Stomach pain was
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also influenced by treatment with a trend toward significance (p=0.069), with the mean 
rating during inulin supplementation being higher than during L-Rha supplementation 
with a trend approaching significance (p=0.034). None o f the other daily gastrointestinal 
symptoms were influenced by treatment.
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Table 7.16. Mean daily gastrointestinal symptom ratings during Days 4-6 of run-in 
period 1
Analyses carried out by Freidman’ s A N O V A  analysis with post-hoc W ilcoxon (n=12).
P L Inulin L-Rha
Mean SD Mean SD Mean SD P
Flatulence *1.4 0.6 * A2.2 0.9 A1.5 0.5 0.007
Stomach pain 1.3 0.5 #1.5 0.6 #1.1 0.1 0.069
Diarrhoea 1.2 0.3 1.4 0.7 1.3 0.7 NS
Constipation 1.0 0.1 1.0 0.0 1.1 0.0 NS
Belching 1.3 0.4 1.5 0.6 1.3 0.4 NS
Nausea 1.1 0.2 1.2 0.3 1.1 0.3 NS
Acid 1.0 0.0 1.0 0.0 1.0 0.1 NS
Heartburn 1.0 0.1 1.0 0.1 1.0 0.0 NS
Rumbling 1.2 0.4 1.5 0.6 1.7 0.9 NS
Bloating 1.3 0.5 1.7 0.8 1.4 0.7 NS
Mean values marked with the same symbol denote significant differences between treatments *p=0.012, 
Ap=0.011) or a trend approaching significance (#p=0.034)
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Compliance expressed as the mean reported proportion o f jellies consumed over the 6 d 
run-in period was 98 [SD 5], 94 [SD  10] and 99 [SD 2] %  o f the supplied jellies for PL, 
inulin and L-Rha respectively.
According to the food diaries, no alcohol was consumed on the day before the study 
day, the provided ready meals were consumed and all participants fasted overnight for 
12 h.
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7.4.8 Compliance with study protocol
Table 7.17 shows the mean energy and macronutrient 24 h intake on the day before the 
study day (Day 6 o f  run in period). N o significant differences were found between 
treatments except CHO intake which was significantly lower with the L-Rha treatment 
(p=0.027) as compared to P L  when analysed by within subject one-way repeated 
measures A N O V A  with post-hoc Bonferroni.
Table 7.17. E l and macronutrient intake on day preceding study day (Day 6 of 
run-in period )1,2
No significant effect o f ND C  treatment on energy and macronutrient intake was found, 
except for CHO intake. Analysis was carried out using within subjects one-way 
repeated measures A N O V A  (n=13).
P L Inulin L-Rha
PMean SD Mean SD Mean SD
Energy (kJ) 8847 1851 8647 2378 7686 1937 NS
Fat (g) 82.6 29.8 80.5 35.8 71.3 24.5 NS
Protein (g) 79.8 21.5 73.4 21.8 75.2 24.5 NS
CHO (g) *266.3 65.5 268.1 69.7 *224.8 71.2 0.024
*Fibre (g) 13.9 3.0 12.7 4.8 12.8 3.1 NS
Alcohol (g) 0.0 - 0.0 - 0.0 - -
1 Data for fibre excluding fibre from supplements
2 Mean values marked with same symbol denote significant differences between treatments ( :|:p<0.027)
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Table 7.18 shows the mean weight, BM I, % body fat and fasting blood metabolite 
concentrations on each study leg.
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7.4.9 Participant characteristics
Table 7.18. Anthropometric measures &  fasting plasma metabolite concentrations 
on each study day.
The weight, B M I and % body fat and blood metabolite concentrations did not differ 
significantly between study days. Analysis was carried out using within subjects one­
way repeated measures A N O V A  (n=13).
P L Inulin L-Rha
Mean SD Mean SD Mean SD P
Weight (kg) 66.8 10.5 67.2 10.4 67.2 10.5 NS
BM I (kgm"2) 22.1 1.4 22.3 1.6 22.3 1.3 NS
Body fat (%) 21.6 6.7 21.7 6.6 21.8 6.3 NS
Plasma glucose (mmol/1) 4.8 0.4 4.9 0.4 4.9 0.4 NS
Total cholesterol (mmol/1) 3.82 0.54 4.00 0.49 3.99 0.67 0.072
HDL-C (mmol/1) 1.44 0.31 1.46 0.32 1.48 0.32 NS
NEFA (mmol/1) 0.59 0.20 0.61 0.28 0.62 0.29 NS
TAG (mmol/1) 1.00 0.40 1.03 0.31 1.05 0.33 NS
Insulin (pmol/ml) 63.2 24.5 66.1 26.7 71.5 35.2 NS
None o f the anthropometric or fasting plasma metabolite concentrations differed 
significantly between each treatment when analysed by one way within-subjects 
repeated measures A N O V A . The total cholesterol concentrations did differ with a trend 
towards significance (p=0.072), however post-hoc bonferroni found no significant 
differences between treatments.
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The present investigation found that N D C  supplementation (with 25.5 g L-Rha or 22.4 g 
inulin HP) served as a split dose alongside a mixed meal served at breakfast (two-thirds 
dose) and lunch (one-third dose) and fo llow ing a 6 d run-in period did not influence 
quantitative and subjective appetite measures, except a treatment x time interaction for 
the desire to eat a meal (p=0.008, during morning) and desire to eat sweet (p=0.036, 
after lunch) to a significant level, and for hunger (p=0.070, during morning) with a trend 
approaching significance. This suggests that neither 25.5 g L-Rha nor 22.4 g inulin HP 
appear to influence appetite when served as a split dose alongside a mixed meal served 
at breakfast (two-thirds dose) and lunch (one-third dose) follow ing a 6 d run-in period.
To our knowledge this is the first study that has examined the influence o f L- 
Rha on appetite regulation. Furthermore there are a number o f design limitations in 
previous investigations into the role o f inulin-type fructans on appetite regulation, and 
effects on inulin HP have not been extensively investigated (reviewed in section 1.8.2).
The present investigation also found that N D C  supplementation resulted in significant 
treatment x time interactions for postprandial plasma insulin (entire study day, 
p=0.009), N E FA  (fo llow ing lunch, p=0.046) and T A G  (fo llow ing breakfast, p=0.006) 
concentrations. This was accompanied by a significant treatment effect and treatment x 
time interaction for postprandial breath H2 levels (p<0.001 for the entire study 
duration), indicating the ND C  had reached the colon and was being fermented.
Post-hoc W ilcoxon analysis o f the insulin IA U C  indicated the postprandial 
insulin response was significantly lower with L-Rha treatment relative to PL, evidenced 
by the IA U C  for L-Rha and P L  differing significantly for first 120 min (p=0.011), and 
with a trend approaching significance for first 180 min (p=0.033), and entire study
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7.5 Discussion
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duration (p=0.023). N o post-hoc differences between inulin and the other treatments 
were found, suggesting inulin did not alter the postprandial insulin response.
The differences between treatment groups for postprandial N E FA  and T A G  
responses were less clear, with post-hoc analysis o f A U C  and IA U C  not finding any 
significant differences. Looking at the timecourse curve, L-Rha appeared to suppress 
the rise in N E FA  concentrations prior to lunch, and concentrations remained suppressed 
following lunch relative to PL  and inulin. However, the postprandial T A G  timecourse 
was elevated both fo llow ing L-Rha and particularly follow ing inulin supplementation 
relative to PL, suggesting a negative impact o f NDC supplementation 011 postprandial 
T A G  concentrations.
Focusing first on the metabolic findings, our findings are in contrast to previous reports 
which found no effects o f L-Rha supplementation on postprandial metabolites. 
However, there is only limited previous data regarding the influence o f L-Rha on 
metabolic parameters, with one published study examining acute (Vogt et al., 2004b) 
and one examining chronic (Vogt et al., 2006) effects, both from the same group. Both 
were 3-way crossover studies delivering a daily dose o f 25 g L-Rha and comparing 
effects to supplementation with 25 g lactulose and 25 g glucose. The acute study only 
collected data on the postprandial glycaemic response (n=22), and found the A U C  for 
the entire study day (0 to 12 h) did not differ between treatments (Vogt et al., 2004b). In 
the chronic study, participants (n = l l )  attended an acute challenge study day after 4 wk 
supplementation during which it was found the A U C  for the entire study day (0 to 12 h) 
did not differ between treatments for postprandial plasma insulin, glucose, N E FA  and 
T A G  responses (Vogt et al., 2006).
However these previous studies (Vogt et al., 2006, Vogt et al., 2004b) were not 
appropriately designed to investigate postprandial effects on plasma insulin, glucose and
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N E FA  concentrations, all o f which change rapidly follow ing a meal, particularly during 
the first 1-2 h. In both studies postprandial blood samples were collected only hourly, 
meaning these rapid changes were not monitored, thereby limiting interpretation. 
Furthermore, glucose was used for the control arm o f the studies, which would be 
rapidly digested and absorbed from the upper G IT  and can therefore be argued as an 
unsuitable control for comparison to L-Rha.
Therefore to our knowledge, the present study is the first to examine effects o f 
L-Rha on postprandial metabolites with regular blood sampling follow ing each meal, 
allowing more detailed analysis o f  metabolic profiles, and explaining why our results 
contrast from previous findings.
It may be postulated that the observed suppression o f postprandial plasma insulin and 
N E FA  follow ing L-Rha supplementation in the present study arose via propionate 
mediated activation o f GPR41 and/or GPR43 in adipose tissue and colonic mucosa (see 
section 1.7). L-Rha is reported to modulate colonic propionate production (Fernandes et 
al., 2000), accompanied by a rise in serum propionate (Vogt et al., 2004b), and 
propionate is the most potent ligand for GPR41. It is therefore conceivable that 
propionate generated from colonic fermentation o f L-Rha interacted with GPR41 and 
GPR43, which are co-expressed with P Y Y , to initiate ileal brake mechanisms (see 
section 1.7.1 and 1.7.3). This would slow the rate o f absorption o f digested nutrients 
into the bloodstream, thereby reducing insulin production rates. However as significant 
effects were seen follow ing breakfast, and breath H2 data indicates L-Rha did not appear 
to reach the colon until 90-120 min postprandially this theory does not provide an 
explanation for effects immediately follow ing breakfast. It is possible colonic 
propionate concentrations at the start o f  the study morning were raised relative to usual 
levels due to the 6 d run-in supplementation period. Effects on plasma N E FA
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suppression may have arisen from propionate mediated activation o f  GPR43 in 
adipocytes, which has been shown in vitro  to inhibit lipolysis (see section 1.7.2).
The lack o f effect o f inulin supplementation on postprandial metabolites in the present 
study agrees with findings from some previous studies, but not others. As reviewed in 
section 1.9.2, only a few  studies have examined postprandial effects o f inulin-type 
fructans (Causey et al., 2000, Forcheron and Beylot, 2007, Parnell and Reimer, 2009, 
van Dokkum et al., 1999, Rumessen et al., 1990), with variable findings. O f these, only 
one included an inulin-type fructan as part o f  the acute challenge mixed test meal 
preload (Parnell and Reimer, 2009), and one included the inulin-type fructan alongside 
bread (Rumessen et al., 1990) thus allowing direct comparison with the present study. 
The other studies used an O G TT challenge following a supplementation period (Causey 
et al., 2000, Forcheron and Beylot, 2007, van Dokkum et al., 1999).
Parnell and Reimer reported that the inclusion o f 21 g OF as part o f a mixed meal acute 
challenge follow ing a 12 wk supplementation period significantly reduced postprandial 
plasma insulin and glucose concentrations (in contrast to findings from the present 
study), with no effect on postprandial lipid responses (in agreement with findings from 
the present study). In the present study a slightly higher dose o f inulin-type fructan 
(22.4 g) than supplied in the Parnell and Reimer study (21 g) was used. However there 
were a number o f  contrasts between the present study and the Parnell and Reimer study, 
in terms o f type o f inulin-type fructan used (inulin HP vs. OF) and the duration o f the 
supplementation period (6 d vs. 12 wk), both o f which may explain the differing 
findings. This suggests it is possible that when consumed habitually and included as 
part o f a mixed meal, OF may improve postprandial insulinaemia (Parnell and Reimer, 
2009). The long term effects o f inulin HP supplementation on postprandial metabolic 
responses are unknown. Inulin HP has the benefit o f being associated with less adverse
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G IT  symptoms than OF (Bruhwyler et al., 2008), therefore long term effects o f inulin 
HP could warrant further investigation.
Rumessen and colleagues found an acute challenge with a 10 g OF/inulin 
mixture alongside wheat bread significantly lowered the plasma glucose IA U C  in 
comparison to bread with no OF/inulin (Rumessen et al., 1990). This evidence along 
with results from Parnell and Reimer and from the present study suggest the presence o f 
the low  DP inulin-type fructans (O F ) rather than high DP inulin (as used in the present 
study) may be necessary to alter postprandial metabolic response.
Focusing now on the lack o f effect on appetite in the present study, the only previously 
published data on the effect o f inulin HP on appetite was an acute crossover study 
(n=33). In this study, 24 h E l was significantly lower follow ing a muffin and sausage 
pattie preload containing 24 g inulin HP than following P L  (no N D C ) (Archer et al., 
2004), which is in contrast to the present study, although rated satiety was not 
influenced. However subjective appetite ratings were only monitored for 225 min 
postprandially, which is insufficient to assess fermentation effects, and were measured 
using a single continuous scale questionnaire rather than VAS . Quantitative appetite 
effects were assessed solely with a 24 h weighed food record with no measurements o f 
intake o f an ad libitum  test meal. Furthermore the preloads were not isoenergetic, as the 
P L  had a higher fat and therefore E content than the inulin preload.
Therefore although the lack o f effect o f inulin HP on 24 h intake in the present 
study did not agree with the findings o f Archer and colleagues, as the preloads in the 
Archer study were not isoenergetic, it is difficult to differentiate effects o f inulin HP 
from those o f fat and E content. This suggests the findings from the present study are 
more valid. However the present study had a smaller sample size, and may be 
underpowered for E l and macronutrient intake assessment.
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One other study may have investigated a high DP inulin, as the type o f inulin was not 
specified in the paper (Perrigue et al., 2009) (discussed below). However that study 
investigated a much lower dose o f inulin (8 g) than the present study and only 
monitored effects for 2 h follow ing the preload, therefore the results are not comparable 
to the present study.
Quantitative appetite measures assessed in the present study included E l at an ad libitum  
buffet meal provided 7 h postprandially, total 24 h E l on the study day and mean 24 h 
intake over 3 d during the run-in, none o f which were altered by treatment with 25.5 g 
L-Rha or 22.4 g inulin HP.
As far as we are aware the present study is the first to appropriately measure 
quantitative effects on appetite by measuring ad libitum  intake o f a test meal follow ing 
a high DP inulin-containing preload using the “ preload-test meal”  paradigm in a 
controlled setting (reviewed in section 1.4.2) (Stubbs et al., 1998).
Only two other studies have fo llowed the “ preload-test meal”  method to investigate 
effects o f inulin-type fructans on appetite (Perrigue et al., 2009, Peters et al., 2009), 
both acute studies. Peters and colleagues reported ad libitum  E l at a test meal 4 h 
follow ing a OF-containing meal replacement bar preload did not differ from P L  (Peters 
et al., 2009). However, Peters and colleagues used a low  DP inulin-type fructan in a 
much lower dose (8 g) than the present study (14.9 + 7.5 g). The overall energy content 
o f the test preload was only 190 kcal, which is lower than a usual breakfast E l and may 
override effects on appetite. A lso, the buffet meal was served much earlier than in the 
present study, thereby missing the peak stages o f fermentation, and participants were 
allowed to leave the clinical unit in between the preload and the test meal.
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The other study to fo llow  a “preload-test meal”  method found ad libitum  EI at a test 
meal 2 h following a low  and high E yogurt preload (180 and 440 kcal respectively) 
with 6 g added inulin (D P  not specified) was significantly lower than when no preload 
was supplied (P L ) but did not differ from EI following the yogurts with no inulin 
(Perrigue et al., 2009). However, this study was not designed to investigate fermentative 
effects o f inulin, as the test meal was supplied only 2 h follow ing the preload, giving 
insufficient time for inulin to reach the colon. A lso the dose used was very low  
compared to the present study.
Effects o f inulin-type fructans on ad libitum  intake at a buffet meal has also been 
investigated by Cani and colleagues (Cani et al., 2006a, Cani et al., 2009). However 
neither o f these followed the “preload-test meal”  paradigm and instead measured intake 
follow ing a 2 wk supplementation period with no acute inulin-type fructan challenge on 
the study days. Therefore neither study design is comparable to that in the present study.
Looking in more detail now at the subjective appetite data, as stated above, no 
significant treatment effects were found for any appetite measures, and treatment x time 
interactions were only found during the morning for desire to eat a meal (p=0.008) and 
hunger (p=0.070) and fo llow ing lunch for desire to eat sweet (p=0.036), with hunger 
(p=0.070, during morning). This lack o f effect for both inulin HP and L-Rha agrees with 
previous investigations into subjective appetite effects fo llow ing an inulin HP preload 
(Archer et al., 2004). However the present investigation was underpowered for 
subjective V A S  data, due to the fairly low  sample size (n=13). Flint and colleagues 
suggest 20 participants should be recruited to a crossover study to detect a 5 mm 
difference in mean 4.5 h fullness ratings. However, as the p values were far from 
significance for many o f the parameters examined it is unlikely that a larger sample size 
w ill have detected further significant differences.
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As discussed earlier in this thesis (see section 1.11) an important consideration for 
appetite investigations is test product palatability. The L-Rha mousse was rated as less 
acceptable than the inulin and P L  mousses, with the L-Rha products having the lowest 
rating scores both for taste and texture at breakfast and lunch. There was a significant 
treatment influence on taste ratings at breakfast (p=0.011), but not at lunch and the 
texture rating was significantly influenced at lunch (p=0.050) and influenced with a 
trend towards significance at breakfast (p=0.073). Aftertaste was not influenced by 
treatment. However the mean rating scores were still fairly high for the L-Rha mousses 
58 [SD 21] and 69 [SD 19] for taste, and 59 [SD 21] and 63 [SD 20] for texture for 
breakfast and lunch respectively, with 0 being not at all pleasant and 100 being 
extremely pleasant. This suggests that although the L-Rha mousses were considered less 
pleasant than the inulin and P L  mousses, they were still not considered to be unpleasant. 
Furthermore, daily taste ratings o f  the jellies provided during the run-in were not 
significantly influenced by addition o f N D C  supplement. However it is still possible 
that the lower palatability o f the L-Rha mousse may have influenced appetite.
Data collected on gastrointestinal symptoms during the study suggest the inulin and L- 
Rha supplements were fairly well tolerated. Daily symptom ratings for flatulence were 
significantly higher follow ing inulin than P L  (p=0.012) and L-Rha (p=0.001), and 
stomach pain was also influenced by treatment with a trend approaching significant 
(p=0.069), with a higher A U C  follow ing inulin than L-Rha (p=0.034) and P L  (NS). 
None o f the other ratings (fo r diarrhoea, constipation, belching, nausea, acid reflux, 
heartburn, rumbling stomach or bloating) were influenced by treatment.
On study days, the mean V A S  rating scores for G IT  symptoms were low  (<25 
mm) for all parameters and only the A U C  for urge to defacate (p=0.046) and stomach 
discomfort (p=0.046) were influenced significantly by treatment. Both were highest
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fo llow ing L-Rha, although this was only significant for urge to defacate (p=0.007) 
relative to PL. None o f  the ratings were significantly influenced by inulin, although 
stomach discomfort was higher with a trend approaching significance (p=0.039, post- 
hoc W ilcoxon).
These findings are in agreement with a recent study that found inulin-type 
fructans consumed at a level o f 5-20g per day for 2 weeks were well tolerated 
(Bruhwyler et al., 2008).
Compliance with consuming jellies during the run-in period was good according to the 
monitoring diaries. Ideally compliance would have been assessed by monitoring the 
number o f je lly  containers returned, however logistically this was not practical. The fact 
that daily gastrointestinal symptoms and fasting breath H2 concentrations were higher 
with inulin treatment suggests participants had consumed the jellies.
7.6 Conclusion
In summary, the current investigation found that supplementation with 25.5 g L-Rha 
supplied as a split dose alongside a mixed meal at breakfast (two-thirds dose) and lunch 
(one-third dose) fo llow ing a 6 d run-in period acutely reduced the postprandial 
insulinaemic response, significantly so for 2 h follow ing breakfast (p=0.011, post-hoc 
W ilcoxon), and with a trend approaching significance for the entire 7 h study day 
(p=0.023, post-hoc W ilcoxon) relative to PL. It also appears to suppress postprandial 
N E FA  concentrations, evidenced by a significant treatment x time interaction (p=0.046, 
fo llow ing lunch). This was accompanied by a significant increase in postprandial breath 
H2 concentrations, indicative that colonic fermentation occurred.
It was also found that 22.4 g o f  a high DP inulin supplement (inulin HP) did not 
significantly alter any o f postprandial metabolic measures monitored.
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The present study is the first to examine effects o f L-Rha on postprandial metabolites 
with regular blood sampling. This is in contrast to previous studies that took samples at 
hourly intervals and found no effect o f L-Rha on postprandial metabolites (Vogt et al., 
2006, Vogt et al., 2004b). W e postulate that observed effects may have been mediated 
by propionate generated during colonic fermentation o f the L-Rha activating GPR41 
and GPR43 SCFA receptors in the colonic mucosa and in adipocytes to modulate P Y Y  
production and suppress lipolysis respectively.
The other important finding from the present study was that neither the L-Rha nor the 
inulin HP supplements appeared to influence appetite, as assessed using subjective 
(V A S ) and quantitative (ad libitum  intake 7 h postprandially, 24 h intake, mean daily 
intake during run-in) measures, except V A S  ratings for the desire to eat a meal 
(p=0.008, during morning) and desire to eat sweet (p=0.036, after lunch). This lack o f 
effect may be explained due to the study being underpowered, however as the p values 
were far from significant for most parameters, a larger sample size is unlikely to have 
detected further significant differences.
To  our knowledge, this is the first study to investigate effects o f L-Rha 
supplementation on appetite, and is also the first to investigate quantitative effects o f 
high DP inulin on appetite with the “preload-test meal”  paradigm for 7 h postprandially.
Overall, the findings from the present study are suggestive that L-Rha may influence 
postprandial metabolites, in particular plasma insulin and NEFA. This finding may 
warrant further investigation to look at effects o f supplementation on insulin sensitivity 
measured in a clinical setting. However, our findings do not support a role for L-Rha 
nor inulin HP in regulating appetite, although it is possible that this finding is in part 
due to a short supplementation period and a low  sample size.
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Chapter 8. General discussion
The clinical studies described within this thesis were designed to investigate the role o f 
SCFA  in modulating appetite and the metabolic response in different parts o f the GIT. 
Three studies investigated the role o f orally delivered SCFA to the upper G IT (Chapters 
3-5) and one study investigated the role o f  colonically derived SCFA generated via 
fermentation o f ND C (Chapter 7). W ork was also carried out to determine if  tethering 
specific SCFA to an N D C  scaffold can modulate colonic production o f that specific 
SCFA follow ing ingestion (Chapter 6). The discussion herein w ill draw together the 
main findings from this work.
8.1 Overview of main findings
8.1.1 Orally delivered SCFA
Three o f the clinical studies reported within this thesis were designed to investigate the 
role o f orally delivered SC FA  on appetite regulation (Chapters 3-5), follow ing on from 
previous work primarily carried out by Bjorck and colleagues. These previous studies 
found supplementation with SCFA  (propionate, acetate and lactate) acutely reduced 
glycaemia and insulinaemia and increased satiety postprandially (Darwiche et al., 2001, 
H lebowicz et al., 2007, H lebowicz et al., 2008, Johnston and Buller, 2005, Johnston et 
al., 2004, Liljeberg and Bjorck, 1998, Liljeberg and Bjorck, 1996, Liljeberg et al., 1995, 
Ostman et al., 2005, Sugiyama et al., 2003) (reviewed in Chapter 1, sections 1.10.1 and 
1.11.1). However conclusions regarding effects o f oral SCFA on satiety were solely 
based on results from a single bipolar rating scale, with no quantitative assessment o f 
appetite, thus warranting further investigation. Furthermore, palatability o f test prodcts 
were not controlled for.
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In the first study, reported in Chapter 3, it was found that a palatable propionate-rich 
sourdough bread delivering 6.0 mmol propionate ingested as part o f  a standard breakfast 
did not acutely influence postprandial appetite or plasma glucose or T A G  levels and that 
it may even worsen postprandial insulinaemia, contrary to previous findings.
By contrast, the next study, reported in Chapter 4, found that supplementation with 25 
mmol acetic acid (supplied within white wine vinegar) alongside a standard breakfast 
significantly increased satiety postprandially, indicated by both postprandial subjective 
appetite V A S  ratings and quantitative measures o f appetite, and significantly reduced 
postprandial glycaemia. However, the results indicated the unpleasant taste o f the 
vinegar-containing product may have influenced these outcomes, possibly via cephalic 
phase mechanisms. This was evidenced by effects on subjective appetite ratings and 
quantitative appetite measures being greater fo llow ing Unpal treatment compared to Pal 
treatment. Nausea ratings were additionally significantly higher follow ing Unpal than 
Pal. There also were medium to strong correlations between palatability ratings and 
appetite parameters. These findings in combination with the lack o f effect on satiety 
following oral ingestion o f propionate in a palatable form (study reported in Chapter 3) 
is also suggestive o f a role for palatability, although far lower quantities o f SCFA were 
used in the study reported in Chapter 3. However it was not possible to ascertain i f  
palatability was the sole cause o f observed effects.
Following on from these findings, the study reported in Chapter 5 aimed to determine 
the role o f palatability o f SCFA-containing products in modulating effects on appetite 
and the metabolic response with the use o f  the M SF technique. This study found that 
orosensory stimulation with a vinegar-containing drink (as a source o f acetate) 
follow ing a milkshake preload did not significantly alter postprandial glycaemia,
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insulinaemia or quantitative appetite measures relative to PL, although it did reduce 
postprandial V A S  ratings, some significantly. O f note, hunger, the desire for a snack 
and the desire to eat something salty were significantly reduced over the entire study 
duration, and prospective consumption and the desire to eat a meal were significantly 
reduced over the first 90 min o f the study. This led to the conclusion that while 
orosensory stimulation with an acetate-containing product may transiently reduce 
subsequent appetite ratings, these effects are not as strong as when vinegar is ingested. 
This suggests that while the unpleasant taste o f the vinegar-product in the oral cavity 
appears to influence appetite at least transiently, this may not be the only reason for a 
reduced appetite follow ing vinegar ingestion. Possible additional explanations may 
include increased nausea follow ing ingestion or ‘tasting’ o f the acetate by taste 
receptors located in the upper GIT.
It is also o f course possible that SCFA  have a physiological effect in addition to the 
effect o f palatability, and that the the lack o f effect in the first study (Chapter 3) was due 
a lower dose o f propionate being delivered in comparison to previous studies, meaning 
it did not reach the required threshold for an effect.
To explore this possibility further, it is necessary to supply higher quantity o f 
SCFA in a palatable form, which is a difficult, i f  not impossible proposition.
8.1.2 Colomcally delivered SCFA
In addition to considering the effects o f orally delivered SCFA, the effects o f colon- 
derived SCFA on appetite and the metabolic response were investigated as reported in 
Chapter 7. It was initially planned to investigate the effects o f colon-derived propionate 
via the provision o f propionate tethered to an insulin scaffold (inulin propionyl ester
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(IPE )) as part o f a 4-way crossover study in comparison to the ND C  L-Rha and inulin 
HP and to PL.
Unfortunately part way into this study, it was necessary to stop running the IPE part o f 
the investigation due to supply and QC problems and the investigation became a 3-way 
crossover study (25.5 g L-Rha vs. 22.4 g inulin HP v\s. PL). The study was still novel as 
there is a lack o f  good quality data investigating the effects o f  high DP inulin-type 
fructans on appetite and the metabolic response. There is also no published data 
investigating the role o f L-Rha, an ND C previously demonstrated to enhance colonic 
propionate production (Fernandes et al., 2000, Vogt et al., 2004b), in appetite 
regulation.
This study found no effect o f supplementation with the either o f the fermentable NDC 
investigated (L-Rha and high DP inulin) on satiety. This was the case for subjective and 
quantitative measures o f appetite. These finding therefore do not support a case for 
colonically derived SCFA influencing appetite.
There was however the interesting finding that supplementation with L-Rha 
significantly suppressed the postprandial plasma insulin and N E FA  response relative to 
PL. This finding was in contrast to previous reports that found no effect o f  L-Rha 
supplementation on postprandial plasma metabolites (Vogt et al., 2006, Vogt et al., 
2004b) when supplied in a similar dosage to the study reported in this thesis. The lack 
o f effect in those previous studies was explained follow ing closer examination o f the 
data which revealed that postprandial blood sampling was only hourly thereby missing 
the rapid changes that occur fo llow ing a meal (Vogt et al., 2006, Vogt et al., 2004b).
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Supplementation with the high DP inulin did not significantly alter postprandial plasma 
metabolites. This is in contrast to published data in which an acute challenge with a 
meal including inulin-type fructans was reported to significantly lower postprandial 
glycaemia (Parnell and Reimer, 2009, Rumessen et al., 1990) and insulinaemia (Parnell 
and Reimer, 2009). However in both these studies OF was included, suggesting a low 
DP inulin-type fructan may be necessary to alter the postprandial metabolic response.
Prior to commencing this investigation, the effectiveness o f  IPE in enhancing 
propionate production was explored in a separate dose-response study reported in 
Chapter 6, in which 24 h urinary propionate levels were measured as a proxy indication 
o f body propionate levels. However the findings from this study were inconclusive. 
There were no obvious dose-response effects, and it was not clear i f  the lack o f effect 
was due to weaknesses in the analytical method or i f  the IPE was ineffective in 
enhancing propionate production. It had therefore been planned to collect serum 
samples to acutely monitor the appearance o f propionate follow ing ingestion o f IPE, 
however due to the problems with the IPE in the subsequent study this was not possible.
8.2 Study limitations
There were a number o f limitations with the studies reported in this thesis.
O f importance are the methods used to investigate appetite. Eating behaviour is 
regulated by a complex and multidimensional array o f factors, as reviewed in Chapter 1 
(section 1.3). Therefore experimentally it is not straightforward to assess effects on 
appetite. The use o f  a battery o f  V A S  regarding different aspects o f  appetite completed 
in a controlled laboratory setting used in conjunction with quantitative measures o f  
appetite are considered to be one o f the more validated and robust methods to
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investigate effects on appetite. However these methods are not without limitation, not 
least in terms o f the validity o f  findings when applied to a free-living setting and also 
the difficulty in controlling for the influence o f psychological factors such as a 
participant’ s mood on a study day. Furthermore Stubbs and colleagues consider that 
V A S  are not necessarily sensitive to relatively modest manipulations in an intervention 
(Stubbs et al., 2000). This therefore raises the question does a lack o f effect on rated 
appetite with the use o f V A S  imply a lack o f effect on appetite? However in the absence 
o f any better methods, the use o f  appetite V A S  in conjunction with quantitative appetite 
measures still remains the best method to investigate appetite.
A  potential confounder in the studies reported in this thesis is that blood samples 
were being collected at the same time as appetite being measured, which w ill have 
influenced appetite. However as the studies are all crossover studies, it is probable that 
the influence o f this effect w ill have been minimised, apart from when there were 
particular difficulties with blood sampling (e.g. difficulties in obtaining blood and the 
need to manipulate or replace cannulae in order to collect blood).
Furthermore, postprandial gut peptides concentrations were not measured in the 
studies reported in Chapters 3 and 7, despite blood samples being collected for this 
purpose. It would have added to the data enabling a fuller picture o f effects, however 
the high cost o f analysis could not be justified in view  o f the lack o f effect on subjective 
and quantitative appetite measures.
The studies reported in this thesis were also under-powered for assessment o f subjective 
and quantitative appetite measures, although not greatly so. Data from previous work by 
our group suggests 22 participants are required to detect a significant difference in ad 
libitum  intake at 80% power with significance assumed at a level o f p<0.05 (Bodinham
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et al., 2010). Arvanti and colleagues (2000) have also reported that 17 participants are 
required to detect a 500 kJ difference in a crossover design study with a power o f 0.8.
In terms o f subjective appetite assessment Flint and co-workers (2000) suggest 
at least 20 participants should be recruited to detect a 5 mm difference in mean 4.5 h 
fullness ratings (Flint et al., 2000).
However, it is likely that more participants than this would be required in three- 
way crossover studies, such as the studies reported in Chapters 4 and 7.
Data generated from diet diaries is also not without limitations. These include under­
reporting due to forgetting / not bothering to write foods down and not wishing to seem 
greedy, altering food choices to appear more healthy or to make it easier to note in the 
food diary, difficulties for the investigator in interpreting portion sizes, inadequate 
descriptions o f food choices (although this was minimised in the studies reported in this 
thesis by going through the food diaries with participants when possible) and limitations 
in food composition databases in terms o f choice and differences between recipes for 
seemingly the same foods. Therefore again data generated from diet diaries need to be 
interpreted with these limitations in mind.
Looking in more detail at the fermentable N D C  crossover study reported in Chapter 7, it 
would have been preferable to have had a longer run-in period than 6 d prior to each 
study day. The rationale for the 6 d run-in was to allow the G IT  to adapt to the dose 
given on study days, and to identify any participants with tolerance problems. A  longer 
run-in period would have been required to result in physiological alterations within the 
gut. However the main limiting factor in the crossover study was the quantity o f L-Rha 
available, as it was expensive, so it was not possible to offer a longer run-in without 
reducing the sample size.
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A  further limitation in this study was that it was necessary to drop the IPE leg, 
so the effectiveness o f  the IPE to modulate plasma propionate production alongside a 
suppressed appetite and metabolic response was not investigated as had initially been 
planned.
An original aim o f the studies reported in Chapters 3 and 7 was to monitor the 
postprandial appearance o f SCFA into the peripheral circulation to determine i f  the 
propionate-rich sourdough bread and the IPE, L-Rha and inulin HP modulated plasma 
concentrations o f propionate and other SCFA. Attempts were made to set up an 
analytical method for plasma SCFA (findings not reported). However it unfortunately 
proved difficult to set up and validate an accurate method within the time and budget 
available, largely due to difficulties in analysing plasma SCFA in the very low 
concentrations that occur in peripheral blood. It was therefore not possible to determine 
i f  and when plasma SCFA  concentrations were altered by the intervention.
Finally, all the clinical studies reported in this thesis included female participants. 
Efforts were made to control for the hormonal changes that occur throughout the 
menstrual cycle in the studies reported in Chapters 3 and 7. This was not possible for 
the studies reported in Chapters 4 and 5 due to practical and logistical considerations. 
However, as study days were very close to each other in both these studies, the 
influence o f these effects were minimised. Furthermore, a large proportion o f the female 
participants were using oral contraceptives or the implant in the study reported in 
Chapters 4, which would have regulated the hormonal levels.
A  further consideration is the how representative the recruited participants were 
o f the general population. For example, a number o f the participants were nutrition
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students who have a particular interest in food, which may have biased the appetite 
results.
8.3 Overall conclusions
Overall, the data reported within this thesis does not support a role for orally delivered 
or colonically derived SCFA  in regulating appetite, with no effects on appetite 
follow ing ingestion o f a meal made with a palatable sourdough bread delivering 6 mmol 
propionate (Chapter 3) nor fo llow ing supplementation with fermentable ND C  (Chapter 
7). However the data was not entirely conclusive, as supplementation with 25 mmol 
acetate significantly increased satiety, with a greater effect fo llow ing delivery in an 
unpalatable form relative to a more palatable form (Chapter 4). Discrepancies between 
findings from the oral SCFA supplementation studies may be explained by product 
palatability or the SCFA  dose or both, and further work is required to investigate this.
Data from the M SF study (Chapter 5) suggests that while the unpleasant taste o f 
the vinegar-product in the oral cavity has a transient effect, this may not be the only 
reason for a reduced appetite follow ing vinegar ingestion. Possible additional 
explanations include increased nausea fo llow ing ingestion or ‘tasting’ o f  the acetate by 
taste receptors located in the upper GIT. It is also possible that the M SF vinegar drink 
was not sufficiently ‘unpleasant’ to participants as nausea ratings were not high 
compared to oral delivery o f the vinegar drink, making data from the M SF study 
inconclusive.
Further work is required to determine unpick the role o f palatability relative to 
the dose o f  SCFA being provided.
The picture for metabolic effects o f SCFA  is less clear. W hile oral supplementation 
with acetate significantly reduced the acute glycaemic response (Chapter 4), palatable
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propionate-rich sourdough bread did not significantly alter postprandial glycaemia and 
appeared to worsen postprandial insulinaemia (Chapter 3). Again these discrepancies 
may be explained by product palatability or the SCFA dose or both, and further work is 
required to investigate this. M SF with a vinegar-drink did not significantly alter 
postprandial glycaemia and insulinaemia (Chapter 5), suggesting palatability did not 
have an influence, although this study was not entirely conclusive due to the lack o f 
effect o f the intervention on nausea ratings.
Colon-derived SCFA had differing metabolic effects depending on the NDC 
source. Supplementation with the propionate-generating N D C  L-Rha significantly 
suppressed postprandial plasma insulin and N E FA  concentrations, while inulin HP had 
no effect.
8.4 Future work
Looking first at the studies reported in this thesis, i f  the budget was available it would 
enhance interpretation o f the data i f  postprandial plasma concentrations o f appetite 
related gut peptides were analysed in the plasma samples collected for the studies 
reported in Chapters 3 and 7. This would allow an evaluation o f physiological measures 
o f appetite as well as subjective and quantitative measures.
Furthermore, i f  a suitable method is developed, it would be interesting to 
quantify postprandial plasma SCFA levels in samples collected in the same studies (in 
Chapters 3 and 7), to determine i f  the interventions successfully modulated SCFA 
concentrations.
Finally, as it was necessary to drop the IPE leg in the fermentable ND C study 
(Chapter 7), this is still an area that remains to be investigated.
Julia Darzi Thesis
262
Looking now at studies to fo llow  on from findings in the present thesis, as L-Rha was 
found to significantly suppress postprandial plasma insulin and N E FA  concentrations 
(Chapter 7), further work could be carried out to investigate this. For example effects on 
insulin sensitivity in participants with the metabolic syndrome measured either by 
intravenous glucose tolerance test (IV G T T ) or insulin tolerance test (IT T ) following 
chronic supplementation. In addition an acute challenge study day could be included to 
monitor postprandial effects on plasma glucose, insulin and C-peptide.
It also appears that low DP inulin (O F) is more likely to suppress postprandial 
insulinaemia and glycaemia than the high DP inulin (inulin H P) used in the study 
reported in this thesis (Chapter 7). However despite a fairly large number o f published 
studies exploring metabolic effects o f inulin-type fructans, the majority o f  these 
previous studies have only reported effects on fasting parameters follow ing a period o f 
supplementation (reviewed in section 1.9.2). Only a limited number investigated 
postprandial effects (Causey et al., 2000, Forcheron and Beylot, 2007, Parnell and 
Reimer, 2009, Rumessen et al., 1990, van Dolckum et al., 1999), o f  which only two 
carried out an acute challenge (Parnell and Reimer, 2009, Rumessen et al., 1990). This 
lack o f data therefore warrants further investigation to measure postprandial effects on 
plasma glucose, insulin and lipids follow ing an acute challenge.
As data on the role o f palatability o f  oral SCFA in postprandial effects on appetite and 
the metabolic response is inconclusive, due to the differences in doses used in the SCFA 
supplementation studies (Chapters 3 and 4) and also as the vinegar intervention in the 
M SF did not significantly influence nausea ratings, further work is required. It is not an 
easy task to supply a large SCFA dose in an palatable, non-invasive form.
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One possibility is to bypass the mouth, thereby eliminating orosensory stimulation, 
thereby just observing the physiological effects o f  SCFA in the GIT. This could be 
achieved via gastric infusion o f an SCFA  solution (propionate or acetate) vs. saline 
alongside a standard oral preload. A  less invasive option is to encapsulate SCFA and 
ingest these capsules alongside a mixed meal compared to ingestion o f P L  capsules. 
However a large quantity o f  capsules would need to be ingested to deliver similar 
quantities o f SCFA  used in previous studies.
Alternatively, the M SF study reported in Chapter 5 could be repeated, this time using a 
solid mixed meal (rather than a liquid milkshake) preload, with the M SF phase 
occurring prior to ingestion o f  the meal. The study duration could also be shorter 
(possibly 2 h postprandially) to determine i f  there are orosensory influences ealier in the 
postprandial phase. It would be worthwhile strengthening the vinegar-containing drink 
to attempt to adversely influence nausea ratings.
A  further interesting and easy study that could be carried out is to investigate the 
satiating effects o f  SCFA, for example by adding increasing concentrations o f vinegar 
to a soup and measuring the ad libitum  intake o f the soup.
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ARRendgxC: Dutch Eating Behaviour Questionnaire
Please answer the follow ing questions as carefully and honestly as possible. 
Read each question and simply fill in the column which best applies to you.
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1. I f  you have put on weight, do you eat less than you usually do?
2. Do you have a desire to eat when you are irritated?
1
3. I f  food tastes good to you, do you eat more than you usually do?
4. Do you try to eat less at meal times than you would like to eat?
5. Do you have a desire to eat when you have nothing to do?
6. Do you have a desire to eat when you are depressed or discouraged?
7. I f  food smells and looks good, do you eat more than you usually eat?
8. How often do you refuse food or drink offered because you are concerned about your 
weight?
9. Do you have a desire to eat when you are feeling lonely?
10. I f  you see or smell something delicious, do you have a desire to eat it?
11. Do you watch exactly what you eat?
12. Do you have a desire to eat when somebody lets you down?
13. I f  you have something delicious to eat, do you eat it straight away?
14. Do you deliberately eat foods that are slimming?
15. Do you have a desire to eat when you are cross?
16. Do you have a desire to eat when you are approaching something unpleasant to happen?
17. I f  you walk past the baker do you have a desire to buy something delicious?
18. When you have eaten too much, do you eat less than usual the following days?
19. Do you get a desire to eat when you are anxious, worried or tense?
20. I f  you walk past a snack bar or cafe, do you have a desire to buy something delicious?
21. Do you deliberately eat less in order not to become heavier?
22. Do you have a desire to eat when things are going against you, or things have gone 
wrong?
23. I f  you see others eating, do you have also the desire to eat?
24. How often do you try not to eat between meals because you are watching your weight?
25. Do you have a desire to eat when you are frightened?
26. Can you resist eating delicious food?
27. How often in the evening do you try not to eat because you are watching your weight?
28. Do you have a desire to eat when you are disappointed?
29. Do you eat more than usual when you see other eating?
30. Do you take your weight into account when you eat?
31. Do you have a desire to eat when you are emotionally upset?
32. When preparing a meal are you inclined to eat something?
33. Do you have a desire to eat when you are bored or restless?
292
Participants were given a V A S  answer booklet with each question presented on a 
separate page.
Appendix D : V A S  to assess appetite and nausea
Answer the follow ing questions by placing a vertical mark through the line for each 
question. Mark the line according to how you feel at this moment. Regard both the 
ends o f the lines as indicating the most extreme sensations von have ever felt.
H ow  hungry do you feel?  T hav„
I am not . b J , 1 liave
hungry at all ' never been
more hungry
H ow  fu ll do you feel?
Not at all full |   1 Extremely full
H ow  much do you think you can eat?
Nothing at all |----------------------------------------------------------------------i A  lot
H ow  strong is your desire to eat a meal?
Not at all strong |----------------------------------------------------------------------1 Extremely strong
H ow  strong is your desire to eat a snack?
Not at all strong |----------------------------------------------------------------------1 Extremely strong
W ou ld  you like to eat something salty/savoury/sweet?
No, not at all |----------------------------------------------------------------------1 Yes, very much
H ow  nauseous do you feel?
Not at all j | Extremely
nauseous nauseous
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Appendix E: VA S  to assess gastrointestinal symptoms 
Participants were given a V A S  answer booklet with each question presented on a 
separate page.
Answer the follow ing questions by placing a vertical mark through the line for each 
question. Mark the line according to how you feel at this moment. Regard both the 
ends o f the lines as indicating the most extreme sensations you have ever felt.
Have you experienced any flatulence in the past hour?
No, none at all |--------------------------------------------------------------------------- 1 Yes, a lot
Have you experienced any diarrhoea in the past hour?
No, not at all | 1 Yes, a lot
Did you experience any bloating in the past hour?
No, none at all |--------------------------------------------------------------------------- 1 Yes, a lot
Have you needed to belch/burp in the past hour?
No, not at all | 1 Yes, a lot
Have you experienced any stomach discomfort
. in the past hour? .
No, none at all | —  1 Yes, a lot
Have you had the urge to defacate in the past hour?
No, not at all | 1 Yes, a lot
Have you experienced heartburn over the past hour?
No, none at all |--------------------------------------------------------------------------- 1 Yes, a lot
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Appendix F : Exam ple Sensory Evaluation Questionnaire
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Appendix G: Calculations for pentose/liexose equivalents used for N D C  dose in 
Chapter 7
It has been estimated by Cani and colleagues (2004) that there are 25 hexose &  pentose 
units per mole o f inulin HP and there are 1 hexose/pentose units per mole o f L-Rha 
monohydrate.
Based on this, the daily dose o f inulin HP for the study reported in Chapter 7 was 
calculated to match the hexose &  pentose equivalents o f the L-Rha dose given in 
previous studies (Vogt et al., 2004a, Vogt et al., 2004b, Vogt et al., 2006). In these 
previous studies, participants were supplied with 25 g L-Rha monohydrate.
The dose for inulin HP was calculated by first determining the molar hexose equivalents 
per 1 g o f NDC, knowing the molecular mass (M r) is 4073 g / mole:
Molar pentose &  hexose equiv per 1 g = (1/Mr)*  hexose &  pentose equivs per mole
Molar pentose &  hexose equiv per 1 g inulin HP = (1/4073) * 25
= 0.00614 molar equivs / g
The dose o f inulin HP required to match a 25 g dose o f L-Rha monohydrate (M r = 
182.11) was then determined by the follow ing calculation:
g inulin HP dose required to match a 25 g dose o f L-Rha
=  (molar pentose &  hexose equiv per 1 g inulin HP / molar pentose &  hexose equiv per 
1 g L-Rha) * 25
= (0.00614/(1/182.11)) * 25 = 24.3 g
The daily dose o f L-Rha monohydrate supplied in the study reported in Chapter 7 was 
actually 25.5 g to compensate for the L-Rha provided being 98 % pure.
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Appendix H : Daily  Compliance and Gastrointestinal Symptom D iary
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Appendix I: L o w  F ibre Diet Sheet
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